0000950170-24-079718.txt : 20240701 0000950170-24-079718.hdr.sgml : 20240701 20240701165528 ACCESSION NUMBER: 0000950170-24-079718 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240701 DATE AS OF CHANGE: 20240701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cineverse Corp. CENTRAL INDEX KEY: 0001173204 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-VIDEO TAPE RENTAL [7841] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 223720962 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31810 FILM NUMBER: 241091488 BUSINESS ADDRESS: STREET 1: 224 W. 35TH ST. STREET 2: SUITE 500, #947 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-206-8600 MAIL ADDRESS: STREET 1: 224 W. 35TH ST. STREET 2: SUITE 500, #947 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Cinedigm Corp. DATE OF NAME CHANGE: 20130925 FORMER COMPANY: FORMER CONFORMED NAME: Cinedigm Digital Cinema Corp. DATE OF NAME CHANGE: 20091006 FORMER COMPANY: FORMER CONFORMED NAME: Access Integrated Technologies, Inc. d/b/a Cinedigm Digital Cinema Corp. DATE OF NAME CHANGE: 20081202 10-K 1 cnvs-20240331.htm 10-K 10-K
FYFalseFalse0001173204FalseFalsefalse0001173204cnvs:OTTStreamingandDigitalMember2023-04-012024-03-310001173204us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012023-03-310001173204us-gaap:FairValueInputsLevel3Member2023-03-310001173204us-gaap:RevolvingCreditFacilityMembercnvs:EastWestBankMember2023-03-310001173204srt:MaximumMembercnvs:ExercisePriceRangeTwoMember2024-03-310001173204cnvs:OptionsExercisableMember2023-04-012024-03-310001173204srt:MinimumMemberus-gaap:CustomerRelationshipsMember2024-03-310001173204cnvs:ExerciseOfPreFundedWarrantsMember2023-07-012023-07-310001173204us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012024-03-310001173204us-gaap:FairValueInputsLevel1Member2024-03-310001173204us-gaap:AdditionalPaidInCapitalMember2024-03-310001173204us-gaap:SeriesAPreferredStockMember2023-03-310001173204cnvs:EquityIncentivePlanMember2023-04-012024-03-310001173204us-gaap:CustomerRelationshipsMembersrt:MaximumMember2024-03-310001173204cnvs:BloodyDisgustingLLCMember2024-03-3100011732042020-03-310001173204us-gaap:NoncontrollingInterestMember2022-04-012023-03-310001173204us-gaap:PropertySubjectToOperatingLeaseMember2024-03-3100011732042023-06-140001173204srt:MaximumMembercnvs:ExercisePriceRangeOneMember2024-03-3100011732042021-03-310001173204cnvs:ExercisePriceRangeTwoMember2024-03-310001173204us-gaap:AdditionalPaidInCapitalMember2023-03-310001173204us-gaap:FairValueInputsLevel3Member2024-03-310001173204cnvs:ExercisePriceRangeThreeMember2024-03-310001173204us-gaap:CustomerRelationshipsMember2023-03-310001173204us-gaap:RightsMember2023-03-310001173204us-gaap:FairValueInputsLevel2Member2024-03-310001173204us-gaap:DomesticCountryMember2024-03-310001173204srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2024-03-310001173204srt:MinimumMembercnvs:ExercisePriceRangeOneMember2023-03-310001173204us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-03-310001173204us-gaap:CommonStockMember2023-04-012024-03-310001173204us-gaap:CommonStockMembercnvs:AtmSalesAgreementMember2023-04-012024-03-3100011732042022-03-310001173204cnvs:HoldingsMember2022-04-012023-03-310001173204us-gaap:RevolvingCreditFacilityMembercnvs:EastWestBankMemberus-gaap:PrimeRateMember2023-04-012024-03-310001173204us-gaap:CommonStockMember2022-04-012023-03-310001173204us-gaap:NoncontrollingInterestMember2023-03-310001173204us-gaap:TreasuryStockCommonMember2022-03-310001173204srt:MinimumMember2023-04-012024-03-310001173204country:US2024-03-310001173204us-gaap:ParentMember2023-04-012024-03-3100011732042022-04-012023-03-310001173204us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-03-310001173204us-gaap:RightsMember2023-04-012024-03-310001173204srt:MinimumMember2024-03-310001173204cnvs:OperatingLeasesLiabilitiesMember2024-03-310001173204us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2022-03-310001173204us-gaap:StateAndLocalJurisdictionMember2024-03-310001173204us-gaap:CustomerRelationshipsMember2024-03-310001173204us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-04-012023-03-310001173204us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2024-03-310001173204cnvs:ExercisePriceRangeOneMember2024-03-310001173204cnvs:ExercisesPriceRangeFourMember2022-04-012023-03-310001173204us-gaap:ParentMember2024-03-310001173204cnvs:StarriseMember2020-04-100001173204us-gaap:PropertySubjectToOperatingLeaseMember2023-03-310001173204us-gaap:SeriesAPreferredStockMember2022-03-1500011732042024-06-1700011732042023-04-012024-03-310001173204cnvs:AdvertiserRelationshipsAndChannelMember2023-03-310001173204cnvs:ExercisePriceRangeTwoMember2023-03-310001173204us-gaap:MachineryAndEquipmentMembersrt:MaximumMember2024-03-310001173204us-gaap:FiniteLivedIntangibleAssetsMember2024-03-310001173204us-gaap:CommonClassAMember2023-03-310001173204cnvs:OtherNonRecurringMember2022-04-012023-03-310001173204us-gaap:SeriesAPreferredStockMember2022-03-012022-03-150001173204us-gaap:FairValueInputsLevel1Member2023-03-310001173204srt:MaximumMembercnvs:ContentLibraryMember2024-03-310001173204cnvs:AdvertiserRelationshipsAndChannelMembersrt:MaximumMember2024-03-310001173204us-gaap:NoncontrollingInterestMember2023-04-012024-03-310001173204cnvs:ExercisePriceRangeOneMember2023-03-310001173204us-gaap:SeriesAPreferredStockMember2024-03-3100011732042022-03-012022-03-150001173204us-gaap:RetainedEarningsMember2022-03-310001173204us-gaap:ForeignCountryMember2024-03-310001173204us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012024-03-310001173204country:IN2024-03-310001173204country:IN2023-04-012024-03-310001173204cnvs:SoftwareMember2023-03-3100011732042023-06-142023-06-140001173204srt:MinimumMembercnvs:ContentLibraryMember2024-03-310001173204srt:MinimumMembercnvs:ExercisePriceRangeTwoMember2023-03-310001173204cnvs:AtmSalesAgreementMember2020-07-310001173204us-gaap:TreasuryStockCommonMember2024-03-310001173204us-gaap:RevolvingCreditFacilityMembercnvs:EastWestBankMember2022-04-012023-03-310001173204us-gaap:ParentMember2022-03-310001173204us-gaap:StockAppreciationRightsSARSMember2023-04-012024-03-310001173204us-gaap:SubsequentEventMember2024-06-300001173204cnvs:StarriseMembercnvs:StockExchangeOfHongKongLimitedMember2023-03-310001173204cnvs:FoundationTvPaymentDueInDecemberTwoThousandAndTwentyFourMember2023-04-012024-03-310001173204us-gaap:RetainedEarningsMember2023-04-012024-03-310001173204cnvs:BloodyDisgustingLLCMember2023-04-012024-03-310001173204cnvs:CapitalizedContentMember2024-03-310001173204srt:BoardOfDirectorsChairmanMember2023-04-012024-03-310001173204cnvs:StarriseMember2020-02-140001173204us-gaap:AdditionalPaidInCapitalMember2023-04-012024-03-310001173204us-gaap:AdditionalPaidInCapitalMember2022-04-012023-03-310001173204us-gaap:RevolvingCreditFacilityMembercnvs:EastWestBankMember2023-04-012024-03-310001173204srt:MinimumMembercnvs:InternalUseSoftwareMember2024-03-310001173204cnvs:CONtvMember2024-03-310001173204us-gaap:RevolvingCreditFacilityMembercnvs:EastWestBankMember2024-03-3100011732042023-06-092023-06-090001173204cnvs:TotalIntangibleAssetsMember2023-03-310001173204srt:MaximumMember2024-03-310001173204us-gaap:ParentMember2023-03-310001173204cnvs:MinorityOwnersMember2024-03-310001173204cnvs:PodcastAndOtherMember2023-04-012024-03-310001173204cnvs:ExercisePriceRangeThreeMember2023-04-012024-03-310001173204us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012023-03-310001173204us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001173204us-gaap:RevolvingCreditFacilityMembercnvs:EastWestBankMemberus-gaap:PrimeRateMember2024-03-310001173204srt:MaximumMembercnvs:InternalUseSoftwareMember2024-03-310001173204cnvs:DigitalMediaRightsPaymentDueInMarchTwoThousandAndTwentyFiveMember2023-04-012024-03-310001173204cnvs:OperatingLeasesLiabilitiesNetOfCurrentPortionMember2024-03-310001173204us-gaap:FairValueInputsLevel2Member2023-03-310001173204srt:BoardOfDirectorsChairmanMembercnvs:RestrictedStockAwardsMember2022-04-012023-03-310001173204cnvs:BaseDistributionMember2023-04-012024-03-310001173204cnvs:ContentLibraryMember2024-03-310001173204cnvs:OTTStreamingandDigitalMember2022-04-012023-03-310001173204cnvs:DistributionAgreementsMembercnvs:TerrifierThreeFinancingMemberus-gaap:SubsequentEventMember2024-04-052024-04-050001173204us-gaap:RelatedPartyMember2022-04-012023-03-3100011732042020-04-012020-04-100001173204cnvs:StockExchangeOfHongKongLimitedMember2022-04-012023-03-310001173204srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2024-03-310001173204us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2024-03-310001173204us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-03-310001173204cnvs:BloodyDisgustingLLCMember2022-04-012023-03-310001173204cnvs:AdvertiserRelationshipsAndChannelMembersrt:MinimumMember2024-03-310001173204us-gaap:TrademarksAndTradeNamesMember2024-03-310001173204cnvs:TerrifierThreeFinancingMemberus-gaap:SubsequentEventMembercnvs:GuarantyAgreementMember2024-04-052024-04-050001173204us-gaap:TrademarksAndTradeNamesMember2023-03-3100011732042024-03-310001173204us-gaap:RetainedEarningsMember2024-03-310001173204srt:BoardOfDirectorsChairmanMember2022-04-012023-03-310001173204cnvs:HoldingsMember2023-03-310001173204us-gaap:CommonStockMember2021-10-110001173204us-gaap:TreasuryStockCommonMember2023-03-310001173204us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2023-03-310001173204us-gaap:ParentMember2022-04-012023-03-310001173204us-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMembercnvs:EastWestBankMember2024-06-012024-06-300001173204us-gaap:SoftwareDevelopmentMember2024-03-310001173204us-gaap:MachineryAndEquipmentMembersrt:MinimumMember2024-03-310001173204us-gaap:PerformanceSharesMember2023-04-012024-03-310001173204us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001173204cnvs:OperatingLeasesLiabilitiesNetOfCurrentPortionMember2023-03-310001173204us-gaap:RightsMember2024-03-310001173204us-gaap:CommonClassAMember2024-03-310001173204srt:MinimumMembercnvs:ExercisePriceRangeOneMember2024-03-3100011732042023-09-300001173204cnvs:TerrifierThreeFinancingMemberus-gaap:SubsequentEventMember2024-04-052024-04-050001173204cnvs:OtherNonRecurringMember2023-04-012024-03-310001173204us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001173204cnvs:PodcastAndOtherMember2022-04-012023-03-310001173204cnvs:ExercisePriceRangeOneMember2023-04-012024-03-310001173204us-gaap:NoncontrollingInterestMember2022-03-310001173204cnvs:SupplierAgreementsMember2023-03-3100011732042021-04-012021-12-310001173204cnvs:AtmSalesAgreementMember2023-04-012024-03-310001173204us-gaap:CommonStockMembercnvs:SalesAgreementMemberus-gaap:SubsequentEventMember2024-05-030001173204cnvs:ExercisePriceRangeOneMember2022-04-012023-03-310001173204cnvs:ExercisesPriceRangeFourMember2023-03-310001173204us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-04-012024-03-310001173204cnvs:OperatingLeasesLiabilitiesMember2023-03-310001173204us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2024-03-3100011732042023-03-310001173204us-gaap:TreasuryStockCommonMember2023-04-012024-03-310001173204cnvs:BaseDistributionMember2022-04-012023-03-310001173204us-gaap:FairValueInputsLevel1Member2023-04-012024-03-310001173204cnvs:ExercisePriceRangeTwoMember2022-04-012023-03-310001173204us-gaap:NoncontrollingInterestMember2024-03-310001173204cnvs:ExercisePriceRangeTwoMember2023-04-012024-03-3100011732042024-01-012024-03-310001173204srt:MaximumMembercnvs:ExercisePriceRangeOneMember2023-03-310001173204srt:MaximumMemberus-gaap:ComputerEquipmentMember2024-03-310001173204us-gaap:RetainedEarningsMember2023-03-310001173204cnvs:BloodyDisgustingLLCMember2023-03-310001173204srt:BoardOfDirectorsChairmanMembercnvs:RestrictedStockAwardsMember2023-04-012024-03-310001173204cnvs:HoldingsMember2024-03-310001173204cnvs:SupplierAgreementsMember2024-03-310001173204cnvs:TerrifierThreeFinancingMemberus-gaap:SubsequentEventMember2024-04-050001173204srt:MinimumMembercnvs:ExercisePriceRangeTwoMember2024-03-310001173204us-gaap:AdditionalPaidInCapitalMember2022-03-3100011732042020-04-100001173204cnvs:AdvertiserRelationshipsAndChannelMember2024-03-310001173204cnvs:FoundationTVIncMember2023-04-012024-03-310001173204us-gaap:PerformanceSharesMember2023-03-310001173204cnvs:FoundationTvPaymentDueInJuneTwoThousandAndTwentyFiveMember2023-04-012024-03-310001173204srt:MinimumMemberus-gaap:ComputerEquipmentMember2024-03-310001173204cnvs:TotalIntangibleAssetsMember2024-03-310001173204us-gaap:CommonClassAMembercnvs:SalesAgreementMemberus-gaap:SubsequentEventMember2024-05-030001173204cnvs:SalesAgreementMemberus-gaap:SubsequentEventMember2024-05-032024-05-030001173204srt:MaximumMembercnvs:ExercisePriceRangeTwoMember2023-03-310001173204cnvs:SoftwareMember2024-03-310001173204cnvs:HoldingsMember2023-04-012024-03-310001173204cnvs:OptionsExercisableMember2024-03-310001173204cnvs:ContentLibraryMember2023-03-310001173204us-gaap:StockAppreciationRightsSARSMember2024-03-310001173204us-gaap:CommonClassAMember2023-12-080001173204cnvs:ExercisePriceRangeThreeMember2023-03-310001173204us-gaap:RetainedEarningsMember2022-04-012023-03-310001173204cnvs:ExercisePriceRangeThreeMember2022-04-012023-03-31cnvs:Customersxbrli:purexbrli:sharesiso4217:USDxbrli:sharesiso4217:USDcnvs:Lease

The Company’s streaming technology platform, known as MatchpointTM, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform. ema

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-K

(Mark One)

ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: March 31, 2024

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-31810

 

Cineverse Corp.

(Exact name of registrant as specified in its charter)

 

Delaware

22-3720962

(State or Other Jurisdiction of
Incorporation or Organization)

(I.R.S. Employer
Identification No.)

224 W. 35th St., Suite 500 #947, New York, NY

10001

(Address of principal executive offices)

(Zip Code)

(212) 206-8600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange
on which registered

CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE

CNVS

The Nasdaq Stock Market

Securities registered pursuant to Section 12(g) of the Act: NONE

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.

Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes  No

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the issuer based on a price of $1.17 per share, the closing price of such common equity on The Nasdaq Stock Market, as of September 30, 2023, was $12,987,466.07. For purposes of the foregoing calculation, all directors, officers and shareholders who beneficially own 10% of the shares of such common equity have been deemed to be affiliates, but the Company disclaims that any of such persons are affiliates.

As of June 17, 2024, 15,606,341 shares of Class A Common Stock, $0.001 par value were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None.

 

 


 

Cineverse Corp.

TABLE OF CONTENTS

 

Page

FORWARD-LOOKING STATEMENTS

ii

PART I

1

ITEM 1.

Business

1

ITEM 1A.

Risk Factors

4

ITEM 1B.

Unresolved Staff Comments

13

ITEM 1C.

Cybersecurity

13

ITEM 2.

Properties

13

ITEM 3.

Legal Proceedings

13

ITEM 4.

Mine Safety Disclosures

13

PART II

14

ITEM 5.

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

14

ITEM 6.

[Reserved]

15

ITEM 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

ITEM 8.

Financial Statements and Supplementary Data

27

ITEM 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

59

ITEM 9A.

Controls and Procedures

59

ITEM 9B.

Other Information

59

ITEM 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

60

PART III

61

ITEM 10.

Directors, Executive Officers and Corporate Governance

61

ITEM 11.

Executive Compensation

67

ITEM 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

75

ITEM 13.

Certain Relationships and Related Transactions, and Director Independence

76

ITEM 14.

Principal Accountant Fees and Services

77

PART IV

79

ITEM 15.

Exhibits and Financial Statement Schedules

79

SIGNATURES

85

 

i


 

FORWARD-LOOKING STATEMENTS

Various statements contained in this report or incorporated by reference into this report constitute “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are based on current expectations and are indicated by words or phrases such as “believe,” “expect,” “may,” “will,” “should,” “seek,” “plan,” “intend” or “anticipate” or the negative thereof or comparable terminology, or by discussion of strategy. Forward-looking statements represent as of the date of this report our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. Such forward-looking statements are based largely on our current expectations and are inherently subject to risks and uncertainties. Our actual results could differ materially from those that are anticipated or projected as a result of certain risks and uncertainties, including, but not limited to, a number of factors, such as:

successful execution of our business strategy, particularly for new endeavors;
the performance of our targeted markets;
competitive product and pricing pressures;
changes in business relationships with our major customers;
successful integration of acquired businesses;
the content we distribute through our in-theatre, on-line and mobile services may expose us to liability;
general economic and market conditions;
our financial condition and financial flexibility, including, but not limited to, our ability to obtain necessary financing for our business as and when needed;
the other risks and uncertainties that are set forth in Item 1, “Business”, Item 1A “Risk Factors” and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the Securities and Exchange Commission (“SEC”) pursuant to the SEC’s rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks and uncertainties, we cannot assure you that the forward-looking information contained in this report will in fact transpire.

ii


 

PART I

ITEM 1. BUSINESS

OVERVIEW

Cineverse Corp. (“Cineverse”, “us”, “our”, "we", and “Company” refers to Cineverse Corp. and its subsidiaries unless the context otherwise requires) was incorporated in Delaware on March 31, 2000. Since our inception, we have played a significant role in the digital distribution revolution that continues to transform the media and entertainment landscape.

 

The Company has a long legacy in using technology to transform the entertainment industry and played a pioneering role in transitioning movie screens from traditional analog film prints to digital distribution. Over the past several years, Cineverse has transformed itself from being a digital cinema equipment and physical content distributor to a leading independent streaming company, and we continue to push the bounds of our industry with innovative technology offerings.

 

Cineverse is a premier streaming technology and entertainment company with its core business operating as (i) a portfolio of owned and operated streaming channels with enthusiast fan bases; (ii) a large-scale global aggregator and full-service distributor of feature films and television programs; and (iii) a proprietary technology software-as-a-service platform for over-the-top (“OTT”) app development and content distribution through subscription video on demand ("SVOD"), dedicated ad-supported ("AVOD"), ad-supported streaming linear ("FAST") channels, social video streaming services, and audio podcasts. Our streaming channels reach audiences in several distinct ways: direct-to-consumer, through these major application platforms, and through third party distributors of content on platforms.

 

The Company’s streaming technology platform, known as MatchpointTM, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform.

 

We distribute products for major brands such as Hallmark, ITV, Nelvana, ZDF, Konami, NFL and Highlander, as well as leading international and domestic content creators, movie producers, television producers and other short-form digital content producers. We collaborate with producers, major brands and other content owners to market, source, curate and distribute quality content to targeted audiences through (i) existing and emerging digital home entertainment platforms, including but not limited to Apple iTunes, Amazon Prime, Netflix, Hulu, Xbox, Pluto, and Tubi, as well as (ii) physical goods, including DVD and Blu-ray Discs.

Cineverse’s broad portfolio enables the Company to achieve significant market share on key consumer streaming devices and platforms. As its channel portfolio has grown, the Company’s viewership and subscription metrics have grown significantly. The Company has rights to a library of over 33,000 film & TV assets, has reached over 82 million streaming viewers, has over 1.4 million SVOD subscribers, and 25 million followers on social media. The Company is well positioned in a changing media and entertainment landscape. As a leading independent distributor, the Company believes the enthusiast segment provides a significant and underserved market opportunity on a global basis. Today, the Company operates channels in numerous specialty sectors, including faith and family, anime, action, horror, sports, Westerns, Asian, standup comedy, and other major segments. From time to time, the Company will cease operating or distributing channels that do not find adequate audiences or meet the needs of platforms or audiences. We believe our scaled channel portfolio, our superior capabilities in launching and managing channels at scale, and our strategic partnerships with key content owners and platforms will provide us a strategic advantage to gain considerable market share in the immediate future.

Given our extensive experience in operating and distributing enthusiast content, and the ability to centralize operations and reduce operating costs due to our proprietary technology, the Company also pursues accretive M&A opportunities in order to grow profitably and fortify its competitive advantage.

 

 

 

1


 

As part of its M&A strategy, the Company:

Focuses on acquiring premium content and streaming channels;
Explores opportunities for new technology and other revenue channels including ecommerce, podcasts and merchandise; and
Leverages its proprietary tech platform (MatchpointTM), which allows for on-boarding multiple acquisitions concurrently.

 

The Company believes it is positioned to deliver sustained profitable growth in the future by executing on several key initiatives:

Content: Acquiring and distributing high-quality, curated content through SVOD, AVOD and linear FAST channels
Technology & Distribution:
o
Expanding streaming content business through its Matchpoint™ platform,
o
Launching and scaling our portfolio of enthusiast streaming channels.
o
Accelerating the Company’s device and platform reach and further establishing key strategic advantages through expanded partnership deals with connected streaming TV companies including Amazon, Samsung, Roku, YouTube TV and Vizio, as well as large OEM’s, cable companies and technology platforms including LG, Sling TV, and others.
o
Licensing film and TV content to every key player in OTT streaming ecosystem with Amazon, Apple, Netflix and Google.
Audience: Growing viewership and subscription numbers significantly beyond our current base of more than 82 million monthly viewers to potentially hundreds of millions of global viewers across billions of connected devices.
Financial Performance/Metrics:
o
Driving EBITDA through incremental revenue growth from technology product launches such as Matchpoint, expansion of distribution, improved monetization and partnerships, and continuous efforts on cost mitigation.

Our common stock is listed on the Nasdaq Capital Market, or Nasdaq, under the symbol “CNVS.”

 

On April 4, 2022, the Company received a letter from the Nasdaq indicating that the Company no longer met the Bid Price Rule. On June 7, 2023, The Nasdaq Stock Market LLC (“Nasdaq”) approved an additional extension through July 19, 2023, during which the Company may cure the previously-announced minimum bid price deficiency. In order to regain compliance with the Bid Price Rule, in addition to the initiation of the implementation of a stock repurchase program of up to 500 thousand shares in the open market over a 12 month period since announcement in March 2023, the Company has effected a reverse stock split. The Company has maintained its compliance with the $1.00 bid price requirement for continued listing on The Nasdaq Capital Market and remains subject to a one-year “Panel Monitor” as that term is defined by Nasdaq Listing Rule 5815(d)(4)(A) through June 30, 2024.

 

On June 9, 2023, the Company effected a 1-for-20 reverse stock split of the Company's Class A common stock. All shares and price amounts in this report reflect the 1-for-20 reverse stock split.

 

2


 

Our Strategy

The shift from traditional entertainment consumption to streaming continues to accelerate. We believe that our large library of film and television programs, long-standing relationships with digital platforms, state of the art technologies and years of experience operating and growing streaming audiences (collectively, our “Streaming” business) will allow us to continue to build a diversified portfolio of enthusiasts OTT channels that generate recurring revenue streams from advertising, subscriptions and merchandising. We believe that our success, market leadership and scale will continue to attract strong brands and media companies who bring name recognition, high-quality film and television content, and strong marketing support.

We believe that we are well positioned to succeed in the streaming channel business for the following key reasons:

More than 15 years of experience as a primary distributor of content to scale third party OTT platforms such as Netflix, Hulu, Amazon Prime, Tubi, Apple iTunes and more, and nearly seven years of history operating OTT channels with millions of downloads, hundreds of thousands of registered users, and hundreds of millions of discrete data points on our customer’s behavior and preferences;
The depth and breadth of our over 33,000 title film and television episode library;
Our digital assets and deep, long-standing relationships as launch partners that cover the major digital platforms and devices;
Our marketing expertise;
Our flexible releasing strategies, which differ from larger entertainment companies that need to protect their legacy businesses;
Our proprietary streaming technology enabling us to operate at scale and at lower operating costs than our competitors; and
Our experienced management team.

 

Intellectual Property

We own certain copyrights, trademarks and Internet domain names in connection with our business. We view these proprietary rights as valuable assets. We maintain registrations, where appropriate, to protect them and monitor them on an ongoing basis.

 

ENVIRONMENTAL

The nature of our business does not subject us to environmental laws in any material manner.

EMPLOYEES

As of March 31, 2024 we had 179 employees, 176 full-time and 3 part time, on-leave, or temporaries. Of these employees, 74 are in operations, 16 are in sales and marketing, and 89 are in executive, finance, technology and administrative functions. There are 85 employees based in the United States and 94 employees based in India.

AVAILABLE INFORMATION

Our Internet website address is www.cineverse.com. We will make available, free of charge at the “Investor Relations - Financial Information” section of our website, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements and all amendments to those reports and statements filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such reports are electronically filed with, or furnished to, the SEC.

3


 

In addition, the SEC maintains a website that contains reports, proxy and information statements, and other information regarding companies that file electronically with the SEC. This information is available at www.sec.gov.

 

ITEM 1A. RISK FACTORS

An investment in our securities involves a degree of risk. The risks described below are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also have a material adverse effect on us. If any of the following risks actually occur, our financial condition, results of operations, cash flows or business could be harmed. In that case, the market price of our stock could decline and you could lose part or all of your investment in our securities.

Risks Related to our Business

We face the risks of doing business in new and rapidly evolving markets and may not be able to successfully address such risks and achieve acceptable levels of success or profits.

We have encountered and may continue to encounter the challenges, uncertainties and difficulties frequently experienced in new and rapidly evolving markets, including:

limited operating experience;
net losses;
lack of sufficient customers or loss of significant customers;
a changing business focus;
the downward trend in sales of physical DVD and Blu-ray discs;
rapidly-changing technology for some of the products and services we offer; and
difficulties in managing potentially rapid growth.

We expect competition to be intense. If we are unable to compete successfully, our business and results of operations will be seriously harmed.

The markets for technology and content distribution business are competitive, evolving and subject to rapid technological and other changes. We expect the intensity of competition in each of these areas to increase in the future. Companies willing to expend the necessary capital to create facilities and/or capabilities similar to ours may compete with our business. Increased competition may result in reduced, or prevent us from generating forecasted, revenues and/or margins and loss of market share, any of which could seriously harm our business. In order to compete effectively in each of these fields, we must differentiate ourselves from our competitors.

Many of our current and potential competitors may have longer operating histories and greater financial, technical, marketing and other resources than we do, which may permit them to adopt aggressive pricing policies. As a result, we may suffer from pricing pressures that could adversely affect our ability to generate revenues and our results of operations. Many of our competitors also have significantly greater name and brand recognition and a larger customer base than us. If we are unable to compete successfully, our business and results of operations will be seriously harmed.

Our plan to acquire additional businesses involves risks, including our inability to complete or integrate an acquisition successfully, our assumption of liabilities, dilution of your investment and significant costs.

Strategic and financially appropriate acquisitions are a key component of our growth strategy. Although there are no acquisitions identified by us as probable at this time, we may make acquisitions of similar or complementary businesses or assets. Even if we identify appropriate acquisition candidates, we may be unable to negotiate successfully the terms of the acquisitions, finance them, integrate the acquired business into our then existing business, obtain required regulatory approvals, and/or attract and retain customers. Completing an acquisition and integrating an acquired business may require a significant diversion of management time and resources and may

4


 

involve assuming new liabilities. Any acquisition also involves the risks that the assets acquired may prove less valuable than expected and/or that we may assume unknown or unexpected liabilities, costs and problems. If we make one or more significant acquisitions in which any of the consideration consists of our capital stock, your equity interest in the Company could be diluted, perhaps significantly. If we were to proceed with one or more significant acquisitions in which the consideration included cash, we could be required to use a substantial portion of our available cash or obtain additional financing to consummate them.

We have recorded goodwill impairment charges in the past and may be required to record additional charges to future earnings if our goodwill becomes further impaired or our intangible assets become impaired.

We are required under generally accepted accounting principles to review our goodwill and definite-lived intangible assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill must be tested for impairment at least annually. Factors that may be considered a change in circumstances indicating that the carrying value of our reporting units and intangible assets may not be recoverable include, slower growth rates in our industry or our own operations, and/or other materially adverse events that have implications on the profitability of our business. In the current fiscal year, we recognized $14 million of impairment, and we may be required to record additional charges to earnings during any period in which further impairment of our goodwill or other intangible assets is determined that could adversely affect our results of operations.

If we do not manage our growth, our business will be harmed.

We may not be successful in managing our growth. Past growth has placed, and future growth will continue to place, significant challenges on our management and resources. To manage the expected growth of our operations, we will need to improve our existing, and implement new, operational and financial systems, procedures and controls. We may also need to expand our finance, administrative, client services and operations staffs and train and manage our growing employee base effectively. Our current and planned personnel, systems, procedures and controls may not be adequate to support our future operations. Our business, results of operations and financial position will suffer if we do not effectively manage our growth.

If we are not successful in protecting our intellectual property, our business will suffer.

We depend heavily on technology and viewing content to operate our business. Our success depends on protecting our intellectual property, which is one of our most important assets. We have intellectual property consisting of:

rights to certain domain names;
registered service marks on certain names and phrases;
various unregistered trademarks and service marks;
film, television and other forms of viewing content;
know-how; and
rights to certain logos.

If we do not adequately protect our intellectual property, our business, financial position and results of operations would be harmed. Our means of protecting our intellectual property may not be adequate. Unauthorized parties may attempt to copy aspects of our intellectual property or to obtain and use information that we regard as proprietary. In addition, competitors may be able to devise methods of competing with our business that are not covered by our intellectual property. Our competitors may independently develop similar technology, duplicate our technology or design around any intellectual property that we may obtain.

Although we hold rights to various web domain names, regulatory bodies in the United States and abroad could establish additional top-level domains, appoint additional domain name registrars or modify the requirements for holding domain names. The relationship between regulations governing domain names and laws protecting trademarks and similar proprietary rights is unclear. We may be unable to prevent third parties from acquiring domain names that are similar to or diminish the value of our proprietary rights.

5


 

We maintain outstanding indebtedness, which could impair our ability to operate our business and react to changes in our business, remain in compliance with debt covenants and make payments on our debt.

We maintain an amount of outstanding indebtedness, which could impair our ability to operate our business and react to changes in our business, remain in compliance with debt covenants and make payments on our debt. Our level of indebtedness could require a significant portion of our cash flow from operations to be dedicated to the payment of principal and interest on our indebtedness, therefore reducing our ability to use our cash flow to fund our operations, capital expenditures and future business opportunities.

In addition, our current credit facilities contain, and any future credit facilities will likely contain, covenants and other provisions that restrict our operations. These restrictive covenants and provisions could limit our ability to obtain future financing, make needed capital expenditures, withstand a future downturn in our business or the economy in general, or otherwise conduct necessary corporate activities, and may prevent us from taking advantage of business opportunities that arise in the future. If we refinance our credit facilities, we cannot guarantee that any new credit facility will not contain similar covenants and restrictions.

 

Cinedigm Digital Funding 2, LLC ("CDF2") and CDF2 Holdings, LLC ("CDF2 Holdings") are our indirect wholly-owned, non-consolidated variable interest entities ("VIEs") that are intended to be special purpose, bankruptcy remote entities. CDF2 Holdings has entered into the a lease (the “CHG Lease”) pursuant to which CHG-Meridian U.S. Finance, Ltd. provided sale/leaseback financing for digital cinema projection systems that were partially financed as part of the Phase II deployment of our legacy digital equipment business. The CHG Lease is non-recourse to Cineverse and our subsidiaries, excluding our VIEs, CDF2 and CDF2 Holdings, as the case may be. Our financial exposure related to the debt of CDF2 and CDF2 Holdings is limited to the $2.0 million initial investment we made into CDF2 and CDF2 Holdings. CDF2 Holding’s total stockholder’s deficit at March 31, 2024 was $59.2 million. We have no obligation to fund the operating loss or the deficit beyond our initial investment, and accordingly, we carried our investment in CDF2 Holdings at $0 as of March 31, 2024 and 2023.

The obligations and restrictions under the CHG Lease could have important consequences for CDF2 and CDF2 Holdings, including:

limiting our ability to obtain necessary financing in the future;
restricting us from incurring liens on the digital cinema projection systems financed and from subleasing, assigning or modifying the digital cinema projection systems financed; and
requiring them to dedicate a substantial portion of their cash flow to payments on their debt obligations, thereby reducing the availability of their cash flow for other uses.

If we are unable to meet our debt obligations, we could be forced to restructure or refinance our obligations, to seek additional equity financing or to sell assets, which we may not be able to do on satisfactory terms or at all. As a result, we could default on those obligations and in the event of such default, our lenders could accelerate our debt or take other actions that could restrict our operations.

The foregoing risks would be intensified to the extent we borrow additional money or incur additional debt.

We may not be able to generate the amount of cash needed to fund our future operations.

Our ability either to make payments on or to refinance our indebtedness, or to fund planned capital expenditures and research and development efforts, will depend on our ability to generate cash in the future. Our ability to generate cash is in part subject to general economic, financial, competitive, regulatory and other factors that are beyond our control.

Based on our current level of operations and in conjunction with the cost reduction measures that we have recently implemented and continue to implement, we believe our cash flow from operations, available borrowings and loan and credit agreement terms will be adequate to meet our future liquidity needs through at least the next twelve months. Significant assumptions underlie this belief, including, among other things, that there will be no material

6


 

adverse developments in our business, liquidity or capital requirements. If we are unable to service our indebtedness, we will be forced to adopt an alternative strategy that may include actions such as:

reducing capital expenditures;
reducing our overhead costs and/or workforce;
reducing research and development efforts;
selling assets;
restructuring or refinancing our remaining indebtedness; and
seeking additional funding.

We cannot assure you, however, that our business will generate sufficient cash flow from operations, or that we will be able to make future borrowings in amounts sufficient to enable us to pay the principal and interest on our current indebtedness or to fund our other liquidity needs. We may need to refinance all or a portion of our indebtedness on or before maturity. We cannot assure you that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.

We have incurred losses over the long term.

We have incurred long term losses and have financed our operations principally through equity investments and borrowings. As of March 31, 2024, though we had a positive working capital, defined as current assets less current liabilities, of $1.5 million, and cash and cash equivalents of $5.2 million, and total equity of $32.2 million, the Company used $10.6 million of net cash flows in operating activities.

Our net losses and cash outflows may increase as and to the extent that we increase the size of our business operations, increase our sales and marketing activities, increase our content distribution rights acquisition activities, enlarge our customer support and professional services and acquire additional businesses. These efforts may prove to be more expensive than we currently anticipate which could further increase our losses. We must continue to increase our revenues in order to become profitable. We cannot reliably predict when, or if, we will become profitable. Even if we achieve profitability, we may not be able to sustain it. If we cannot generate operating income or positive cash flows in the future, we will be unable to meet our working capital requirements.

Many of our corporate actions may be influenced by our officers, directors and principal stockholders; these actions may benefit these principal stockholders more than our other stockholders.

As of June 17, 2024, our directors, executive officers and principal stockholders, those known by us to beneficially own more than 5% of the outstanding shares of our Common Stock, beneficially own, directly or indirectly, in the aggregate, approximately 20.8% of our outstanding Common Stock. These stockholders, as a group, may have significant influence over our business affairs, with the ability to influence matters requiring approval by our security holders, including elections of directors and approvals of mergers or other business combinations.

Our success will significantly depend on our ability to hire and retain key personnel.

Our success will depend in significant part upon the continued performance of our senior management personnel and other key technical, sales and creative personnel. We do not currently have significant “key person” life insurance policies for any of our employees. We currently have employment agreements with our Chief Executive Officer, our President and Chief Strategy Officer, our Chief Operating Officer and Chief Technology Officer, our Chief Legal Officer, and our Chief Financial Officer. If we lose one or more of our key employees, we may not be able to find a suitable replacement(s) and our business and results of operations could be adversely affected. In addition, competition for key employees necessary to create and distribute our entertainment content and software products is intense and may grow in the future. Our future success will also depend upon our ability to hire, train, integrate and retain qualified new employees and our inability to do so may have an adverse impact upon our business, financial condition, operating results, liquidity and prospects for growth.

 

7


 

Our success depends on external factors in the media industry.

Our success depends on the commercial success of media content, which is unpredictable. Operating in the motion picture and television industry involves a substantial degree of risk. Content is an individual artistic work, and inherently unpredictable audience reactions primarily determine commercial success. Generally, the popularity of content depends on many factors, including the critical acclaim they receive, the format of their initial release, for example, theatrical or direct-to-streaming, the actors and other key talent, their genre and their specific subject matter. The commercial success of movies and television programs also depends upon the quality and acceptance of movies or programs that our competitors release into the marketplace at or near the same time, critical reviews, the availability of alternative forms of entertainment and leisure activities, general economic conditions and other tangible and intangible factors, many of which we do not control and all of which may change. We cannot predict the future effects of these factors with certainty, any of which could have a material adverse effect on our business, financial condition, operating results, liquidity and prospects. In addition, because a theatrical movie or streaming content's performance in ancillary markets, such as branded consumer goods, is often directly related to its box office performance or television ratings, poor box office results or poor television ratings may negatively affect future revenue streams. Our success will depend on the experience and judgment of our management to select and develop new content acquisition and investment opportunities. We cannot make assurances that movies and streaming content will obtain favorable reviews or ratings, will perform well at the box office or in ancillary markets or that broadcasters will license the rights to broadcast any of our content in development or renew licenses to use programs in our library. The failure to achieve any of the foregoing could have a material adverse effect on our business, financial condition, operating results, liquidity and prospects.

Our business involves risks of liability claims for media content, which could adversely affect our business, results of operations and financial condition.

As a distributor of media content, we may face potential liability for:

defamation;
invasion of privacy;
negligence;
copyright or trademark infringement (as discussed above); and
other claims based on the nature and content of the materials distributed.

These types of claims have been brought, sometimes successfully, against producers and distributors of media content. Any imposition of liability that is not covered by insurance or is in excess of insurance coverage could have a material adverse effect on our business, financial condition, operating results, liquidity and prospects.

Our revenues and earnings are subject to market downturns.

Our revenues and earnings may fluctuate significantly in the future. General economic or other conditions could cause lower than expected revenues and earnings within our digital cinema, technology or content and entertainment businesses. A global economic turmoil can cause a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, an unprecedented level of intervention from the U.S. federal government and other foreign governments, decreased consumer confidence, overall slower economic activity and extreme volatility in credit, equity and fixed income markets. A decrease in economic activity in the U.S. or in other regions of the world in which we do business could adversely affect demand for our content, thus reducing our revenue and earnings. Moreover, financial institution failures may cause us to incur increased expenses or make it more difficult either to financing of any future acquisitions, or financing activities. Any of these factors could have a material adverse effect on our business, results of operations and could result in significant additional dilution to shareholders.

 

8


 

Changes in economic conditions could have a material adverse effect on our business, financial position and results of operations.

Our operations and performance could be influenced by worldwide economic conditions. Uncertainty about current global economic conditions poses a risk as consumers and businesses may postpone spending in response to tighter credit, negative financial news and/or declines in income or asset values, which could have a material negative effect on the demand for our products and services. Other factors that could influence demand include increases in energy costs, conditions in the residential real estate and mortgage markets, labor and healthcare costs, access to credit, consumer confidence, and other macroeconomic factors affecting consumer-spending behavior. These and other economic factors could have a material adverse effect on demand for our products and services and on our financial condition and operating results. Uncertainty about current global economic conditions could also continue to increase the volatility of our stock price.

Changes to existing accounting pronouncements or taxation rules or practices may affect how we conduct our business and affect our reported results of operations.

New accounting pronouncements or tax rules and varying interpretations of accounting pronouncements or taxation practice have occurred and may occur in the future. A change in accounting pronouncements or interpretations or taxation rules or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. Changes to existing rules and pronouncements, future changes, if any, or the questioning of current practices or interpretations may adversely affect our reported financial results or the way we conduct our business.

Our ability to utilize our net operating loss carryforwards in the future is subject to substantial limitations and we may not be able to use some identified net operating loss carryforwards, which could result in increased tax payments in future periods.

 

Under Section 382 of the Internal Revenue Code, if a corporation undergoes an ownership change (generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period), the corporation’s ability to use its pre-change net operating loss (“NOL”) carryforwards to offset its post-change income may be limited. Similar rules may apply under state tax laws. On November 1, 2017, we experienced an ownership change with respect to the Bison acquisition. Accordingly, our ability to utilize our NOL carryforwards attributable to periods prior to November 1, 2017, is subject to substantial limitations. These limitations could result in increased future tax payments, which could be material. We experienced subsequent ownership changes under Section 382 on September 15, 2020 and November 1, 2022, which resulted in additional limitations in our ability to utilize our NOL carryforwards attributable to periods prior to September 15, 2020 and November 2022, respectively. The limitations triggered by the September 15, 2020 and November 1, 2022 ownership changes were significantly less substantial than the limitation triggered by the November 1, 2017 ownership change, however.

 

Global health threats may adversely affect our business.

Our business could be adversely affected by the effects of a widespread outbreak of contagious disease, such as the outbreak of COVID-19. A significant outbreak of contagious diseases in the human population and resulting widespread health crisis could adversely affect the economies and financial markets of many countries, resulting in an economic downturn and reduced spending on media and technology. The reduction of economic activity and reduced spending related to such outbreaks and actions taken by governments to mitigate the spread of a virus or other infectious agent could have a material impact on our earnings, cash flow and financial condition.

 

We are subject to cybersecurity risk

 

We have controls in place to protect against and mitigate cyber security risk, including employee education and technological tools; however, actual or attempted security incidents or breaches, loss of data, or other disruptions could expose us to material liability and materially and adversely affect our business, financial condition, and our reputation.

 

 

9


 

Risks Related to Common Stock

The liquidity of our Common Stock is uncertain; the limited trading volume of our Common Stock may depress the price of such stock or cause it to fluctuate significantly.

Although our Common Stock is listed on Nasdaq, there has been a limited public market for our Common Stock and there can be no assurance that a more active trading market for our Common Stock will develop. As a result, you may not be able to sell your shares of our Common Stock in short time periods, or possibly at all. The absence of an active trading market may cause the price per share of our Common Stock to fluctuate significantly.

Substantial resales or future issuances of our Common Stock could depress our stock price.

The market price for our Common Stock could decline, perhaps significantly, as a result of resales or issuances of a large number of shares of our Common Stock in the public market or even the perception that such resales or issuances could occur. In addition, we have outstanding a substantial number of options and warrants exercisable for shares of our Common Stock that may be exercised in the future. These factors could also make it more difficult for us to raise funds through future offerings of our equity securities.

You will incur substantial dilution as a result of certain future equity issuances.

We have a substantial number of options and warrants currently outstanding which may be immediately exercised for shares of Common Stock. To the extent that these options or warrants are exercised, or to the extent we issue additional shares of Common Stock in the future, as the case may be, there will be further dilution to holders of shares of the Common Stock.

Our issuance of preferred stock could adversely affect holders of Common Stock.

Our Board of Directors (the "Board of Directors") is authorized to issue series of preferred stock without any action on the part of our holders of Common Stock. The Board of Directors also has the power, without stockholder approval, to set the terms of any such series of preferred stock that may be issued, including voting rights, dividend rights, preferences over our Common Stock with respect to dividends or if we liquidate, dissolve or wind up our business and other terms. If we issue preferred stock in the future that has preference over our Common Stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our Common Stock, the rights of holders of our Common Stock or the price of our Common Stock could be adversely affected.

Our stock price has been volatile and may continue to be volatile in the future; this volatility may affect the price at which you could sell our Common Stock.

The trading price of our Common Stock has been volatile and may continue to be volatile in response to various factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on an investment in our securities:

actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us;
changes in the market’s expectations about our operating results;
success of competitors;
our operating results failing to meet the expectation of securities analysts or investors in a particular period;
changes in financial estimates and recommendations by securities analysts concerning us, the market for digital and physical content, content distribution and entertainment in general;
operating and stock price performance of other companies that investors deem comparable to us;
our ability to market new and enhanced products on a timely basis;

10


 

changes in laws and regulations affecting our business or our industry;
commencement of, or involvement in, litigation involving us;
changes in our capital structure, such as future issuances of securities or the incurrence of debt;
the volume of shares of the Common Stock available for public sale;
any major change in our Board of Directors or management;
sales of substantial amounts of Common Stock by our directors, executive officers or significant stockholders or the perception that such sales could occur; and
general economic and political conditions such as recessions, interest rates, international currency fluctuations and acts of war or terrorism.

Broad market and industry factors may materially harm the market price of the Common Stock irrespective of our operating performance. The stock market in general, and Nasdaq in particular, have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of the Common Stock, may not be predictable. A loss of investor confidence in the market for retail stocks or the stocks of other companies that investors perceive to be similar to us could depress our stock price regardless of our business, prospects, financial conditions or results of operations. A decline in the market price of the Common Stock also could adversely affect our ability to issue additional securities and our ability to obtain additional financing in the future.

Anti-takeover provisions contained in our certificate of incorporation and bylaws, as well as provisions of Delaware law, could impair a takeover attempt.

The Company's Fifth Amended and Restated Certificate of Incorporation, as amended, and our Second Amended and Restated Bylaws contain provisions that could have the effect of delaying or preventing changes in control or changes in our management without the consent of the Board of Directors.

These provisions include:

no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;
the exclusive right of the Board of Directors to elect a director to fill a vacancy created by the expansion of the Board of Directors or the resignation, death, or removal of a director, which prevents stockholders from being able to fill vacancies on the Board of Directors;
the ability of the Board of Directors to determine to issue shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
the requirement that an annual meeting of stockholders may be called only by the Board of Directors, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;
limiting the liability of, and providing indemnification to, our directors and officers;
controlling the procedures for the conduct and scheduling of stockholder meetings; and
providing that directors may be removed prior to the expiration of their terms by the Board of Directors only for cause.

In addition, our certificate of incorporation authorizes the issuance of 15 million shares of preferred stock. The terms of our preferred stock may be fixed by the company’s Board of Directors without further stockholder action. The terms of any outstanding series or class of preferred stock may include priority claims to assets and dividends and special voting rights, which could adversely affect the rights of holders of Common Stock. Any future issuance(s) of preferred stock could make the takeover of the company more difficult, discourage unsolicited bids for control of the

11


 

company in which our stockholders could receive premiums for their shares, dilute or subordinate the rights of holders of Common Stock and adversely affect the trading price of the Common Stock.

These provisions, alone or together, could delay hostile takeovers and changes in control of the Company or changes in our management.

As a Delaware corporation, we are also subject to provisions of Delaware law, including Section 203 of the General Corporation Law of the State of Delaware (the "DGCL"), which prevents some stockholders holding more than 15% of our outstanding Common Stock from engaging in certain business combinations without approval of the holders of substantially all of our outstanding common stock. Any provision of our certificate of incorporation or bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our securities.

We may not be able to maintain the listing of our Common Stock on Nasdaq, which may adversely affect the flexibility of holders of Common Stock to resell their securities in the secondary market.

 

The Common Stock is presently listed on Nasdaq. If the Company is unable to meet the continued listing criteria of Nasdaq and the Common Stock became delisted, trading of the Common Stock could thereafter be conducted in the over-the-counter markets in the OTC Pink, also known as “pink sheets” or, if available, on another OTC trading platform. Any such delisting could harm our ability to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the loss of confidence in our financial stability by suppliers, customers and employees. Investors would likely find it more difficult to dispose of, or to obtain accurate market quotations for, the Common Stock, as the liquidity that Nasdaq provides would no longer be available to investors. In addition, the failure of our Common Stock to continue to be listed on the Nasdaq could adversely impact the market price for the Common Stock and our other securities, and we could face a lengthy process to re-list the Common Stock, if we are able to re-list the Common Stock.

 

The Company's share price has decreased since the end of its fiscal year ending March 31, 2023. A sustained decrease in share price may indicate a risk the Company’s goodwill may become impaired.

On March 31, 2023, the Company's share price was $8.40 and had since declined to a share price of $1.39 as of March 31, 2024. Under ASC 350, Goodwill, a sustained decline in share price represents a triggering event which would require the Company to test for impairment and there may be a risk that the Company incurs expenses related to goodwill impairment. The Company incurred Goodwill impairment of $14.0 million during the twelve months ended March 31, 2024, and there may be additional impairment incurred if there are further declines in the Company's share price.

 

We have no present intention of paying dividends on our Common Stock.

We have never paid any cash dividends on our Common Stock and have no present plans to do so. In addition, certain of our credit facilities restrict our ability to pay dividends on the Common Stock. As a result, you may not receive any return on an investment in our Common Stock unless you sell any shares you hold for a price greater than that which you paid for them.

Our ability to raise capital in the future may be limited, which could make us unable to fund our capital requirements.

Our business and operations may consume resources faster than we anticipate, or we may require additional funds to pursue acquisition or expansion opportunities. In the future, we may need to raise additional funds through the issuance of new equity securities, debt or a combination of both. Additional financing may not be available on favorable terms or at all. If adequate funds are not available on acceptable terms, we may be unable to fund our capital requirements. If we issue new debt securities, the debt holders would have rights senior to common stockholders to make claims on our assets, and the terms of any debt could restrict our operations, including our ability to pay dividends on our Common Stock. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing

12


 

or nature of our future offerings. Thus, our stockholders bear the risk of our future securities offerings reducing the market price of our Common Stock, diluting their interest or being subject to rights and preferences senior to their own.

 

The execution of our stock repurchase program may not provide the desired return on investment.

In March 2023, the Company approved a program to share repurchase program, which was renewed in February 2024. The Company will execute on this program if and when management perceives the share price of the Company's common stock to be attractive. Any share repurchase under this program will take the place of other use of Company funds and may not achieve the same level of return on investment.

 

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

 

ITEM 1C. CYBERSECURITY

We recognize the critical importance of maintaining the trust and confidence of customers, business partners, and employees toward our business and are committed to protecting the confidentiality, integrity, and availability of our business operations and systems. Our board of directors is actively involved in oversight of our risk management activities, and cybersecurity represents an important element of our overall approach to risk management. We seek to address cybersecurity risks through a comprehensive, cross-functional approach that is focused on preserving the confidentiality, security, integrity, and availability of the information that we collect and store by identifying, preventing, and mitigating cybersecurity threats and effectively responding to cybersecurity incidents when they occur.

ITEM 2. PROPERTIES

As of March 31, 2024, our leased Principal Executive Office address is 224 W. 35th St., Suite 500 #947, New York, NY 10001; however, we primarily operate as a company with a virtual workforce.

 

We do not own any real estate or invest in real estate or related investments.

 

ITEM 3. LEGAL PROCEEDINGS

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

13


 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

COMMON STOCK

 

Our Common Stock trades publicly on Nasdaq, under the trading symbol “CNVS” following a rebranding announcement on May 22, 2023, when we changed our name from Cinedigm Corp. to Cineverse Corp. Previously, the Company traded under the trading symbol "CIDM". The following table shows the high and low sales prices per share of our Common Stock as reported by Nasdaq for the periods indicated, as adjusted for the June 2023 reverse stock split:

 

 

 

For the Fiscal Year Ended March 31,

 

 

 

2024

 

 

2023

 

 

 

HIGH

 

 

LOW

 

 

HIGH

 

 

LOW

 

April 1 – June 30

 

$

9.00

 

 

$

1.91

 

 

$

17.20

 

 

$

9.80

 

July 1 – September 30

 

$

1.86

 

 

$

1.00

 

 

$

15.40

 

 

$

7.80

 

October 1 – December 31

 

$

1.38

 

 

$

1.01

 

 

$

12.20

 

 

$

7.60

 

January 1 – March 31

 

$

2.35

 

 

$

1.25

 

 

$

12.20

 

 

$

8.00

 

The reported closing price per share of our Common Stock as reported by Nasdaq on June 17, 2024 was $0.86 per share. As of June 20, 2024, there were 52 holders of record of our Common Stock, not including beneficial owners of our Common Stock whose shares are held in the names of various dealers, clearing agencies, banks, brokers and other fiduciaries.

 

DIVIDEND POLICY

We have never paid any cash dividends on our Common Stock and do not anticipate paying any on our Common Stock in the foreseeable future. Any future payment of dividends on our Common Stock will be in the sole discretion of our Board of Directors.

The holders of our Series A 10% Non-Voting Cumulative Preferred Stock are entitled to receive dividends. There were $89 thousand of cumulative dividends in arrears on our Preferred Stock at March 31, 2024.

SALES OF UNREGISTERED SECURITIES

 

On September 17, 2021, the Company acquired substantially all of the assets of Bloody Disgusting, LLC (“Bloody Disgusting”). On February 29, 2024, the Company issued 84,610 shares of Common Stock as a deferred earnout payment of consideration for the acquisition, pursuant to Section 4(a)(2) of the Securities Act.

 

On March 25, 2022, the Company acquired substantially all of the equity of Asian Media Rights, LLC d/b/a Digital Media Rights (“DMR”). On March 28, 2024, the Company issued 2,284,496 shares of Common Stock as a deferred earnout payment of consideration for the acquisition, pursuant to Section 4(a)(2) of the Securities Act.

PURCHASE OF EQUITY SECURITIES

There were no repurchases of shares of our Common Stock made by us or on our behalf during the year ended March 31, 2024 and 2023.

 

In connection with the settlement of the Company’s fiscal year 2023 employee bonuses, the Company paid cash for the bonus-related payroll taxes upon the surrender to the Company by the employees of 222,761 shares to the Company.

On February 29, 2024, the Board approved the renewal of the Company's stock repurchase program to purchase up to an aggregate of 500,000 shares of its outstanding Class A common stock. Acquisitions pursuant to the stock repurchase program may be made through a combination of open market repurchases in compliance with Rule

14


 

10b-18 promulgated under the Securities Exchange Act of 1934, as amended, privately negotiated transactions, and/or other transactions at the Company’s discretion. The stock repurchase program, which is subject to certain consents, will expire on March 1, 2025 unless otherwise modified by the Board at any time in its sole discretion. In May 2024, the Company entered into a 10b5-1 repurchase plan with B. Riley Securities, Inc. and under this plan repurchased 184,495 shares for a total of $188 thousand, gross of fees in May 2024.

 

ITEM 6. [Reserved]

15


 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our historical consolidated financial statements and the related notes included elsewhere in this report.

This report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which are indicated by words or phrases such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “will,” “estimates,” and similar words. Forward-looking statements represent, as of the date of this report, our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond our control that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

OVERVIEW

 

Cineverse is a premier streaming technology and entertainment company with its core business operating as (i) a portfolio of owned and operated streaming channels with enthusiast fan bases; (ii) a large-scale global aggregator and full-service distributor of feature films and television programs; and (iii) a proprietary technology software-as-a-service platform for over-the-top (“OTT”) app development and content distribution through subscription video on demand ("SVOD"), dedicated ad-supported ("AVOD"), ad-supported streaming linear ("FAST") channels, social video streaming services, and audio podcasts. Our streaming channels reach audiences in several distinct ways: direct-to-consumer, through these major application platforms, and through third party distributors of content on platforms.

 

The Company’s streaming technology platform, known as MatchpointTM, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform.

Risks and Uncertainties

 

Our business and prospects are exposed to numerous risks and uncertainties. For more information, see “Item 1A. Risk Factors” in this report.

Liquidity

We have incurred net losses historically and a net loss for the year ended March 31, 2024 of $21.8 million. As of March 31, 2024, we had an accumulated deficit of $504.2 million and net cash used in operating activities for the fiscal year ended March 31, 2024 was $10.6 million. Though we have working capital of $1.5 million, we may continue to generate net losses for the foreseeable future.

 

The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $7.5 million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to September 15, 2025, subject to definitive documentation.

 

As of March 31, 2024, $6.4 million was outstanding on the Line of Credit Facility. Under the Line of Credit Facility, the Company is subject to certain financial and nonfinancial covenants including terms which require the Company to maintain certain metrics and ratios, maintain certain minimum cash on hand, and to report financial information to our lender on a periodic basis. Please see Note 5 - Debt for further information regarding the Company's Line of Credit Facility.

 

16


 

On June 16, 2023, the Company issued and sold 2,150,000 thousand shares of Common Stock, 516,667 thousand prefunded warrants, and warrants to purchase up to 2,666,667 thousand shares of Common Stock at a combined public offering price of $3.00 per share and accompanying warrant for aggregate gross proceeds of approximately $7.4 million, after deducting placement agent fees and other offering expenses in the amount of $0.6 million. The warrants have an exercise price of $3.00 per share, were exercisable immediately and will expire five years from issuance. The Company received $2.999 per share for the pre-funded warrants, with the remaining $0.001 due at the time of exercise. All 516,667 pre-funded warrants were subsequently exercised in July 2023 for total proceeds of $0.5 thousand.

 

On April 5, 2024, Cineverse Terrifier LLC (“T3 Borrower”), a wholly-owned subsidiary of the Company entered into a Loan and Security Agreement with BondIt LLC (“T3 Lender”) and the Company, as a guarantor (the “T3 Loan Agreement”). The T3 Loan Agreement provides for a term loan with a principal amount not to exceed $3,666,000 (the “T3 Loan”), and a maturity date of April 1, 2025, unless extended for 120 days under certain conditions. The T3 Loan bears no interest until the maturity date other than an interest advance equal to $576,000 at the closing of the T3 Loan on April 5, 2024. After the principal of the T3 Loan is paid in full, T3 Lender will be entitled to receive 15% of all royalties earned by the Company on the Film under its distribution agreements for the Film until T3 Lender has received 1.75 times the full commitment amount of $3,666,000, consisting of the principal amount plus interest and fees advanced to T3 Borrower, plus any extension interest. See Note 8 - Subsequent Events for further information.

 

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on Nasdaq at the time of the sale of such shares. For the twelve months ended March 31, 2024, the Company sold 176,751 thousand shares for $1.1 million in net proceeds, respectively, after deduction of commissions and fees. The ATM Sales Agreement has expired in accordance with its terms.

 

On May 3, 2024, the Company entered into a Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners and The Benchmark Company, LLC (collectively, the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of its Class A common stock, par value $0.001 per share (the “Common Stock”). Shares of Common Stock may be offered and sold for an aggregate offering price of up to $15 million. The Sales Agents’ obligations to sell shares under the Sales Agreement are subject to satisfaction of certain conditions, including the continuing effectiveness of the Registration Statement on Form S-3 (Registration No. 333-273098) (the “Registration Statement”) filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on June 30, 2023 and declared effective by the SEC on January 25, 2024, and other customary closing conditions. The Company will pay the Sales Agents a commission of 3.00% of the aggregate gross proceeds from each sale of shares and has agreed to provide the Sales Agents with customary indemnification and contribution rights. The Company has also agreed to reimburse the Sales Agents for certain specified expenses. The Company is not obligated to sell any shares under the Sales Agreement and has not sold any shares through the date of this report.

 

The Company will continue to invest in content development and acquisition, from which it believes it will obtain an appropriate return on its investment. As of March 31, 2024 and March 31, 2023, short term content advances were $9.3 million and $3.7 million, respectively, and content advances, net of current portion were, $2.6 million and $1.4 million, respectively.

Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. We believe our cash and cash equivalent balances as of March 31, 2024 (See Note 8 - Subsequent Events) will be sufficient to support our operations for at least twelve months from the filing of this report. The Company may also undertake equity or debt offerings, if necessary and opportunistically available, for further capital needs.

17


 

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In connection with the preparation of our consolidated financial statements, we are required to make assumptions and estimates about future events and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our consolidated financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

Our significant accounting policies are discussed in Note 2 – Basis of Presentation and Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of this Annual Report on Form 10-K. Management believes that the following accounting policies are the most critical to aid in fully understanding and evaluating our reported financial results, and they require management’s most difficult, subjective or complex judgments, resulting from the need to make estimates about the effect of matters that are inherently uncertain. Management has reviewed these critical accounting estimates and related disclosures with the Audit Committee of our Board of Directors.

FAIR VALUE ESTIMATES

Goodwill

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

In certain reporting periods, the Company may have the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.

Property and Equipment, net and Intangible Assets, net

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. Determining whether impairment has occurred typically requires various estimates and assumptions, including determining which cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount and the asset’s residual value, if any. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the assets the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows.

In the years ended March 31, 2024 and 2023, no impairment charges were recorded to intangible assets.

18


 

REVENUE RECOGNITION

We determine revenue recognition by:

identifying the contract, or contracts, with the customer;
identifying the performance obligations in the contract;
determining the transaction price;
allocating the transaction price to performance obligations in the contract; and
recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.

We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (DVD’s and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities, such as sales value-added taxes and other similar taxes.

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less.

Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”) on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied, which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation.

Revenue from the sale of physical goods is recognized after deducting reserves for sales returns and other allowances. Reserves for potential sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

For the theatrical distribution of third party feature movies and alternative content, distribution fee revenue and participation in box office receipts are recognized at the time a feature movie and alternative content are viewed. The Company may have the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

Principal Agent Considerations

We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

which party is primarily responsible for fulfilling the promise to provide the specified good or service; and
which party has discretion in establishing the price for the specified good or service.

19


 

Shipping and Handling

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in direct operating expenses because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

Credit Losses

We maintain reserves for expected credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical credit losses, customer concentrations, customer credit worthiness, current and forecasted economic trends and changes in customer payment patterns to evaluate the adequacy of this allowance.

Contract Assets and Liabilities

We generally record a receivable related to revenue or a unbilled revenue (contract asset) when we have an unconditional right to invoice and receive payment. Unbilled revenue includes an accrued revenue, the right to which has been earned at the period end based on completed performance. We record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable. Deferred revenue includes payments related to the sale of DVDs with future release dates or subscription dues paid in advance.

Deferred revenue which is short term in nature, carried a balance as of March 31, 2024 and 2023 of $0.4 million and $0.2 million, respectively. For the years ended March 31, 2024 and 2023, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.

Participations and Royalties Payable

When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

ASSET ACQUISITIONS

An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business as substantially all of the fair value of the gross assets acquired are concentrated in a single or group of similar, identifiable assets. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on a relative fair value basis. Determining the cost of an acquisition may require judgment in certain circumstances depending on the nature of the asset transferred as consideration.

 

20


 

Results of Operations for the Fiscal Years Ended March 31, 2024 and 2023 (in thousands, except where noted below)

Revenues

 

 

For the Fiscal Year Ended March 31,

 

 

 

2024

 

 

2023

 

 

$ Change

 

 

% Change

 

Streaming and digital

 

$

37,312

 

 

$

40,423

 

 

$

(3,111

)

 

 

(8

)%

Base distribution

 

 

5,259

 

 

 

13,341

 

 

$

(8,082

)

 

 

(61

)%

Podcast and other

 

 

2,718

 

 

 

2,213

 

 

$

505

 

 

 

23

%

Other non-recurring

 

 

3,842

 

 

 

12,049

 

 

$

(8,207

)

 

 

(68

)%

Total Revenue

 

$

49,131

 

 

$

68,026

 

 

$

(18,895

)

 

 

(28

)%

 

For the twelve months ended March 31, 2024, the Company's revenue declined by $18.9 million. The decrease was driven by the decrease in Other non-recurring revenue, related to the run-off of the Company's legacy digital cinema business. Following the legacy business' active operations' run-off at the end of fiscal year 2023, the Company had $0.5 million of digital system sales, with the remaining $3.3 million revenue relating to the recognition of previously constrained variable consideration. The Company does not anticipate this revenue to recur at a substantial level in fiscal year 2025 and beyond.

 

In addition, the Company experienced a $8.1 million decline in the Company's base distribution, driven by a $3.8 million decline in theatrical revenue following fiscal year 2023's theatrical success with films such as Terrifier 2, a $3.0 million decrease in DVD and related supply chain revenue, as the Company has shifted its focus away from the physical business.

 

Streaming and digital revenue decreased by $3.1 million, driven by a $6.6 million decrease in AVOD from the headwinds faced in the advertising market, partially offset by a $2.7 million increase in SVOD and a $0.6 million increase from digital revenue as the Company continued to see the benefits from recent years' acquisitions, such as DMR, Fandor and Bloody Disgusting, which have contributed value-accretive libraries, distribution platforms and technologies.

Direct Operating Expenses

 

 

For the Fiscal Year Ended March 31,

 

 

 

2024

 

 

2023

 

 

$ Change

 

 

% Change

 

Direct operating expenses

 

$

19,131

 

 

$

36,364

 

 

$

(17,233

)

 

 

(47

)%

 

For the twelve months ended March 31, 2024, the Company's direct operating expenses decreased $17.2 million. The decrease was primarily driven by a $7.0 million reduction in royalties and participation expenses from lower revenue and a $2.3 million decrease in estimated OTT royalty accrual as of March 31, 2024, $3.1 million in fulfillment and manufacturing costs associated with the decline in the Company's physical distribution business, a $1.9 million decrease in the Company's costs associated with the Company's reserves against advances to partners, and a $0.6 million decrease related to the estimated Bloody Disgusting earnout liability based on fiscal year 2024 performance.

 

21


 

Selling, General and Administrative Expenses

 

 

For the Fiscal Year Ended March 31,

 

 

 

2024

 

 

2023

 

 

$ Change

 

 

% Change

 

Compensation expense

 

 

17,756

 

 

$

20,190

 

 

$

(2,434

)

 

 

(12

)%

Corporate expenses

 

 

3,762

 

 

 

5,538

 

 

 

(1,777

)

 

 

(32

)%

Share-based compensation

 

 

1,439

 

 

 

4,807

 

 

 

(3,368

)

 

 

(70

)%

Other operating expenses

 

 

4,947

 

 

 

6,284

 

 

 

(1,337

)

 

 

(21

)%

Selling, General and Administrative

 

$

27,904

 

 

$

36,819

 

 

$

(8,915

)

 

 

(24

)%

 

During the twelve months ended March 31, 2024, the Company's SG&A decreased by $8.9. million relative to the twelve months ended March 31, 2023.

 

The decrease was primarily related to a decrease in share-based expense of $3.4 million as a result of the US-based workforce reduction, a decline in stock price, and a number of legacy awards tranches fully vesting.

 

Compensation expense also declined primarily due to a $2.1 million decrease in employee wage, tax, and benefit-related expenses as a result of the lower cost from a shift in employees to Cineverse Services India, and a reduction in the Company's bonus expense of $1.1 million based on fiscal year 2024 performance, partially offset by a $0.5 million increase in severance expense.

 

Corporate expenses declined by $1.8 million primarily decreased due to a corporate focus on reducing third-party costs due to the Company's cost-saving initiatives, including $1.1 million in consulting and service providers and legal costs in the amount of $0.9 million.

 

Other operating expense declined by $1.3, which includes $0.9 million from decreased legal settlement costs and $0.8 million reduction in direct marketing campaigns.

Depreciation and Amortization

 

 

For the Fiscal Year Ended March 31,

 

 

 

2024

 

 

2023

 

 

$ Change

 

 

% Change

 

Amortization of intangible assets

 

$

3,196

 

 

$

2,888

 

 

$

308

 

 

 

11

%

Depreciation of property and equipment

 

 

575

 

 

 

875

 

 

 

(300

)

 

 

(34

)%

Depreciation and Amortization

 

$

3,771

 

 

$

3,763

 

 

$

8

 

 

 

0

%

 

Depreciation expense decreased primarily due to the remainder of our digital cinema assets reaching the conclusion of their ten-year useful lives during the fiscal year ended March 31, 2023. Amortization expense has continued to increase as a result of the Company's shift away from the physical business to its focus on content-related spend, including $0.2 million from the amortization of capitalized content costs.

Goodwill impairment

For the twelve months ended March 31, 2024, the Company recognized an impairment on its carrying value of goodwill in the amount of $14.0 million following a sustained depressed share price for the Company's fiscal year 2024, which was deemed a triggering event. In accordance with process outlined in ASC 350, the Company first determined that its finite long-lived assets were recoverable. The impairment was quantified using a market multiple approach which utilized information from comparable businesses. The Company does not anticipate any material change to future operating cash flows as a result of the impairment recognized.

 

22


 

Interest expense

 

Interest expense decreased by $0.2 million to $1.1 million for the twelve months ended March 31, 2024 primarily as a result of lower deferred and earnout consideration accretion related to the acquisitions of Bloody Disgusting and DMR.

Loss from equity investment in Metaverse, a related party

Following the halting of trading on The Stock Exchange of Hong Kong Limited in April 2022, the Company valued our equity investment in Metaverse as of March 31, 2023 using a market approach and categorized it as a Level 3 investment (See Note 2, Basis of Presentation and Summary of Significant Accounting Policies). As of March 31, 2023, the fair value was $5.2 million, resulting in a decrease in fair value of $1.8 million for the year ended March 31, 2023.

 

On November 6, 2023, Metaverse's stock resumed trading on The Stock Exchange of Hong Kong Limited. During the year ended March 31, 2024, the Company sold 220,550,005 of its original 362,307,397 million shares held as of March 31, 2023, which resulted in a realized loss of $0.3 thousand during the twelve months ended March 31, 2024. The resumption of active trading status represented renewed availability of quoted, unadjusted prices in active markets for identical assets, upon which the Company can execute a sale and readily access pricing information at the measurement date. Accordingly, the Company has presented the fair value of its Metaverse shares held as of March 31, 2024 within the Level 1 grouping. The fair value of the shares held as of March 31, 2024 was $0.4 million, with associated losses of $4.3 million recognized during the fiscal year ended March 31, 2024.

 

Employee Retention Tax Credit

 

The Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") provided an employee retention credit that was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the "Appropriations Act") extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to 70% of qualified wages paid to employees during the 2021 fiscal year.

 

The Company qualified for the employee retention credit beginning in June 2020 for qualified wages through September 2021 and filed a cash refund claim during the fiscal year ended March 31, 2023 in the amount of $2.5 million in the Employee retention tax credit line on the Company’s Consolidated Statements of Operations.

 

As of March 31, 2024 and March 31, 2023, the tax credit receivable of $1.7 and $2.1 million, respectively, has been included in the Employee retention tax credit line on the Company's Consolidated Balance Sheet. The Company received notification during the second quarter of fiscal year 2024 that its ERTC claim was under examination with the Internal Revenue Service ("IRS"). In April 2024, the Company received a letter from the IRS indicating that its claim had been accepted and $1.7 million was received in June 2024.

Income Tax Expense

For the year ended March 31, 2024, the Company had income tax expense of $10 thousand consisted of $35 thousand of current foreign income taxes, offset by the recognition of a $14 thousand deferred tax benefit, and a tax benefit of $11 thousand for a return to provision adjustment related to U.S. state income taxes.

 

Adjusted EBITDA

We define Adjusted EBITDA to be earnings before interest, taxes, depreciation and amortization, other income, net, stock-based compensation and expenses, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and non-recurring items.

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the

23


 

financial performance of the business because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including its stockholders, as a valuable financial metric.

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net income (loss) from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net loss from continuing operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to loss from operations or net loss from continuing operations as an indicator of performance or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

Following is the reconciliation of our consolidated net loss to Adjusted EBITDA (in thousands):

 

For the Fiscal Year Ended March 31,

 

 

2024

 

 

2023

 

Net loss

$

(21,265

)

 

$

(9,694

)

Add Back:

 

 

 

 

 

Income tax expense

 

10

 

 

 

119

 

Depreciation and amortization

 

3,771

 

 

 

3,763

 

Interest expense

 

1,066

 

 

 

1,290

 

Loss from equity investment in Metaverse

 

4,299

 

 

 

1,828

 

Provision for credit losses

 

 

 

 

54

 

Stock-based compensation

 

1,439

 

 

 

4,470

 

Employee retention tax credit

 

 

 

 

(2,475

)

Other (income) expense, net

 

(140

)

 

 

13

 

Net income attributable to noncontrolling interest

 

(142

)

 

 

(39

)

Goodwill impairment

 

14,025

 

 

 

 

Transition-related costs

 

1,335

 

 

 

541

 

Mergers and acquisition costs

 

 

 

 

207

 

Adjusted EBITDA

$

4,398

 

 

$

76

 

 

Recent Accounting Pronouncements

See Note 2 - Basis of Presentation and Summary of Significant Accounting Policies to our consolidated financial statements included herein.

24


 

Cash Flow

Changes in our cash flows were as follows (in thousands):

 

 

For the Fiscal Year Ended
March 31,

 

 

 

2024

 

 

2023

 

Net cash used in operating activities

 

 

(10,593

)

 

$

(8,797

)

Net cash used in investing activities

 

 

(531

)

 

 

(1,271

)

Net cash provided by financing activities

 

 

9,138

 

 

 

4,158

 

Net change in cash and cash equivalents

 

$

(1,985

)

 

$

(5,910

)

 

As of March 31, 2024 and 2023, we had cash balances of $5.2 million and $7.2 million, respectively.

For the year ended March 31, 2024, the change in net cash used in operating activities was primarily driven by a net loss of $21.3 million and decreases from the Company's operating assets and liabilities ($11.5 million), offset by the non-cash goodwill impairment charge of $14.0 million, depreciation and amortization of $3.8 million, and the non-cash change in the valuation of the Company's investment in Metaverse which is recognized in earnings ($4.3 million).

Cash flows used in investing activities of $0.5 million were driven by the acquisition of long-lived fixed and intangible assets, partially offset by cash received from the sale of Company shares in Metaverse.

Cash flows provided by financing activities were driven by issuance of the Company's Class A common stock in the first quarter of fiscal year 2024 ($8.5 million) and a net increase of $1.4 million funds, following the Company's expansion of its revolving line of credit from $5.0 million to $7.5 million in February 2024.

For the year ended March 31, 2023, net cash used by operating activities was primarily driven by a net loss ($9.7 million), offset by non-cash expenses of stock based compensation ($4.4 million), allowance against advances, a decrease in the valuation of the Company's investment in Metaverse, and non-cash interest expense. The Company's changes in working capital also contributed to cash used operations, highlighted by a decrease in accounts payable and accrued expenses by $18.0 million, offset by a decrease in accounts receivable by $9.9 million, due to the continued growth in streaming.

Cash flows used in investing activities consisted of purchases of property and equipment of $0.7 million, and expenditures to acquire intangible assets of $0.6 million.

Cash flows provided by financing activities consisted of drawdowns under the line of credit of $31.0 million and corresponding repayments of $26.0 million. Additionally, the Company paid $0.7 million in acquisition-related liabilities and $0.2 million for deferred financing fees.

Contractual Obligations

The following table summarizes our significant recognized contractual obligations as of March 31, 2024 (in thousands):

 

 

 

Payments Due

 

Contractual Obligations

 

Total

 

 

2025

 

 

2026

 

 

2027

 

 

2028

 

 

2029

 

 

Thereafter

 

Operating lease obligations

 

$

905

 

 

$

423

 

 

$

200

 

 

$

210

 

 

$

72

 

 

$

 

 

$

 

In addition, the Company presents its unrecognized commitments to content partners in the notes to the Financial Statements, Note 6 - Commitments and Contingencies.

Seasonality

The timing of movie and streaming content releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or any other quarter. While our business benefits from the winter holiday season, we believe the seasonality of the movie and streaming landscape,

25


 

is becoming less pronounced as the motion picture studios are releasing movies somewhat more evenly throughout the year.

Off-Balance Sheet Arrangements

We are not a party to any off-balance sheet arrangements. In addition, as discussed further in Note 2 - Basis of Presentation and Summary of Significant Accounting Policies and Note 3 - Other Interests to the consolidated financial statements included in Item 8 of this Annual Report on Form 10-K, we hold a 100% equity interest in CDF2 Holdings, which is an unconsolidated variable interest entity (“VIE”), which wholly owns CDF2; however, we are not the primary beneficiary of the VIE.

Impact of Inflation

The impact of inflation on our operations has not been significant to date. However, there can be no assurance that a sustained high rate of inflation in the future would not have an adverse impact on our operating results.

26


 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Cineverse Corp.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm (PCAOB ID# 274)

F-1

Consolidated Balance Sheets at March 31, 2024 and 2023

F-3

Consolidated Statements of Operations for the fiscal years ended March 31, 2024 and 2023

F-4

Consolidated Statements of Comprehensive Loss for the fiscal years ended March 31, 2024 and 2023

F-5

Consolidated Statements of Cash Flows for the fiscal years ended March 31, 2024 and 2023

F-6

Consolidated Statements of Equity for the fiscal years ended March 31, 2024 and 2023

F-9

Notes to Consolidated Financial Statements

F-10

27


 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

Cineverse Corp.

 

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Cineverse Corp. (the “Company”) as of March 31, 2024 and 2023, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of March 31, 2024 and 2023, and the consolidated results of their operations and their cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Goodwill Impairment Assessment

As discussed in Note 2, the Company performs goodwill impairment testing on an annual basis on March 31 at the end of its fiscal year or when events occur or circumstances change that would indicate the carrying value exceeds the

F-1


 

fair value. An impairment loss is recognized when the carrying amount of a reporting unit’s net assets exceeds the estimated fair value of the reporting unit. These estimates are subject to significant management judgment, including the determination of many factors such as, but not limited to, selection of the appropriate valuation model in estimating the fair value and selection of guideline peer public companies. Changes in these estimates can have a significant impact on the determination of cash flows and the resulting fair values. During the fourth quarter of the year ended March 31, 2024, the Company determined that the Company’s declining stock price was a triggering event which required a quantitative evaluation of goodwill at March 31, 2024. As part of their quantitative assessment, the fair value was determined using a market approach. Based on the impairment test performed, the Company recorded a $14.0 million impairment charge.

We identified the goodwill impairment assessment as a critical audit matter because of the significant management judgment and subjectivity in developing the fair value measurement of the reporting unit. This required a high degree of auditor judgment and an increase in audit effort to perform procedures and evaluate audit evidence related to the consideration of the valuation model selected by management, the consideration of the reasonableness of the guideline peer public companies selected and consideration of the market capitalization of the Company in relation to the estimated fair value.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, (i) obtaining an understanding of management’s process and evaluating the design of controls related to the goodwill impairment assessment; (ii) testing management’s process for developing the fair value estimate; (iii) evaluating the appropriateness of the valuation model used in management’s estimate; (iv) testing the completeness, accuracy, and evaluating the reconciliation of estimated fair value to the Company’s stock price in relation to relevant transactions. We involved valuation professionals with specialized skills and knowledge when performing audit procedures to evaluate the reasonableness of Management’s estimates and assumptions related to the selection the appropriate valuation model and reconciliation of fair value to the Company’s stock price.

 

/s/EISNERAMPER LLP

 

We have served as the Company’s auditor since 2004.

EISNERAMPER LLP

Iselin, New Jersey

July 1, 2024

F-2


 

Cineverse Corp.

CONSOLIDATED BALANCE SHEETS

(In thousands, except for share and per share data)

 

 

March 31,

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

5,167

 

 

$

7,152

 

Accounts receivable, net of allowance for credit losses of $269 and $0, respectively

 

 

8,667

 

 

 

20,846

 

Unbilled revenue

 

 

6,439

 

 

 

2,036

 

Employee retention tax credit

 

 

1,671

 

 

 

2,085

 

Content advances

 

 

9,345

 

 

 

3,724

 

Other current assets

 

 

1,432

 

 

 

1,734

 

Total current assets

 

 

32,721

 

 

 

37,577

 

Equity investment in Metaverse, a related party, at fair value

 

 

362

 

 

 

5,200

 

Property and equipment, net

 

 

2,276

 

 

 

1,833

 

Intangible assets, net

 

 

18,328

 

 

 

19,868

 

Goodwill

 

 

6,799

 

 

 

20,824

 

Content advances, net of current portion

 

 

2,551

 

 

 

1,421

 

Other long-term assets

 

 

1,341

 

 

 

1,265

 

Total Assets

 

$

64,378

 

 

$

87,988

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

20,817

 

 

$

34,531

 

Line of credit, including unamortized debt issuance costs of $81 and $76, respectively

 

 

6,301

 

 

 

4,924

 

Current portion of deferred consideration on purchase of business

 

 

3,114

 

 

 

3,788

 

Earnout consideration on purchase of business

 

 

180

 

 

 

1,444

 

Current portion of operating lease liabilities

 

 

401

 

 

 

418

 

Deferred revenue

 

 

436

 

 

 

226

 

Total current liabilities

 

 

31,249

 

 

 

45,331

 

Deferred consideration on purchase of business, net of current portion

 

 

457

 

 

 

2,647

 

Operating lease liabilities, net of current portion

 

 

462

 

 

 

863

 

Other long-term liabilities

 

 

59

 

 

 

74

 

Total Liabilities

 

 

32,227

 

 

 

48,915

 

Commitments and contingencies (see Note 6)

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at March 31, 2024 and March 31, 2023. Liquidation preference of $3,648.

 

 

3,559

 

 

 

3,559

 

Common Stock, $0.001 par value; Class A Stock: 275,000,000 shares authorized as of March 31, 2024, and March 31, 2023; 15,985,620 and 9,413,597 shares issued, with 15,699,135 and 9,347,805 shares outstanding as of March 31, 2024, and March 31, 2023, respectively.

 

 

194

 

 

 

185

 

Additional paid-in capital

 

 

545,996

 

 

 

530,998

 

Treasury stock, at cost; 288,554 and 65,792 shares at March 31, 2024 and March 31, 2023, respectively.

 

 

(11,978

)

 

 

(11,608

)

Accumulated deficit

 

 

(504,153

)

 

 

(482,395

)

Accumulated other comprehensive loss

 

 

(345

)

 

 

(402

)

Total stockholders’ equity of Cineverse Corp.

 

 

33,273

 

 

 

40,337

 

Deficit attributable to noncontrolling interest

 

 

(1,122

)

 

 

(1,264

)

Total equity

 

 

32,151

 

 

 

39,073

 

Total Liabilities and Equity

 

$

64,378

 

 

$

87,988

 

See accompanying Notes to Consolidated Financial Statements

F-3


 

Cineverse Corp.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except for per share data)

 

 

For the Fiscal Year Ended
March 31,

 

 

2024

 

 

2023

 

Revenues

$

49,131

 

 

$

68,026

 

Costs and expenses

 

 

 

 

 

Direct operating

 

19,131

 

 

 

36,364

 

Selling, general and administrative

 

27,904

 

 

 

36,819

 

Depreciation and amortization

 

3,771

 

 

 

3,763

 

Goodwill impairment

 

14,025

 

 

 

 

Total operating expenses

 

64,831

 

 

 

76,946

 

Operating loss

 

(15,700

)

 

 

(8,920

)

Interest expense

 

(1,066

)

 

 

(1,290

)

Loss from equity investment in Metaverse, a related party

 

(4,299

)

 

 

(1,828

)

Employee retention tax credit

 

 

 

 

2,475

 

Other expenses, net

 

(190

)

 

 

(13

)

Net loss before income taxes

 

(21,255

)

 

 

(9,575

)

Income tax expense

 

(10

)

 

 

(119

)

Net loss

 

(21,265

)

 

 

(9,694

)

Net income attributable to noncontrolling interest

 

(142

)

 

 

(39

)

Net loss attributable to controlling interests

 

(21,407

)

 

 

(9,734

)

Preferred stock dividends

 

(350

)

 

 

(351

)

Net loss attributable to common stockholders

$

(21,757

)

 

$

(10,085

)

Net loss per share attributable to common stockholders:

 

 

 

 

 

Basic

$

(1.78

)

 

$

(1.13

)

Diluted

$

(1.78

)

 

$

(1.13

)

Weighted average shares of Common Stock outstanding:

 

 

 

 

 

Basic

 

12,253

 

 

 

8,889

 

Diluted

 

12,253

 

 

 

8,889

 

 

See accompanying Notes to Consolidated Financial Statements

F-4


 

Cineverse Corp.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(In thousands)

 

For the Fiscal Year Ended
March 31,

 

2024

 

 

2023

 

Net loss

$

(21,265

)

 

$

(9,694

)

Other comprehensive loss:

 

 

 

 

 

Foreign exchange translation

 

57

 

 

 

(239

)

Net income attributable to noncontrolling interest

 

(142

)

 

 

(39

)

Comprehensive loss

$

(21,350

)

 

$

(9,973

)

 

See accompanying Notes to Consolidated Financial Statements

F-5


 

Cineverse Corp.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

For the Fiscal Year Ended
March 31,

 

 

 

2024

 

 

2023

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(21,265

)

 

$

(9,694

)

Adjustments to reconcile net loss to cash used in operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

3,771

 

 

 

3,829

 

Impairment of goodwill

 

 

14,025

 

 

 

 

Changes in fair value of equity investment in Metaverse

 

 

4,299

 

 

 

1,828

 

Amortization of debt issuance costs

 

 

188

 

 

 

101

 

Stock-based compensation

 

 

1,439

 

 

 

4,470

 

Change in estimated earnout consideration

 

 

(612

)

 

 

80

 

Interest expense for deferred consideration and earnouts

 

 

503

 

 

 

986

 

Capitalized content expenditures

 

 

(1,822

)

 

 

 

Stock-based bonus to acquired company

 

 

100

 

 

 

 

Revenue recognized under nonmonetary purchase and exchange of content

 

 

 

 

 

(1,022

)

Barter-related non-cash expenses

 

 

341

 

 

 

 

Other

 

 

(16

)

 

 

130

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

11,969

 

 

 

9,943

 

Content advances

 

 

(5,621

)

 

 

1,075

 

Unbilled revenue

 

 

(4,403

)

 

 

313

 

Other current and long-term assets

 

 

(942

)

 

 

(2,816

)

Accounts payable and accrued expenses

 

 

(12,756

)

 

 

(18,049

)

Deferred revenue

 

 

210

 

 

 

30

 

Net cash used in operating activities

 

$

(10,593

)

 

$

(8,796

)

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(1,069

)

 

 

(1,271

)

Sale of investment securities

 

 

538

 

 

 

 

Net cash used in investing activities

 

$

(531

)

 

$

(1,271

)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from line of credit

 

 

43,955

 

 

 

31,046

 

Payments on line of credit

 

 

(42,572

)

 

 

(26,046

)

Payment of business acquisition related liabilities

 

 

(576

)

 

 

(665

)

Financing fees for line of credit

 

 

(193

)

 

 

(177

)

Issuance of Class A common stock, net of issuance costs

 

 

8,524

 

 

 

 

Net cash provided by financing activities

 

$

9,138

 

 

$

4,158

 

Net change in cash and cash equivalents

 

 

(1,985

)

 

 

(5,910

)

Cash and cash equivalents at beginning of year

 

 

7,152

 

 

 

13,062

 

Cash and cash equivalents at end of year

 

$

5,167

 

 

$

7,152

 

 

See accompanying Notes to Consolidated Financial Statements

F-6


 

Cineverse Corp.

SUPPLEMENTAL CASH FLOW INFORMATION AND DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITY

(In thousands)

 

 

For the Fiscal Year Ended
March 31,

 

 

 

2024

 

 

2023

 

Cash interest paid

 

$

376

 

 

$

203

 

Lease liability related payments

 

$

446

 

 

$

373

 

Income taxes paid

 

$

55

 

 

$

98

 

Noncash investing and financing activities:

 

 

 

 

 

 

Issuance of Class A common stock for payment of accrued employee bonuses

 

$

1,203

 

 

$

 

Accrued dividends on preferred stock

 

$

89

 

 

$

87

 

Issuance of Class A common stock for intangible asset purchase

 

$

 

 

$

898

 

Right of use assets recognized underlying lease arrangements

 

$

 

 

$

781

 

Treasury shares acquired for withholding taxes

 

$

370

 

 

$

5

 

Deferred consideration settled in stock

 

$

3,000

 

 

$

3,000

 

Earnout liability settled in stock

 

$

392

 

 

$

238

 

Issuance of Class A common stock for payment of accrued preferred stock dividends

 

$

350

 

 

$

351

 

 

See accompanying Notes to Consolidated Financial Statements

F-7


 

Cineverse Corp.

CONSOLIDATED STATEMENTS OF EQUITY

(In thousands)

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Treasury

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

Non
Controlling

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

Equity

 

 

Interest

 

 

Total

 

Balances as of March 31, 2023

 

 

1

 

 

$

3,559

 

 

 

9,348

 

 

$

185

 

 

 

66

 

 

$

(11,608

)

 

$

530,998

 

 

$

(482,395

)

 

$

(402

)

 

$

40,337

 

 

$

(1,264

)

 

$

39,073

 

Foreign exchange translation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

57

 

 

 

57

 

 

 

 

 

 

57

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,271

 

 

 

 

 

 

 

 

 

1,271

 

 

 

 

 

 

1,271

 

Preferred stock dividends paid with common stock

 

 

 

 

 

 

 

 

196

 

 

 

0

 

 

 

 

 

 

 

 

 

350

 

 

 

 

 

 

 

 

 

350

 

 

 

 

 

 

350

 

Preferred stock dividends accrued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(350

)

 

 

 

 

 

(350

)

 

 

 

 

 

(350

)

Issuance of common stock for Board of Director compensation

 

 

 

 

 

 

 

 

400

 

 

 

 

 

 

 

 

 

 

 

 

168

 

 

 

 

 

 

 

 

 

168

 

 

 

 

 

 

168

 

Issuance of Class A common stock in connection with ATM raises, net

 

 

 

 

 

 

 

 

177

 

 

 

3

 

 

 

 

 

 

 

 

 

1,080

 

 

 

 

 

 

 

 

 

1,084

 

 

 

 

 

 

1,084

 

Issuance of Class A common stock in connection with direct equity offering

 

 

 

 

 

 

 

 

2,150

 

 

 

2

 

 

 

 

 

 

 

 

 

7,437

 

 

 

 

 

 

 

 

 

7,439

 

 

 

 

 

 

7,439

 

Issuance of Class A common stock in connection employee bonuses

 

 

 

 

 

 

 

 

725

 

 

 

1

 

 

 

 

 

 

 

 

 

1,203

 

 

 

 

 

 

 

 

 

1,203

 

 

 

 

 

 

1,203

 

Issuance in connection with the exercise of warrants

 

 

 

 

 

 

 

 

517

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

Issuance of Class A common stock for earnout commitment

 

 

 

 

 

 

 

 

41

 

 

 

 

 

 

 

 

 

 

 

 

392

 

 

 

 

 

 

 

 

 

392

 

 

 

 

 

 

392

 

Treasury stock in connection with taxes withheld from employees

 

 

 

 

 

 

 

 

(223

)

 

 

 

 

 

223

 

 

 

(370

)

 

 

 

 

 

 

 

 

 

 

 

(370

)

 

 

 

 

 

(370

)

Issuance of common stock for deferred and earnout consideration

 

 

 

 

 

 

 

 

2,369

 

 

 

3

 

 

 

 

 

 

 

 

 

3,097

 

 

 

 

 

 

 

 

 

3,100

 

 

 

 

 

 

3,100

 

Net loss (income)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(21,407

)

 

 

 

 

 

(21,407

)

 

 

142

 

 

 

(21,265

)

Balances as of March 31, 2024

 

 

1

 

 

$

3,559

 

 

 

15,699

 

 

$

194

 

 

 

289

 

 

$

(11,978

)

 

$

545,996

 

 

$

(504,153

)

 

$

(345

)

 

$

33,273

 

 

$

(1,122

)

 

$

32,151

 

 

See accompanying Notes to Consolidated Financial Statements

 

 

F-8


 

 

Cineverse Corp.

CONSOLIDATED STATEMENTS OF EQUITY

(In thousands)

 

 

 

Series A
Preferred Stock

 

 

Class A
Common Stock

 

 

Treasury
Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Accumulated Other

 

 

Total
Stockholders’
Equity

 

 

Non-
Controlling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Comprehensive Loss

 

 

(Deficit)

 

 

Interest

 

 

Equity

 

Balances as of March 31, 2022

 

 

1

 

 

$

3,559

 

 

 

8,766

 

 

$

174

 

 

 

66

 

 

$

(11,608

)

 

$

522,601

 

 

$

(472,310

)

 

$

(163

)

 

$

42,253

 

 

$

(1,303

)

 

 

40,950

 

 Foreign exchange translation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(239

)

 

 

(239

)

 

 

 

 

 

(239

)

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,045

 

 

 

 

 

 

 

 

 

3,045

 

 

 

 

 

 

3,045

 

Preferred stock dividends paid with common stock

 

 

 

 

 

 

 

 

37

 

 

 

 

 

 

 

 

 

 

 

 

351

 

 

 

 

 

 

 

 

 

351

 

 

 

 

 

 

351

 

Preferred stock dividends accrued

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(351

)

 

 

 

 

 

(351

)

 

 

 

 

 

(351

)

Issuance of common stock for with PSUs and incentives, net of payroll taxes

 

 

 

 

 

 

 

 

103

 

 

 

2

 

 

 

 

 

 

 

 

 

871

 

 

 

 

 

 

 

 

 

873

 

 

 

 

 

 

873

 

Issuance of common stock for earnout commitment

 

 

 

 

 

 

 

 

17

 

 

 

 

 

 

 

 

 

 

 

 

238

 

 

 

 

 

 

 

 

 

238

 

 

 

 

 

 

238

 

Issuance of common stock for Board of Director compensation

 

 

 

 

 

 

 

 

34

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

1

 

Issuance of common stock for acquisition

 

 

 

 

 

 

 

 

391

 

 

 

8

 

 

 

 

 

 

 

 

 

3,892

 

 

 

 

 

 

 

 

 

3,900

 

 

 

 

 

 

3,900

 

Net loss (income)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,734

)

 

 

 

 

 

(9,734

)

 

 

39

 

 

 

(9,694

)

Balances as of March 31, 2023

 

 

1

 

 

$

3,559

 

 

 

9,348

 

 

$

185

 

 

 

66

 

 

$

(11,608

)

 

$

530,998

 

 

$

(482,395

)

 

$

(402

)

 

$

40,337

 

 

$

(1,264

)

 

 

39,073

 

 

See accompanying Notes to Consolidated Financial Statements

F-9


 

Cineverse Corp.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. NATURE OF OPERATIONS AND LIQUIDITY

Cineverse Corp. (“Cineverse”, “us”, "we", “our”, and “Company” refers to Cineverse Corp. and its subsidiaries unless the context otherwise requires) was incorporated in Delaware on March 31, 2000.

 

Cineverse is a premier streaming technology and entertainment company with its core business operating as (i) a portfolio of owned and operated streaming channels with enthusiast fan bases; (ii) a large-scale global aggregator and full-service distributor of feature films and television programs; and (iii) a proprietary technology software-as-a-service platform for over-the-top (“OTT”) app development and content distribution through subscription video on demand ("SVOD"), dedicated ad-supported ("AVOD"), ad-supported streaming linear ("FAST") channels, social video streaming services, and audio podcasts. Our streaming channels reach audiences in several distinct ways: direct-to-consumer, through these major application platforms, and through third party distributors of content on platforms.

 

The Company’s streaming technology platform, known as MatchpointTM, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform.

 

Financial Condition and Liquidity

 

As of March 31, 2024, the Company has an accumulated deficit of $504.2 million. For the year ended March 31, 2024, the Company had a net loss attributable to common shareholders of $21.8 million. Though the Company had positive working capital of $1.5 million, net cash used in operating activities for the year ended March 31, 2024 was $10.6 million. We may continue to generate net losses for the foreseeable future.

 

The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $7.5 million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to September 15, 2025, subject to definitive documentation. For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.

 

Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. We believe our cash and cash equivalent balances as of March 31, 2024 (See Note 8 - Subsequent Events) will be sufficient to support our operations for at least twelve months from the filing of this report. The Company may also undertake equity or debt offerings, if necessary and opportunistically available, for further capital needs.

2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation

 

The accompanying consolidated financial statements of Cineverse Corp. have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). These consolidated financial Statements have been prepared by the Company following the rules and regulations of the SEC. All intercompany transactions and balances have been eliminated in consolidation. Certain columns and rows may not add due to rounded numbers.

 

We own an 85% interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the internet and other consumer digital distribution platforms,

F-10


 

such as gaming consoles, set-top boxes, handsets, and tablets. We evaluated the investment under the voting interest entity model and determined that the entity should be consolidated as we have a controlling financial interest in the entity through our ownership of outstanding voting shares, and that other equity holders do not have substantive voting, participating or liquidation rights. We record net income or loss attributable to noncontrolling interest in our Consolidated Statements of Operations equal to the proportionate share of outstanding profit interest units retained by the noncontrolling interests.

 

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

 

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification ("ASC") 810, Consolidation ("ASC 810"). ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

Use of Estimates

 

The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include revenue recognition, share-based compensation expense, valuation allowance for deferred income taxes, recovery of content advances, goodwill and intangible asset impairments, estimated royalties payable to content partners, and the assessment of amortization lives to intangible assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On a regular basis, the Company evaluates the assumptions, judgments and estimates. Actual results may differ from these estimates.

 

Reclassifications

 

Certain amounts have been reclassified to conform to the current presentation.

Cash and Cash Equivalents

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal.

Non-monetary Transactions

 

During the year ended March 31, 2023, the Company entered into a non-monetary transaction for the purchase and sale of content licenses with an unrelated third party. The fair value of the content was based on a market approach and determined to be $1.0 million which is included in Revenues in our Consolidated Statements of Operations. No gain or loss was recognized, as the fair value of the content licenses purchased was determined to be $1.0 million and recognized within Intangible Assets, Net on our Consolidated Balance Sheets, and will be amortized over its

F-11


 

three year estimated life. For the years ended March 31, 2024 and March 31, 2023, $341 thousand and $85 thousand of related amortization expense had been recognized, respectively.

Accounts Receivable, Net

We maintain reserves for expected credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical credit losses, customer concentrations, customer credit worthiness, current and forecasted economic trends and changes in customer payment patterns to evaluate the adequacy of this allowance.

During the year ended March 31, 2024, the Company had no write-offs of previously reserved accounts receivable and as of March 31, 2024, accrued an allowance for expected credit losses of $0.3 million. During the year ended March 31, 2023, the Company had written off $2.8 million of previously reserved accounts receivable balances and as of March 31, 2023, carried an allowance for credit losses of $0.

 

Employee Retention Tax Credit

 

The Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") provided an employee retention credit which was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the "Appropriations Act") extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to 70% of qualified wages paid to employees during the 2021 fiscal year.

 

The Company qualified for the employee retention credit beginning in June 2020 for qualified wages through September 2021 and filed a cash refund claim during the fiscal year ended March 31, 2023 in the amount of $2.5 million in the Employee retention tax credit line on the Company’s Consolidated Statements of Operations.

 

As of March 31, 2024 and March 31, 2023, the tax credit receivable of $1.7 and $2.1 million, respectively, has been included in the Employee retention tax credit line ("ERTC") on the Company's Consolidated Balance Sheet. The Company received notification during the second quarter of fiscal year 2024 that its ERTC claim was under examination with the Internal Revenue Service ("IRS"). In April 2024, the Company received a letter from the IRS indicating that its claim had been accepted and $1.7 million was received in June 2024.

Content Advances

Content advances represents amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record a provision for amounts that we expect may not be recoverable. Amounts which are expected to be recovered within 12 months are classified as current, which were $9.3 million and $3.7 million as of March 31, 2024, and March 31, 2023, respectively. Amounts estimated to be recoverable in more than 12 months are classified as long term and presented within content advances, net of current portion, which were $2.6 million and $1.4 million as of March 31, 2024, and March 31, 2023, respectively. For the twelve months ended March 31, 2024 and March 31, 2023, the Company recorded a recovery and increase in the provision for advances of $0.5 million and $1.3 million, respectively.

Property and Equipment, Net

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets, with useful life ranges by major asset class as follows:

 

Computer equipment and software

 

3 - 5 years

Internal use software

 

3 - 5 years

Machinery and equipment

 

3 - 10 years

Furniture and fixtures

 

2 - 7 years

 

F-12


 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software on a straight-line basis. Post-configuration training and maintenance costs are expensed as incurred.

Intangible Assets, Net

Intangible assets are stated at cost less accumulated amortization. For intangible assets that have finite lives, the assets are amortized using the straight-line method over the estimated useful lives of the related assets.

During both of the years ended March 31, 2024 and 2023, we did not record any impairment.

Amortization expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Content Library

 

3 – 20 years

Trademarks and Tradenames

 

2 – 15 years

Customer Relationships

 

5 – 13 years

Advertiser Relationships and Channel

 

2 – 13 years

Software

 

10 years

Capitalized Content

 

3 years

Supplier Agreements

 

2 years

 

The Company’s intangible assets include the following (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

24,133

 

 

$

(21,492

)

 

$

2,641

 

Advertiser Relationships and Channel

 

 

12,603

 

 

 

(2,541

)

 

 

10,062

 

Customer Relationships

 

 

8,690

 

 

 

(7,872

)

 

 

818

 

Software

 

 

3,200

 

 

 

(880

)

 

 

2,320

 

Trademark and Tradenames

 

 

3,914

 

 

 

(3,059

)

 

 

855

 

Capitalized Content

 

 

1,822

 

 

 

(190

)

 

 

1,632

 

Total Intangible Assets

 

$

54,362

 

 

$

(36,034

)

 

$

18,328

 

 

 

 

 

As of March 31, 2023

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

23,970

 

 

$

(21,126

)

 

$

2,844

 

Advertiser Relationships and Channel

 

 

12,604

 

 

 

(1,062

)

 

 

11,542

 

Supplier Agreements

 

 

11,430

 

 

 

(11,430

)

 

 

 

Customer Relationships

 

 

10,658

 

 

 

(9,568

)

 

 

1,090

 

Trademark and Tradenames

 

 

4,026

 

 

 

(2,274

)

 

 

1,752

 

Software

 

 

3,200

 

 

 

(560

)

 

 

2,640

 

Total Intangible Assets

 

$

65,888

 

 

$

(46,020

)

 

$

19,868

 

 

F-13


 

As of March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):

 

 

Total

 

In-process intangible assets

 

 

448

 

2025

 

 

3,186

 

2026

 

 

3,006

 

2027

 

 

2,225

 

2028

 

 

1,356

 

2029

 

 

1,356

 

Thereafter

 

 

6,751

 

Total

 

$

18,328

 

 

Capitalized Content

 

The Company capitalizes direct costs incurred in the production of content from which it expects to generate a return over the anticipated useful life and the Company’s predominant monetization strategy informs the method of amortizing these deferred costs. The determination of the predominant monetization strategy is made at commencement of the production or license period and the classification of the monetization strategy as individual or group only changes if there is a significant change to the title’s monetization strategy relative to its initial assessment. The costs are capitalized to the Capitalized Content costs within Intangible Assets and are amortized as a group within Depreciation and Amortization within the Consolidated Statements of Operations.

 

Impairment of Long-lived and Finite-lived Intangible Assets

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. There were no impairment charges recorded for long-lived and finite-lived intangible assets during the twelve months ended March 31, 2024 and 2023.

Goodwill

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test. For the twelve months ended March 31, 2024, the Company recognized a goodwill impairment loss of $14.0 million. The Company considered the sustained decrease in its share price to be a goodwill impairment indicator and determined that it would be appropriate to proceed with a quantitative test. Primarily utilizing a market-multiple approach, which took into account the sustained decrease in share price, the Company determined that goodwill impairment of $14.0 million would be recognized.

F-14


 

For the twelve months ended March 31, 2023, the Company assessed goodwill impairment on its annual measurement date of March 31, 2023 by performing a qualitative analysis and determined that it was not more likely than not that the fair value of its reporting unit was greater than its carrying amount. During the year ended March 31, 2023, the Company recorded a purchase price adjustment to reduce Goodwill by $260 thousand.

No goodwill impairment charge was recorded for the twelve months ended March 31, 2023.

 

Fair Value Measurements

 

The authoritative guidance on fair value measurements establishes a framework with respect to measuring assets and liabilities at fair value on a recurring basis and non-recurring basis, within ASC 820, Fair Value Measurement. Under the framework, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as of the measurement date. The framework also establishes a three-tier hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability and are developed based on the best information available in the circumstances. The hierarchy consists of the following three levels:

Level 1 – quoted prices in active markets for identical investments
Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)
Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

 

 

 

As of March 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

 

 

F-15


 

Equity Investment in Metaverse

 

On February 14, 2020, the Company acquired an approximate 11.5% interest in A Metaverse Company (“Metaverse”), a publicly traded Chinese entertainment company, formerly Starrise Media Holdings Limited, whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Metaverse that is related to our major shareholders. Our major shareholders also maintain a significant beneficial interest ownership in Metaverse.

 

On April 10, 2020, the Company purchased an additional 15% interest in Metaverse in a private transaction from shareholders of Metaverse that are affiliated with the major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which was the fair market value of the Metaverse shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.0 million, valued at the date of the issuance of the Common Stock of the Company. The difference in the value of shares received in Metaverse and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Metaverse.

 

The Company accounted for this investment under the equity method of accounting as the Company was deemed to be able to exert significant influence over Metaverse with its direct ownership and affiliation with the Company’s majority shareholders. At the time, the Company made an irrevocable election to apply the fair value option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Metaverse.

 

Following the halting of Metaverse stock trading on the Stock Exchange of Hong Kong in April 2022, the Company valued our equity investment in Metaverse using a market approach and is categorized as a Level 3 valuation based on unobservable inputs. The Company estimated the fair value of Metaverse based on the last known enterprise value at the time and then adjusting for trends in enterprise valuations for comparable companies. As of March 31, 2023, the fair value was $5.2 million, resulting in a decrease in fair value of $1.8 million for the year ended March 31, 2023.

 

On November 6, 2023, Metaverse's stock resumed trading on The Stock Exchange of Hong Kong Limited. During the year ended March 31, 2024, the Company sold 221 million of its original 362 million shares held as of March 31, 2023, which resulted in a realized loss of $0.3 thousand during the twelve months ended March 31, 2024. The resumption of active trading status represented renewed availability of quoted, unadjusted prices in active markets for identical assets, upon which the Company can execute a sale and readily access pricing information at the measurement date. Accordingly, the Company has presented the fair value of its Metaverse shares held as of March 31, 2024 within the Level 1 grouping. The fair value of the shares held as of March 31, 2024 was $0.4 million, with associated losses of $4.3 million recognized during the fiscal year ended March 31, 2024.

 

As a result of the decrease in ownership of its investment in Metaverse from its sale of shares, along with a corresponding decrease in influence, the Company no longer accounts for its investment in Metaverse under the equity method and instead will follow the guidance for equity securities for which the equity method is no longer appropriate under ASC 321, Investments - Equity Securities, and accordingly, the Company will continue to measure its investment at fair value, with changes in the value of securities held to be recognized in earnings.

 

Earnout consideration on purchase of business

 

The Company estimated the fair value of its earnout liability using contractual inputs from the related business combination, which established specific fiscal year revenue growth, profitability and EBITDA targets. Prior to the completion of the earnout period at the end of fiscal year 2024, the Company utilized the most up to date forecast to estimate the outcome against these targets to determine the ultimate estimated payout. The amounts recognized are not discounted.

 

During the fiscal year ended March 31, 2024, the final year of the earnout measurement period, the Company estimated a $612 thousand decrease in its earnout liability, issued $392 thousand worth of equity to settle its liability, made cash payments of $291 thousand, and incurred interest of $29 thousand.

 

F-16


 

During the fiscal year ended March 31, 2023, the Company increased the estimated earnout liability by $80 thousand and made payments of $238 thousand to reduce this liability, partially offset by $83 thousand of interest accrued.

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.

Asset Acquisitions

An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of relative fair values.

 

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

 

 

As of

 

 

 

March 31,
2024

 

 

March 31,
2023

 

Accounts payable

 

$

5,804

 

 

$

15,042

 

Amounts due to producers

 

 

9,889

 

 

 

13,114

 

Accrued compensation and benefits

 

 

1,119

 

 

 

2,532

 

Accrued other expenses

 

 

4,005

 

 

 

3,843

 

Total accounts payable and accrued expenses

 

$

20,817

 

 

$

34,531

 

 

As of March 31, 2024, the Company's accrued royalty estimate decreased by $2.3 million, which contributed to a decrease in Amounts due to producers relative to March 31, 2023.

 

Deferred Consideration

The Company has recognized liabilities related to deferred consideration arrangements related to the acquisition of FoundationTV ("FTV") and Digital Media Rights ("DMR"). These payments are fixed in nature and are due to the sellers of the respective companies. The Company initially recognized the liability at fair value at the time of acquisition and has since recognizes interest expense related to accretion in advance of the ultimate settlement of these liabilities. Amounts due within 12 months under the terms of the agreements are classified as current within the Consolidated Balance Sheets.

The deferred consideration related to the acquisition of DMR is payable in either Class A common shares of the Company stock or cash, at the Company's discretion and subject to certain conditions. Payments of $2.4 million are due in March 2025.

The deferred consideration related to the FTV acquisition is payable in the amount of $238 thousand in each of June 2024 and December 2024, and $464 thousand in June 2025. There is $475 thousand presently due and payable. The Company has the right to pay up to 25% of post-close purchase price in equity.

F-17


 

Disaggregation of Revenue

The following table presents the Company’s revenue by source (in thousands):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Streaming and digital

$

37,312

 

 

$

40,423

 

Base distribution

 

5,259

 

 

 

13,341

 

Podcast and other

 

2,718

 

 

 

2,213

 

Other non-recurring

 

3,842

 

 

 

12,049

 

Total revenue

$

49,131

 

 

$

68,026

 

Streaming and digital revenue represents advertising and subscription fees earned through the operation of the Company's owned and managed channels. Certain revenue recognition estimates may be required for this source at the end of a reporting period when we are not contractually entitled to receive final performance reporting from our partners for an extended period of time.

Base distribution revenue is generated by the Company's physical revenue streams such as DVD's and related supply chain revenue, as well as theatrical revenue. Other non-recurring revenue represents remaining system sales and the release of previously constrained variable consideration, following the run-off of the Company's legacy digital cinema business at the conclusion of fiscal year 2023. The Company also has contracts for the theatrical distribution of third party feature movies and alternative content. Distribution fee revenue and participation in box office receipts are recognized at the time a feature movie and alternative content are viewed.

Podcast and other revenue represents advertising fees earned in support of the Company's podcast programming.

 

Other non-recurring revenue relates to the Company's legacy digital cinema operations, whose operations have run-off, still may generate non-recurring revenue from the sale of cinema assets or the recognition of variable consideration as the associated uncertainty associated with the revenue is resolved.

Revenue Recognition

Fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or "Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Base Distribution”). Fees earned are typically a percentage of the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”) on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the content is available for subscription on the digital platform (the Company’s digital content is considered functional IP), at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Base Distribution Revenue from the sale of physical goods is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration. Reserves for potential sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

We have the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. As the Company satisfies its performance obligations, whether relating to the delivery of digital content, physical goods, or licensing, revenue is generally measured at a point in time.

F-18


 

The Company follows the five-step model established by ASC 606, Revenue from Contracts with Customers when preparing its assessment of revenue recognition.

Principal Agent Considerations

Revenue earned from the delivery of digital content and physical goods may be recognized gross or net depending on the terms of the arrangement. We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

which party is primarily responsible for fulfilling the promise to provide the specified good or service; and
which party has discretion in establishing the price for the specified good or service.

Shipping and Handling

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in direct operating expenses because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

Contract Liabilities

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable. Deferred revenue includes amounts related to advances, he sale of DVDs or theatrical releases with future release dates.

The ending deferred revenue balance, all current as of March 31, 2024 and 2023 was $0.4 million and $0.2 million, respectively. There were no long term amounts at either date.

Participations and Royalties Payable

When we use third parties to distribute Company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

Concentrations

For the fiscal year ended March 31, 2024, one customer represented 26% of consolidated revenue. For the fiscal year ended March 31, 2023, one customer represented 10% of consolidated revenue.

Direct Operating Costs

Direct operating costs consist of operating costs such as cost of revenue, fulfillment expenses, shipping costs, property taxes and insurance on systems, royalty and participation expenses, allowance against advances, and marketing and direct personnel costs.

Stock-based Compensation

The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the Consolidated Statements of Operations based on their fair values. The Company measures the compensation expense of employee and non-employee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and non-employee is required

F-19


 

to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility, risk-free rate and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.

 

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax basis.

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States and India.

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes, which provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

Earnings per Share

 

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include stock options and stock appreciation right outstanding during the period, and performance awards which are expected to be settled in shares and would be issuable at period end, using the treasury stock method. Potentially dilutive common shares are excluded from the computations of diluted income (loss) per share if their effect would be anti-dilutive. A net loss available to common stockholders causes all potentially dilutive securities to be anti-dilutive and are not included.

 

Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Basic net loss per share:

 

 

 

 

 

Net loss attributable to common stockholders

$

(21,757

)

 

$

(10,085

)

Shares used in basic computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Basic net loss per share

$

(1.78

)

 

$

(1.13

)

 

 

 

 

 

 

Shares used in diluted computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Stock options and SARs

 

 

 

 

 

Weighted-average number of shares

 

12,253

 

 

 

8,889

 

Diluted net loss per share

$

(1.78

)

 

$

(1.13

)

 

F-20


 

The calculation of diluted net income (loss) per share for the year ended March 31, 2024 and 2023 does not include the impact of 3,443 and 700 thousand potentially dilutive shares, respectively, relating to warrants, stock options, performance shares and stock appreciation rights, as their impact would have been anti-dilutive due to the respective period's income (loss) and an exercise price which exceeded period-end share price.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

The Company evaluates all Accounting Standard Updates ("ASUs") issued but not yet effective by FASB for consideration of their applicability. ASU's not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company's consolidated financial statements or disclosures.

 

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280)—Improvements to Reportable Segment Disclosures." The update requires disclosure of incremental segment information, including significant segment expenses, on an annual and interim basis, and would apply to single segment companies. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The Company is required to apply the updates retrospectively. The Company is assessing the impact of ASU 2023-07 on its consolidated financial statements.

 

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740)—Improvements to Income Tax Disclosures" On an annual basis, this update requires the disclosure of specific tax categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The amendments are effective for annual periods beginning after December 15, 2024. Prospective and retrospective adoption is permitted. The Company is still evaluating its method of adoption and assessing the impact of ASU 2023-09 on the disclosures within its consolidated financial statements.

 

In March 2024, the FASB issued ASU 2024-01, "Compensation—Stock Compensation (Topic 718)—Scope Application of Profits Interest and Similar Awards." This update clarifies the scope of "Profit Interest" and similar awards and adds an illustrative example to the existing ASC 718 standard that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The amendments in this Update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The amendments in this Update should be applied either (1) retrospectively to all prior periods presented in the financial statements or (2) prospectively to profits interest and similar awards granted or modified on or after the date at which the entity first applies the amendments. Based on the Company's population of awards, the Company does not anticipate a material impact on its financial results as a result of adoption.

F-21


 

3. OTHER INTERESTS

CDF2 Holdings

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in ASC 810, Consolidation. ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial statements. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

As of March 31, 2024 and 2023, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $0.0 million and $0.5 million as of March 31, 2024 and 2023, respectively, which are included in accounts receivable, net on the accompanying Consolidated Balance Sheets.

The accompanying Consolidated Statements of Operations include $0.0 million and $0.2 million of digital cinema servicing revenue from CDF2 Holdings for the year ended March 31, 2024 and 2023, respectively.

Total stockholders’ deficit of CDF2 Holdings at March 31, 2024 and 2023 was $59.2 and $59.2 million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $2.0 million and, accordingly, our investment in CDF2 Holdings as of March 31, 2024 and 2023 is carried at $0.

CONtv

We own an 85% interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets. CONtv is consolidated in our consolidated financial statements with the 15% minority interest presented as a non-controlling interest.

Roundtable

On March 15, 2022, the Company entered into a stock purchase agreement with Roundtable Entertainment Holdings, Inc. (“Roundtable”) pursuant to which the Company purchased 0.5 thousand shares of Roundtable Series A Preferred Stock and warrants to purchase 0.1 thousand shares of Roundtable Common Stock (together, the “Roundtable Securities”). The Company paid the purchase price for the Roundtable Securities by issuing 16 thousand shares of Common Stock to Roundtable, after taking into account the June 2023 reverse stock split (further described in the Stockholders' Equity footnote). The Company recorded $0.2 million for the purchase of the Roundtable Securities which is included in other long-term assets on the accompanying Consolidated Balance Sheets. The investment in the Roundtable Securities was made in connection with a proposed collaboration with Roundtable regarding production and distribution of streaming content including the launch of high profile branded enthusiast streaming channels. The Roundtable investment was accounted for using the cost method of accounting as we own less than 20% of Roundtable and do not exert a significant influence over their operations. Our President and Chief Strategy Officer is on the Roundtable Board of Directors.

F-22


 

4. STOCKHOLDERS’ EQUITY

COMMON STOCK

Common Stock

On October 11, 2021, the Company filed an Amended and Restated Certificate of Incorporation which authorized an increase in the number of shares of Common Stock for issuance to 275 million shares, the level at which it remains.

 

On June 9, 2023, the Company effected a 1-for-20 reverse stock split of the Company's Class A common stock. All shares and price amounts in this report reflect the 1-for-20 reverse stock split effected on June 9, 2023.

During the fiscal year ended March 31, 2024, the Company issued 6.4 million shares of Common Stock, through a direct offering, ATM sales, preferred stock dividends, issuance for shares for employee bonuses net of shares withheld for taxes, exercise of pre-funded warrants, Board fees, deferred consideration and earnout commitments.

During the fiscal year ended March 31, 2023, the Company issued 582 thousand shares of Common Stock in payment of preferred stock dividends, Board fees, payment of performance shares, pursuant to a business combinations, and the acquisition of intangible assets.

 

Direct Offering

 

On June 14, 2023, the Company sold in a public offering an aggregate of 2,150,000 shares of the Company’s Class A common stock, pre-funded warrants to purchase up to 516,667 shares of Common Stock, and common warrants to purchase up to 2,666,667 shares of Common Stock at an effective combined purchase price of $3.00 per share and related Common Warrant, for aggregate gross proceeds of approximately $8.0 million, before deducting placement agents fees and offering expenses payable by the Company. The purchase price of each Pre-Funded Warrant and related Common Warrant was equal to the Purchase Price less the $0.001 per share exercise price of each Pre-Funded Warrant. All pre-funded and common warrants were issued as immediately exercisable. All pre-funded warrants were subsequently exercised in July 2023 for total proceeds of $0.5 thousand. All common warrants remain outstanding as of March 31, 2024.

 

ATM Sales Agreement

 

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on Nasdaq at the time of the sale of such shares. The Company is not obligated to sell any shares under the ATM Sales Agreement. Any sales of shares made under the ATM Sales Agreement will be made pursuant to the 2020 Shelf Registration Statement, for an aggregate offering price of up to $30 million.

 

No sales under the ATM Sales Agreement were made during the year ended March 31, 2023. For the twelve months ended March 31, 2024, the Company sold 177 thousand shares for $1.1 million in net proceeds, respectively, after deduction of commissions and fees. The ATM Sales Agreement has expired in accordance with its terms.

 

On May 3, 2024, Cineverse Corp. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners and The Benchmark Company, LLC (collectively, the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of its Class A common stock, par value $0.001 per share (the “Common Stock”). Shares of Common Stock may be offered and sold for an aggregate offering price of up to $15 million. The Sales Agents’ obligations to sell shares under the Sales Agreement are subject to satisfaction of certain conditions, including the continuing effectiveness of the Registration Statement on Form S-3 (Registration No. 333-273098) (the “Registration Statement”) filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on June 30, 2023 and declared effective by the SEC on January 25, 2024, and other customary closing conditions. The Company will pay the Sales Agents a commission of 3.00% of the aggregate gross proceeds from each sale of shares and has agreed to provide the Sales Agents with customary indemnification and contribution rights. The Company has also agreed to reimburse the Sales Agents for

F-23


 

certain specified expenses. The Company is not obligated to sell any shares under the Sales Agreement and has not sold any shares through the date of this report.

PREFERRED STOCK

Cumulative dividends in arrears on preferred stock were $0.1 million as of March 31, 2024 and 2023. For the years ended March 31, 2024 and 2023, we paid preferred stock dividends in the form of 196 thousand and 37 thousand shares of Common Stock, respectively.

TREASURY STOCK

We have treasury stock, at cost, consisting of 289 thousand shares and 66 thousand shares of Common Stock as of March 31, 2024 and 2023, respectively.

EQUITY INCENTIVE PLANS

Stock Based Compensation Awards

Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) were in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provided for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options were set at the discretion of our Compensation Committee. The Company does not estimate forfeitures, but recognizes forfeitures in the period in which they occur.

Options outstanding and exercisable under the 2000 Plan are as follows:

 

As of March 31, 2024

 

Min

 

 

Max

 

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

148.0

 

 

$

148.0

 

 

 

0.3

 

 

 

1.25

 

 

$

148

 

 

$

 

$

280.0

 

 

$

488.0

 

 

 

0.6

 

 

 

0.52

 

 

$

345

 

 

 

 

 

 

 

 

 

0.9

 

 

 

0.72

 

 

$

290

 

 

$

 

 

As of March 31, 2023

 

Min

 

 

Max

 

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

148.0

 

 

$

148.0

 

 

 

0.3

 

 

 

2.25

 

 

$

148

 

 

$

 

$

280.0

 

 

$

488.0

 

 

 

10.0

 

 

 

0.50

 

 

$

290

 

 

 

 

 

 

 

 

 

10.2

 

 

 

0.54

 

 

$

287

 

 

$

 

A total of 9 thousand options expired during the year ended March 31, 2024.

 

In August 2017, the Company adopted the 2017 Equity Incentive Plan (the “2017 Plan). The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provides for the issuance of up to 2,055 thousand shares of Common Stock as of December 8, 2023, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards.

During the year ended March 31, 2024, the Company granted 207 thousand stock appreciation rights (“SARs”), which were granted under the 2017 Plan. All SARs issued have an exercise price equal to the market price of the

F-24


 

Company’s Common Stock on the date of grant and a maturity date of 10 years after grant date. The Company has the option to settle the SARs through a cash payment, issuance of shares, or some combination of cash payment and shares. Based on past practice and intent to settle these awards with shares of Class A common stock, the Company has determined that these awards should be classified in equity.

The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:

 

 

For the Year Ended March 31,

 

 

 

2024

 

 

2023

 

Expected dividend yield

 

 

 

 

 

 

Expected equity volatility

 

 

107

%

 

 

112

%

Expected term (years)

 

 

6.50

 

 

 

6.50

 

Risk-free interest rate

 

4.51% - 3.82%

 

 

 

4.49

%

Exercise price

 

$5.80 - $10.43

 

 

$9.82

 

Market price per share

 

$5.80 - $10.43

 

 

$9.82

 

The weighted average fair value of outstanding grants made during the year ended March 31, 2024, was $4.99 per award. The weighted average fair value of outstanding the grants made during the year ended March 31, 2023, was $8.52 per award.

SARs outstanding under the 2017 Plan, along with the minimum and maximum strike price of each group, are as follows:

 

As of March 31, 2024

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

5.8

 

 

$

12.8

 

 

 

632

 

 

 

7.92

 

 

$

9.45

 

 

$

 

$

23.2

 

 

$

29.4

 

 

 

98

 

 

 

5.12

 

 

$

27.77

 

 

 

 

$

39.4

 

 

$

46.4

 

 

 

46

 

 

 

6.96

 

 

$

40.15

 

 

 

 

 

 

 

 

 

 

 

776

 

 

 

7.51

 

 

$

13.58

 

 

$

 

 

As of March 31, 2023

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

7.80

 

 

$

14.80

 

 

 

430

 

 

 

8.37

 

 

$

11.15

 

 

$

3

 

$

23.20

 

 

$

29.40

 

 

 

105

 

 

 

6.25

 

 

$

27.62

 

 

 

 

$

34.20

 

 

$

42.00

 

 

 

100

 

 

 

8.78

 

 

$

40.18

 

 

 

 

$

44.60

 

 

$

51.20

 

 

 

21

 

 

 

8.57

 

 

$

45.46

 

 

 

 

 

 

 

 

 

 

 

657

 

 

 

8.10

 

 

$

19.33

 

 

$

3

 

 

Exercisable SARs under the 2017 Plan as of March 31, 2024 are as follows:

 

SARs Exercisable
(In thousands)

 

 

Weighted Average
Remaining Life in Years

 

 

Weighted Average
Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

 

469

 

 

 

8.5

 

 

$

17.64

 

 

$

 

F-25


 

As of March 31, 2024, the compensation cost not yet recognized related nonvested SARS awards totaled $703 thousand, to be recognized over the weighted average remaining vesting period of 0.8 years.

 

SARs activity for the year ended March 31, 2024 is as follows (in thousands):

 

 

 

Year Ended
March 31, 2024

 

 SARs Outstanding March 31, 2023

 

 

657

 

 Issued

 

 

207

 

 Forfeited

 

 

(88

)

 Total SARs Outstanding March 31, 2024

 

 

776

 

 

A total of $1.4 million and $4.8 million of stock based compensation was included within Selling, General and Administrative expenses for the years ended March 31, 2024 and 2023, respectively.

 

In addition, the Company grants performance stock unit ("PSU") awards under the 2017 Plan to employees of the Company that vest upon certain performance goals being achieved. Upon vesting, the award may be settled in shares or cash at the Company's discretion.

 

There were no shares granted or issued in fiscal year 2024. Based on performance for the year ended March 31, 2023, the Company accrued for 16 thousand unvested.

Of this stock based compensation expense, there was $0.3 million and $0.4 million of stock-based compensation expense for the year ended March 31, 2024 and 2023, respectively, related to Board of Director fees. During the years ended March 31, 2024 and 2023, the Company issued 400 thousand and 34 thousand restricted shares to non-employee directors, respectively.

 

F-26


 

5. DEBT

 

Line of Credit Facility

 

The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $7.5 million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to September 15, 2025, subject to definitive documentation.

 

As of March 31, 2024 and March 31, 2023, $6.4 million and $5.0 million was outstanding on the Line of Credit Facility, respectively. Under the Line of Credit Facility, the Company is subject to certain financial and nonfinancial covenants including terms which require the Company to maintain certain metrics and ratios, maintain certain minimum cash on hand, and to report financial information to our lender on a periodic basis. For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.

 

For the year ended March 31, 2024 and March 31, 2023, the Company incurred interest expense of $0.4 million and $0.2 million to EWB related to the Line of Credit Facility, respectively.

6. COMMITMENTS AND CONTINGENCIES

Operating Leases

 

Cineverse is a virtual company with one domestic operating lease, acquired through the acquisition of Digital Media Rights ("DMR") and subleased to a third party. The Company has not been relieved of the its original lease obligation and therefore recognizes both a lease liability and right-of-use asset as part of the arrangement. The end of both the original lease and sublease's term is January 2025. The Company has recognized $0.2 million of sublease income related to its subleasing arrangement for the twelve months ended March 31, 2024.

 

The Company's two operating leases for its India operations expire in July 2027.

The table below presents the lease-related assets and liabilities recorded on our Consolidated Balance Sheets (in thousands):

 

 

 

Classification on the Balance Sheet

 

March 31,
2024

 

 

March 31,
2023

 

Assets

 

 

 

 

 

 

 

 

Noncurrent

 

 Other long-term assets

 

$

834

 

 

$

1,265

 

Liabilities

 

 

 

 

 

 

 

 

Current

 

 Operating leases liabilities

 

 

401

 

 

 

418

 

Noncurrent

 

 Operating leases liabilities, net of current portion

 

 

462

 

 

 

863

 

Total operating lease liabilities

 

 

 

$

863

 

 

$

1,281

 

 

 

F-27


 

The table below presents the annual gross undiscounted cash flows related to the Company's operating lease commitments and subleasing arrangements (in thousands):

 

Fiscal year ending March 31,

Operating Lease Commitments

 

2025

$

423

 

2026

 

200

 

2027

 

210

 

2028

 

72

 

2029

 

 

Thereafter

 

 

Total lease payments

$

905

 

Less imputed interest

 

(42

)

Total

$

863

 

 

For leases which have a term of twelve months or less and do not contain an option to extend which the Company is

reasonably certain to extend the term, the Company has elected to not apply the recognition provisions of ASC 842

and recognizes these expenses on a straight-line basis over the term of the agreement.

 

Since our operating leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at Cineverse's lease commencement date. The average discount rate utilized was 3.34%.

The Company incurred $445 thousand and $441 thousand in rental expense associated with its operating leases during the years ended March 31, 2024 and 2023, respectively.

 

 

Commitments

 

 

In the ordinary course of business, the Company enters into contractual arrangements, from time to time, under which it agrees to commitments with content providers for certain rights which are in production or have not yet been completed, delivered to, and accepted by the Company. Based on the nature of these agreements, which may be subject to delay or project abandonment, there is uncertainty with the amounts and timing of its commitments. Certain of these advances are eligible to be recouped through future revenue sharing arrangements. Based on the stage of the Company's projects, the table presented below represents an estimate of the Company's gross project commitments over the next five fiscal years (in thousands).

 

 

 

Fiscal Year Ended March 31,

 

 

 

2025

 

 

2026

 

 

2027

 

 

2028

 

 

2029

 

Total Project Commitments

 

$

2,094

 

 

$

915

 

 

$

965

 

 

$

665

 

 

$

315

 

 

F-28


 

7. INCOME TAXES

 

We recorded income tax expense of $0.0 million and $0.1 million from operations for the years ended March 31, 2024 and 2023, respectively. For the year ended March 31, 2023, the income tax expense of $0.1 million was mainly related to foreign income taxes.

The following table presents the components of income tax expense (benefit) (in thousands):

 

 

 

For the Fiscal Year
Ended March 31,

 

 

 

2024

 

 

2023

 

Federal:

 

 

 

 

 

 

Current

 

$

 

 

$

 

Deferred

 

 

 

 

 

 

Total federal

 

$

 

 

$

 

State:

 

 

 

 

 

 

Current

 

$

(11

)

 

$

12

 

Deferred

 

 

 

 

 

 

Total state

 

$

(11

)

 

$

12

 

Foreign:

 

 

 

 

 

 

Current

 

$

35

 

 

$

107

 

Deferred

 

 

(14

)

 

 

 

Total foreign

 

$

21

 

 

$

107

 

Income tax expense

 

$

10

 

 

$

119

 

 

Net deferred taxes consisted of the following (in thousands):

 

 

 

As of March 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

20,945

 

 

$

18,318

 

Stock-based compensation

 

 

3,724

 

 

 

3,246

 

Intangibles

 

 

6,423

 

 

 

4,800

 

Accrued liabilities

 

 

535

 

 

 

908

 

Capital loss carryforward

 

 

3,924

 

 

 

 

Investments

 

 

1,977

 

 

 

4,344

 

Non-deductible interest expense

 

 

4,213

 

 

 

3,479

 

Other

 

 

240

 

 

 

750

 

Total deferred tax assets before valuation allowance

 

 

41,981

 

 

 

35,845

 

Less: Valuation allowance

 

 

(41,668

)

 

 

(35,755

)

Total deferred tax assets after valuation allowance

 

$

312

 

 

$

90

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use asset

 

$

(248

)

 

$

 

Depreciation and amortization

 

 

(50

)

 

 

(90

)

Total deferred tax liabilities

 

 

(298

)

 

 

(90

)

Net deferred tax

 

$

14

 

 

$

 

 

We have provided a valuation allowance to our net deferred tax assets as of March 31, 2024 and 2023. We are required to recognize all or a portion of our deferred tax assets if we believe that it is more likely than not that such assets will be realized, given the weight of all available evidence. We assess the realizability of the deferred tax assets at each interim and annual balance sheet date. In assessing the need for a valuation allowance, we considered both positive and negative evidence, including recent financial performance, projections of future taxable income and scheduled reversals of deferred tax liabilities. The net changes in the valuation allowance of $5.9 million and $2.5 million during the fiscal years ended March 31, 2024 and 2023, respectively, were mainly due to increases in the deferred tax asset related to the net operating loss carryforward and other temporary differences. We will

F-29


 

continue to assess the realizability of the deferred tax assets at each interim and annual balance sheet date based upon actual and forecasted operating results.

As of March 31, 2024, we had utilizable federal and state net operating loss carryforwards of approximately $70.3 million available in the United States of America (“U.S.”) to reduce future taxable income. U.S. federal and state net operating loss carryforwards of approximately $22.5 and $70.3 million, respectively, generally begin to expire in 2026. U.S. federal net operating loss carryforwards that were generated during the years ended March 31, 2020, 2021, 2022, 2023, and 2024 of approximately $47.9 million, do not expire.

On March 27, 2020, the CARES Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable.

The differences between the U.S. statutory federal tax rate and our effective tax rate are as follows:

 

 

 

For the Year
Ended March 31,

 

 

 

2024

 

 

2023

 

Provision at the U.S. statutory federal tax rate

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefit

 

 

14.2

%

 

 

8.0

%

Change in valuation allowance

 

 

(27.8

)%

 

 

(27.8

)%

Non-deductible expenses

 

 

(1.0

)%

 

 

(8.3

)%

Executive officer compensation limitation – Section 162(m)

 

 

%

 

 

(2.0

)%

Goodwill impairment

 

 

(6.3

)%

 

 

 

Losses from non-consolidated entities

 

 

%

 

 

7.9

%

Other

 

 

%

 

 

(0.1

)%

Income tax expense

 

 

(0.1

)%

 

 

(1.3

)%

 

We file income tax returns in the U.S. federal jurisdiction, various U.S. states, and India. For federal income tax purposes, our fiscal 2021 through 2024 tax years remain open for examination by the tax authorities under the normal three-year statute of limitations. For U.S. state tax purposes, our fiscal 2020 through 2024 tax years generally remain open for examination by most of the tax authorities under a four-year statute of limitations. For Indian income tax purposes, our fiscal 2022 through 2024 tax years remain open for examination by the tax authorities.

F-30


 

8. SUBSEQUENT EVENTS

Terrifier 3 Financing

 

On April 5, 2024, Cineverse Terrifier LLC (“T3 Borrower”), a wholly-owned subsidiary of the Company entered into a Loan and Security Agreement with BondIt LLC (“T3 Lender”) and the Company, as guarantor (the “T3 Loan Agreement”).

 

The T3 Loan Agreement provides for a term loan with a principal amount not to exceed $3,666 thousand (the “T3 Loan”), and a maturity date of April 1, 2025, with a permitted extension of the term for 120 days under certain conditions. The T3 Loan bears no interest until the maturity date other than an interest advance equal to $576 thousand at the closing of the T3 Loan on April 5, 2024. If the T3 Loan is extended as noted above, the T3 Loan will bear interest at a rate of 1.44% per month. T3 Borrower may prepay the obligations under the T3 Loan, in full or in part, without penalty or premium. The proceeds under the T3 Loan Agreement will be used for the funding under the Company’s distribution arrangements for the film titled Terrifier 3 (the “Film”). The T3 Loan Agreement contains customary covenants, representation and warranties and events of default.

 

After the principal of the T3 Loan is paid in full, T3 Lender will be entitled to receive 15% of all royalties earned by the Company on the Film under its distribution agreements for the Film until T3 Lender has received 1.75 times the full commitment amount of $3,666 thousand, consisting of the principal amount plus interest and fees advanced to T3 Borrower, plus any extension interest. The T3 Loan is secured by a first priority interest in all of T3 Borrower’s rights and interest in the Film and the distribution agreements, including the proceeds to T3 Borrower from the distribution of the Film.

 

The Company entered into a Guaranty Agreement pursuant to which it provided a guarantee of the T3 Loan which is capped at obligations not exceeding $1,500 thousand (the “Guaranty Agreement”). The Guaranty is subordinated in payment and performance to the Line of Credit Facility pursuant to an intercreditor agreement between EWB and the T3 Lender, and acknowledged by the Company and the T3 Borrower. In connection with the T3 Loan Agreement, the Company entered into Amendment No. 3 to the Amended and Restated Loan, Guaranty and Security Agreement dated as of September 15, 2022 with East West Bank and the Guarantors named therein, as amended to date (the “EWB Amendment”) to facilitate the T3 Loan and the Guarantee.

F-31


 

PART II. OTHER INFORMATION

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Definition and Limitations of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.

Evaluation of Disclosure Controls and Procedures

 

The management of the Company, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in the Exchange Act), as of March 31, 2024. Based on such evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported, on a timely basis, and (ii) accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures in our internal control over financial reporting as of March 31, 2024.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria set forth in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this evaluation, management has concluded that our internal control over financial reporting was effective as of March 31, 2024.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting, except that we have redesigned our royalty accrual estimation process, following the upgrade of certain accounting systems and integration of acquirees into a more centralized accounting process.

ITEM 9B. OTHER INFORMATION

 

On February 29, 2024, the Board approved the renewal of the previously approved stock repurchase program to purchase up to an aggregate of 500,000 shares of its outstanding Class A common stock. Acquisitions pursuant to the stock repurchase program may be made through a combination of open market repurchases in compliance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended, privately negotiated transactions, and/or other transactions at the Company’s discretion. The stock repurchase program, which is subject to certain consents, will expire on March 1, 2025 unless otherwise modified by the Board at any time in its sole discretion.

 

59


 

The Company did not make any purchases under this plan during the fiscal year ended, March 31, 2024. In May 2024, the Company entered into a plan with B. Riley Securities, Inc. intended to satisfy the affirmative defense conditions of Rule 10b5-1 promulgated under the Exchange Act. and under this plan purchased 184,495 shares for a total of $188 thousand, gross of fees in May 2024.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

Not applicable.

60


 

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors

Christopher J. McGurk, 67, has been the Company’s Chief Executive Officer and Chairman of the Board since January 2011. Mr. McGurk was the founder and Chief Executive Officer of Overture Films from 2006 until 2010, and also the Chief Executive Officer of Anchor Bay Entertainment, which distributed Overture Films’ products to the home entertainment industry. From 1999 to 2005, Mr. McGurk was Vice Chairman of the Board and Chief Operating Officer of Metro-Goldwyn-Mayer Inc. (“MGM”), acting as the company’s lead operating executive until MGM was sold for approximately $5 billion to a consortium of investors. Mr. McGurk joined MGM from Universal Pictures, where he served in various executive capacities, including President and Chief Operating Officer, from 1996 to 1999. From 1988 to 1996, Mr. McGurk served in several senior executive roles at The Walt Disney Studios, including Studios Chief Financial Officer and President of The Walt Disney Motion Picture Group. Mr. McGurk has previously served on the boards of IDW Media Holdings, Inc., BRE Properties, Inc., DivX Inc., DIC Entertainment, Pricegrabber.com, LLC and MGM Studios, Inc. Mr. McGurk has had a long and transformative executive career in film, TV and streaming content industries.


Peter C. Brown
, 65, has been a member of the Board since September 2010. He is Chairman of Grassmere Partners, LLC, a private investment firm he founded in 2009. He served as Chairman of the Board, Chief Executive Officer, and President of AMC Entertainment Inc. (“AMC”), one of the world’s leading theatrical exhibition companies, from 1999 to 2009, and Chief Financial Officer from 1991 to 1999. In 1997, he founded EPR Properties, (NYSE: EPR) a real estate investment trust and served as Chairman of the Board until 2003. He currently serves on the board of EPR Properties. Mr. Brown also serves as a director of Lumen Technologies, Inc. (NYSE: LUMN), an international facilities-based technology and communications company. Past additional public company boards include National CineMedia, Inc., Midway Games, Inc., LabOne, Inc., and Protection One, Inc.


Mary Ann Halford
, 65, has been a member of the Board since December 2023. Ms. Halford is an internationally recognized media and entertainment operator, advisor, and entrepreneur. She is the Founder and Managing Principal of Halford Media Advisory, working with clients in the US and internationally on transformation strategies. Prior to setting up her own firm, she was a Partner at Altman Solon, a Telecommunications, Media, and Technology (“TMT”) strategy consultancy focusing on the media industry. Ms. Halford has previously served as a Senior Managing Director at FTI Consulting and EVP of Fox International Entertainment Channels, a division of Fox Entertainment Group. In 2002, she co-founded El Camino Entertainment Group which consolidated operating businesses in the live family entertainment industry, which currently operates as North American Midway Entertainment. Ms. Halford also serves on the board of EightCo Holdings (NASDAQ: OCTO). Past board positions include director of Media and Games Invest (OMX: M8G), Vinco Ventures (NASDAQ: BBIG) and Triton Digital (private).


Patrick W. O’Brien, 77, has been a member of the Board since July 2015. He currently serves as the Managing Director & Principal of Granville Wolcott Advisors, a company he formed in 2009, which provides business consulting, due diligence and asset management services for public and private clients. Mr. O’Brien has previously served as Chairman of the Board and CEO of Livevol, Inc., a private company that was a leader in equity and index options technology, which was successfully sold to CBOE Holdings. During the past five years, Mr. O’Brien has also served on the boards of Creative Realities, Inc., ICPW Liquidation Trust, and Merriman Holdings, Inc.

 

Executive Officers

The Company’s executive officers are Christopher J. McGurk, Chief Executive Officer and Chairman of the Board, Erick Opeka, President and Chief Strategy Officer, Gary S. Loffredo, Chief Legal Officer, Secretary and Senior Advisor, Tony Huidor, Chief Operating Officer and Chief Technology Officer, Mark Lindsey, Chief Financial Officer, Yolanda Macias, Chief Content Officer, and Mark Torres, Chief People Officer. Biographical information for Mr. McGurk is included above.

61


 

 

Erick Opeka, 50, has served as the Company’s Chief Strategy Officer and President since December 2020, overseeing the day-to-day operations of the Company's streaming and distribution operations, and driving Cineverse's corporate strategy and M&A initiatives. Prior to his current role, Mr. Opeka served as EVP of the company’s Global Digital Distribution business. Before joining Cineverse, he co-founded and led the independent distributor New Video's streaming business. Mr. Opeka began his entertainment career at Madstone Entertainment, and prior to that, he served in the US Army infantry. He currently serves as the Vice Chairman of streaming trade organization OTT.X and on the Board of Directors of film and television production company Roundtable Entertainment. Mr. Opeka holds a BA degree from The University of Texas at Austin and an MBA from Florida State University.

 

Gary S. Loffredo, 59, is the Company’s Chief Legal Officer, Secretary and Senior Advisor. Mr. Loffredo has served in numerous executive leadership roles with the Company since joining in 2000 including President, Chief Operating Officer, Senior Vice President of Business Affairs, and General Counsel. He also served as President of Digital Cinema from 2011 to 2023, as Interim Co-Chief Executive Officer from June 2010 through December 2010, and was a member of the Company’s Board of Directors from September 2000 - October 2015. Prior to joining Cineverse, from March 1999 to August 2000, Mr. Loffredo was Vice President, General Counsel and Secretary of Cablevision Cinemas d/b/a Clearview Cinemas, a film exhibitor. From September 1992 to February 1999, he was an attorney at the law firm of Kelley Drye & Warren LLP.

Tony Huidor, 55, is the Company’s Chief Operating Officer and Chief Technology Officer. Since joining Cineverse in 2015, Huidor has managed the launch and daily operations of the Company’s portfolio of all subscription and ad-supported digital-first channels. He conceived and designed Cineverse’s proprietary Matchpoint Dispatch distribution platform and oversees overall product development of Matchpoint Blueprintwhich powers all streaming apps for Cineverse’s portfolio of streaming services. In addition, Mr. Huidor recently developed cineSearch which is the Company’s AI-based conversational chatbot for advanced content recommendations. Prior to joining the Company, Mr. Huidor served as Vice President of Operations for Universal Music Group (UMG) and then VP of Technical Product Development for Universal Music Group Distribution (UMGD). Prior to his tenure at Universal Music Group, Mr. Huidor worked as Director of Product Development for the Walt Disney Internet Group, where he was responsible for the creation and development of subscription-based entertainment services worldwide.

Mark Lindsey, 57, is the Company’s Chief Financial Officer. Mr. Lindsey oversees all facets of accounting including reporting, financing, working capital management, treasury, tax compliance and planning, internal controls and policy development. Prior to joining Cineverse he most recently served as Chief Accounting Officer and acting Chief Financial Officer for Firefly Systems, Inc., a digital out-of-home (DOOH) and mobility advertising company. Mr. Lindsey was also CFO and CCO for Canapi Ventures, a financial technology-focused venture capital firm. Earlier in his career Mr. Lindsey served in related executive capacities with American Capital, LTD., XM Satellite Radio, the Public Company Accounting Oversight Board and PricewaterhouseCoopers.


Yolanda Macias, 59,
joined Cineverse in 2013 and has been the Chief Content Officer of Cineverse Entertainment Group since December 2020. She is responsible for acquiring global content rights for all distribution and streaming platforms and oversees marketing. Ms. Macias has over 25 years of entertainment distribution experience, including executive positions at Vivendi/Universal from 2004 to 2012, DIRECTV from 1996 to 2003, and The Walt Disney Company from 1992 to 1995. Ms. Macias serves on the board of Skechers USA, Inc. (NYSE: SKX) and as vice chair for C5LA a non-profit organization supporting under resourced and high potential teen. Macías received her MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and her B.S. degree in Finance from California State University, Northridge.


Mark Torres, 64,
is the Company’s Chief People Officer. He joined Cineverse in 2018 as Senior Vice President of Human Resources. Mr. Torres has served as a senior human resources executive for over 20 years, including prior to the Company, at Sony Pictures Entertainment, Ticketmaster and Reed Elsevier/Variety, as well as several technology and media start-up companies. Mr. Torres served as SVP of People & Culture at AdTec Rubicon Project (now

62


 

Magnite). Mr. Torres is a graduate of California State University, Long Beach with a bachelor’s degree in Telecommunications.

 

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act requires the Company’s directors, executive officers and persons who beneficially own more than 10% of its Common Stock to file reports of ownership and changes in ownership with the SEC and to furnish the Company with copies of all such reports they file.

 

Based on the Company’s review of the copies of such forms received by it, or written representations from certain reporting persons, the Company believes that none of its directors, executive officers or persons who beneficially own more than 10% of the Common Stock failed to comply with Section 16(a) reporting requirements during the fiscal year ended March 31, 2024 (the “Last Fiscal Year”), except for Mr. Torres, who filed a late Form 3.

Code of Business Conduct and Ethics

We have adopted a code of ethics applicable to all members of the Board, executive officers and employees. Such code of ethics is available on our Internet website, www.investor.cineverse.com. We intend to disclose any amendment to, or waiver of, a provision of our code of ethics by filing a Form 8-K with the SEC.

Stockholder Communications

The Board currently does not provide a formal process for stockholders to send communications to the Board. In the opinion of the Board, it is appropriate for the Company not to have such a process in place because the Board believes there is currently not a need for a formal policy due to, among other things, the limited number of stockholders of the Company. While the Board will, from time to time, review the need for a formal policy, at the present time, stockholders who wish to contact the Board may do so by submitting any communications to the Company’s Secretary, Mr. Loffredo, 224 W. 35th St. Suite 500, #947 New York, New York 10001, with an instruction to forward the communication to a particular director or the Board as a whole. Mr. Loffredo will receive the correspondence and forward it to any individual director or directors to whom the communication is directed.

MATTERS RELATING TO OUR GOVERNANCE

Board of Directors

The Board oversees the Company’s risk management including understanding the risks the Company faces and what steps management is taking to manage those risks, as well as understanding what level of risk is appropriate for the Company. The Board’s role in the Company’s risk oversight process includes receiving regular updates from members of senior management on areas of material risk to the Company, including operational, financial, legal and regulatory, human resources, employment, and strategic risks.

The Company’s leadership structure currently consists of the combined role of Chairman of the Board and Chief Executive Officer and a separate Lead Independent Director. Mr. O’Brien serves as our Lead Independent Director. The Lead Independent Director’s responsibilities include presiding at all meetings of the Board at which the Chairman is not present, including executive sessions of the independent directors, serving as a liaison between the Chairman and the independent directors, reviewing information sent to the Board, consulting with the Nominating Committee with regard to the membership and performance evaluations of the Board and Board committee members, calling meetings of and setting agendas for the independent directors, and serving as liaison for communications with stockholders.

The Board intends to meet at least quarterly and the independent directors serving on the Board intend to meet in executive session (i.e., without the presence of any non-independent directors and management) immediately following regularly scheduled Board meetings. During the Last Fiscal Year, the Board held nine (9) meetings. Each current member of the Board, who was then serving, attended at least 75 percent of the total number of meetings of the Board, and of the committees of the Board on which they served in the Last Fiscal Year. Messrs. Brown and O’Brien and Ms. Halford are considered “independent” under the rules of the SEC and Nasdaq.

63


 

 

The Company does not currently have a policy in place regarding attendance by Board members at the Company’s annual meetings of stockholders.

The Board has three standing committees, consisting of an Audit Committee, a Compensation Committee and a Nominating Committee. Membership in each committee is shown in the following table.

 

Audit
Committee

Compensation
Committee

Nominating
and Corporate
Governance
Committee

Christopher J. McGurk*

 

 

 

Mary Ann Halford

Peter C. Brown

Patrick W. O’Brien**

▲ Committee Chair ● Committee Member * Chairperson of the Board ** Lead Independent Director

Audit Committee

The Audit Committee consists of Messrs. Brown and O’Brien and Ms. Halford. Mr. Brown is the Chair of the Audit Committee. The Audit Committee held four (4) meetings in the Last Fiscal Year. The Audit Committee has met with the Company’s management and the Company’s independent registered public accounting firm to review and help ensure the adequacy of its internal controls and to review the results and scope of the auditors’ engagement and other financial reporting and control matters. Mr. Brown is financially literate, and Mr. Brown is financially sophisticated, as those terms are defined under the rules of Nasdaq. Mr. Brown is also a financial expert, as such term is defined under the Sarbanes-Oxley Act of 2002. Messrs. Brown and O’Brien and Ms. Halford are considered “independent” under the rules of the SEC and Nasdaq.

The Audit Committee has adopted a formal written charter (the “Audit Charter”). The Audit Committee is responsible for ensuring that the Company has adequate internal controls and is required to meet with the Company’s auditors to review these internal controls and to discuss other financial reporting matters. The Audit Committee is also responsible for the appointment, compensation and oversight of the auditors. Additionally, the Audit Committee is responsible for the review and oversight of all related party transactions and other potential conflict of interest situations between the Company and its officers, directors, employees and principal stockholders. The Audit Committee Charter is available on the Company’s Internet website at www.investor.cineverse.com.

Compensation Committee

The Compensation Committee consists of Messrs. Brown and O’Brien and Ms. Halford. Ms. Halford is the Chair of the Compensation Committee. The Compensation Committee met two (2) times during the Last Fiscal Year and acted three (3) times by unanimous written consent in lieu of holding a meeting. The Compensation Committee approves the compensation package of the Company’s Chief Executive Officer and, based on recommendations by the Company’s Chief Executive Officer, approves the levels of compensation and benefits payable to the Company’s other executive officers, reviews general policy matters relating to employee compensation and benefits and recommends to the entire Board, for its approval, stock option and other equity-based award grants to its executive officers, employees and consultants and discretionary bonuses to its executive officers and employees. The Compensation Committee has the authority to appoint and delegate to a sub-committee the authority to make grants and administer bonus and compensation plans and programs. Messrs. Brown and O’Brien and Ms. Halford are considered “independent” under the rules of the SEC and the Nasdaq.

The Compensation Committee has adopted a formal written charter (the “Compensation Charter”). The Compensation Charter sets forth the duties, authorities and responsibilities of the Compensation Committee. The Compensation Committee Charter is available on the Company’s Internet website at www.investor.cineverse.com.

64


 

The Compensation Committee, when determining executive compensation (including under the executive compensation program, as discussed below under the heading Compensation Discussion and Analysis), evaluates the potential risks associated with the compensation policies and practices. The Compensation Committee believes that the Company’s compensation programs are designed with an appropriate balance of risk and reward in relation to the Company’s overall compensation philosophy and do not encourage excessive or unnecessary risk-taking behavior. In general, the Company compensates its executives in a combination of cash and equity awards. The equity awards contain either or both performance targets and vesting provisions, both of which encourage the executives, on a long-term basis, to strive to enhance the value of such compensation as measured by the trading price of the Class A common stock or other performance metrics. The Compensation Committee does not believe that this type of compensation encourages excessive or unnecessary risk-taking behavior. As a result, we do not believe that risks relating to our compensation policies and practices for our employees are reasonably likely to have a material adverse effect on the Company. The Company intends to recapture compensation if and as required under the Sarbanes-Oxley Act. However, there have been no instances where it needed to recapture any compensation.

The Compensation Committee has engaged Aon, a compensation consulting firm to provide guidance for cash and equity compensation to executive officers and directors, as requested, which the Compensation Committee considered in reaching its determinations of such compensation. In addition, Aon was available to respond to specific inquiries throughout the year.

 

SEC rules adopted pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, enacted in July 2010 (the “Dodd-Frank Act”), enable our stockholders to vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Company’s proxy statements. The Company annually holds an advisory vote on executive compensation at its annual meetings.

Compensation Committee Interlocks and Insider Participation

The Compensation Committee currently consists of Messrs. Brown, and O’Brien and Ms. Halford. Ms. Halford is the Chair of the Compensation Committee. None of such members was, at any time during the Last Fiscal Year or at any previous time, an officer or employee of the Company.

None of the Company’s directors or executive officers serves as a member of the Board of Directors or compensation committee of any other entity that has one or more of its executive officers serving as a member of the Company’s Board of Directors. No member of the Compensation Committee had any relationship with us requiring disclosure under Item 404 of Securities and Exchange Commission Regulation S-K.

Nominating Committee

The Nominating Committee consists of Messrs. Brown and O’Brien and Ms. Halford. Mr. O'Brien is the Chair of the Nominating Committee. The Nominating Committee held one (1) meeting during the Last Fiscal Year. The Nominating Committee evaluates and approves nominations for annual election to, and to fill any vacancies in, the Board and recommends to the Board the directors to serve on committees of the Board. The Nominating Committee also approves the compensation package of the Company’s directors. Messrs. Brown and O’Brien and Ms. Halford are considered “independent” under the rules of the SEC and the Nasdaq.

The Nominating Committee has adopted a formal written charter (the “Nominating Charter”). The Nominating Charter sets forth the duties and responsibilities of the Nominating Committee and the general skills and characteristics that the Nominating Committee employs to determine the individuals to nominate for election to the Board. The Nominating Committee Charter is available on the Company’s Internet website at www.investor.cineverse.com.

The Nominating Committee will consider any director candidates recommended by stockholders. In considering a candidate submitted by stockholders, the Nominating Committee will take into consideration the needs of the Board and the qualifications of the candidate. Nevertheless, the Board may choose not to consider an unsolicited recommendation if no vacancy exists on the Board and/or the Board does not perceive a need to increase the size of the Board.

65


 

There are no specific minimum qualifications that the Nominating Committee believes must be met by a Nominating Committee-recommended director nominee. However, the Nominating Committee believes that director candidates should, among other things, possess high degrees of integrity and honesty; have literacy in financial and business matters; have no material affiliations with direct competitors, suppliers or vendors of the Company; and preferably have experience in the Company’s business and other relevant business fields (for example, finance, accounting, law and banking). The Nominating Committee considers diversity together with the other factors considered when evaluating candidates but does not have a specific policy in place with respect to diversity.

Members of the Nominating Committee meet in advance of each of the Company’s annual meetings of stockholders to identify and evaluate the skills and characteristics of each director candidate for nomination for election as a director of the Company. The Nominating Committee reviews the candidates in accordance with the skills and qualifications set forth in the Nominating Charter and the rules of the Nasdaq. There are no differences in the manner in which the Nominating Committee evaluates director nominees based on whether or not the nominee is recommended by a stockholder.

 

Recoupment (“Clawback”) Policy

The Company has a policy to recapture compensation as currently required under the Sarbanes-Oxley Act and the rules of The Nasdaq Stock Market. However, there have been no instances to date where it needed to recapture any compensation.

Additionally, we recognize that our compensation program is subject to the stock exchange listing standards required by Section 954 of the Dodd-Frank Act effective in October 2023, which required that stock exchange listing standards be amended to require issuers to adopt a policy providing for the recovery from any current or former executive officer of any incentive-based compensation (including stock options) awarded during the three-year period prior to an accounting restatement resulting from material noncompliance of the issuer with financial reporting requirements.

Restrictions on Speculative Transactions

The Company’s Insider Trading and Disclosure Policy restricts employees and directors of the Company from engaging in speculative transactions in Company securities, including short sales, and discourages employees and directors of the Company from engaging in hedging transactions, including “cashless” collars, forward sales, and equity swaps, that may indirectly involve short sales. Pre-clearance by the Company is required for all equity transactions.

Stock Ownership Guidelines

The Board has adopted stock ownership guidelines for its non-employee directors, pursuant to which the non-employee directors are required to acquire, within three (3) years, and maintain until separation from the Board, shares equal in value to a minimum of three (3) times the value of the annual cash retainer (not including committee or per-meeting fees) payable to such director. Shares acquired as Board retainer fees and shares owned by an investment entity with which a non-employee director is affiliated may be counted toward the stock ownership requirement. As of March 31, 2024, each of Messrs. Brown and O’Brien and Ms. Halford currently meet the stock ownership guidelines.

Environmental, Social and Governance (ESG)

The Company is committed to responsible and sustainable business practices. We are currently in the process of building our ESG strategy, with the goal of transparently communicating about our most material ESG impacts and initiatives.

Sustainability

The Company is committed to working in a responsible and sustainable way to produce as few negative environmental effects as possible from our operations. Our core business does not result in any significant negative

66


 

environmental effects. We note our leading role in the conversion, starting in 2005, from using analog films, which had to be shipped to theatre destinations, causing greenhouse gas emissions and ultimately waste of the film after use, to digital projection of virtually all major and independent studio films, which are now electronically delivered to theatre destinations. In addition, our current business concentrates on digital and streaming distribution of content, which again is environmentally-friendly. This conversion and streaming approach significantly reduces the carbon footprint associated with the film exhibition industry.

Talent

We are evolving our culture and our human capital strategies to best serve all of our employees and align with our growth strategies and the changing social environments. We believe that fostering a culture that is values-based, responsible, ethical and inclusive motivates and empowers our employees, which enables us to attract and retain talented people, engage them in meaningful and inspiring work and, as a result, fulfill our business goals and objectives. We regularly engage with our employees to monitor their needs and expectations and respond to meet these evolving employee needs.

We provide market-competitive compensation and benefits to our employees. Our benefits programs are reviewed each year to ensure that we are meeting current practices in providing benefits that meet the health and safety needs of our employees. When special circumstances occur, such as the recent pandemic, we adjust our benefits to meet our employees’ needs.

Health and Safety

We are focused on the health, safety and well-being of our employees. We provide mental and physical well-being programs to all employees. .

Diversity, Equity and Inclusion

We are committed to diverse representation across all levels of our workforce to reflect the vibrant and thriving diversity of the communities which make up our customers, stockholders and home communities. Fostering a work environment that is culturally diverse, inclusive and equitable is important to us. We believe that our business accomplishments are a result of the efforts of our employees and that a diverse employee population will result in a better understanding of our customers’ needs. We respect the unique attributes of each individual. Our DE&I purpose is to evolve the organization and our culture to reflect the customers and communities we serve, where differences in background, thought and experience are welcomed, valued and celebrated. We demonstrate purposeful actions and incorporate intentional practices to drive these inclusive behaviors in our daily work. We are committed to continually reviewing our operational practices and aligning DE&I initiatives with business objectives.

Social

We encourage our employees to give back to the community. In 2021, we initiated a Community Service Policy that provides paid time off to employees volunteering with qualified charitable organizations or causes (which organizations or causes may not discriminate based on creed, race, color, national origin, religion, age, disability, sex, gender, identity, sexual orientation, pregnancy or any other legally protected classification).

 

In addition, we have implemented a summer internship program in conjunction with C5 Youth Foundation of Southern California, a non-profit inner-city youth program. This 8-week program will provide for four college students to rotate through four departments at Cineverse.

 

 

 

 

 

67


 

ITEM 11. EXECUTIVE COMPENSATION

Named Executive Officers

The following table sets forth certain information concerning compensation received by the Company’s named executive officers ("NEOs"), consisting of the Company’s Chief Executive Officer and its two other most highly compensated individuals who were serving as executive officers at the end of the Last Fiscal Year, plus up to two additional persons for whom disclosures would have been provided but for the fact that they were not serving as executive officers at the end of the Last Fiscal Year, for services rendered in all capacities during the Last Fiscal Year.

SUMMARY COMPENSATION TABLE

 

Name and Principal Position(s)

 

Year

 

Salary
($)

 

 

Bonus
($) (1)

 

 

Stock Awards ($)(2)

 

 

Option Awards ($)(3)

 

 

All Other Compensation ($)(4)

 

 

Total ($)

 

Christopher J. McGurk

 

2024

 

 

650,000

 

 

 

325,000

 

 

 

 

 

 

 

 

 

39,286

 

 

 

1,014,286

 

Chief Executive Officer

 

2023

 

 

650,000

 

 

 

707,969

 

 

 

26,250

 

 

 

1,200,000

 

 

 

39,431

 

 

 

2,623,650

 

and Chairman

 

2022

 

 

650,000

 

 

 

650,000

 

 

 

90,146

 

 

 

 

 

 

33,500

 

 

 

1,423,646

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gary S. Loffredo

 

2024

 

 

460,000

 

 

 

161,000

 

 

 

 

 

 

196,323

 

 

 

55,521

 

 

 

872,844

 

Chief Legal Officer,

 

2023

 

 

460,000

 

 

 

350,717

 

 

 

15,750

 

 

 

 

 

 

58,785

 

 

 

885,252

 

Secretary and Senior Adviser

 

2022

 

 

460,000

 

 

 

322,000

 

 

 

54,088

 

 

 

 

 

 

33,810

 

 

 

869,898

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Erick Opeka

 

2024

 

 

475,000

 

 

 

120,000

 

 

 

 

 

 

368,106

 

 

 

55,536

 

 

 

1,018,642

 

Chief Strategy Officer

 

2023

 

 

400,000

 

 

 

261,404

 

 

 

15,750

 

 

 

 

 

 

49,571

 

 

 

726,725

 

and President
of Digital Networks

 

2022

 

 

400,000

 

 

 

240,000

 

 

 

54,088

 

 

 

 

 

 

20,327

 

 

 

714,415

 

 

(1)
The Company's bonus program, the MAIP incentive program, is described below. For fiscal year 2023 and 2024, the MAIP bonuses were settled in the Company's Common Stock.

 

(2)
Includes performance share units (“PSUs”) earned during the respective fiscal year. See above for a description of the material terms of the PSUs.
(3)
The amounts in this column reflect the grant date fair value for all fiscal years presented in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts are included in footnote 2 to the Company’s audited financial statements for the fiscal years ended March 31, 2024 and 2023, included in the Annual Report on Form 10-K for the fiscal year ended March 31, 2024 (the “Form 10-K”).
(4)
Includes life insurance premiums, disability insurance premiums and certain medical expenses paid by the Company for each NEO.

 

68


 

Employment agreements between the Company and Named Executive Officers

 

Christopher J. McGurk. On October 17, 2022, the Company entered into an employment agreement with Christopher J. McGurk (the “2022 McGurk Employment Agreement”). The 2022 McGurk Employment Agreement took effect on April 1, 2023, and has a term ending on March 31, 2026 with an automatic one-year renewal unless either party provides written notice to the other no later than ninety days prior to the expiration of the initial term. Pursuant to the 2022 McGurk Employment Agreement, Mr. McGurk will continue to serve as the Chief Executive Officer and Chairman of the Board of the Company.

 

The 2022 McGurk Employment Agreement also provides that Mr. McGurk will receive an annual base salary of $650,000 and will be eligible for (i) under the Company’s Management Annual Incentive Plan, a Target Bonus opportunity of $650,000 consistent with goals established from time to time by the Compensation Committee, (ii) under the 2017 Plan, performance share units for up to 25,000 shares of Common Stock, subject to EBITDA targets to be determined in the sole and absolute discretion of the Compensation Committee and financial performance targets, and such other terms as the Compensation Committee shall determine, and (iii) under the 2017 Plan, 125,000 SARs having an exercise price of $9.60 and a term of ten (10) years, one-third (1/3) of which will vest on April 1 of each of 2023, 2024 and 2025, provided that any unvested SARs shall immediately vest upon termination following a Change in Control (as defined in the 2017 Plan) or a termination other than for Cause (as defined in the 2022 McGurk Employment Agreement). Mr. McGurk will also be entitled to participate in all benefit plans and programs that the Company provides to its senior executives.

 

The 2022 McGurk Employment Agreement provides that, in the event of a termination without Cause (as defined in the 2022 McGurk Employment Agreement) or a resignation for Good Reason (as defined in the 2022 McGurk Employment Agreement), Mr. McGurk shall be entitled to payment of (i) the greater of any Base Salary for the remainder of the Term or eighteen (18) months’ Base Salary at the time of termination and (ii) an amount equivalent to one and one-half (1.5) times the average of the last two (2) bonus payments under the MAIP, if any, under the 2022 McGurk Employment Agreement. In the event of, on or after April 1, 2023 and within two (2) years after a Change in Control (as defined in the Plan), a termination without Cause (other than due to Mr. McGurk’s death or disability), a resignation for Good Reason, or upon notice by the Company that it does not wish to renew the Term (as defined in the McGurk Employment Agreement), then in lieu of receiving the amounts described above, Mr. McGurk would be entitled to receive a lump sum payment equal to three (3) times the sum of (a) his then-current annual Base Salary and (b) his Target Bonus for the year of termination.

 

Erick Opeka. On May 16, 2023, the Company entered into an employment agreements with Erick Opeka (the “Opeka Employment Agreement,”). The Opeka Employment Agreements was effective as of May 1, 2023 and supersedes the prior employment agreement between the Company and Mr. Opeka. The Opeka Employment Agreement has a term ending on April 30, 2025 with an automatic one-year renewal unless either party provides written notice to the other no later than ninety days prior to the expiration of the initial term.

 

Pursuant to the Opeka Employment Agreement, Mr. Opeka will serve as the Chief Strategy Officer and President of the Company. The Opeka Employment Agreement also provides that Mr. Opeka will receive an annual base salary of $475,000 and will be eligible for (i) under the Company’s Management Annual Incentive Plan (“MAIP”), a target bonus opportunity (the “Target Bonus”) of $356,250 consistent with goals established from time to time by the Compensation Committee (the “Compensation Committee”) of the Company’s Board of Directors, (ii) under the Company’s 2017 Equity Incentive Plan (the “Plan”), performance share units for up to 15,000 shares of the Company’s Class A common stock (the “Common Stock”), subject to EBITDA targets to be determined in the sole and absolute discretion of the Compensation Committee and financial performance targets, and such other terms as the Compensation Committee shall determine (“PSUs”), and (iii) under the Plan, 75,000 stock appreciation rights (“SARs”) having an exercise price of $5.80 and a term of ten (10) years, one-third (1/3) of which will vest on May 16, 2024, one-third (1/3) on May 1, 2025 and the final one-third (1/3) on May 1, 2026 (the “SAR Vesting Schedule”), provided that any unvested SARs shall immediately vest upon termination following a Change in Control (as defined in the Plan) or a termination other than for Cause (as defined in the Opeka Employment Agreement). Mr. Opeka will also be entitled to participate in all benefit plans and programs that the Company provides to its senior executives.

69


 

 

The Opeka Employment Agreement provides that, in the event of a termination without Cause (as defined in the Opeka Employment Agreement) or a resignation for Good Reason (as defined in the Opeka Employment Agreement), Mr. Opeka shall be entitled to payment of 12 months’ Base Salary at the time of termination. In the event of, on or after May 1, 2023 and during the Term, and within two (2) years after a Change in Control (as defined in the Plan), a termination without Cause (other than due to Mr. Opeka’s death or disability), a resignation for Good Reason, or upon notice by the Company that it does not wish to renew the Term (as defined in the Opeka Employment Agreement) (“CIC Termination”), then in lieu of receiving the amounts described above, Mr. Opeka would be entitled to receive a lump sum payment equal to two times the sum of (a) his then-current annual Base Salary and (b) his Target Bonus under the MAIP for the year of termination.

 

Gary S. Loffredo. On May 16, 2023, the Company entered into an employment agreement with Gary S. Loffredo (the “Loffredo Employment Agreement”). The Loffredo Employment Agreement was effective as of May 1, 2023 and supersedes the prior employment agreement between the Company and Mr. Loffredo. The Loffredo Employment Agreement has a term ending on April 30, 2025 with an automatic one-year renewal unless either party provides written notice to the other no later than ninety days prior to the expiration of the initial term.

 

Pursuant to the Loffredo Employment Agreement, Mr. Loffredo will serve as the Chief Legal Officer, Secretary & Senior Advisor of the Company. The Loffredo Employment Agreement also provides that Mr. Loffredo will receive an annual base salary of $460,000 and will be eligible for (i) a target bonus opportunity under the MAIP of $322,000 (the “Target Bonus”) consistent with goals established from time to time by the Compensation Committee, (ii) under the Plan, PSUs for up to 8,000 shares of Common Stock, subject to EBITDA targets to be determined in the sole and absolute discretion of the Compensation Committee and financial performance targets, and such other terms as the Compensation Committee shall determine, and (iii) under the Plan, 40,000 SARs having an exercise price of $5.80 and a term of ten (10) years which shall vest on the SAR Vesting Schedule, provided that any unvested SARs shall immediately vest upon termination following a Change in Control (as defined in the Plan) or a termination other than for Cause (as defined in the Loffredo Employment Agreement). Mr. Loffredo will also be entitled to participate in all benefit plans and programs that the Company provides to its senior executives.

 

The Loffredo Employment Agreement provides that, in the event of a termination without Cause (as defined in the Loffredo Employment Agreement) or a resignation for Good Reason (as defined in the Loffredo Employment Agreement), Mr. Loffredo shall be entitled to payment of 12 months’ Base Salary at the time of termination under the Loffredo Employment Agreement. In the event of a CIC Termination, on or after May 1, 2023 and during the Term, then in lieu of receiving the amounts described above, Mr. Loffredo would be entitled to receive a lump sum payment equal to two (2) times the sum of (a) his then-current annual Base Salary and (b) his Target Bonus under the MAIP for the year of termination.

 

Equity Compensation Plans

The following table sets forth certain information, as of March 31, 2024, regarding the shares of Cineverse’s Class A common stock under Cineverse’s equity compensation plan.

 

Plan

 

Number of shares of Class A common stock issuable upon exercise of outstanding options, warrants or rights (1)

 

 

Weighted average of exercise price of outstanding options, warrants and rights

 

 

Number of shares of Class A common stock remaining available for future issuance

 

Cineverse Second Amended and Restated 2000 Equity

 

 

 

 

 

 

 

 

 

Incentive Plan (“the 2000 Plan”)

 

 

892

 

 

$

289.57

 

 

 

 

Cineverse 2017 Equity Incentive Plan (the “2017 Plan”)

 

 

775,701

 

 

$

13.58

 

 

 

1,279,212

 

 

(1)
Shares of Common Stock.

 

 

70


 

The 2000 Plan

Our Board originally adopted the 2000 Plan on June 1, 2000 and our shareholders approved the 2000 Plan by written consent in July 2000. Certain terms of the Plan were last amended and approved by our shareholders in September 2016. Under the 2000 Plan, we may grant incentive and non-statutory stock options, stock, restricted stock, restricted stock units (RSUs), stock appreciation rights, and performance awards to our employees, non-employee directors and consultants. The primary purpose of the 2000 Plan is to enable us to attract, retain and motivate our employees, non-employee directors and consultants. The term of the 2000 Plan expired on June 1, 2020. The 2000 Plan has been replaced by the 2017 Plan, and no new awards will be granted from the 2000 Plan; however, the adoption of the 2017 Plan did not affect awards already granted under the 2000 Plan.

Options granted under the 2000 Plan expire ten years following the date of grant (or such shorter period of time as may be provided in a stock option agreement or five years in the case of incentive stock options granted to stockholders who own greater than 10% of the total combined voting power of the Company) and are subject to restrictions on transfer. Options granted under the Plan generally vest over periods of up to three or four years. The 2000 Plan is administered by the Compensation Committee, and may be amended or terminated by the Board, although no amendment or termination may adversely affect the right of any individual with respect to any outstanding option without the consent of such individual. The 2000 Plan provides for the granting of incentive stock options with exercise prices of not less than 100% of the fair market value of the Common Stock on the date of grant. Incentive stock options granted to stockholders of more than 10% of the total combined voting power of the Company must have exercise prices of not less than 110% of the fair market value of the Common Stock on the date of grant. Incentive and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is generally subject to the continuous service of the optionee, except for consultants. The exercise prices and vesting periods (if any) for non-statutory options may be set at the discretion of the Board or the Compensation Committee. Upon a change of control of the Company, all options (incentive and non-statutory) that have not previously vested will vest immediately and become fully exercisable. Options covering no more than 50 thousand shares may be granted to one participant during any calendar year unless pursuant to a multi-year award, in which case no more than options covering 50 thousand shares per year of the award may be granted, and during which period no additional options may be granted to such participant.

Grants of restricted stock and restricted stock units are subject to vesting requirements, generally vesting over periods up to three years, determined by the Compensation Committee and set forth in notices to the participants. Grants of stock, restricted stock and restricted stock units shall not exceed 40% of the total number of shares available to be issued under the 2000 Plan.

SARs consist of the right to the monetary equivalent of the increase in value of a specified number of shares over a specified period of time. Upon exercise, SARs may be paid in cash or shares of Common Stock or a combination thereof. Grants of SARs are subject to vesting requirements, similar to those of stock options, determined by the Compensation Committee and set forth in agreements between the Company and the participants. RSUs shall be similar to restricted stock except that no Class A common stock is actually awarded to the Participant on the grant date of the RSUs and the Compensation Committee shall have the discretion to pay such RSUs upon vesting in cash or shares of Common Stock or a combination thereof.

 

Performance awards consist of awards of stock and other equity-based awards that are valued in whole or in part by reference to, or are otherwise based on, the market value of the Common Stock, or other securities of the Company, and may be paid in shares of Common Stock, cash or another form of property as the Compensation Committee may determine. Grants of performance awards shall entitle participants to receive an award if the measures of performance established by the Committee are met. Such measures shall be established by the Compensation Committee but the relevant measurement period for any performance award must be at least 12 months. Grants of performance awards shall not cover the issuance of shares that would exceed 20% of the total number of shares available to be issued under the 2000 Plan, and no more than 2,500 shares pursuant to any performance awards shall be granted to one participant in a calendar year unless pursuant to a multi-year award. The terms of grants of performance awards would be set forth in agreements between the Company and the participants.

 

71


 

The 2017 Plan

Our Board adopted the 2017 Plan on August 7, 2017 and our stockholders approved the 2017 Plan on August 31, 2017. Under the 2017 Plan, we may grant incentive and non-statutory stock options, stock, restricted stock, restricted stock units (RSUs), stock appreciation rights, performance awards and other equity-based awards to our employees, non-employee directors and consultants. The primary purpose of the 2017 Plan is to enable us to attract, retain and motivate our employees, non-employee directors and consultants.

Options granted under the 2017 Plan expire ten years following the date of grant (or such shorter period of time as may be provided in a stock option agreement, or five years in the case of incentive stock options granted to stockholders who own greater than 10% of the total combined voting power of the Company) and are subject to restrictions on transfer. The 2017 Plan is administered by the Compensation Committee, and may be amended or terminated by the Committee, although no amendment or termination may have a material adverse effect on the rights of any individual with respect to any outstanding option, without the consent of such individual. The exercise prices of stock options granted must be not less than 100% of the fair market value of the Common Stock on the date of grant. Incentive stock options granted to stockholders of more than 10% of the total combined voting power of the Company must have exercise prices of not less than 110% of the fair market value of the Common Stock on the date of grant. Incentive and non-statutory stock options granted under the 2017 Plan may be subject to vesting provisions, and exercise is generally subject to the continuous service of the optionee, except for consultants. The exercise prices and vesting periods (if any) for non-statutory options may be set at the discretion of the Board or the Compensation Committee. Upon a change of control of the Company, where the Common Stock does not continue to be publicly traded, unless replacement awards are issued in connection with the transaction, all options (incentive and non-statutory) that have not previously vested will vest immediately and become fully exercisable. SARs consist of the right to the monetary equivalent of the increase in value of a specified number of shares over a specified period of time. Upon exercise, SARs may be paid, at the discretion of the Compensation Committee, in cash or shares of Common Stock or a combination thereof. Grants of SARs are subject to terms determined by the Compensation Committee and set forth in agreements between the Company and the participants.

Grants of restricted stock and restricted stock units are subject to vesting requirements, generally vesting over periods up to three years, determined by the Compensation Committee and set forth in notices to the participants.

RSUs shall be similar to restricted stock except that no Common Stock is actually awarded to the Participant on the grant date of the RSUs and the Compensation Committee shall have the discretion to pay such RSUs upon vesting in cash or shares of Common Stock or a combination thereof.

Performance awards consist of awards of stock and other equity-based awards that are valued in whole or in part by reference to, or are otherwise based on, the market value of the Common Stock, or other securities of the Company, and may be paid in shares of Common Stock, cash or another form of property as the Compensation Committee may determine. Grants of performance awards shall entitle participants to receive an award if the measures of performance established by the Committee are met. Such measures shall be established by the Compensation Committee but the relevant measurement period for any performance award must be at least 12 months. The terms of grants of performance awards would be set forth in agreements between the Company and the participants.

With respect to limits on Award grants under the 2017 Plan, aggregate shares granted to non-employee directors in any year may not exceed $1,000,000 in value.

Our Common Stock is listed for trading on Nasdaq under the symbol “CNVS”.

 

72


 

The following table sets forth certain information concerning outstanding equity awards of the NEOs at the end of the Last Fiscal Year. All outstanding stock awards reported in this table represent restricted stock that vests in equal annual installments over three years. At the end of the Last Fiscal Year, there were no unearned equity awards under performance-based plans.

 

 

OUTSTANDING EQUITY AWARDS AT MARCH 31, 2024

 

EQUITY AWARDS (1)

 

STOCK AWARDS

 

Name

 

Number of Securities Underlying Unexercised Options Exercisable
(#)

 

 

 

Number of Securities Underlying Unexercised Options Unexercisable
(#)

 

 

 

Option Exercise Price
($)

 

 

Option Expiration Date

 

Number of Shares or Units of Stock That Have Not Vested
(#)

 

 

Market Value of Shares or Units of Stock That Have Not Vested
($)

 

Christopher J. McGurk

 

 

35,000

 

(2)

 

 

 

 

 

 

29.40

 

 

6/7/2028

 

 

 

 

 

 

 

 

 

125,000

 

(3)

 

 

 

 

 

 

10.80

 

 

11/19/2030

 

 

 

 

 

 

 

 

 

41,666

 

(4)

 

 

83,334

 

(5)

 

 

9.60

 

 

10/17/2032

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gary S. Loffredo

 

 

30,000

 

(5)

 

 

 

 

 

 

29.40

 

 

9/13/2031

 

 

 

 

 

 

 

 

 

60,000

 

(6)

 

 

 

 

 

 

12.80

 

 

12/3/2030

 

 

 

 

 

 

 

 

 

 

 

 

 

40,000

 

(7)

 

 

5.80

 

 

5/16/2033

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Erick Opeka

 

 

400

 

(8)

 

 

 

 

 

 

362.00

 

 

9/2/2024

 

 

 

 

 

 

 

 

 

17,750

 

(9)

 

 

 

 

 

 

23.20

 

 

9/28/2028

 

 

 

 

 

 

 

 

 

60,000

 

(10)

 

 

 

 

 

 

12.80

 

 

12/20/2030

 

 

 

 

 

 

 

 

 

 

 

 

 

75,000

 

(11)

 

 

5.80

 

 

5/16/2033

 

 

 

 

 

 

 

(1)
Reflects stock appreciation rights granted under the 2000 Plan and SARs granted under the 2017 Plan.
(2)
Consists of stock appreciation rights, of which 1/3 vested on March 31 of each 2019, 2020 and 2021.
(3)
Consists of stock appreciation rights, of which 62,500 vested on each of November 19, 2020 and March 31, 2023.
(4)
Consists of stock appreciation rights, of which 41,666 vested on April 1, 2023, and 41,667 subsequently vested on April 1, 2024, and 41,667 will vest on April 1, 2025.
(5)
Consists of stock appreciation rights, of which 1/3 of which vested on December 10 of each 2019, 2020 and 2021.
(6)
Consists of stock appreciation rights, of which 25,000 vested on March 31 of each 2023 and 2022; and 10,000 vested on June 30, 2023.
(7)
Of such stock appreciation rights, 13,333 vest on May 16, 2024, 13,333 vest on May 1, 2025 and 13,334 vest on May 1, 2026.
(8)
Consists of options, of which 100 vested on September of each of 2015, 2016, 2017, and 2018.
(9)
Consists of stock appreciation rights, of which 1/3 vested on March 31 of each 2019, 2020, and 2021.
(10)
Of such stock appreciation rights, 25,000 vested on March 31, 2022, 25,000 vested on March 31, 2023 and 10,000 vest on December 31, 2023.
(11)
Of such stock appreciation rights, 25,000 vest on May 16, 2024, 25,000 vest on May 1, 2025 and 25,000 vest on May 1, 2026.

73


 

Non-employee Directors

The following table sets forth certain information concerning compensation earned by the Company’s non-employee directors for services rendered as a director during the Last Fiscal Year.

 

Name

 

Cash Fees Earned
($)

 

 

Stock Awards
($) (1)

 

 

Total
($)

 

Peter C. Brown

 

$

91,848

 

 

$

90,000

 

 

$

181,848

 

Patrick W. O’Brien

 

$

105,000

 

 

$

90,000

 

 

$

195,000

 

Mary Ann Halford (2)

 

$

26,793

 

 

$

270,000

 

 

$

296,793

 

Ashok Amritraj (3)

 

$

37,500

 

 

$

-

 

 

$

37,500

 

Peixin Xu (3)

 

$

30,000

 

 

$

-

 

 

$

30,000

 

 

(1) Peter C. Brown and Patrick O'Brien received 80,372 shares of restricted stock and Mary Ann Halford received 241,115 shares of restricted stock, which remain unvested as of March 31, 2024.

(2) Mary Ann Halford joined the board on December 8, 2023

(3) Ashok Amritraj and Peixin Xu left the Board of Directors on December 8, 2023

 

Non-employee directors receive the following compensation for board service. The annual cash retainer amount is $60,000 and the annual stock grant of restricted shares of Common Stock amount is valued at $90,000 based on the trailing 20-day volume weighted average price (“VWAP”) of the Common Stock as of the date of the most recent prior annual shareholder’s meeting. In addition, non-employee directors receive annual committee fees of $15,000 for service as a committee chair and of $5,000 for service on a committee (other than as chair). In addition to the cash and stock retainers paid to all non-employee directors for Board service, the Lead Independent Director receives an annual cash fee of $20,000. Finally, new non-employee directors will receive a grant of restricted stock valued at $180,000 based on the trailing 20-day VWAP of the Common Stock as of the grant date (the date the director joins the Board), and such shares will vest in three equal installments on the first three anniversaries of the date of grant.

 

The Company has adopted Stock Ownership Guidelines for its non-employee directors as discussed under MATTERS RELATING TO OUR GOVERNANCE, above.

74


 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

As of June 17, 2024, the Company’s directors, executive officers, and principal stockholders beneficially own, directly or indirectly, in the aggregate, approximately 20.8% of its outstanding Common Stock. These stockholders have significant influence over the Company’s business affairs, with the ability to control matters requiring approval by the Company’s stockholders.

The following table sets forth as of June 17, 2024, certain information with respect to the beneficial ownership of the Common Stock as to (i) each person known by the Company to beneficially own more than 5% of the outstanding shares of the Class A common stock, (ii) each of the Company’s directors, (iii) each of the NEOs and (iv) all of the Company’s directors and executive officers as a group.

CLASS A COMMON STOCK

 

 

 

Shares Beneficially Owned (b)

 

Name (a)

 

Number

 

 

 

Percent

 

Christopher J. McGurk

 

 

789,377

 

 

(c)

4.9%

 

Gary S. Loffredo

 

 

273,459

 

 

(d)

 

1.7

%

Erick Opeka

 

 

297,113

 

 

(e)

 

1.9

%

Mary Ann Halford

 

 

241,115

 

 

 

 

1.5

%

Peter C. Brown

 

 

108,118

 

 

(f)

*

 

Patrick W. O’Brien

 

 

104,060

 

 

 

*

 

Peixin Xu

 

 

958,782

 

 

(g)

 

6.1

%

All directors and executive officers as a group (9 persons)

 

 

2,402,754

 

 

(h)

 

14.9

%

 

(a)
Unless otherwise indicated, the business address of each person named in the table is c/o Cineverse Corp., 224 W. 35th St. Suite 500, #947 New York, New York 10001.
(b)
Applicable percentage of ownership is based on 15,606,341 shares of Common Stock outstanding as of June 17, 2024 together with all applicable options, warrants and other securities convertible into shares of our Common Stock for such stockholder. Beneficial ownership is determined in accordance with the rules of the SEC, and includes voting and investment power with respect to shares. Shares of Common Stock subject to options, warrants or other convertible securities exercisable within 60 days after June 17, 2024 are deemed outstanding for computing the percentage ownership of the person holding such options, warrants or other convertible securities, but are not deemed outstanding for computing the percentage of any other person. Except as otherwise noted, the named beneficial owner has the sole voting and investment power with respect to the shares of Common Stock shown. Certain information is based on the numbers of shares reported in the most recent Schedule 13D or Schedule 13G, as amended, as applicable, filed by stockholders with the SEC through June 17, 2024 and information provided by holders or otherwise known to the Company
(c)
Includes (i) 243,332 shares of Class A common stock underlying currently exercisable stock appreciation rights and (ii) 103,526 shares owned by the Christopher and Jamie McGurk Living Trust, of which Mr. McGurk is a trustee.
(d)
Includes 103,333 shares of Class A common stock underlying currently exercisable stock appreciation rights.
(e)
Includes (i) 400 shares of Common Stock underlying currently exercisable options and (ii) 102,750 shares of Common Stock underlying currently exercisable stock appreciation rights.
(f)
Includes 4,603 shares owned by Grassmere Partners LLC, of which Mr. Brown is Chairman. Mr. Brown disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
(g)
Includes (i) 21,585 shares of Common Stock owned directly, (ii) 410,884 shares of Common Stock held by Mingtai Investment LP (“Mingtai”), (iii) 194,931 shares of Common Stock held by Antai Investment LP (“Antai”), and (v) 331,382 shares of Common Stock held by Shangtai Asset Management LP (“Shangtai”). BEMG is wholly-owned by Bison Capital Holding Company Limited. Mr. Xu’s spouse, Fengyun Jiang, is the sole owner of Bison Capital Holding Company Limited. Mingtai is indirectly managed by a subsidiary of Bison Finance Group Limited (“BFGL”), which is controlled by Mr. Xu. Shangtai is indirectly managed by a subsidiary of BFGL. Mr. Xu controls the manager of the general partner of Antai. The business address of Mr. Xu is 609-610 21st Century Tower, No. 40 Liangmaqiao Road, Chaoyang District, Beijing, China, 100016. Information presented is based Amendment No. 4 to Schedule 13D filed by Mr. Xu on May 31, 2023.

75


 

(h)
Includes a total of 524,279 shares that are not currently outstanding, consisting of (i) 697 shares of Common Stock underlying currently exercisable options and (ii) 523,582 shares of Common Stock underlying currently exercisable stock appreciation rights

 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Related Party Transactions

The Audit Committee, pursuant to its charter, is responsible for the review and oversight of all related party transactions and other potential conflict of interest situations, by review in advance or ratification afterward. The Audit Committee charter does not set forth specific standards to be applied; rather, the Audit Committee reviews each transaction individually on a case by case, facts and circumstances basis.

 

There have been no significant reportable transactions or currently proposed transactions between the Company and any director or executive officer of the Company or any 5% security holder of the Company or any member of the immediate family of any of the foregoing persons, since the beginning of the Last Fiscal Year.

 

On January 5, 2022, the Company entered into a letter agreement with Hyde Park, pursuant to which the Company and Hyde Park are collaborating on the development, production and/or distribution of a project based on the novel Audition by Ryu Murakami (the “Audition Project”). Each of the Company and Hyde Park owns 50% of the rights in connection with the Audition Project. The Company paid $100 thousand to Hyde Park plus $26 thousand in legal fees to counsel for the Audition project. Ashok Amritraj, a former director of the Company whose role ended in December 2023, is the Chairman and CEO of Hyde Park and has an interest in 100% of the revenues of Hyde Park. The approximate dollar value of the amount of Mr. Armitraj's interest in the transaction is undeterminable at this time. Mr. Amritraj is a current board member and related party to the Company.

 

On April 4, 2023, Christopher McGurk, the Company’s Chief Executive Officer and Chairman of the Board, purchased 1 share of the Company’s Series B Preferred Stock, $.001 par value, for $10,000 which hold 1,800,000,000 votes (not adjusted for Reverse Stock Split) only on a measure pertaining to a reverse stock split proposal of the Company under certain conditions. The Series B Preferred has no right to vote on any other matter except as may be required by the General Corporation Law of the State of Delaware. The share of Series B Preferred is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Series B Preferred did not have the right to be transferred at any time prior to stockholder approval of the reverse stock split matter without the prior written consent of the Company's Board of Directors. The outstanding share was redeemed on June 9, 2023 for a price of $10,000 following the approval of the reverse stock split matter.

Director Independence

Please see the discussion of director independence under “MATTERS RELATING TO OUR GOVERNANCE, Board of Directors” above.

76


 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS

The Audit Committee oversees the Company’s financial reporting process on behalf of the Board. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management the audited financial statements in the Form 10-K, including a discussion of the acceptability of the accounting principles, the reasonableness of significant judgments and the clarity of disclosures in the financial statements.

The Audit Committee reviewed and discussed with the independent registered public accounting firm, which is responsible for expressing an opinion on the conformity of those audited financial statements with the standards of the Public Company Accounting Oversight Board, the matters required to be discussed by Statements on Auditing Standards (SAS 61), as may be modified or supplemented, and their judgments as to the acceptability of the Company’s accounting principles and such other matters as are required to be discussed with the Audit Committee under the standards of the Public Company Accounting Oversight Board.

In addition, the Audit Committee has discussed with the independent registered public accounting firm their independence from management and the Company, including receiving the written disclosures and letter from the independent registered public accounting firm as required by the Independence Standards Board Standard No. 1, as may be modified or supplemented, and has considered the compatibility of any non-audit services with the auditors’ independence.

The Audit Committee discussed with the Company’s independent registered public accounting firm the overall scope and plans for their audit. The Audit Committee meets with the independent registered public accounting firm, with and without management present, to discuss the results of their examinations and the overall quality of the Company’s financial reporting.

In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board, and the Board approved, that the audited financial statements be included in the Form 10-K for the year ended March 31, 2024 for filing with the SEC.

Respectfully submitted,

The Audit Committee of the Board of Directors

Peter C. Brown, Chairman

Mary Ann Halford

Patrick W. O’Brien

THE FOREGOING AUDIT COMMITTEE REPORT SHALL NOT BE “SOLICITING MATERIAL” OR BE DEEMED “FILED” WITH THE SEC, NOR SHALL SUCH INFORMATION BE INCORPORATED BY REFERENCE INTO ANY FILING UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT THE COMPANY SPECIFICALLY INCORPORATES IT BY REFERENCE INTO SUCH FILING.

EisnerAmper LLP served as the independent registered public accounting firm to audit the Company’s consolidated financial statements since the fiscal year ended March 31, 2005.

The Company’s Audit Committee has adopted policies and procedures for pre-approving all services, including non-audit work, performed by EisnerAmper LLP for the fiscal years ended March 31, 2024 and 2023. In determining whether to approve a particular audit or permitted non-audit service, the Audit Committee will consider, among other things, whether the service is consistent with maintaining the independence of the independent registered public accounting firm. The Audit Committee will also consider whether the independent registered public accounting firm is best positioned to provide the most effective and efficient service to our Company and whether the service might be expected to enhance our ability to manage or control risk or improve audit quality. Specifically, the Audit Committee has pre-approved the use of EisnerAmper LLP for detailed, specific types of services within the following categories of non-audit services: acquisition due diligence and audit services; tax services; and reviews

77


 

and procedures that the Company requests EisnerAmper LLP to undertake on matters not required by laws or regulations. In each case, the Audit Committee has required management to obtain specific pre-approval from the Audit Committee for any engagements.

The aggregate fees billed for professional services by EisnerAmper LLP for these various services were:

 

Type of Fees

 

For the fiscal year ended March 31,

 

 

 

2024

 

 

2023

 

(1) Audit Fees

 

$

580,650

 

 

$

558,075

 

(2) Audit-Related Fees

 

 

 

 

 

 

(3) Tax Fees

 

 

 

 

 

 

(4) All Other Fees

 

 

 

 

 

 

 

 

$

580,650

 

 

$

558,075

 

 

In the above table, in accordance with the SEC’s definitions and rules, “audit fees” are fees the Company paid EisnerAmper LLP for professional services for the audit of the Company’s consolidated financial statements for the fiscal years ended March 31, 2024 and 2023 included in Form 10-K and review of consolidated financial statements incorporated by reference into Form S-1 and Form S-3 and included in Form 10-Qs and for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements; “audit-related fees” are fees for assurance and related services that are reasonably related to the performance of the audit or review of the Company’s consolidated financial statements; “tax fees” are fees for tax compliance, tax advice and tax planning; and “all other fees” are fees for any services not included in the first three categories. All of the services set forth in sections (1) through (4) above were approved by the Audit Committee in accordance with the Audit Committee Charter.

For the fiscal years ended March 31, 2024 and 2023, the Company retained a firm other than EisnerAmper LLP for tax compliance, tax advice and tax planning.

78


 

PART IV

ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES

(a)(1) Financial Statements

See Index to Financial Statements in Item 8 herein.

(a)(2) Financial Statement Schedules

None.

(a)(3) Exhibits

The exhibits are listed in the Exhibit Index beginning on the following page herein.

79


 

EXHIBIT INDEX

 

Exhibit

Description of Document

3.1

-

Fifth Amended and Restated Certificate of Incorporation of the Company, as amended. (42)

3.2

-

Second Amended and Restated Bylaws of the Company. (16)

4.1

-

Specimen certificate representing Class A common stock. (1)

4.2

-

Specimen certificate representing Series A Preferred Stock. (7)

4.3

-

Security Agreement, dated as of October 18, 2011, among CDF2 Holdings, LLC and each Grantor from time to time party thereto and Société Générale, New York Branch, as Collateral Agent for CHG-Meridian U.S. Finance, Ltd. And any other CHG Lease Participants. (13)

4.4

-

Trademark Security Agreement dated as of September 15, 2022 by and between East West Bank and each of Cinedigm Corp. and the Guarantors thereto. (36)

4.5

-

Copyright Security Agreement dated as of September 15, 2022 by and between East West Bank and each of Cinedigm Corp. and the Guarantors thereto. (36)

4.5.1

-

Amendment No. 1 to Copyright Security Agreement, dated as of August 8, 2023, by and among East West Bank and each of Cineverse Corp. and the Guarantors party thereto. (47)

4.6

-

Form of Pre-Funded Warrant (41)

4.7

-

Form of Common Warrant (41)

4.8

-

Description of Securities*

10.1†

-

Second Amended and Restated 2000 Equity Incentive Plan of the Company. (3)

10.1.1†

-

Amendment dated May 9, 2008 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (5)

10.1.2†

-

Form of Notice of Restricted Stock Award. (3)

10.1.3†

-

Form of Non-Statutory Stock Option Agreement. (4)

10.1.4†

-

Form of Restricted Stock Unit Agreement (employees). (5)

10.1.5†

-

Form of Stock Option Agreement. (2)

10.1.6†

-

Form of Restricted Stock Unit Agreement (directors). (5)

10.1.7†

-

Amendment No. 2 dated September 4, 2008 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (6)

10.1.8†

-

Amendment No. 3 dated September 30, 2009 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (8)

10.1.9†

-

Amendment No. 4 dated September 14, 2010 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (11)

10.1.10†

-

Amendment No. 5 dated April 20, 2012 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (12)

10.1.11†

-

Amendment No. 6 dated September 12, 2012 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (14)

10.1.12†

-

Amendment No. 7 dated September 16, 2014 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (15)

10.1.13†

-

Amendment No. 8 dated September 8, 2016 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (17)

10.1.14†

-

Amendment No. 9 dated September 27, 2016 to the Second Amended and Restated 2000 Equity Incentive Plan of the Company. (18)

10.2†

-

Cinedigm Corp. Management Incentive Award Plan. (9)

10.3†

-

Form of Indemnification Agreement for non-employee directors. (10)

10.4†

-

2017 Equity Incentive Plan of the Company. (19)

10.4.1†

-

Form of Notice of Incentive Stock Option Grant. (20)

10.4.2†

-

Form of Notice of Option Grant. (20)

10.4.3†

-

Form of Notice of Restricted Stock Award. (20)

10.4.4†

-

Form of Notice of Restricted Stock Unit Award. (20)

10.4.5†

-

Form of Notice of Performance-Based Restricted Stock Award. (22)

10.4.6†

-

Form of Notice of Stock Appreciation Right Grant (revised). (23)

10.4.7†

-

Amendment No. 1 to the 2017 Equity Incentive Plan. (24)

10.4.8†

-

Amendment No. 2 to the 2017 Equity Incentive Plan. (26)

10.4.9†

-

Amendment No. 3 to the 2017 Equity Incentive Plan. (27)

10.4.10†

-

Amendment No. 4 to the 2017 Equity Incentive Plan. (29)

80


 

Exhibit

Description of Document

10.4.11†

-

Amendment No. 5 to the 2017 Equity Incentive Plan (30)

10.4.12†

-

Form of Notice of Restricted Stock Award (Directors). (33)

10.4.13†

-

Form of Notice of Performance-Based Restricted Stock Unit Award. (37)

10.4.14†

-

Amendment No. 6 to the 2017 Equity Incentive Plan. (38)

10.5

-

Equipment Purchase Agreement effective as of March 17, 2021 between Cinedigm Digital Funding I, LLC and American Multi-Cinema, Inc. (34)

10.6

-

Equipment Purchase Agreement effective as of March 17, 2021 between Access Digital Cinema Phase 2, Corp., Access Digital Cinema Phase 2 B/AIX Corp. and American Multi-Cinema, Inc. (34)

10.7

-

Common Stock Purchase Agreement dated as of October 12, 2021 between Cinedigm Corp. and B. Riley Principal Capital, LLC. (31)

10.8

-

Registration Rights Agreement dated as of October 12, 2021 between Cinedigm Corp. and B. Riley Principal Capital, LLC. (31)

10.9†

-

Employment Agreement between Cinedigm Corp. and Christopher J. McGurk dated as of October 17, 2022.** (37)

10.10

-

Multiparty Agreement, dated as of October 18, 2011, among Cinedigm Digital Funding 2, LLC, as Borrower, Access Digital Cinema Phase 2, Corp., CDF2 Holdings, LLC, Cinedigm Digital Cinema Corp., CHG-MERIDIAN U.S. Finance, Ltd., Société Générale, New York Branch, as Senior Administrative Agent and Ballantyne Strong, Inc., as Approved Vendor. (13)

10.11

-

Master Equipment Lease No. 8463, effective as of October 18, 2011, by and between CHG- MERIDIAN U.S. Finance, Ltd. And CDF2 Holdings, LLC. (13)

10.12

-

Master Equipment Lease No. 8465, effective as of October 18, 2011, by and between CHG-MERIDIAN U.S. Finance, Ltd. And CDF2 Holdings, LLC. (13)

10.13

-

Sale and Leaseback Agreement, dated as of October 18, 2011, by and between CDF2 Holdings, LLC and CHG-MERIDIAN U.S. Finance, Ltd. (13)

10.14

-

Registration Rights Agreement, dated as of November 1, 2017, between the Company and the purchasers listed on Schedule I therein. (21)

10.15

-

Form of Voting Agreement. (21)

10.16

-

Amended and Restated Loan, Guaranty and Security Agreement dated as of September 15, 2022 by and among Cinedigm Corp., East West Bank and the Guarantors named therein. (36)

10.16.1

-

Amendment No. 1 to Amended and Restated Loan, Guaranty and Security Agreement, dated as of August 8, 2023, by and between Cineverse Corp., East West Bank and the Guarantors named therein.** (47).

10.16.2

-

Amendment No. 2 to Amended and Restated Loan, Guaranty and Security Agreement dated as of February 9, 2024 by and among Cineverse Corp., East West Bank and the Guarantors named therein. ** (43).

10.17†

 -

Employment Agreement dated as of September 13, 2021 between Cinedigm Corp. and John Canning. (32)

10.17.1†

-

Separation Agreement dated September 15, 2023 between Cineverse Corp. and John Canning (Certain Portions Omitted). (45).

10.18†

-

Form of Stock Appreciation Rights Agreement – Canning. (32)

10.19†

Form of Performance Stock Unit Agreement – Canning. (32)

10.20†

-

Employment Agreement between Cinedigm Corp. and Gary S. Loffredo dated as of December 23, 2020. (25)

10.20.1†

Employment Agreement between Cinedigm Corp. and Gary S. Loffredo dated as of May 16, 2023. (40)

10.21†

-

Employment Agreement between Cinedigm Corp. and Erick Opeka dated as of December 23, 2020. (25)

10.21.1†

-

Employment Agreement between Cinedigm Corp. and Erick Opeka dated as of May 16, 2023.**(40)

10.22

-

Sales Agreement, dated July 6, 2020, by and between Cinedigm Corp., A.G.P./Alliance Global Partners and B. Riley FBR, Inc. (28)

10.23

-

Amended and Restated Equity Purchase Agreement dated March 25, 2022 among the Company, and David Chu, Augustine Hong, Helen Hong, Michael Hong, Justin Lee, Steven Park, and Kingsoon Ong (collectively, the “Sellers”) and David Chu as representative of the Sellers.(35)

10.24†

-

Employment Agreement between Cinedigm Corp. and Antonio Huidor dated as of May 16, 2023.(40)

81


 

Exhibit

Description of Document

10.25

-

Purchase Agreement, dated April 4, 2023, by and between Cinedigm Corp. and the purchaser named therein. (39)

10.26

-

Securities Purchase Agreement dated June 14, 2023. (41)

10.27†

-

Employment Agreement dated September 14, 2023 between Cineverse Corp. and Mark Lindsey (Certain Portions Omitted). (46).

10.27

-

Sales Agreement, dated May 3, 2024 between Cineverse Corp., A.G.P./Alliance Global Partners and The Benchmark Company, LLC. (44)

21.1

-

List of Subsidiaries.*

23.1

-

Consent of EisnerAmper LLP.*

24.1

-

Powers of Attorney.* (Contained on signature page)

31.1

-

Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2

-

Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1

-

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

32.2

-

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

97.1

-

Clawback Policy dated November 25, 2023.*

101.INS

Inline XBRL Instance Document.

101.SCH

Inline XBRL Taxonomy Extension Schema With Embedded Linkbases Document.

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.

† Management compensatory arrangement.

** Portions of this exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

Documents Incorporated Herein by Reference:

(1)
Previously filed with the Securities and Exchange Commission on November 4, 2003 as an exhibit to the Company’s Amendment No. 3 to Registration Statement on Form SB-2 (File No. 333-107711).
(2)
Previously filed with the Securities and Exchange Commission on April 25, 2005 as an exhibit to the Company’s Registration Statement on Form S-8 (File No. 333-124290).
(3)
Previously filed with the Securities and Exchange Commission on September 24, 2007 as an exhibit to the Company’s Form 8-K (File No. 000-51910).
(4)
Previously filed with the Securities and Exchange Commission on April 3, 2008 as an exhibit to the Company’s Form 8-K (File No. 000-51910).
(5)
Previously filed with the Securities and Exchange Commission on May 14, 2008 as an exhibit to the Company’s Form 8-K (File No. 000-51910).
(6)
Previously filed with the Securities and Exchange Commission on September 10, 2008 as an exhibit to the Company’s Form 8-K (File No. 000-51910).
(7)
Previously filed with the Securities and Exchange Commission on February 9, 2009 as an exhibit to the Company’s Form 8-K (File No. 000-51910).
(8)
Previously filed with the Securities and Exchange Commission on October 6, 2009 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(9)
Previously filed with the Securities and Exchange Commission on October 27, 2009 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(10)
Previously filed with the Securities and Exchange Commission on September 21, 2009 as an exhibit to the Company’s Form 8-K (File No. 001-31810).

82


 

(11)
Previously filed with the Securities and Exchange Commission on September 16, 2010 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(12)
Previously filed with the Securities and Exchange Commission on April 24, 2012 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(13)
Previously filed with the Securities and Exchange Commission on October 24, 2011 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(14)
Previously filed with the Securities and Exchange Commission on September 14, 2012 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(15)
Previously filed with the Securities and Exchange Commission on September 17, 2014 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(16)
Previously filed with the Securities and Exchange Commission on March 3, 2023 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(17)
Previously filed with the Securities and Exchange Commission on September 8, 2016 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(18)
Previously filed with the Securities and Exchange Commission on September 28, 2016 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(19)
Previously filed with the Securities and Exchange Commission on September 1, 2017 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(20)
Previously filed with the Securities and Exchange Commission on October 2, 2017 as an exhibit to the Company’s Registration Statement on Form S-8 (File No. 333-220773).
(21)
Previously filed with the Securities and Exchange Commission on November 6, 2017 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(22)
Previously filed with the Securities and Exchange Commission on November 16, 2017 as an exhibit to the Company’s Form 10-Q (File No. 001-31810).
(23)
Previously filed with the Securities and Exchange Commission on December 7, 2018 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(24)
Previously filed with the Securities and Exchange Commission on December 5, 2019 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(25)
Previously filed with the Securities and Exchange Commission on December 30, 2020 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(26)
Previously filed with the Securities and Exchange Commission on September 4, 2020 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(27)
Previously filed with the Securities and Exchange Commission on October 26, 2020 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(28)
Previously filed with the Securities and Exchange Commission on July 6, 2020 as an exhibit to the Company’s Registration Statement on Form S-3 (File No. 333-239710).
(29)
Previously filed with the Securities and Exchange Commission on August 10, 2021 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(30)
Previously filed with the Securities and Exchange Commission on October 12, 2021 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(31)
Previously filed with the Securities and Exchange Commission on October 12, 2021 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(32)
Previously filed with the Securities and Exchange Commission on September 17, 2021 as an exhibit to the Company’s Form 8-K (File No. 001-31810).

83


 

(33)
Previously filed with the Securities and Exchange Commission on August 13, 2021 as an exhibit to the Company’s Form 8-K/A (File No. 001-31810).
(34)
Previously filed with the Securities and Exchange Commission on July 30, 2021 as an exhibit to the Company’s Form 10-K (File No. 001-31810).
(35)
Previously filed with the Securities and Exchange Commission on September 9, 2021 as an exhibit to the Company’s Form 10-Q (File No. 001-31810).
(36)
Previously filed with the Securities and Exchange Commission on February 14, 2023 as an exhibit to the Company’s Form 10-Q (File No. 001-31810).
(37)
Previously filed with the Securities and Exchange Commission on October 19, 2022 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(38)
Previously filed with the Securities and Exchange Commission on December 13, 2023 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(39)
Previously filed with the Securities and Exchange Commission on April 7, 2023 as an exhibit to the Company’s Form 8-K (File No. 001-31810).
(40)
Previously filed with the Securities and Exchange Commission on May 22, 2023 as an exhibit to the Company’s Form 8-K (File No. 001-31810)
(41)
Previously filed with the Securities and Exchange Commission on June 15, 2023 as an exhibit to the Company’s form 8-K (File No. 001-31810).
(42)
Previously filed with the Securities and Exchange Commission on June 29, 2023 as an exhibit to the Company’s Form 10-K (File No. 001-31810).
(43)
Previously filed with the Securities and Exchange Commission on February 14, 2024 as an exhibit to the Company’s Form 10-Q (File No. 001-31810).
(44)
Previously filed with the Securities and Exchange Commission on May 3, 2024 as an exhibit to the Company’s form 8-K (File No. 001-31810).
(45)
Previously filed with the Securities and Exchange Commission on September 19, 2024 as an exhibit to the Company’s form 8-K (File No. 001-31810).
(46)
Previously filed with the Securities and Exchange Commission on September 18, 2024 as an exhibit to the Company’s form 8-K (File No. 001-31810).
(47)
Previously filed with the Securities and Exchange Commission on August 14, 2024 as an exhibit to the Company’s form 8-K (File No. 001-31810).

84


 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Cineverse Corp.

Date:

July 1, 2024

By:

/s/ Christopher J. McGurk

Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)

Date:

July 1, 2024

By:

/s/ Mark Lindsey

Chief Financial Officer
(Principal Financial Officer)

 

 

85


 

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each individual whose signature appears below hereby constitutes and appoints Christopher J. McGurk and Gary S. Loffredo, and each of them individually, his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments to this Report together with all schedules and exhibits thereto, (ii) act on, sign and file with the Securities and Exchange Commission any and all exhibits to this Report and any and all exhibits and schedules thereto, (iii) act on, sign and file any and all such certificates, notices, communications, reports, instruments, agreements and other documents as may be necessary or appropriate in connection therewith and (iv) take any and all such actions which may be necessary or appropriate in connection therewith, granting unto such agents, proxies and attorneys-in-fact, and each of them individually, full power and authority to do and perform each and every act and thing necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person, and hereby approving, ratifying and confirming all that such agents, proxies and attorneys-in-fact, any of them or any of his, her or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE(S)

TITLE(S)

DATE

/s/ Christopher J. McGurk

Chief Executive Officer and Chairman of the Board of Directors

July 1, 2024

Christopher J. McGurk

(Principal Executive Officer)

/s/ Mark Lindsey

Chief Financial Officer

July 1, 2024

Mark Lindsey

(Principal Financial and Accounting Officer)

/s/ Mary Ann Halford

Director

July 1, 2024

Mary Ann Halford

/s/ Peter C. Brown

Director

July 1, 2024

Peter C. Brown

/s/ Patrick O´Brien

Director

July 1, 2024

Patrick O´Brien

 

86


EX-4.8 2 cnvs-ex4_8.htm EX-4.8 EX-4.8

 

 

Exhibit 4.8

DESCRIPTION OF SECURITIES

Authorized and Outstanding Capital Stock

The following description of Cineverse Corp.’s capital stock and provisions of our certificate of incorporation and bylaws are summaries and are qualified by reference to our certificate of incorporation and bylaws, which have been incorporated by reference as exhibits to the Annual Report on Form 10-K to which this Description of Securities is an exhibit.

As of June 17, 2024, our authorized capital stock consists of 275,000,000 shares of Class A common stock, par value $0.001 per share (the “Class A common stock”), and 15,000,000 shares of preferred stock, par value $0.001 per share, of which 20 shares are authorized as Series A 10% Non-Voting Cumulative Preferred Stock (the “Series A Preferred Stock”) and 1 shares is authorized as Series B Preferred Stock (the “Series B Preferred Stock”).

As of June 17, 2024, there were 15,606,341 shares of Class A common stock outstanding, 7 shares of Series A Preferred Stock, and no shares of Series B Preferred Stock were outstanding.

Description of Common Stock

Voting Rights. Holders of Class A common stock are entitled to one vote per share on all matters submitted to a vote of our stockholders.

Holders of a majority of our outstanding shares of Class A common stock present or represented by proxy at any meeting of our stockholders constitute a quorum.

Dividends; Liquidation; Preemptive Rights. Holders of Class A common stock are entitled to receive dividends only if, as and when declared by our board of directors out of funds legally available for that purpose. In the event of our liquidation, dissolution or winding-up, holders of Class A common stock are entitled, subject to any priorities due to any holders of our preferred stock, ratably to share in all assets remaining after payment of our liabilities. Holders of Class A common stock have no preemptive rights nor any other rights to subscribe for shares or securities convertible into or exchangeable for shares of Class A common stock.

Our Class A common stock is traded on Nasdaq under the symbol “CNVS.”

Preferred Stock

Our Board of Directors is authorized, subject to any limitations prescribed by law, without further stockholder approval, to issue from time to time up to an aggregate of 15,000,000 shares of our preferred stock, in one or more series. The Series A Preferred Stock may be redeemed by the Company at any time after the second anniversary of the date such shares were issued in cash or, at the Company’s option if certain conditions are met, in shares of Class A common stock. The holders of Series A Preferred Stock are entitled to receive cumulative dividends from the date of issuance at an annual rate of 10% of the original issue price. Such dividends shall be payable in arrears in cash or, at the Company’s option, in shares of Class A common stock if certain conditions are met, quarterly on the last day of each calendar quarter, until such shares of Preferred Stock are redeemed. The single authorized share of Series B Preferred Stock was issued and subsequently redeemed and no additional Series B Preferred Stock may be issued.

Each other series of preferred stock to be issued, if any, will have such number of shares, designations, preferences, powers and qualifications and special or relative rights or privileges as will be determined by our board of directors, which may include, among others, dividend rights, voting rights, redemption and sinking fund provisions, liquidation preferences, conversion rights and preemptive rights. The rights of the holders of our common stock will be subject to the rights of holders of any preferred stock outstanding and issued in the future. The issuance of preferred stock, while providing desirable flexibility in connection with the possible acquisitions

 


 

and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or of discouraging a third party from acquiring, a majority of our outstanding voting stock.

Anti-Takeover Effects of Delaware Law; Our Certificate of Incorporation and Our Bylaws

Delaware law, our certificate of incorporation and our bylaws contain provisions that could have the effect of delaying, deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, are intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our Board.

No Cumulative Voting. Under Delaware law, the right to vote cumulatively does not exist unless the certificate of incorporation specifically authorizes cumulative voting. Our Fifth Amended and Restated Certificate of Incorporation does not grant shareholders the right to vote cumulatively.

Blank Check Preferred Stock. We believe that the availability of the preferred stock under our Fifth Amended and Restated Certificate of Incorporation provides us with flexibility in addressing corporate issues that may arise. Having these authorized shares available for issuance will allow us to issue shares of preferred stock without the expense and delay of a special stockholders’ meeting. The authorized shares of preferred stock, as well as shares of Class A common stock, will be available for issuance without further action by our stockholders, with the exception of any actions required by applicable law or the rules of any stock exchange on which our securities may be listed. Our Board of Directors will have the power, subject to applicable law, to issue classes or series of preferred stock that could, depending on the terms of the class or series, impede the completion of a merger, tender offer or other takeover attempt.

Stockholder Action by Written Consent. Our Fifth Amended and Restated Certificate of Incorporation provides that any action required or permitted to be taken at any annual or special meeting of our stockholders may be taken without a meeting, without prior notice and without a vote if a consent or consents in writing, setting forth the action so taken, are signed by the holders of outstanding capital stock of having not less than the minimum number of votes necessary to authorize such action at a meeting at which all shares of capital stock entitled to vote thereon were present and voted.

 

 


EX-21.1 3 cnvs-ex21_1.htm EX-21.1 EX-21.1

 

Exhibit 21.1

Subsidiaries of Cineverse Corp. (the "Company")

1.
Access Digital Media, Inc., a Delaware corporation and a wholly-owned subsidiary of Cinedigm DC Holdings, LLC.

 

2.
Christie/AIX, Inc., a Delaware corporation and a wholly-owned subsidiary of Access Digital Media, Inc.

 

3.
Vistachiara Productions Inc., d/b/a The Bigger Picture, a Delaware corporation and a wholly-owned subsidiary of the Company.

 

4.
Access Digital Cinema Phase 2, Corp., a Delaware corporation and a wholly-owned subsidiary of the Company.

 

5.
Access Digital Cinema Phase 2 B/AIX Corp., a Delaware corporation and a wholly-owned subsidiary of Access Digital Cinema Phase 2 Corp.
6.
Cinedigm Digital Funding 1, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Christie/AIX, Inc.
7.
CDF2 Holdings, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Access Digital Cinema Phase 2 Corp.
8.
Cinedigm Digital Funding 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of CDF2 Holdings, LLC.
9.
Cineverse Entertainment Corp., a New York corporation and a wholly-owned subsidiary of the Company.
10.
Cinedigm DC Holdings, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company.
11.
Cineverse Entertainment Holdings, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company.
12.
Cineverse Home Entertainment, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse Entertainment Holdings, LLC.
13.
Con TV, LLC, a Delaware limited liability company and an 85% owned subsidiary of Cineverse Entertainment Corp.
14.
Docurama, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
15.
Dove Family Channel, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.

1

 


 

16.
Cineverse OTT Holdings, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse Entertainment Corp.
17.
Cinedigm Productions, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse Entertainment Corp.
18.
Comic Blitz II LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
19.
Viewster, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
20.
TFD Acquisition LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
21.
Fandor Acquisition LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
22.
Screambox Acquisition LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
23.
FoundationTV, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company.
24.
Asian Media Rights, LLC, a New York limited liability company and a wholly-owned subsidiary of the Company.
25.
Cinedigm India Private Limited, an Indian corporation, owned 99.99% by Cineverse Corp. and .01% by FoundationTV, Inc.
26.
Bloody Disgusting Acquisition LLC, a Delaware limited liability company and a wholly-owned subsidiary of Cineverse OTT Holdings, LLC.
27.
Cineverse Matchpoint LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company.
28.
Cineverse Terrifier LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company.

 

 

2

 


EX-23.1 4 cnvs-ex23_1.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements of Cineverse Corp. on Form S-­1 (No. 333-214486), Form S-3 (Nos. 333-273098 and 333-222190) and Form S­-8 (No. 333-266939) of our report dated July 1, 2024, on our audits of the financial statements as of March 31, 2024 and 2023 and for each of the years then ended, which report is included in this Annual Report on Form 10-K to be filed on or about July 1, 2024.

/s/ EisnerAmper LLP

EISNERAMPER LLP

Iselin, New Jersey

July 1, 2024

 


EX-31.1 5 cnvs-ex31_1.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Christopher J. McGurk, certify that:

1.

I have reviewed this Form 10-K of Cineverse Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

          (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:

July 1, 2024

By:

/s/ Christopher J. McGurk

Christopher J. McGurk

Chief Executive Officer and

Chairman of the Board of Directors

(Principal Executive Officer)

 


EX-31.2 6 cnvs-ex31_2.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Mark Lindsey, certify that:

1.

I have reviewed this Form 10-K of Cineverse Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:

July 1, 2024

By:

/s/ Mark Lindsey

Mark Lindsey

Chief Financial Officer (Principal Financial Officer)

 


EX-32.1 7 cnvs-ex32_1.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with Form 10-K of Cineverse Corp. (the “Company”) for the period ended March 31, 2024 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date:

July 1, 2024

By:

/s/ Christopher J. McGurk

Christopher J. McGurk

Chief Executive Officer and

Chairman of the Board of Directors

(Principal Executive Officer)

 


EX-32.2 8 cnvs-ex32_2.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with Form 10-K of Cineverse Corp. (the “Company”) for the period ended March 31, 2024 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date:

July 1, 2024

By:

/s/ Mark Lindsey

Mark Lindsey

Chief Financial Officer (Principal Financial Officer)

 


EX-97.1 9 cnvs-ex97_1.htm EX-97.1 EX-97.1

 

Exhibit 97.1

CINEVERSE CORP.

CLAWBACK POLICY

As adopted by the Board of Directors, effective November 25, 2023

Introduction

The Board of Directors (“Board”) of Cineverse Corp. (the “Company”) believes that it is in the best interests of the Company and its shareholders to maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. To implement this goal, the Board has adopted this policy (the “Policy”) which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws. This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934, as amended, and Rule 10D-1 promulgated thereunder (collectively, “Section 10D”).

Employees Covered by the Policy

This Policy applies to the Company’s current and former executive officers, as determined by the Board in accordance with Section 10D and the listing standards of the national securities exchange on which the Company’s securities are listed (the “Listing Standards”), as well as such other senior executives and employees who may from time to time be deemed subject to the Policy by the Board (“Covered Executives”).

Administration

This Policy shall be administered by the Compensation Committee of the Board (“Committee”), and references herein to the Board shall be deemed references to the Committee. Any determinations made by the Board shall be final and binding on all affected individuals.

Clawbacks Due to Accounting Restatements

In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, the Board will require reimbursement or forfeiture of any excess Incentive Compensation received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement (or any transition period that results from a change in the Company’s fiscal year (as set forth in the Listing Standards)), as determined in accordance with Section 10D and any applicable rules or Listing Standards. The date on which the Company is required to prepare an accounting restatement is the earlier to occur of (A) the date the Board or a Board committee (or authorized officers of the Company if Board action is not required) concludes, or reasonably

 

 


 

should have concluded, that the Company is required to prepare an accounting restatement or (B) the date a court, regulator, or other legally authorized body directs the Company to prepare an accounting restatement.

Incentive Compensation

For purposes of this Policy, “Incentive Compensation” means any compensation that is granted, earned, or vested based wholly or in part on the attainment of a “financial reporting measure” (as defined under Section 10D, and including, for the avoidance of doubt, stock price and total stockholder return (“TSR”) measures), including, but not limited to, performance-based cash, stock, options or other equity-based awards paid or granted to the Covered Executive. Compensation that is granted, vests or is earned based solely upon the occurrence of non-financial events, such as base salary, restricted stock or options with time-based vesting only, or a bonus awarded solely at the discretion of the Board and not based on the attainment of any financial measure, is not subject to this Policy.

Amounts Subject to Recovery

The amounts to be recovered pursuant to this Policy will be the excess of the Incentive Compensation received by the Covered Executive based on the erroneous data, over the Incentive Compensation that would have been received by the Covered Executive had it been based on the restated results, as determined by the Board and without regard to any taxes paid or withheld.

Incentive Compensation, for purposes of being subject to recoupment, will be deemed received in the fiscal period during which the financial reporting measure on which the Incentive Compensation is based is attained or purportedly attained, regardless of whether the Incentive Compensation is granted or paid after the end of that fiscal period.

For Incentive Compensation based on stock price or TSR, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in the financial restatement, the Board shall determine the amount to be recovered based on a reasonable estimate of the effect of the financial restatement on the stock price or TSR upon which the Incentive Compensation was received and the Company shall document the determination of that estimate and provide it to the national securities exchange on which the Company’s securities are listed.

The compensation recouped under this Policy shall not include Incentive Compensation received by a Covered Executive (i) prior to beginning service as a Covered Executive or (ii) if he or she did not serve as a Covered Executive at any time during the performance period applicable to the Incentive Compensation in question.

Method of Recoupment

The Board will determine, in its sole discretion, the method for recouping Incentive Compensation hereunder, and such method shall be such that the excess compensation is corrected reasonably promptly, the recoupment is not permitted to be paid in installments, and the method used shall consider the implications of other relevant laws including, but not limited to, Section 409A of the Internal Revenue Code. Covered Executives shall be solely responsible for any tax consequences

2

 


 

to them that result from the recoupment or recovery of any amount pursuant to this Policy, and the Company shall have no obligation to administer the Policy in a manner that avoids or minimizes any such tax consequences.

No Indemnification

The Company shall not indemnify any Covered Executives against the loss of any Incentive Compensation resulting from recoupment pursuant to this Policy, including paying premiums on an insurance policy that would cover a Covered Executive’s Incentive Compensation reimbursement obligation or any claims relating to the Company’s enforcement of rights under this Policy.

Interpretation

The Board is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. This Policy shall be interpreted in a manner that is consistent with the requirements of Section 10D and any applicable rules or standards adopted by the Securities and Exchange Commission or any national securities exchange on which the Company’s securities are listed and, to the extent this Policy is in any manner deemed inconsistent with such rules, this Policy shall be treated as retroactively amended to be compliant with such rules.

Amendment; Termination

The Board may amend this Policy from time to time in its discretion. The Board may terminate this Policy at any time subject to applicable law or regulatory requirements.

Other Recoupment Rights and Rules

The Board intends that this Policy will be applied to the fullest extent of the law. Each Covered Executive may be required to sign and return to the Company the acknowledgement form attached hereto as Exhibit A pursuant to which such Covered Executive will agree to be bound by the terms of, and comply with, this Policy. For the avoidance of doubt, each Covered Executive shall be fully bound by, and must comply with, the Policy, whether or not such Covered Executive has executed and returned such acknowledgment form to the Company. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other legal or equitable remedies or rights of recoupment that may be available to the Company, whether arising under applicable law (including pursuant to Section 304 of the Sarbanes-Oxley Act of 2002), regulation or pursuant to the terms of any policy of the Company, employment agreement, equity award agreement, or similar agreement.

The Board shall recover any excess Incentive Compensation in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance with Section 10D and the Listing Standards. In the event that the Board determines recovery to be impracticable, the Company shall comply with any related documentation requirements under Section 10D and the Listing Standards.

3

 


 

The Company shall comply with the disclosure requirements relating to Section 10D and any actions taken in compliance therewith as promulgated by the Securities and Exchange Commission and the Listing Standards.

No-Fault Recovery

 

Recoupment under this Policy shall be required regardless of whether the Covered Executive or any other person was at fault or responsible for accounting errors that contributed to the need for the financial restatement or engaged in any misconduct.

Effective Date

This Policy has been adopted by the Board and shall be effective November 25, 2023 (“Effective Date”) and shall apply to any Incentive Compensation that is received by a Covered Executive on or after the Effective Date.

Successors

This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators, or other legal representatives.

 

 

 

4

 


 

EXHIBIT A

DODD-FRANK COMPENSATION CLAWBACK POLICY

ACKNOWLEDGEMENT FORM

Capitalized terms used but not otherwise defined in this Acknowledgement Form (this “Acknowledgement Form”) shall have the meanings ascribed to such terms in the Policy.

By signing this Acknowledgement Form, the undersigned acknowledges, confirms and agrees that the undersigned: (i) has received and reviewed a copy of the Policy; (ii) is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned’s employment with the Company; and (iii) will abide by the terms of the Policy, including, without limitation, by reasonably promptly returning any recoverable compensation to the Company as required by the Policy, as determined by the Compensation Committee in its sole discretion.

 

Sign: _____________________________

Name: [Employee]

 

 

Date: _____________________________

 


EX-101.SCH 10 cnvs-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Consolidated Statements of Shareholders Equity link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Nature of Operations and Liquidity link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Other Interests link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Nature of Operations and Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of intangible assets link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of accounts payable and accrued expenses link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of revenue categories link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Other Interests (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Notes Payable (Details) - Schedule of notes payable link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Notes Payable (Details) - Schedule of prospect loan link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stockholders' Equity (Details) - Schedule of analysis of option activity link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Stockholders' Equity (Details) - Schedule of weighted average assumptions used to estimate fair value of SARs link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Stockholders' Equity (Details) - Schedule of SARs outstanding link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Debt (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Commitments and Contingencies (Details) - Schedule of operating lease commitments and subleasing arrangements link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease costs and supplemental cash flow information related to leases link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Commitments and Contingencies (Details) - Schedule of estimate gross project commitments over the next five fiscal years link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Income Taxes (Details) - Schedule of components of income tax expense benefit link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Income Taxes (Details) - Schedule of united states statutory federal tax rate and our effective tax rate link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink Deferred consideration settled in stock Deferred Consideration Settled in Stock Deferred consideration settled in stock. Auditor Firm ID Auditor Firm ID 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Document Transition Report Document Transition Report Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected equity volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options outstanding, weighted average remaining contractual term Weighted Average Remaining Life in Years Common Stock Available for Future Issuance under Purchase Agreement Common Stock Available for Future Issuance under Purchase Agreement Common stock available for future issuance under purchase agreement Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Schedule Of Fair Value Measurements Of Our Financial Assets And Liabilities Abstract Schedule of fair value measurements of our financial assets and liabilities [Abstract] Geographical [Axis] Schedule Of Notes Payable Abstract Schedule of notes payable [Abstract] Noncontrolling Interest [Member] Non-Controlling Interest Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Other Liabilities, Noncurrent Other long-term liabilities Rights [Member] Stock appreciation rights [Member] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Earnout consideration on purchase of business EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion The amount of earnout consideration on purchase of a business, net of current portion. Minority Owners. Minority Owners [Member] Minority Owners [Member] Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Entity Public Float Entity Public Float 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Schedule Of Amortization Expense For Intangible Assets Abstract Schedule of amortization expense for intangible assets [Abstract] Document Information [Table] Income Tax, Policy [Policy Text Block] Income Taxes Property, Plant and Equipment, Useful Life Property and equipment estimated useful lives Revenue from Contract with Customer, Excluding Assessed Tax Total revenue Revenue recognized Deferred Consideration Deferred Considerations [Policy Text Block] Deferred Considerations [Policy Text Block] Schedule Of Revenue Categories Abstract Schedule of revenue categories [Abstract] Employee retention tax credit receivable. Employee Retention Tax Credit Receivable Employee retention tax credit receivable Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Compensation cost not yet recognized related to nonvested awards Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Net change in valuation allowance Disaggregation of Revenue [Table Text Block] Schedule of revenue disaggregation Equity Method Investments and Joint Ventures [Abstract] Short-Term Debt, Type [Axis] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Issuance of Class A common stock in connection with ATM raises, net IssuanceOfCommonStockInConnectionWithATMRaisesNet This value for issuance of common stock in connection with ATM raises, net. Lessee operating lease expiration year and month. Lessee Operating Lease Expiration Year and Month Lease expiration Digital cinema system sales. Digital Cinema System Sales [Member] PreferredStockDividends Preferred stock dividends paid in stock Preferred stock dividends value. Title of Individual [Domain] Noncash Investing And Financing Activities Abstract Noncash Investing And Financing Activities [Abstract] Noncash investing and financing activities: Subsequent Events [Text Block] SUBSEQUENT EVENTS ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Options Exercisable (in Shares) Amortization estimated life. Amortization Estimated Life Amortization estimated life Operating Lease, Liability, Noncurrent Operating lease liabilities, net of current portion Pre-funded warrants to purchase common stock Pre-Funded Warrants to Purchase Common Stock Pre-Funded Warrants to Purchase Common Stock Net income attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Stock issued during period shares share based compensation for board of director. Stock Issued During Period Shares Share Based Compensation for Board of Director Issuance of common stock for Board of Director compensation (in shares) WarrantShares Amount of warrant shares. Warrant shares (in Shares) Liabilities, Fair Value Disclosure Total fair value Total Liabilities Debt Instrument, Unamortized Discount, Total Debt Instrument, Unamortized Discount Unamortized debt discount (in Dollars) Shares held for sale Shares Held For Sale Shares held for sale OperatingLeasesLiabilityNoncurrent Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. Assets, Current Total current assets Extinguishment of Debt, Type [Domain] Total Liabilities and Equity Liabilities and Equity System sales. System Sales [Member] System Sales [Member] Entity Address, State or Province Entity Address, State or Province Deferred Tax Assets, Other Other Issuance of Class A common stock in connection with direct equity offering Stock Issued During Period, Value, New Issues Stock issued value Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split Payment of earnout consideration in cash Payment of Earnout Consideration in Cash Payment of earnout consideration in cash. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options, outstanding shares Options Exercisable (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance Advertiser Relationships And Channel Member Advertiser Relationships And Channel [Member] Advertiser relationships and Channel [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average fair value of outstanding grants Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Goodwill and Intangible Assets, Policy [Policy Text Block] Goodwill PaycheckProtectionProgramLoan This value of Paycheck Protection Program loan. PPP Loan Trading Symbol Trading Symbol Deferred Tax Assets, Net of Valuation Allowance Total deferred tax assets before valuation allowance Total deferred tax assets before valuation allowance Major Property Class [Axis] Common Stock, Shares, Issued Common stock shares, issued (in Shares) Common stock, shares issued Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Non-deductible expenses Schedule of operating lease commitments and subleasing arrangement. Schedule of Operating Lease Commitments and Subleasing Arrangement [Table Text Block] Schedule of operating lease commitments and subleasing arrangements Preferred Stock Dividends, Shares Preferred stock dividends paid with common stock (in Shares) Equity Investment in Metaverse Equity Method Investments [Policy Text Block] Issuance of Class A common stock in connection employee bonuses (in Shares) Stock Issued During Period, Shares, For Employee Bonuses Stock issued during period, shares, for employee bonuses. Content Entertainment Business One Member ContentEntertainmentBusinessOneMember Content & Entertainment [Member] Content & Entertainment Segment [Member] Holdings Member HoldingsMember CDF2 Holdings [Member] Schedule of Long-Term Debt Instruments [Table] Foreign Tax Authority [Member] Foreign Tax Authority [Member] Shares, Outstanding Aggregate of outstanding shares (in Shares) Balance (in Shares) Balance (in Shares) 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three DeferredTaxAssetValuationAllowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Less: Valuation allowance AOCI Attributable to Parent [Member] Accumulated Other Comprehensive (Loss) Income Accumulated Other Comprehensive Loss UnbilledRevenueCurrent Unbilled revenue Unbilled revenue current. Bloody Disgusting, LLC [Member] Bloody Disgusting, L L C. [Member] Bloody Disgusting, LLC. Long-Term Debt, Current Maturities Less current portion Long-Term Debt, Current Maturities, Total Stock Dividends, Shares Stock dividends Stock Dividends, Shares, Total Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Schedule of analysis of option activity Entity Address, City or Town Entity Address, City or Town Operating Lease, Weighted Average Discount Rate, Percent Average discount rate Foundation TV [Member] FoundationTV, Inc. [Member] FoundationTVIncMember Foundation T V Inc Member Debt Disclosure [Text Block] DEBT Property, Plant and Equipment [Table Text Block] Schedule of estimated useful lives of property and equipment, net Options expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period AccountsReceivableServiceEquityInvestment Accounts receivable by the company for services provided to CDF2. Accounts receivable Subsequent Event [Member] Subsequent Event Type [Axis] Operating leases liabilities, net of current portion [Member] Operating Leases Longterm Portion Member OperatingLeasesLongtermPortionMember Gaiam Americas Inc And Gaiam Inc G V E Member GaiamAmericasIncAndGaiamIncGVEMember Gaiam Americas, Inc. and Gaiam, Inc. GVE [Member] Gaiam Americas, Inc. and Gaiam, Inc. (GVE) [Member] Additional Paid-in Capital [Member] Additional Paid-In Capital Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Income tax expense related to foreign income taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of components of income tax expense benefit In-process intangible assets Finite-Lived Intangible Asset, Expected Amortization In-process Intangible Assets Finite-lived intangible asset, expected amortization in-process intangible assets Payments due related to the acquisition Business Combination, Consideration Transferred, Liabilities Incurred Net loss The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Net Income Losses Current Liabilities Liabilities, Current [Abstract] Current Assets Assets, Current [Abstract] Accounts receivable, net of allowance for credit losses (in Dollars) Accounts Receivable, Allowance for Credit Loss, Current ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Options Outstanding (in Shares) Goodwill impairment Effective Income Tax Rate Reconciliation, Goodwill Impairment Effective income tax rate reconciliation, goodwill impairment. Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in Dollars per share) Statement of Stockholders' Equity [Abstract] Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent Losses from non-consolidated entities Current portion of operating lease liabilities Operating Lease, Liability, Current Operating lease liabilities Lender Name [Axis] Revenue from Contract with Customer, Including Assessed Tax Digital cinema servicing revenue Total Cinema Equipment Business revenue Debt Instrument, Unamortized Discount, Current Less: Unamortized debt issuance costs and debt discounts Long-Term Debt Total long term portion Long-Term Debt, Total Property, Plant and Equipment, Net Property and equipment, net Property, Plant and Equipment, Net, Total Equity Method Investment, Aggregate Cost Initial investment amount Series A Preferred Stock [Member] Series A Preferred Stock [Member] Series A Series A Preferred Stock Commitmentsand Contingencies Details Scheduleofleaserelatedassetsandliabilities Table Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities [Table] Goodwill, Purchase Accounting Adjustments Purchase price adjustments to goodwill Class of Stock [Domain] Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Provision for (recovery of) doubtful accounts Guaranty Agreement [Member] Guaranty agreement. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Provision at the U.S. statutory federal tax rate Earnout consideration on purchase of a business Business Combination, Contingent Consideration, Liability Business Combination, Contingent Consideration, Liability, Total Statement of Comprehensive Income [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Issuance of common stock for deferred and earnout consideration (in Shares) Stock Issued During Period Shares Issuance of Common Stock for Deferred and Earnout Consideration Stock issued during period shares issuance of common stock for deferred and earnout consideration. Treasury Stock, Common, Shares Treasury stock shares INDIA India Operations Entity Central Index Key Entity Central Index Key Other Intangible Assets [Member] Intangible Assets [Member] Exercise Price Range Three Member ExercisePriceRangeThreeMember $1.71 - $2.10 [Member] Exercise Price Range Three [Member] Warrants to purchase common stock, shares Class of Warrant or Right, Number of Securities Called by Warrants or Rights Plan Name [Domain] Related Party [Member] Assets, Fair Value Disclosure Total fair value Total Assets Other current and long-term assets Increase (Decrease) in Other Operating Assets Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Cinedigm Equity Incentive Plan Member CinedigmEquityIncentivePlanMember Cinedigm Equity Incentive Plan [Member] Current Foreign Tax Expense (Benefit) Income tax expense related to foreign income taxes Current Summaryof Significant Accounting Policies Details Scheduleofamortizationexpenseforintangibleassets Table Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets [Table] Liabilities, Current Total current liabilities Entity Tax Identification Number Entity Tax Identification Number Net loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock-based compensation Line of Credit Facility [Table] Investment, Name [Axis] Non Monetary Transactions Policy Text Block NonMonetaryTransactionsPolicyTextBlock NON-MONETARY TRANSACTIONS Non-monetary Transactions Issuance of Class A common stock for payment of accrued employee bonuses Issuance of Class A common stock for payment of accrued employee bonuses Issuance of Class A common stock for payment of accrued employee bonuses. Plan Name [Axis] AmortizationExpense Amortization expense. Amortization expense (in Dollars) Summaryof Significant Accounting Policies Details Scheduleofamortizationexpenseforintangibleassets Line Items Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets [Line Items] Pre-funded warrants exercise price Pre-Funded Warrants Exercise Price Pre-Funded Warrants Exercise Price Geographical [Domain] Total Assets Assets Total Assets UNITED STATES Domestic Operating Lease C O Ntv Member CONtvMember CON TV, LLC [Member] MaturityDate Maturity date. Maturity date Line of Credit Facility [Line Items] Class A Common Stock [Member] Common Class A [Member] Class A Class A Common Stock Entity Registrant Name Entity Registrant Name Related Party, Type [Domain] Capped obligations amount Maximum Capped Obligation Loan Amount Maximum capped obligation loan amount. Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings (Accumulated Deficit), Total Issuance Of Shares For Asset Acquisition Issuance of shares for asset acquisition. Issuance of common stock value (in Dollars) Issuance of common stock value TotalRecourseNotesPayable This value of recourse notes payable. Total recourse notes payable Capitalized Content Capitalized Content Policy Text Block Capitalized Content. Right to pay post-close purchase price in equity Right to Pay Maximum Percentage of Post Close Purchase Price in Equity Right to pay maximum percentage of post close purchase price in equity Retained Earnings [Member] Accumulated Deficit Long-Term Debt and Lease Obligation, Including Current Maturities Prospect Loan, net Long-Term Debt and Lease Obligation, Including Current Maturities, Total Class of Stock [Axis] Outstanding March 31, 2024 Outstanding March 31, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Shares remained unvested Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Total equity AssetAcquisitionsPolicyTextBlock Disclosure of asset acquisitions policy. Asset Acquisitions Federal Income Tax Expense (Benefit), Continuing Operations Total federal Impairment of Intangible Assets, Finite-Lived Impairment Impairment of intangible assets Impairment of intangible assets Intangible impairment Minimum [Member] Minimum [Member] Nature of Operations and Liquidity Details [Line Items] Nature of Operations and Liquidity Details [Line Items] Percentage of threshold tax benefit recognized upon ultimate settlement Percentage of Threshold Tax Benefit Recognized Upon Ultimate Settlement Percentage of threshold tax benefit recognized upon ultimate settlement. Revenues Revenues Revenues, Total Total revenue Parent [Member] Total Stockholders’ Deficit Total Stockholders' Equity (Deficit) Total Operating Lease, Liability Operating Lease Liabilities Disaggregation of Revenue Revenue [Policy Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected equity volatility, minimum Net loss attributable to controlling interests Amount after tax of income (loss) attributable to nonredeemable noncontrolling preferred unit holders. Net Income Loss Attributable To Controlling Interests Equity Component [Domain] Segments [Axis] Finite-Lived Intangible Assets [Member] Intangible assets [Member] Payments on line of credit Repayments of Lines of Credit Repayments under revolving credit agreement, net Payments of line of credit Software Development [Member] Software [Member] Adjustments to reconcile net loss to cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Distribution Agreements [Member] Distribution agreements. Sublease Income Sublease income Notes Payable [Abstract] Debt Instrument, Basis Spread on Variable Rate Interest rate percentage over the prime rarte Entity Current Reporting Status Entity Current Reporting Status Common Stock, Shares Authorized Common stock, shares authorized Interest expense for deferred consideration and earnouts Accretion Expense Added To Deferred Consideration And Earnout Consideration Accretion expense added to deferred consideration and earnout consideration Deferred Tax Liabilities, Gross Total deferred tax liabilities Deferred Tax Liabilities, Gross, Total Total deferred tax liabilities Software Member SoftwareMember Software [Member] Stockholders Equity Deficit Details Scheduleofstockappreciationrightsoutstanding Line Items Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items] Deferred Foreign Income Tax Expense (Benefit) Tax benefit release of valuation allowances Deferred Schedule Of Intangible Assets Abstract Schedule of intangible assets [Abstract] Non-deductible interest expense Deferred Tax Asset, Interest Carryforward Assets [Abstract] Assets Assets: ASSETS Issuance of Class A common stock, net of issuance costs Proceeds from Issuance of Common Stock Net proceeds from from common stock Stock Issued During Period, Value, Conversion of Units Issuance of common stock for with PSUs and incentives, net of payroll taxes Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Operating lease right-of-use asset [Member] Property Subject to Operating Lease [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares award Percentage of royalties earned receive by entitled Percentage of Royalties Earned Received by Entitled Percentage of royalties earned received by entitled. Schedule Of Lease Costs And Supplemental Cash Flow Information Related To Leases Abstract Schedule Of Lease Costs And Supplemental Cash Flow Information Related To Leases [Abstract] Common Stock, $0.001 par value; Class A Stock: 275,000,000 shares authorized as of March 31, 2024, and March 31, 2023; 15,985,620 and 9,413,597 shares issued, with 15,699,135 and 9,347,805 shares outstanding as of March 31, 2024, and March 31, 2023, respectively. Common Stock, Value, Issued Amortization Expense Per Unit of Production [Table] Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance Other Other Noncash Income (Expense) CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness Current portion of deferred consideration on purchase of a business. Current portion of deferred consideration on purchase of business Furniture and Fixtures [Member] Furniture and fixtures [Member] Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations Income tax expense from operations Preferred Stock, Liquidation Preference, Value Preferred stock, Liquidation preference Value (in Dollars) Current Fiscal Year End Date Current Fiscal Year End Date Share-Based Payment Arrangement, Noncash Expense Share-Based Payment Arrangement, Noncash Expense, Total Stock-based compensation Auditor Name Auditor Name Operating Income (Loss) Income (loss) from operations Operating loss Sublease abstract. Sublease [Abstract] Sublease Payments AccountsPayableAndAccruedExpensesPolicyTextBlock Accounts payable and accrued expenses [Policy Text Block] Accounts Payable and Accrued Expenses Income tax expense Income tax expense Income Tax Expense (Benefit) PreferredStockDividendRatesPercentage The percentage rate used to calculate dividend payments on preferred stock. Preferred stock, dividend rate Contractual Obligation, Fiscal Year Maturity [Table Text Block] Schedule of estimate gross project commitments over the next five fiscal years gain loss on revenue recognized. Gain Loss on Revenue Recognized Gain loss on revenue recognized Nature of Operations [Text Block] NATURE OF OPERATIONS AND LIQUIDITY Stock Issued During Period, Shares, Acquisitions Common stock, acquired Issuance of common stock for third party equity purchase commitment and for acquisition (in Shares) Cash Total Cash Total stock-based compensation Stock based compensation cost Stock-based compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected equity volatility, maximum Indefinite-Lived Intangible Assets [Axis] Stock Issued During Period, Shares, Other Treasury stock in connection with taxes withheld from employees (in Shares) Disaggregation of Revenue [Table] DirectOperatingCostsPolicyTextBlock Direct Operating Costs Policy Text block. Direct Operating Costs NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts This value of total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts. Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts Streaming and Digital [Member] OTT Streaming and Digital [Member] OTT Streaming and Digital [Member] O T T Streaming and Digital Member Base distribution. Base Distribution [Member] Base Distribution [Member] Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net, Beginning Balance Finite-Lived Intangible Assets, Net, Ending Balance Total Net Total Income Taxes Paid Income taxes paid Impairment of Long-lived and Finite-lived Intangible Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Fair value of shares held resulted unrealized losses Fair value of shares held resulted unrealized losses Equity Securities, FV-NI, Unrealized Gain (Loss) Equity Securities, FV-NI, Unrealized Gain (Loss), Total Aggregate Intrinsic Value (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Debt Instrument, Face Amount Prospect Loan, at issuance Earnings Per Share, Policy [Policy Text Block] Earnings per Share Earnout Consideration on Purchase of Business Earnout Consideration On Purchase Of Business [Policy Text Block] Earnout consideration on purchase of business. Employee Retention Credit Cash Refund Claim Employee Retention Credit Cash Refund Claim Employee retention credit cash refund claim Major Property Class_ Domain MajorPropertyClass_ [Domain] Other expenses, net Other Nonoperating Income (Expense), Total Other Nonoperating Income (Expense) Sale of Stock, Price Per Share Market price per share CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities Cash paid for amounts included in the measurement of lease liabilities. Cash paid for amounts included in the measurement of lease liabilities Vested Sharebased Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Number of Vested Sharebased compensation shares authorized under stock option plan exercise price range number of vested Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Operating Lease Commitments Net income attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to noncontrolling interest Right of use asset Right of use asset Deferred Tax Liabilities Right Of Use Asset Deferred tax liabilities right of use asset. Long-Term Debt, Type [Domain] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Depreciation, Depletion and Amortization, Nonproduction, Total 2028 Contractual Obligation, to be Paid, Year Four Entity Voluntary Filers Entity Voluntary Filers Subsequent Events [Abstract] Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Capitalized Content [Member] Capitalized content member Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent Other long-term assets Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Shares under option, granted Granted, Shares Equity [Text Block] STOCKHOLDERS' EQUITY Stock issued during period value share based compensation for board of director. Stock Issued During Period Value Share Based Compensation for Board of Director Issuance of common stock for Board of Director compensation Content advances Increase Decrease In Content Advances Increase decrease in content advances. Interest Paid, Excluding Capitalized Interest, Operating Activities Cash interest paid Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block] Schedule of stock-based compensation expense 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Additional Paid in Capital Additional paid-in capital Additional Paid in Capital, Total Liabilities [Abstract] Liabilities Liabilities: $148 - $148 [Member] Exercise Price Range One Member ExercisePriceRangeOneMember Exercise Price Range One [Member] PreferredStockDividendsAccrued This value for preferred stock dividends accrued. Preferred stock dividends accrued Extinguishment of Debt [Axis] Equity, Attributable to Parent [Abstract] Stockholders’ Equity Investment Owned, Fair Value Equity investment in Metaverse, at fair value Investment Owned, at Fair Value, Beginning Balance Investment Owned, at Fair Value, Ending Balance Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Cinema Equipment Business One Member CinemaEquipmentBusinessOneMember Cinema Equipment [Member] Cinema Equipment Segment [Member] Lease, Cost [Table Text Block] Schedule of lease costs and supplemental cash flow information related to leases Principal amount not to exceed Line of Credit Facility, Maximum Borrowing Capacity Revolving line of credit Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of warrants Capital loss carryforward Deferred Tax Assets, Capital Loss Carryforwards Total Intangible Assets Member TotalIntangibleAssetsMember Total Intangible Assets [Member] Deferred consideration on purchase of business, net of current portion Deferred consideration on purchase of business, net of current portion. Deferred Consideration on Purchase of Business net of Current Portion Earnings Per Share [Abstract] Net income (loss) per share attributable to common stockholders Indefinite-Lived Intangible Assets, Major Class Name [Domain] Weighted average number of shares on stock options and stock appreciation rights. Weighted Average Number of Shares On Stock Options and Stock Appreciation Rights Stock options and SARs Issuance of class A common stock for intangible asset purchase. Issuance Of Class A Common Stock For Intangible Asset Purchase Issuance of Class A common stock for intangible asset purchase Investment, Name [Domain] Deferred Tax Liabilities, Net, Total Deferred Tax Liabilities, Net Net deferred tax liabilities Accounting Policies [Abstract] Segments [Domain] 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five 2026 IncreaseDecreaseInUnbilledRevenue Unbilled revenue Unbilled Revenue means amounts due to Borrower for services rendered in the ordinary course of Borrower's business, but which have not been billed to its customers, and which meet all Borrower's representations. Stock Issued During Period, Shares, Conversion of Units Issuance of common stock for with PSUs and incentives, net of payroll taxes (in Shares) Issuance of common stock for earnout commitment Stock issued during period value issuance of common stock for earnout commitment. Stock Issued During Period Value Issuance of Common Stock For Earnout Commitment Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Issuance of common stock for deferred and earnout consideration Stock Issued During Period Value Issuance of Common Stock for Deferred and Earnout Consideration Stock issued during period value issuance of common stock for deferred and earnout consideration. Schedule Of Net Deferred Tax Abstract Schedule of net deferred tax [Abstract] EquityLinePurchaseAgreementDescription Equity line purchase agreement, description. Equity line purchase agreement, description Revolving Credit Facility [Member] Revolving Credit Facility [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Forfeited Basic net loss per share Earnings Per Share, Basic Earnings Per Share, Basic, Total Net (loss) income per share attributable to common stockholders - basic: (in Dollars per share) ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Range of Prices, Maximum Natureof Operationsand Liquidity Details Table Nature of Operations and Liquidity (Details) [Table] PurchasePriceShares Amount of purchase price shares. Purchase price shares (in Shares) Commitments and Contingencies Commitments and contingencies (see Note 6) Income Statement [Abstract] Related Party, Type [Axis] Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Performance Shares [Member] Performance Stock Units [Member] Increase (decrease) in estimated earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Increase in estimated earnout liability Statistical Measurement [Domain] ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Range of Prices, Minimum Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Preferred Stock, Shares Subscribed but Unissued Preferred stock shares (in Shares) Document Period End Date Document Period End Date Statistical Measurement [Axis] Stockholders Equity Deficit Details Line Items Stockholders’ Equity (Deficit) (Details) [Line Items] Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES Stockholders' Equity Note [Abstract] Diluted net loss per share Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Net (loss) income per share attributable to common stockholders - diluted: (in Dollars per share) Employee Retention Tax Credit Percentage Employee Retention Tax Credit Percentage Employee retention tax credit percentage Theatre Relationship Member TheatreRelationshipMember Theatre Relationship [Member] Theatre Relationship [Member] Product and Service [Domain] ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross Gross number of share options (or share units) granted during the period. Granted shares Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Other Interests Details Table Other Interests (Details) [Table] ProspectLoan Prospect Loan Prospect loan. 2027 Contractual Obligation, to be Paid, Year Three Fair Value Hierarchy and NAV [Domain] PreferredStockDividendsinShares Preferred stock dividends paid in stock (in Shares) Preferred stock dividends paid with common stock in Shares. Common Stock Dividends, Shares Common stock shares Operating leases liabilities [Member] Operating Leases Current Portion Member OperatingLeasesCurrentPortionMember Two Thousand Seventeen Plan Member TwoThousandSeventeenPlanMember Two Thousand seventeen Plan [Member] 2017 Plan [Member] FiniteLivedIntangibleAssetsAmortizationExpenseThereafter Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Thereafter Digital Media Rights, Payment due in March 2024 [Member] Digital Media Rights Payment Due in March Two Thousand and Twenty Four Member Digital Media Rights Payment Due in March Two Thousand and Twenty Four Member Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net change in cash and cash equivalents Deferred Tax Assets, Net Net deferred tax Net deferred tax ScheduleOfSARsOutstandingTableTextBlock Schedule of SARs outstanding Tabular disclosure of SARs outstanding. Equity, Attributable to Noncontrolling Interest Deficit attributable to noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest, Total Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Finite-Lived Intangible Assets, Major Class Name [Domain] Public Utility, Property, Plant and Equipment [Line Items] Public Utility, Property, Plant and Equipment [Table] Consolidation, Policy [Policy Text Block] Consolidation Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS’ EQUITY Payment of business acquisition related liabilities Payment of Business Acquisition Related Liabilities Payment of business acquisition related liabilities. Stock Issued During Period, Value, Acquisitions Issuance of common stock for third party equity purchase commitment and for acquisition Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Discoounted precentage of fixed volume weighted average price of common stock. Discounted Precentage of Fixed Volume Weighted Average Price of Common Stock Discounted precentage of fixed volume weighted average price of common stock Subsidiary, Ownership Percentage, Noncontrolling Owner Percentage of minority interest Decrease in accrued royalty payments Decrease in accrued royalty payments Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Payable, Total 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Credit Facility [Domain] 2029 Contractual Obligation, to be Paid, Year Five Less imputed interest Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Shares granted Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Commitmentsand Contingencies Details Line Items Commitments and Contingencies (Details) [Line Items] Stock-based bonus to acquired company Stock Based Bonus to Acquired Company Stock-based bonus to acquired company. Amended 2017 Plan [Member] Amended Two Thousand Seventeen Plan [Member] Amended two thousand seventeen plan Precentage of fixed volume weighted average price of common stock. Precentage of Fixed Volume Weighted Average Price of Common Stock Percenatge of volume weighted average price of common stock Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Commitmentsand Contingencies Details Scheduleofleaserelatedassetsandliabilities Line Items Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities [Line Items] Cash and Cash Equivalents, Policy [Policy Text Block] CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash and Cash Equivalents Basic net loss per share: Earnings Per Share, Basic [Abstract] Equity Components [Axis] Schedule Of Accounts Payable And Accrued Expenses Abstract Schedule of accounts payable and accrued expenses [Abstract] Increase (Decrease) in Accounts Receivable Accounts receivable Equity Method Investment, Quoted Market Value Initial investment Issuance Of Common Stock In Connection With A Business Combinationin Shares IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares Issuance of common stock in connection with business combinations (in Shares) Board of Directors Chairman [Member] Board of Directors [Member] Local Phone Number Local Phone Number Sale of Stock [Axis] Increase (Decrease) in Deferred Revenue Deferred revenue Current Federal Tax Expense (Benefit) Current Share Issuance in Connection with Employee Bonuses [Member] Share issuance in connection with employee bonuses. Equity Securities, FV-NI, Gain (Loss), Total Equity Securities, FV-NI, Gain (Loss) Changes in fair value of equity investment in Metaverse StockIssuedDuringPeriodStockCompensationAndExpenses This value for stock compensation and expenses. Stock compensation and expenses Goodwill Goodwill Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance Line of credit, including unamortized debt issuance costs of $81 and $76, respectively Notes Payable, Current, Total Notes Payable, Current Statement of Cash Flows [Abstract] Commitmentsand Contingencies Details Table Commitments and Contingencies (Details) [Table] SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold Share-based compensation arrange by share-based payment award, equity incentive plan, percent voting power threshold. Percent voting power threshold Income Tax Authority [Domain] Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Property, Plant and Equipment, Policy [Policy Text Block] PROPERTY AND EQUIPMENT Property and Equipment, Net Document Annual Report Document Annual Report Common stock, par value and per share (in Dollars per share) Common Stock, Par or Stated Value Per Share Common stock, par value (in Dollars per share) Schedule Of Stock Appreciation Rights Outstanding Abstract Schedule of stock appreciation rights outstanding [Abstract] Debt Instrument, Interest Rate, Stated Percentage Debt interest rate Interest rate, stated percentage Warrants to Purchase Common Stock Warrants to purchase common stock Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average remaining vesting period Long-Lived Tangible Asset [Axis] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Maximum [Member] Maximum [Member] 2025 Contractual Obligation, to be Paid, Year One Incurred interest Interest Payable Shares used in diluted computation: Earnings Per Share, Diluted [Abstract] Diluted net income (loss) per share: Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Internal Use Software Member InternalUseSoftwareMember Internal use software [Member] Cash Provided by (Used in) Operating Activities, Discontinued Operations Net cash used by operating activities Short-Term Debt, Type [Domain] Ownership [Domain] Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1s Weighted Average Exercise Price. Weighted Average Exercise Price UnamortizedDebtIssuanceCostsAndDebtDiscounts Unamortized debt issuance costs and debt discounts. Less unamortized debt issuance costs and debt discounts Lease liability related payments. Lease Liability Related Payments Lease liability related payments Deferred Tax Assets, Investments Investments Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Options forfeited Share based compensation arrangement by share based payment award equity instruments other than options issued in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period Shares issued Income Taxes Details Table Income Taxes (Details) [Table] Exercise of Pre-Funded Warrants [Member] Exercise of pref-funded warrants. Document Financial Statement Error Correction [Flag] NonrecourseNotesPayable This value of total non-recourse notes payable. Total non-recourse notes payable Increase (decrease) in fair value of equity method investment. Increase Decrease In Fair Value Of Equity Method Investment Increase (decrease) in fair value of equity method investment Other Non-Recurring [Member] Other non-recurring City Area Code City Area Code Deferred State and Local Income Tax Expense (Benefit) Deferred Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Foundation TV, Payment Due in June 2025 [Member] Foundation TV Payment Due in June Two Thousand and Twenty Five [Member] Foundation TV, payment due in june two thousand and twenty five. Document Information [Line Items] Document Information Line Items Accumulated Deficit Accumulated deficit. Accumulated deficit Increase in provision for advances Increase (Decrease) in Provision for Advances Increase (decrease) in provision for advances. Content Advances Content Advances [Policy Text Block] Content Advances. Restricted Stock Awards Member RestrictedStockAwardsMember Restricted Stock Awards [Member] Schedule Of Estimated Useful Lives Of Property And Equipment Abstract Schedule of estimated useful lives of property and equipment [Abstract] Selling, General and Administrative Expenses [Member] Selling, general and administrative [Member] Selling, General and Administrative Expenses [Member] Accrued dividends on preferred stock. Accrued Dividends on Preferred Stock Accrued dividends on preferred stock ConcentrationRiskPercentage Concentration risk percentage. Concentration risk percentage Weighted-average shares of Common Stock outstanding Weighted Average Number of Shares Outstanding, Basic, Total Weighted average shares of common stock outstanding: basic (in Shares) Weighted-average shares of common stock outstanding Shares sold resulted in a realized loss Shares Sold Resulted In A Realized Loss shares sold resulted in a realized loss. Summaryof Significant Accounting Policies Details Scheduleoffairvaluemeasurementsofourfinancialassetsandliabilities Line Items Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities [Line Items] Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Foreign Income Tax Expense (Benefit), Continuing Operations Total foreign Schedule Of Components Of Income Tax Expense Benefit Abstract Schedule of components of income tax expense benefit [Abstract] Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of activity for performance stock unit awards Sale of investment securities SaleOfInvestmentSecurities Sale of investment securities. Statement [Table] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted average assumptions used to estimate fair value of SARs Asset Acquisition, Consideration Transferred, Total Asset Acquisition, Consideration Transferred Asset consideration Document Fiscal Period Focus Document Fiscal Period Focus Total lease payments Lessee, Operating Lease, Liability, to be Paid EquityMethodInvestmentsSummarizedFinancialInformationEquity Amount of equity, including noncontrolling interest, reported by an equity method investment of the entity. Total stockholders' deficit Sales Agreement [Member] Sales agreement. 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Statement [Line Items] Partially offset of accrued interest. Partially Offset Of Accrued Interest Partially offset of accrued interest Schedule Of Analysis Of Option Activity Abstract Schedule of analysis of option activity [Abstract] Employee Retention Tax Credit, Policy [Policy Text Block] Employee Retention Tax Credit, Policy [Policy Text Block] Employee Retention Tax Credit Financing fees for line of credit Payments of Financing Costs Payments of Financing Costs, Total OperatingLeaseRightOfUseAssets Noncurrent Amount of lessee's right to use underlying asset under operating lease. CreditFacility This value payment of credit facility. Credit Facility Anti-dilutive shares excluded from calculation of diluted net loss per share | shares Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Other Accrued Liabilities Accrued other expenses Machinery and Equipment [Member] Machinery and equipment [Member] OperatingLeasesLiabilityCurrent Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. Exercise Price Range [Domain] Subsequent Event [Line Items] Digital Cinema Projection Systems Member DigitalCinemaProjectionSystemsMember Digital cinema projection systems [Member] Asset Class [Domain] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of net deferred tax Accounts receivable, net of allowance for credit losses of $269 and $0, respectively Accounts Receivable, after Allowance for Credit Loss, Current Accounts Receivable, after Allowance for Credit Loss, Current, Total Content Library Member ContentLibraryMember Content Library [Member] Schedule of amortization expense is recorded using straight-line method over the estimated useful lives of assets. Schedule Of Amortization Expense Is Recorded Using Straight-Line Method Over The estimated Useful Lives Of Assets [Table Text Block] Schedule of amortization expense Common Stock [Member] Common Stock [Member] Common Stock Debt Instrument [Line Items] Debt instrument other than interest in advance Interest in Advance Amount Interest in advance amount. Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts This value of total recourse notes payable, net of unamortized debt issuance costs and debt discounts. Total recourse notes payable, net of unamortized debt issuance costs and debt discounts DeferredTaxLiabilitiesDepreciationAndAmortization Depreciation and amortization. Depreciation and amortization Depreciation and amortization Other current assets Other Assets, Current NumberofEmployeesJoiningCompanyFollowingAcquisition Number of employees joining company following acquisition. Number of employees joining company following acquisition Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Stockholders Equity Deficit Details Scheduleofstockappreciationrightsoutstanding Table Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Table] Amounts due to producers. Amounts Due To Producers Amounts due to producers Issuance of common stock for earnout commitment (in shares) Stock issued during period shares issuance of common stock for earnout commitment. Stock Issued During Period Shares Issuance of Common Stock for Earnout Commitment Fair value of purchased content licenses. Fair Value of Purchased Content Licenses Fair value of purchased content licenses State Abstract StateAbstract State: Exercises Price Range Four Member ExercisesPriceRangeFourMember $2.23 - $2.56 [Member] Exercise Price Range Four [Member] Treasury stock, at cost; 288,554 and 65,792 shares at March 31, 2024 and March 31, 2023, respectively. Treasury Stock, Value Treasury Stock, Value, Total Equity line purchase agreement. Equity Line Purchase Agreement [Member] Cover [Abstract] Selling, General and Administrative Expense Selling, general and administrative Selling, General and Administrative Expense, Total Document Fiscal Year Focus Document Fiscal Year Focus DebtInstrumentPaymentsToDate Debt instrument payments to date. Payments to date Intangible Assets, Finite-Lived, Policy [Policy Text Block] INTANGIBLE ASSETS Intangible Assets, Net Summaryof Significant Accounting Policies Details Scheduleofintangibleassets Table Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Table] StockCompensationAndExpenses Stock compensation and expenses. Stock compensation and expenses (in Shares) Stock issued during period value reverse stock splits. Stock Issued During Period Value Reverse Stock Splits Stock issued during period value, reverse stock splits Stock Exchange Of Hong Kong Limited Member StockExchangeOfHongKongLimitedMember Stock Exchange of Hong Kong [Member] Sublease payments, due year two. Sublease Payments, Due Year Two 2025 State and Local Income Tax Expense (Benefit), Continuing Operations Total state Sale of Stock [Domain] Option Indexed to Issuer's Equity, Type [Domain] Preferred Stock [Member] Preferred Stock PikInterestAccrued Pik interest accrued. PIK Interest Other Interests Details [Line Items] Other Interests Details [Line Items] Share-Based Payment Arrangement [Policy Text Block] Stock-based Compensation Patents [Member] Patents [Member] Operating leases liabilities, net of current portion [Member] Operating Leases Liabilities, Net of Current Portion [Member] Operating leases liabilities, net of current portion. Security Exchange Name Security Exchange Name Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Aware expiration period Accounts Receivable [Policy Text Block] ACCOUNTS RECEIVABLE Accounts Receivable, Net Aggregate offering price. Aggregate Offering Price Aggregate offering price Domestic Tax Authority [Member] Domestic Tax Authority [Member] Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Schedule of amortization expense for intangible assets Supplier Agreements Member SupplierAgreementsMember Supplier Agreements [Member] New Accounting Pronouncements, Policy [Policy Text Block] RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Authorized Preferred stock, shares authorized Customer Relationships [Member] Customer Relationships [Member] Summaryof Significant Accounting Policies Details Table Summary of Significant Accounting Policies (Details) [Table] Current State and Local Tax Expense (Benefit) Current Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right of use assets recognized underlying lease arrangements Starrise [Member] Starrise Media Holdings Limited [Member] Starrise [Member] Treasury stock in connection with taxes withheld from employees (in Shares) Treasury Stock, Shares, Acquired Business Acquisition, Acquiree [Domain] Accrued Employee Benefits, Current Accrued compensation and benefits Received 1.75 times full commitment amount Line of Credit Facility, Commitment Fee Amount Preferred Stock, Amount of Preferred Dividends in Arrears Dividends preferred stock (in Dollars) Lessee operating sublease term. Lessee Operating Sublease Term Sublease term Entity Emerging Growth Company Entity Emerging Growth Company Schedule Of Lease Related Assets And Liabilities Abstract Schedule of lease-related assets and liabilities [Abstract] Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Share-based payment arrangement, option, exercise price range, shares outstanding Options Outstanding (in Shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Beginning Balance Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Ending Balance Amendment Flag Amendment Flag Content advances, net of current portion Content Advances Noncurrent Net of Current Portion Content advances noncurrent net of current portion. WorkingCapital Working Capital Working capital Foundation TV, Payment Due in June 2024 [Member] Foundation Tv Payment Due In June Two Thousand and Twenty Four [Member] Foundation tv payment due in June2024. Intermediate-life Plants, Useful Life Estimated useful lives Equity Incentive Plan. Equity Incentive Plan [Member] Deferred Tax Assets Abstract DeferredTaxAssetsAbstract Deferred tax assets: Shares sold Shares, Issued Shares issued Equity Method Investment, Ownership Percentage Majority interest, percentage Ownership percentage Deferred Tax Liabilities, Gross [Abstract] Deferred tax liabilities: Proceeds from Lines of Credit, Total Proceeds from Lines of Credit Proceeds from line of credit Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remainings Contractual Term2 Weighted Average Remaining Life in Years. Weighted Average Remaining Life in Years Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Share-based payment arrangement, option, exercise price range, outstanding, weighted average exercise price (in Dollars per share) Weighted Average Exercise Price Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Beginning Balance Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Ending Balance Variable Rate [Domain] Entity File Number Entity File Number Line of Credit Facility, Expiration Date Credit facility expiration date Line of credit, maturity date Schedule Of Amortization Expense Abstract Schedule of amortization expense [Abstract] 2026 Contractual Obligation, to be Paid, Year Two Accounts Payable [Member] Accounts Payable [Member] Operating leases liabilities [Member] Operating Leases Liabilities [Member] Operating leases liabilities. Barter-related non-cash expenses Barter Related Non Cash Expenses Barter related non cash expenses Sublease payments, due next twelve months. Sublease Payments, Due Next Twelve Months 2024 Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Share-Based Payment Arrangement [Abstract] Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of intangible assets Operating Expenses Total operating expenses Total operating expenses ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock Schedule of lease-related assets and liabilities Tabular disclosure of lease-related assets and liabilities. Options Exercisable Member OptionsExercisableMember Options Exercisable [Member] Issued equity to reduce liability Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Employee retention tax credit. Employee Retention Tax Credit Employee retention tax credit Auditor Location Auditor Location Schedule of prospect loan [Abstract] Schedule of prospect loan. Maximum roundtable investment percentage. Maximum Roundtable Investment Percentage Maximum roundtable investment percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Stockholders' Equity, Reverse Stock Split Reverse stock split description Entity Address, Address Line Two Deferred Tax Assets, Goodwill and Intangible Assets Intangibles Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Ownership percentage Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at March 31, 2024 and March 31, 2023. Liquidation preference of $3,648. Preferred Stock, Value, Issued Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Title of Individual [Axis] Sale of Stock, Number of Shares Issued in Transaction Shares of common stock Number of shares purchased TreasurySharesAcquiredForWithholdingTaxes Treasury shares acquired for withholding taxes. Treasury shares acquired for withholding taxes Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Exercise price Range of Exercise Prices Warrants exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share Exercise Price Range Two Member ExercisePriceRangeTwoMember Exercise Price Range Two [Member] $280 - $488 [Member] Content advances Content advances current Content Advances Current Content advances current. Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Shares withheld to pay taxes Computer Equipment [Member] Computer equipment and software [Member] Stock Issued During Period, Value, Other Treasury stock in connection with taxes withheld from employees Stockholders Equity Deficit Details Table Stockholders’ Equity (Deficit) (Details) [Table] Trademarks and Trade Names [Member] Trademarks and Tradenames Income Taxes Details Line Items Income Taxes (Details) [Line Items] Entity Address, Address Line One Entity Address, Address Line One LongTermPortionMember Long Term Portion [Member] Long term portion. Option Indexed to Issuer's Equity, Type [Axis] Employee retention tax credit current. Employee Retention Tax Credit Current Employee retention tax credit Digital Media Rights, Payment due in March 2025 [Member] Digital Media Rights Payment Due in March Two Thousand and Twenty Five Member Digital Media Rights, payment due in march two thousand and twenty five. Finite-Lived Intangible Assets, Gross Cost Basis Finite-Lived Intangible Assets, Gross, Total Subsequent Event Type [Domain] Issuance of Class A common stock in connection with ATM raises, net (in Shares) IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares This share of issuance of common stock in connection with ATM raises, net. Decrease in estimated equity issuance fee, net Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, minimum Income Statement Location [Axis] Christian cinema LLC. Christian Cinema LLC [Member] Christian Cinema LLC [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, maximum Exercise Price Range [Axis] Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Accrued liabilities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Long-Term Debt, Type [Axis] Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net (loss) income Lessee, Operating Lease, Liability, to be Paid, Year Five 2028 Issuance Of Common Stock In Connection With A Business Combination IssuanceOfCommonStockInConnectionWithABusinessCombination Issuance of common stock in connection with business combinations Line of Credit Facility, Lender [Domain] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Issued Shares issued Equity investment in Metaverse, a related party, at fair value Fair value of shares held Equity Method Investments Federal Abstract FederalAbstract Federal: Combined purchase price per share Share Price SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent Share-based compensation arrange by share-based payment award, equity incentive plan, exercise price if voting threshold is met, percent. Exercise price if voting threshold is met, percent Outstanding amount of debt, gross Long-Term Debt, Gross Prospect Loan, gross Depreciation, Depletion and Amortization Depreciation, Depletion and Amortization, Total Depreciation and amortization Product and Service [Axis] Treasury stock in connection with taxes withheld from employees Treasury Stock, Value, Acquired, Cost Method Earnout consideration on purchase of business Current Earnout Consideration On Purchase of Business The amount of current earnout consideration on purchase of a business. Title of 12(b) Security Title of 12(b) Security Summaryof Significant Accounting Policies Details Line Items Summary of Significant Accounting Policies (Details) [Line Items] Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Accumulated Amortization Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture, Total Aggregate gross proceeds from equity financing Aggregate Gross Proceeds from Equity Financing Aggregate gross proceeds from equity financing. Prime Rate [Member] Prime Rate [Member] TotalDeferredTaxAssetsAfterValuationAllowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Total deferred tax assets after valuation allowance Total deferred tax assets after valuation allowance Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of fair value measurements of our financial assets and liabilities Foreign. Foreign [Abstract] Foreign: Trademarks [Member] Trademark [Member] Treasury Stock Treasury Stock, Common [Member] Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Amortization of debt issuance costs Amortization of Debt Issuance Costs Amortization of debt issuance costs included in interest expense OperatingLeaseLiabilities Total operating lease liabilities Operating lease liabilities. Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current, Total State and Local Jurisdiction [Member] State and Local Jurisdiction [Member] Accounts Payable and Accrued Liabilities Total accounts payable and accrued expenses Total accounts payable and accrued expenses Impairment of goodwill Goodwill impairment Goodwill impairment loss ATM sales agreement. ATM Sales Agreement [Member] Long-Lived Tangible Asset [Domain] Subsequent Event [Table] Foreign exchange translation Other comprehensive (loss) income: foreign exchange translation Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Other Comprehensive Loss Foreign Exchange Translation Summaryof Significant Accounting Policies Details Scheduleofintangibleassets Line Items Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items] Interest expense, including cash interest and amortization Interest Expense, Debt Interest Expense, Debt, Total Temporary Equity, Foreign Currency Translation Adjustments Foreign exchange translation CurrentPortionMember Current Portion [Member] Current portion. Common Stock, Shares, Outstanding Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Supplemental Cash Flow Elements [Abstract] Gross proceeds from warrants exercised Proceeds from Warrant Exercises Contractual Obligation, Fiscal Year Maturity [Abstract] NumberOfCustomers Number of customers. Number of customers Unamortized debt issuance costs (in Dollars) Unamortized Debt Issuance Expense Increase Decrease In Estimated Earnout Consideration Increase Decrease In Estimated Earnout Consideration Change in estimated earnout consideration Income Statement Location [Domain] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price per share, granted (in Dollars per share) Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block] Schedule of stock appreciation rights outstanding Issuance of Class A common stock for payment of accrued preferred stock dividend IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends Issuance of Class A common stock for payment of preferred stock dividends. Schedule Of United States Statutory Federal Tax Rate And Our Effective Tax Rate Abstract Schedule of united states statutory federal tax rate and our effective tax rate [Abstract] Document Type Document Type Revenue recognized under nonmonetary purchase and exchange of content. Revenue Recognized Under Nonmonetary Purchase And Exchange Of Content Revenue recognized under nonmonetary purchase and exchange of content Revenue recognized under nonmonetary purchase and exchange of content Ownership [Axis] Line of Credit Facility, Interest Rate Description Line of credit facility interest rate description Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Employee Benefits and Share-Based Compensation Stock based compensation (in Dollars) Net loss attributable to common stockholders Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net income (loss) attributable to common shareholders Net loss attributable to common shareholders Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Increase in number of shares authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Entity Filer Category Entity Filer Category Equity Method Investments and Joint Ventures Disclosure [Text Block] OTHER INTERESTS Loss from equity investment in Metaverse, a related party Marketable Security, Unrealized Gain (Loss) Variable Rate [Axis] NotesPayableNetOfUnamortizedDebtIssuanceCosts This value of total notes payable, net of unamortized debt issuance costs. Total notes payable, net of unamortized debt issuance costs Accounts Receivable, Allowance for Credit Loss, Writeoff Accounts receivable, allowance for credit loss, writeoff Trade Names [Member] Trade name [Member] Tradename [Member] Asset Class [Axis] Direct operating expenses. Direct Operating Expenses Direct operating Preferred Stock Dividends Paid With Common Stocks PreferredStockDividendsPaidWithCommonStocks Preferred stock dividends paid with common stock East West Bank. East West Bank [Member] East West Bank [Member] Capitalized content expenditures Capitalized Content Expenditures Capitalized content expenditures. Total Liabilities Liabilities Earnout liability settled in stock Earnout Liability Settled In Stock Earnout liability settled in stock. Impairment charges recorded for long-lived and finite-lived intangible assets Asset Impairment Charges Impairment of intangibles Asset Impairment Charges, Total Equity, Attributable to Parent Stockholders' Equity Attributable to Parent, Beginning Balance Stockholders' Equity Attributable to Parent, Ending Balance Total stockholders' equity of Cineverse Corp. EquityInvestmentsForPurchaseOfRoundtableSecurities This amount for equity investments for purchase of roundtable securities. Investments for purchase of roundtable securities Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference Stock Issued During Period, Shares, Reverse Stock Splits Stock issued during period shares, reverse stock splits Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Intangible Assets, Net (Excluding Goodwill), Total Net loss (income) Net Income (Loss) Attributable to Parent, Total Interest Expense Interest expense Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State income taxes, net of federal benefit Equity Method Investments, Fair Value Disclosure Fair value of equity method investment Percentage of aggregate gross proceeds from each sale of shares Percentage of Aggregate Gross Proceeds From Each Sale of Shares Percentage of aggregate gross proceeds from each sale of shares Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Statement of Financial Position [Abstract] Basis of Presentation and Significant Accounting Policies [Text Block] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Schedule Of Sars Outstanding Abstract Schedule of SARs outstanding [Abstract] Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation (in Shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total Weighted Average Number of Shares Outstanding, Diluted Weighted average shares of common stock outstanding: diluted (in Shares) Weighted-average number of shares Weighted-average number of shares Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of united states statutory federal tax rate and our effective tax rate Credit Facility [Axis] Issuance of Class A common stock in connection employee bonuses Stock Issued During Period, Value, For Employee Bonuses Stock issued during period, value, for employee bonuses. Income tax expense Effective Income Tax Rate Reconciliation, Percent Variable consideration. Variable Consideration [Member] Variable Consideration [Member] Deferred Federal Income Tax Expense (Benefit) Deferred Podcast And Other [Member] Podcast and other. Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable and accrued expenses Issuance in connection with the exercise of warrants (in Shares) Stock Issued During Period, Shares, Issuance in Connection with the Exercise of Warrants Stock issued during period, shares, issuance in connection with the exercise of warrants. Use of Estimates, Policy [Policy Text Block] USE OF ESTIMATES Use of Estimates Income Tax Disclosure [Text Block] INCOME TAXES Terrifier 3 Financing [Member] Terrifier Three Financing [Member] Terrifier three financing. Number of operating lease. Number of operating lease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Aggregate Intrinsic Value (in Dollars) Effective income tax rate reconciliation executive officer compensation limitation percent. Effective Income Tax Rate Reconciliation Executive Officer Compensation Limitation Percent Executive officer compensation limitation - Section 162(m) Dividends, Preferred Stock, Cash Preferred stock dividends Weighted Average Number of Shares, Restricted Stock Restricted shares issued Cinema Equipment Member Cinema Equipment [Member] Cinema Equipment [Member] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net income (loss) per share Disaggregation of Revenue [Line Items] Income Tax Authority [Axis] Costs and expenses Costs and Expenses [Abstract] Fair Value Hierarchy and NAV [Axis] Payments to Acquire Property, Plant, and Equipment Settlement of second lien loan with Class A common stock Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Reclassification, Comparability Adjustment [Policy Text Block] Reclassifications Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested, Shares Shares vested Services and deployment. Services And Deployment [Member] Services and Deployment [Member] Issuance of Class A common stock in connection with direct equity offering (in Shares) Stock Issued During Period, Shares, New Issues Number of stock issued Operating Lease, Expense Rental expense Business Acquisition [Axis] Foundation TV, Payment Due in December 2024 [Member] Foundation Tv Payment Due In December Two Thousand and Twenty Four [Member] Foundation tv payment due in December 2024. Deferred revenue Deferred Revenue, Current Deferred Revenue, Current, Total Deferred revenue, current Credit facility covenant compliance Debt Instrument, Covenant Compliance Income Tax Disclosure [Abstract] Summaryof Significant Accounting Policies Details Scheduleoffairvaluemeasurementsofourfinancialassetsandliabilities Table Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities [Table] Finite-Lived Intangible Assets by Major Class [Axis] Operating Loss Carryforwards Net operating loss carryforwards Shares Issued for Earnout-Related Liabilities [Member] Shares issued for earnout-related liabilities. XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document And Entity Information - USD ($)
12 Months Ended
Mar. 31, 2024
Jun. 17, 2024
Sep. 30, 2023
Document Information Line Items      
Entity Registrant Name Cineverse Corp.    
Trading Symbol CNVS    
Document Type 10-K    
Current Fiscal Year End Date --03-31    
Entity Common Stock, Shares Outstanding   15,606,341  
Entity Public Float     $ 12,987,466.07
Amendment Flag false    
Entity Central Index Key 0001173204    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Mar. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-31810    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 22-3720962    
Entity Address, Address Line One 224 W. 35th St.,    
Entity Address, Address Line Two Suite 500 #947    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10001    
City Area Code (212)    
Local Phone Number 206-8600    
Title of 12(b) Security CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 274    
Auditor Name EISNERAMPER LLP    
Auditor Location Iselin, New Jersey    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Current Assets    
Cash and cash equivalents $ 5,167 $ 7,152
Accounts receivable, net of allowance for credit losses of $269 and $0, respectively 8,667 20,846
Unbilled revenue 6,439 2,036
Employee retention tax credit 1,671 2,085
Content advances 9,345 3,724
Other current assets 1,432 1,734
Total current assets 32,721 37,577
Equity investment in Metaverse, a related party, at fair value 362 5,200
Property and equipment, net 2,276 1,833
Intangible assets, net 18,328 19,868
Goodwill 6,799 20,824
Content advances, net of current portion 2,551 1,421
Other long-term assets 1,341 1,265
Total Assets 64,378 87,988
Current Liabilities    
Accounts payable and accrued expenses 20,817 34,531
Line of credit, including unamortized debt issuance costs of $81 and $76, respectively 6,301 4,924
Current portion of deferred consideration on purchase of business 3,114 3,788
Earnout consideration on purchase of business 180 1,444
Current portion of operating lease liabilities 401 418
Deferred revenue 436 226
Total current liabilities 31,249 45,331
Deferred consideration on purchase of business, net of current portion 457 2,647
Operating lease liabilities, net of current portion 462 863
Other long-term liabilities 59 74
Total Liabilities 32,227 48,915
Commitments and contingencies (see Note 6)
Stockholders’ Equity    
Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at March 31, 2024 and March 31, 2023. Liquidation preference of $3,648. 3,559 3,559
Common Stock, $0.001 par value; Class A Stock: 275,000,000 shares authorized as of March 31, 2024, and March 31, 2023; 15,985,620 and 9,413,597 shares issued, with 15,699,135 and 9,347,805 shares outstanding as of March 31, 2024, and March 31, 2023, respectively. 194 185
Additional paid-in capital 545,996 530,998
Treasury stock, at cost; 288,554 and 65,792 shares at March 31, 2024 and March 31, 2023, respectively. (11,978) (11,608)
Accumulated deficit (504,153) (482,395)
Accumulated other comprehensive loss (345) (402)
Total stockholders' equity of Cineverse Corp. 33,273 40,337
Deficit attributable to noncontrolling interest (1,122) (1,264)
Total equity 32,151 39,073
Total Liabilities and Equity $ 64,378 $ 87,988
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Accounts receivable, net of allowance for credit losses (in Dollars) $ 269 $ 0
Unamortized debt issuance costs (in Dollars) $ 81 $ 76
Preferred stock, shares authorized 15,000,000 15,000,000
Treasury stock shares 288,554 65,792
Series A Preferred Stock    
Preferred stock, shares authorized 20 20
Preferred stock, dividend rate 10.00% 10.00%
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares issued 7 7
Preferred stock, shares outstanding 7 7
Preferred stock, Liquidation preference Value (in Dollars) $ 3,648 $ 3,648
Class A Common Stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 275,000,000 275,000,000
Common stock, shares issued 15,985,620 9,413,597
Common stock, shares outstanding 15,699,135 9,347,805
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Operations - USD ($)
shares in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues $ 49,131,000 $ 68,026,000
Costs and expenses    
Direct operating 19,131,000 36,364,000
Selling, general and administrative 27,904,000 36,819,000
Depreciation and amortization 3,771,000 3,763,000
Goodwill impairment 14,025,000 0
Total operating expenses 64,831,000 76,946,000
Operating loss (15,700,000) (8,920,000)
Interest expense (1,066,000) (1,290,000)
Loss from equity investment in Metaverse, a related party (4,299,000) (1,828,000)
Employee retention tax credit   2,475,000
Other expenses, net (190,000) (13,000)
Net loss before income taxes (21,255,000) (9,575,000)
Income tax expense (10,000) (119,000)
Net loss (21,265,000) (9,694,000)
Net income attributable to noncontrolling interest (142,000) (39,000)
Net loss attributable to controlling interests (21,407,000) (9,734,000)
Preferred stock dividends (350,000) (351,000)
Net loss attributable to common stockholders $ (21,757,000) $ (10,085,000)
Net (loss) income per share attributable to common stockholders - basic: (in Dollars per share) $ (1.78) $ (1.13)
Weighted average shares of common stock outstanding: basic (in Shares) 12,253 8,889
Net (loss) income per share attributable to common stockholders - diluted: (in Dollars per share) $ (1.78) $ (1.13)
Weighted average shares of common stock outstanding: diluted (in Shares) 12,253 8,889
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net loss $ (21,265) $ (9,694)
Other comprehensive loss:    
Foreign exchange translation 57 (239)
Net income attributable to noncontrolling interest (142) (39)
Comprehensive loss $ (21,350) $ (9,973)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (21,265,000) $ (9,694,000)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 3,771,000 3,829,000
Impairment of goodwill 14,025,000 0
Changes in fair value of equity investment in Metaverse 4,299,000 1,828,000
Amortization of debt issuance costs 188,000 101,000
Stock-based compensation 1,439,000 4,470,000
Change in estimated earnout consideration (612,000) 80,000
Interest expense for deferred consideration and earnouts 503,000 986,000
Capitalized content expenditures (1,822,000)  
Stock-based bonus to acquired company 100,000  
Revenue recognized under nonmonetary purchase and exchange of content   (1,022,000)
Barter-related non-cash expenses 341,000  
Other (16,000) 130,000
Changes in operating assets and liabilities:    
Accounts receivable 11,969,000 9,943,000
Content advances (5,621,000) 1,075,000
Unbilled revenue (4,403,000) 313,000
Other current and long-term assets (942,000) (2,816,000)
Accounts payable and accrued expenses (12,756,000) (18,049,000)
Deferred revenue 210,000 30,000
Net cash used in operating activities (10,593,000) (8,796,000)
Cash flows from investing activities:    
Purchases of property and equipment (1,069,000) (1,271,000)
Sale of investment securities 538,000  
Net cash used in investing activities (531,000) (1,271,000)
Cash flows from financing activities:    
Proceeds from line of credit 43,955,000 31,046,000
Payments on line of credit (42,572,000) (26,046,000)
Payment of business acquisition related liabilities (576,000) (665,000)
Financing fees for line of credit (193,000) (177,000)
Issuance of Class A common stock, net of issuance costs 8,524,000  
Net cash provided by financing activities 9,138,000 4,158,000
Net change in cash and cash equivalents (1,985,000) (5,910,000)
Cash and cash equivalents at beginning of year 7,152,000 13,062,000
Cash and cash equivalents at end of year 5,167,000 7,152,000
Supplemental Cash Flow Elements [Abstract]    
Cash interest paid 376,000 203,000
Lease liability related payments 446,000 373,000
Income Taxes Paid 55,000 98,000
Noncash investing and financing activities:    
Issuance of Class A common stock for payment of accrued employee bonuses 1,203,000  
Accrued dividends on preferred stock 89,000 87,000
Issuance of Class A common stock for intangible asset purchase   898,000
Right of use assets recognized underlying lease arrangements   781,000
Treasury shares acquired for withholding taxes 370,000 5,000
Deferred consideration settled in stock 3,000,000 3,000,000
Earnout liability settled in stock 392,000 238,000
Issuance of Class A common stock for payment of accrued preferred stock dividend $ 350,000 $ 351,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Shareholders Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total Stockholders' Equity (Deficit)
Non-Controlling Interest
Series A
Preferred Stock
Class A
Common Stock
Balance at Mar. 31, 2022 $ 40,950 $ (11,608) $ 522,601 $ (472,310) $ (163) $ 42,253 $ (1,303) $ 3,559 $ 174
Balance (in Shares) at Mar. 31, 2022   66           1 8,766
Foreign exchange translation (239)       (239) (239)      
Stock-based compensation 3,045   3,045     3,045      
Preferred stock dividends paid with common stock 351   351     351      
Preferred stock dividends paid with common stock (in Shares)                 37
Preferred stock dividends accrued (351)     (351)   (351)      
Issuance of common stock for with PSUs and incentives, net of payroll taxes 873   871     873     $ 2
Issuance of common stock for with PSUs and incentives, net of payroll taxes (in Shares)                 103
Issuance of common stock for earnout commitment 238   238     238      
Issuance of common stock for earnout commitment (in shares)                 17
Issuance of common stock for Board of Director compensation 1         1     $ 1
Issuance of common stock for Board of Director compensation (in shares)                 34
Issuance of common stock for third party equity purchase commitment and for acquisition 3,900   3,892     3,900     $ 8
Issuance of common stock for third party equity purchase commitment and for acquisition (in Shares)                 391
Net loss (income) (9,694)     (9,734)   (9,734) 39    
Balance at Mar. 31, 2023 39,073 $ (11,608) 530,998 (482,395) (402) 40,337 (1,264) $ 3,559 $ 185
Balance (in Shares) at Mar. 31, 2023   66           1 9,348
Foreign exchange translation 57       57 57      
Stock-based compensation 1,271   1,271     1,271      
Issuance of Class A common stock in connection with ATM raises, net 1,084   1,080     1,084     $ 3
Issuance of Class A common stock in connection with ATM raises, net (in Shares)                 177
Issuance of Class A common stock in connection with direct equity offering 7,439   7,437     7,439     $ 2
Issuance of Class A common stock in connection with direct equity offering (in Shares)                 2,150
Preferred stock dividends paid in stock 350   350     350     $ 0
Preferred stock dividends paid in stock (in Shares)                 196
Preferred stock dividends accrued (350)     (350)   (350)      
Issuance of Class A common stock in connection employee bonuses 1,203   1,203     1,203     $ 1
Issuance of Class A common stock in connection employee bonuses (in Shares)                 725
Issuance in connection with the exercise of warrants (in Shares)                 517
Issuance of common stock for earnout commitment 392   392     392      
Issuance of common stock for earnout commitment (in shares)                 41
Treasury stock in connection with taxes withheld from employees (370) $ (370)       (370)      
Treasury stock in connection with taxes withheld from employees (in Shares)   223             (223)
Issuance of common stock for deferred and earnout consideration (in Shares)                 2,369
Issuance of common stock for deferred and earnout consideration 3,100   3,097     3,100     $ 3
Issuance of common stock for Board of Director compensation 168   168     168      
Issuance of common stock for Board of Director compensation (in shares)                 400
Net loss (income) (21,265)     (21,407)   (21,407) 142    
Balance at Mar. 31, 2024 $ 32,151 $ (11,978) $ 545,996 $ (504,153) $ (345) $ 33,273 $ (1,122) $ 3,559 $ 194
Balance (in Shares) at Mar. 31, 2024   289           1 15,699
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (21,265) $ (9,694)
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.2
Nature of Operations and Liquidity
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
NATURE OF OPERATIONS AND LIQUIDITY

1. NATURE OF OPERATIONS AND LIQUIDITY

Cineverse Corp. (“Cineverse”, “us”, "we", “our”, and “Company” refers to Cineverse Corp. and its subsidiaries unless the context otherwise requires) was incorporated in Delaware on March 31, 2000.

 

Cineverse is a premier streaming technology and entertainment company with its core business operating as (i) a portfolio of owned and operated streaming channels with enthusiast fan bases; (ii) a large-scale global aggregator and full-service distributor of feature films and television programs; and (iii) a proprietary technology software-as-a-service platform for over-the-top (“OTT”) app development and content distribution through subscription video on demand ("SVOD"), dedicated ad-supported ("AVOD"), ad-supported streaming linear ("FAST") channels, social video streaming services, and audio podcasts. Our streaming channels reach audiences in several distinct ways: direct-to-consumer, through these major application platforms, and through third party distributors of content on platforms.

 

The Company’s streaming technology platform, known as MatchpointTM, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform.

 

Financial Condition and Liquidity

 

As of March 31, 2024, the Company has an accumulated deficit of $504.2 million. For the year ended March 31, 2024, the Company had a net loss attributable to common shareholders of $21.8 million. Though the Company had positive working capital of $1.5 million, net cash used in operating activities for the year ended March 31, 2024 was $10.6 million. We may continue to generate net losses for the foreseeable future.

 

The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $7.5 million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to September 15, 2025, subject to definitive documentation. For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.

 

Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. We believe our cash and cash equivalent balances as of March 31, 2024 (See Note 8 - Subsequent Events) will be sufficient to support our operations for at least twelve months from the filing of this report. The Company may also undertake equity or debt offerings, if necessary and opportunistically available, for further capital needs.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation

 

The accompanying consolidated financial statements of Cineverse Corp. have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). These consolidated financial Statements have been prepared by the Company following the rules and regulations of the SEC. All intercompany transactions and balances have been eliminated in consolidation. Certain columns and rows may not add due to rounded numbers.

 

We own an 85% interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the internet and other consumer digital distribution platforms,

such as gaming consoles, set-top boxes, handsets, and tablets. We evaluated the investment under the voting interest entity model and determined that the entity should be consolidated as we have a controlling financial interest in the entity through our ownership of outstanding voting shares, and that other equity holders do not have substantive voting, participating or liquidation rights. We record net income or loss attributable to noncontrolling interest in our Consolidated Statements of Operations equal to the proportionate share of outstanding profit interest units retained by the noncontrolling interests.

 

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

 

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification ("ASC") 810, Consolidation ("ASC 810"). ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

Use of Estimates

 

The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include revenue recognition, share-based compensation expense, valuation allowance for deferred income taxes, recovery of content advances, goodwill and intangible asset impairments, estimated royalties payable to content partners, and the assessment of amortization lives to intangible assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On a regular basis, the Company evaluates the assumptions, judgments and estimates. Actual results may differ from these estimates.

 

Reclassifications

 

Certain amounts have been reclassified to conform to the current presentation.

Cash and Cash Equivalents

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal.

Non-monetary Transactions

 

During the year ended March 31, 2023, the Company entered into a non-monetary transaction for the purchase and sale of content licenses with an unrelated third party. The fair value of the content was based on a market approach and determined to be $1.0 million which is included in Revenues in our Consolidated Statements of Operations. No gain or loss was recognized, as the fair value of the content licenses purchased was determined to be $1.0 million and recognized within Intangible Assets, Net on our Consolidated Balance Sheets, and will be amortized over its

three year estimated life. For the years ended March 31, 2024 and March 31, 2023, $341 thousand and $85 thousand of related amortization expense had been recognized, respectively.

Accounts Receivable, Net

We maintain reserves for expected credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical credit losses, customer concentrations, customer credit worthiness, current and forecasted economic trends and changes in customer payment patterns to evaluate the adequacy of this allowance.

During the year ended March 31, 2024, the Company had no write-offs of previously reserved accounts receivable and as of March 31, 2024, accrued an allowance for expected credit losses of $0.3 million. During the year ended March 31, 2023, the Company had written off $2.8 million of previously reserved accounts receivable balances and as of March 31, 2023, carried an allowance for credit losses of $0.

 

Employee Retention Tax Credit

 

The Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") provided an employee retention credit which was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the "Appropriations Act") extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to 70% of qualified wages paid to employees during the 2021 fiscal year.

 

The Company qualified for the employee retention credit beginning in June 2020 for qualified wages through September 2021 and filed a cash refund claim during the fiscal year ended March 31, 2023 in the amount of $2.5 million in the Employee retention tax credit line on the Company’s Consolidated Statements of Operations.

 

As of March 31, 2024 and March 31, 2023, the tax credit receivable of $1.7 and $2.1 million, respectively, has been included in the Employee retention tax credit line ("ERTC") on the Company's Consolidated Balance Sheet. The Company received notification during the second quarter of fiscal year 2024 that its ERTC claim was under examination with the Internal Revenue Service ("IRS"). In April 2024, the Company received a letter from the IRS indicating that its claim had been accepted and $1.7 million was received in June 2024.

Content Advances

Content advances represents amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record a provision for amounts that we expect may not be recoverable. Amounts which are expected to be recovered within 12 months are classified as current, which were $9.3 million and $3.7 million as of March 31, 2024, and March 31, 2023, respectively. Amounts estimated to be recoverable in more than 12 months are classified as long term and presented within content advances, net of current portion, which were $2.6 million and $1.4 million as of March 31, 2024, and March 31, 2023, respectively. For the twelve months ended March 31, 2024 and March 31, 2023, the Company recorded a recovery and increase in the provision for advances of $0.5 million and $1.3 million, respectively.

Property and Equipment, Net

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets, with useful life ranges by major asset class as follows:

 

Computer equipment and software

 

3 - 5 years

Internal use software

 

3 - 5 years

Machinery and equipment

 

3 - 10 years

Furniture and fixtures

 

2 - 7 years

 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software on a straight-line basis. Post-configuration training and maintenance costs are expensed as incurred.

Intangible Assets, Net

Intangible assets are stated at cost less accumulated amortization. For intangible assets that have finite lives, the assets are amortized using the straight-line method over the estimated useful lives of the related assets.

During both of the years ended March 31, 2024 and 2023, we did not record any impairment.

Amortization expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Content Library

 

3 – 20 years

Trademarks and Tradenames

 

2 – 15 years

Customer Relationships

 

5 – 13 years

Advertiser Relationships and Channel

 

2 – 13 years

Software

 

10 years

Capitalized Content

 

3 years

Supplier Agreements

 

2 years

 

The Company’s intangible assets include the following (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

24,133

 

 

$

(21,492

)

 

$

2,641

 

Advertiser Relationships and Channel

 

 

12,603

 

 

 

(2,541

)

 

 

10,062

 

Customer Relationships

 

 

8,690

 

 

 

(7,872

)

 

 

818

 

Software

 

 

3,200

 

 

 

(880

)

 

 

2,320

 

Trademark and Tradenames

 

 

3,914

 

 

 

(3,059

)

 

 

855

 

Capitalized Content

 

 

1,822

 

 

 

(190

)

 

 

1,632

 

Total Intangible Assets

 

$

54,362

 

 

$

(36,034

)

 

$

18,328

 

 

 

 

 

As of March 31, 2023

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

23,970

 

 

$

(21,126

)

 

$

2,844

 

Advertiser Relationships and Channel

 

 

12,604

 

 

 

(1,062

)

 

 

11,542

 

Supplier Agreements

 

 

11,430

 

 

 

(11,430

)

 

 

 

Customer Relationships

 

 

10,658

 

 

 

(9,568

)

 

 

1,090

 

Trademark and Tradenames

 

 

4,026

 

 

 

(2,274

)

 

 

1,752

 

Software

 

 

3,200

 

 

 

(560

)

 

 

2,640

 

Total Intangible Assets

 

$

65,888

 

 

$

(46,020

)

 

$

19,868

 

 

As of March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):

 

 

Total

 

In-process intangible assets

 

 

448

 

2025

 

 

3,186

 

2026

 

 

3,006

 

2027

 

 

2,225

 

2028

 

 

1,356

 

2029

 

 

1,356

 

Thereafter

 

 

6,751

 

Total

 

$

18,328

 

 

Capitalized Content

 

The Company capitalizes direct costs incurred in the production of content from which it expects to generate a return over the anticipated useful life and the Company’s predominant monetization strategy informs the method of amortizing these deferred costs. The determination of the predominant monetization strategy is made at commencement of the production or license period and the classification of the monetization strategy as individual or group only changes if there is a significant change to the title’s monetization strategy relative to its initial assessment. The costs are capitalized to the Capitalized Content costs within Intangible Assets and are amortized as a group within Depreciation and Amortization within the Consolidated Statements of Operations.

 

Impairment of Long-lived and Finite-lived Intangible Assets

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. There were no impairment charges recorded for long-lived and finite-lived intangible assets during the twelve months ended March 31, 2024 and 2023.

Goodwill

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test. For the twelve months ended March 31, 2024, the Company recognized a goodwill impairment loss of $14.0 million. The Company considered the sustained decrease in its share price to be a goodwill impairment indicator and determined that it would be appropriate to proceed with a quantitative test. Primarily utilizing a market-multiple approach, which took into account the sustained decrease in share price, the Company determined that goodwill impairment of $14.0 million would be recognized.

For the twelve months ended March 31, 2023, the Company assessed goodwill impairment on its annual measurement date of March 31, 2023 by performing a qualitative analysis and determined that it was not more likely than not that the fair value of its reporting unit was greater than its carrying amount. During the year ended March 31, 2023, the Company recorded a purchase price adjustment to reduce Goodwill by $260 thousand.

No goodwill impairment charge was recorded for the twelve months ended March 31, 2023.

 

Fair Value Measurements

 

The authoritative guidance on fair value measurements establishes a framework with respect to measuring assets and liabilities at fair value on a recurring basis and non-recurring basis, within ASC 820, Fair Value Measurement. Under the framework, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as of the measurement date. The framework also establishes a three-tier hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability and are developed based on the best information available in the circumstances. The hierarchy consists of the following three levels:

Level 1 – quoted prices in active markets for identical investments
Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)
Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

 

 

 

As of March 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

 

 

Equity Investment in Metaverse

 

On February 14, 2020, the Company acquired an approximate 11.5% interest in A Metaverse Company (“Metaverse”), a publicly traded Chinese entertainment company, formerly Starrise Media Holdings Limited, whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Metaverse that is related to our major shareholders. Our major shareholders also maintain a significant beneficial interest ownership in Metaverse.

 

On April 10, 2020, the Company purchased an additional 15% interest in Metaverse in a private transaction from shareholders of Metaverse that are affiliated with the major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which was the fair market value of the Metaverse shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.0 million, valued at the date of the issuance of the Common Stock of the Company. The difference in the value of shares received in Metaverse and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Metaverse.

 

The Company accounted for this investment under the equity method of accounting as the Company was deemed to be able to exert significant influence over Metaverse with its direct ownership and affiliation with the Company’s majority shareholders. At the time, the Company made an irrevocable election to apply the fair value option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Metaverse.

 

Following the halting of Metaverse stock trading on the Stock Exchange of Hong Kong in April 2022, the Company valued our equity investment in Metaverse using a market approach and is categorized as a Level 3 valuation based on unobservable inputs. The Company estimated the fair value of Metaverse based on the last known enterprise value at the time and then adjusting for trends in enterprise valuations for comparable companies. As of March 31, 2023, the fair value was $5.2 million, resulting in a decrease in fair value of $1.8 million for the year ended March 31, 2023.

 

On November 6, 2023, Metaverse's stock resumed trading on The Stock Exchange of Hong Kong Limited. During the year ended March 31, 2024, the Company sold 221 million of its original 362 million shares held as of March 31, 2023, which resulted in a realized loss of $0.3 thousand during the twelve months ended March 31, 2024. The resumption of active trading status represented renewed availability of quoted, unadjusted prices in active markets for identical assets, upon which the Company can execute a sale and readily access pricing information at the measurement date. Accordingly, the Company has presented the fair value of its Metaverse shares held as of March 31, 2024 within the Level 1 grouping. The fair value of the shares held as of March 31, 2024 was $0.4 million, with associated losses of $4.3 million recognized during the fiscal year ended March 31, 2024.

 

As a result of the decrease in ownership of its investment in Metaverse from its sale of shares, along with a corresponding decrease in influence, the Company no longer accounts for its investment in Metaverse under the equity method and instead will follow the guidance for equity securities for which the equity method is no longer appropriate under ASC 321, Investments - Equity Securities, and accordingly, the Company will continue to measure its investment at fair value, with changes in the value of securities held to be recognized in earnings.

 

Earnout consideration on purchase of business

 

The Company estimated the fair value of its earnout liability using contractual inputs from the related business combination, which established specific fiscal year revenue growth, profitability and EBITDA targets. Prior to the completion of the earnout period at the end of fiscal year 2024, the Company utilized the most up to date forecast to estimate the outcome against these targets to determine the ultimate estimated payout. The amounts recognized are not discounted.

 

During the fiscal year ended March 31, 2024, the final year of the earnout measurement period, the Company estimated a $612 thousand decrease in its earnout liability, issued $392 thousand worth of equity to settle its liability, made cash payments of $291 thousand, and incurred interest of $29 thousand.

 

During the fiscal year ended March 31, 2023, the Company increased the estimated earnout liability by $80 thousand and made payments of $238 thousand to reduce this liability, partially offset by $83 thousand of interest accrued.

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.

Asset Acquisitions

An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of relative fair values.

 

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

 

 

As of

 

 

 

March 31,
2024

 

 

March 31,
2023

 

Accounts payable

 

$

5,804

 

 

$

15,042

 

Amounts due to producers

 

 

9,889

 

 

 

13,114

 

Accrued compensation and benefits

 

 

1,119

 

 

 

2,532

 

Accrued other expenses

 

 

4,005

 

 

 

3,843

 

Total accounts payable and accrued expenses

 

$

20,817

 

 

$

34,531

 

 

As of March 31, 2024, the Company's accrued royalty estimate decreased by $2.3 million, which contributed to a decrease in Amounts due to producers relative to March 31, 2023.

 

Deferred Consideration

The Company has recognized liabilities related to deferred consideration arrangements related to the acquisition of FoundationTV ("FTV") and Digital Media Rights ("DMR"). These payments are fixed in nature and are due to the sellers of the respective companies. The Company initially recognized the liability at fair value at the time of acquisition and has since recognizes interest expense related to accretion in advance of the ultimate settlement of these liabilities. Amounts due within 12 months under the terms of the agreements are classified as current within the Consolidated Balance Sheets.

The deferred consideration related to the acquisition of DMR is payable in either Class A common shares of the Company stock or cash, at the Company's discretion and subject to certain conditions. Payments of $2.4 million are due in March 2025.

The deferred consideration related to the FTV acquisition is payable in the amount of $238 thousand in each of June 2024 and December 2024, and $464 thousand in June 2025. There is $475 thousand presently due and payable. The Company has the right to pay up to 25% of post-close purchase price in equity.

Disaggregation of Revenue

The following table presents the Company’s revenue by source (in thousands):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Streaming and digital

$

37,312

 

 

$

40,423

 

Base distribution

 

5,259

 

 

 

13,341

 

Podcast and other

 

2,718

 

 

 

2,213

 

Other non-recurring

 

3,842

 

 

 

12,049

 

Total revenue

$

49,131

 

 

$

68,026

 

Streaming and digital revenue represents advertising and subscription fees earned through the operation of the Company's owned and managed channels. Certain revenue recognition estimates may be required for this source at the end of a reporting period when we are not contractually entitled to receive final performance reporting from our partners for an extended period of time.

Base distribution revenue is generated by the Company's physical revenue streams such as DVD's and related supply chain revenue, as well as theatrical revenue. Other non-recurring revenue represents remaining system sales and the release of previously constrained variable consideration, following the run-off of the Company's legacy digital cinema business at the conclusion of fiscal year 2023. The Company also has contracts for the theatrical distribution of third party feature movies and alternative content. Distribution fee revenue and participation in box office receipts are recognized at the time a feature movie and alternative content are viewed.

Podcast and other revenue represents advertising fees earned in support of the Company's podcast programming.

 

Other non-recurring revenue relates to the Company's legacy digital cinema operations, whose operations have run-off, still may generate non-recurring revenue from the sale of cinema assets or the recognition of variable consideration as the associated uncertainty associated with the revenue is resolved.

Revenue Recognition

Fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or "Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Base Distribution”). Fees earned are typically a percentage of the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”) on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the content is available for subscription on the digital platform (the Company’s digital content is considered functional IP), at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Base Distribution Revenue from the sale of physical goods is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration. Reserves for potential sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

We have the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. As the Company satisfies its performance obligations, whether relating to the delivery of digital content, physical goods, or licensing, revenue is generally measured at a point in time.

The Company follows the five-step model established by ASC 606, Revenue from Contracts with Customers when preparing its assessment of revenue recognition.

Principal Agent Considerations

Revenue earned from the delivery of digital content and physical goods may be recognized gross or net depending on the terms of the arrangement. We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

which party is primarily responsible for fulfilling the promise to provide the specified good or service; and
which party has discretion in establishing the price for the specified good or service.

Shipping and Handling

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in direct operating expenses because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

Contract Liabilities

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable. Deferred revenue includes amounts related to advances, he sale of DVDs or theatrical releases with future release dates.

The ending deferred revenue balance, all current as of March 31, 2024 and 2023 was $0.4 million and $0.2 million, respectively. There were no long term amounts at either date.

Participations and Royalties Payable

When we use third parties to distribute Company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

Concentrations

For the fiscal year ended March 31, 2024, one customer represented 26% of consolidated revenue. For the fiscal year ended March 31, 2023, one customer represented 10% of consolidated revenue.

Direct Operating Costs

Direct operating costs consist of operating costs such as cost of revenue, fulfillment expenses, shipping costs, property taxes and insurance on systems, royalty and participation expenses, allowance against advances, and marketing and direct personnel costs.

Stock-based Compensation

The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the Consolidated Statements of Operations based on their fair values. The Company measures the compensation expense of employee and non-employee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and non-employee is required

to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility, risk-free rate and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.

 

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax basis.

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States and India.

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes, which provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

Earnings per Share

 

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include stock options and stock appreciation right outstanding during the period, and performance awards which are expected to be settled in shares and would be issuable at period end, using the treasury stock method. Potentially dilutive common shares are excluded from the computations of diluted income (loss) per share if their effect would be anti-dilutive. A net loss available to common stockholders causes all potentially dilutive securities to be anti-dilutive and are not included.

 

Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Basic net loss per share:

 

 

 

 

 

Net loss attributable to common stockholders

$

(21,757

)

 

$

(10,085

)

Shares used in basic computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Basic net loss per share

$

(1.78

)

 

$

(1.13

)

 

 

 

 

 

 

Shares used in diluted computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Stock options and SARs

 

 

 

 

 

Weighted-average number of shares

 

12,253

 

 

 

8,889

 

Diluted net loss per share

$

(1.78

)

 

$

(1.13

)

 

The calculation of diluted net income (loss) per share for the year ended March 31, 2024 and 2023 does not include the impact of 3,443 and 700 thousand potentially dilutive shares, respectively, relating to warrants, stock options, performance shares and stock appreciation rights, as their impact would have been anti-dilutive due to the respective period's income (loss) and an exercise price which exceeded period-end share price.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

The Company evaluates all Accounting Standard Updates ("ASUs") issued but not yet effective by FASB for consideration of their applicability. ASU's not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company's consolidated financial statements or disclosures.

 

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280)—Improvements to Reportable Segment Disclosures." The update requires disclosure of incremental segment information, including significant segment expenses, on an annual and interim basis, and would apply to single segment companies. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The Company is required to apply the updates retrospectively. The Company is assessing the impact of ASU 2023-07 on its consolidated financial statements.

 

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740)—Improvements to Income Tax Disclosures" On an annual basis, this update requires the disclosure of specific tax categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The amendments are effective for annual periods beginning after December 15, 2024. Prospective and retrospective adoption is permitted. The Company is still evaluating its method of adoption and assessing the impact of ASU 2023-09 on the disclosures within its consolidated financial statements.

 

In March 2024, the FASB issued ASU 2024-01, "Compensation—Stock Compensation (Topic 718)—Scope Application of Profits Interest and Similar Awards." This update clarifies the scope of "Profit Interest" and similar awards and adds an illustrative example to the existing ASC 718 standard that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The amendments in this Update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The amendments in this Update should be applied either (1) retrospectively to all prior periods presented in the financial statements or (2) prospectively to profits interest and similar awards granted or modified on or after the date at which the entity first applies the amendments. Based on the Company's population of awards, the Company does not anticipate a material impact on its financial results as a result of adoption.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.2
Other Interests
12 Months Ended
Mar. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
OTHER INTERESTS

3. OTHER INTERESTS

CDF2 Holdings

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in ASC 810, Consolidation. ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial statements. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

As of March 31, 2024 and 2023, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $0.0 million and $0.5 million as of March 31, 2024 and 2023, respectively, which are included in accounts receivable, net on the accompanying Consolidated Balance Sheets.

The accompanying Consolidated Statements of Operations include $0.0 million and $0.2 million of digital cinema servicing revenue from CDF2 Holdings for the year ended March 31, 2024 and 2023, respectively.

Total stockholders’ deficit of CDF2 Holdings at March 31, 2024 and 2023 was $59.2 and $59.2 million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $2.0 million and, accordingly, our investment in CDF2 Holdings as of March 31, 2024 and 2023 is carried at $0.

CONtv

We own an 85% interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets. CONtv is consolidated in our consolidated financial statements with the 15% minority interest presented as a non-controlling interest.

Roundtable

On March 15, 2022, the Company entered into a stock purchase agreement with Roundtable Entertainment Holdings, Inc. (“Roundtable”) pursuant to which the Company purchased 0.5 thousand shares of Roundtable Series A Preferred Stock and warrants to purchase 0.1 thousand shares of Roundtable Common Stock (together, the “Roundtable Securities”). The Company paid the purchase price for the Roundtable Securities by issuing 16 thousand shares of Common Stock to Roundtable, after taking into account the June 2023 reverse stock split (further described in the Stockholders' Equity footnote). The Company recorded $0.2 million for the purchase of the Roundtable Securities which is included in other long-term assets on the accompanying Consolidated Balance Sheets. The investment in the Roundtable Securities was made in connection with a proposed collaboration with Roundtable regarding production and distribution of streaming content including the launch of high profile branded enthusiast streaming channels. The Roundtable investment was accounted for using the cost method of accounting as we own less than 20% of Roundtable and do not exert a significant influence over their operations. Our President and Chief Strategy Officer is on the Roundtable Board of Directors.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity
12 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY

4. STOCKHOLDERS’ EQUITY

COMMON STOCK

Common Stock

On October 11, 2021, the Company filed an Amended and Restated Certificate of Incorporation which authorized an increase in the number of shares of Common Stock for issuance to 275 million shares, the level at which it remains.

 

On June 9, 2023, the Company effected a 1-for-20 reverse stock split of the Company's Class A common stock. All shares and price amounts in this report reflect the 1-for-20 reverse stock split effected on June 9, 2023.

During the fiscal year ended March 31, 2024, the Company issued 6.4 million shares of Common Stock, through a direct offering, ATM sales, preferred stock dividends, issuance for shares for employee bonuses net of shares withheld for taxes, exercise of pre-funded warrants, Board fees, deferred consideration and earnout commitments.

During the fiscal year ended March 31, 2023, the Company issued 582 thousand shares of Common Stock in payment of preferred stock dividends, Board fees, payment of performance shares, pursuant to a business combinations, and the acquisition of intangible assets.

 

Direct Offering

 

On June 14, 2023, the Company sold in a public offering an aggregate of 2,150,000 shares of the Company’s Class A common stock, pre-funded warrants to purchase up to 516,667 shares of Common Stock, and common warrants to purchase up to 2,666,667 shares of Common Stock at an effective combined purchase price of $3.00 per share and related Common Warrant, for aggregate gross proceeds of approximately $8.0 million, before deducting placement agents fees and offering expenses payable by the Company. The purchase price of each Pre-Funded Warrant and related Common Warrant was equal to the Purchase Price less the $0.001 per share exercise price of each Pre-Funded Warrant. All pre-funded and common warrants were issued as immediately exercisable. All pre-funded warrants were subsequently exercised in July 2023 for total proceeds of $0.5 thousand. All common warrants remain outstanding as of March 31, 2024.

 

ATM Sales Agreement

 

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on Nasdaq at the time of the sale of such shares. The Company is not obligated to sell any shares under the ATM Sales Agreement. Any sales of shares made under the ATM Sales Agreement will be made pursuant to the 2020 Shelf Registration Statement, for an aggregate offering price of up to $30 million.

 

No sales under the ATM Sales Agreement were made during the year ended March 31, 2023. For the twelve months ended March 31, 2024, the Company sold 177 thousand shares for $1.1 million in net proceeds, respectively, after deduction of commissions and fees. The ATM Sales Agreement has expired in accordance with its terms.

 

On May 3, 2024, Cineverse Corp. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners and The Benchmark Company, LLC (collectively, the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of its Class A common stock, par value $0.001 per share (the “Common Stock”). Shares of Common Stock may be offered and sold for an aggregate offering price of up to $15 million. The Sales Agents’ obligations to sell shares under the Sales Agreement are subject to satisfaction of certain conditions, including the continuing effectiveness of the Registration Statement on Form S-3 (Registration No. 333-273098) (the “Registration Statement”) filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on June 30, 2023 and declared effective by the SEC on January 25, 2024, and other customary closing conditions. The Company will pay the Sales Agents a commission of 3.00% of the aggregate gross proceeds from each sale of shares and has agreed to provide the Sales Agents with customary indemnification and contribution rights. The Company has also agreed to reimburse the Sales Agents for

certain specified expenses. The Company is not obligated to sell any shares under the Sales Agreement and has not sold any shares through the date of this report.

PREFERRED STOCK

Cumulative dividends in arrears on preferred stock were $0.1 million as of March 31, 2024 and 2023. For the years ended March 31, 2024 and 2023, we paid preferred stock dividends in the form of 196 thousand and 37 thousand shares of Common Stock, respectively.

TREASURY STOCK

We have treasury stock, at cost, consisting of 289 thousand shares and 66 thousand shares of Common Stock as of March 31, 2024 and 2023, respectively.

EQUITY INCENTIVE PLANS

Stock Based Compensation Awards

Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) were in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provided for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options were set at the discretion of our Compensation Committee. The Company does not estimate forfeitures, but recognizes forfeitures in the period in which they occur.

Options outstanding and exercisable under the 2000 Plan are as follows:

 

As of March 31, 2024

 

Min

 

 

Max

 

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

148.0

 

 

$

148.0

 

 

 

0.3

 

 

 

1.25

 

 

$

148

 

 

$

 

$

280.0

 

 

$

488.0

 

 

 

0.6

 

 

 

0.52

 

 

$

345

 

 

 

 

 

 

 

 

 

0.9

 

 

 

0.72

 

 

$

290

 

 

$

 

 

As of March 31, 2023

 

Min

 

 

Max

 

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

148.0

 

 

$

148.0

 

 

 

0.3

 

 

 

2.25

 

 

$

148

 

 

$

 

$

280.0

 

 

$

488.0

 

 

 

10.0

 

 

 

0.50

 

 

$

290

 

 

 

 

 

 

 

 

 

10.2

 

 

 

0.54

 

 

$

287

 

 

$

 

A total of 9 thousand options expired during the year ended March 31, 2024.

 

In August 2017, the Company adopted the 2017 Equity Incentive Plan (the “2017 Plan). The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provides for the issuance of up to 2,055 thousand shares of Common Stock as of December 8, 2023, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards.

During the year ended March 31, 2024, the Company granted 207 thousand stock appreciation rights (“SARs”), which were granted under the 2017 Plan. All SARs issued have an exercise price equal to the market price of the

Company’s Common Stock on the date of grant and a maturity date of 10 years after grant date. The Company has the option to settle the SARs through a cash payment, issuance of shares, or some combination of cash payment and shares. Based on past practice and intent to settle these awards with shares of Class A common stock, the Company has determined that these awards should be classified in equity.

The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:

 

 

For the Year Ended March 31,

 

 

 

2024

 

 

2023

 

Expected dividend yield

 

 

 

 

 

 

Expected equity volatility

 

 

107

%

 

 

112

%

Expected term (years)

 

 

6.50

 

 

 

6.50

 

Risk-free interest rate

 

4.51% - 3.82%

 

 

 

4.49

%

Exercise price

 

$5.80 - $10.43

 

 

$9.82

 

Market price per share

 

$5.80 - $10.43

 

 

$9.82

 

The weighted average fair value of outstanding grants made during the year ended March 31, 2024, was $4.99 per award. The weighted average fair value of outstanding the grants made during the year ended March 31, 2023, was $8.52 per award.

SARs outstanding under the 2017 Plan, along with the minimum and maximum strike price of each group, are as follows:

 

As of March 31, 2024

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

5.8

 

 

$

12.8

 

 

 

632

 

 

 

7.92

 

 

$

9.45

 

 

$

 

$

23.2

 

 

$

29.4

 

 

 

98

 

 

 

5.12

 

 

$

27.77

 

 

 

 

$

39.4

 

 

$

46.4

 

 

 

46

 

 

 

6.96

 

 

$

40.15

 

 

 

 

 

 

 

 

 

 

 

776

 

 

 

7.51

 

 

$

13.58

 

 

$

 

 

As of March 31, 2023

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

7.80

 

 

$

14.80

 

 

 

430

 

 

 

8.37

 

 

$

11.15

 

 

$

3

 

$

23.20

 

 

$

29.40

 

 

 

105

 

 

 

6.25

 

 

$

27.62

 

 

 

 

$

34.20

 

 

$

42.00

 

 

 

100

 

 

 

8.78

 

 

$

40.18

 

 

 

 

$

44.60

 

 

$

51.20

 

 

 

21

 

 

 

8.57

 

 

$

45.46

 

 

 

 

 

 

 

 

 

 

 

657

 

 

 

8.10

 

 

$

19.33

 

 

$

3

 

 

Exercisable SARs under the 2017 Plan as of March 31, 2024 are as follows:

 

SARs Exercisable
(In thousands)

 

 

Weighted Average
Remaining Life in Years

 

 

Weighted Average
Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

 

469

 

 

 

8.5

 

 

$

17.64

 

 

$

 

As of March 31, 2024, the compensation cost not yet recognized related nonvested SARS awards totaled $703 thousand, to be recognized over the weighted average remaining vesting period of 0.8 years.

 

SARs activity for the year ended March 31, 2024 is as follows (in thousands):

 

 

 

Year Ended
March 31, 2024

 

 SARs Outstanding March 31, 2023

 

 

657

 

 Issued

 

 

207

 

 Forfeited

 

 

(88

)

 Total SARs Outstanding March 31, 2024

 

 

776

 

 

A total of $1.4 million and $4.8 million of stock based compensation was included within Selling, General and Administrative expenses for the years ended March 31, 2024 and 2023, respectively.

 

In addition, the Company grants performance stock unit ("PSU") awards under the 2017 Plan to employees of the Company that vest upon certain performance goals being achieved. Upon vesting, the award may be settled in shares or cash at the Company's discretion.

 

There were no shares granted or issued in fiscal year 2024. Based on performance for the year ended March 31, 2023, the Company accrued for 16 thousand unvested.

Of this stock based compensation expense, there was $0.3 million and $0.4 million of stock-based compensation expense for the year ended March 31, 2024 and 2023, respectively, related to Board of Director fees. During the years ended March 31, 2024 and 2023, the Company issued 400 thousand and 34 thousand restricted shares to non-employee directors, respectively.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.2
Debt
12 Months Ended
Mar. 31, 2024
Notes Payable [Abstract]  
DEBT

5. DEBT

 

Line of Credit Facility

 

The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $7.5 million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to September 15, 2025, subject to definitive documentation.

 

As of March 31, 2024 and March 31, 2023, $6.4 million and $5.0 million was outstanding on the Line of Credit Facility, respectively. Under the Line of Credit Facility, the Company is subject to certain financial and nonfinancial covenants including terms which require the Company to maintain certain metrics and ratios, maintain certain minimum cash on hand, and to report financial information to our lender on a periodic basis. For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.

 

For the year ended March 31, 2024 and March 31, 2023, the Company incurred interest expense of $0.4 million and $0.2 million to EWB related to the Line of Credit Facility, respectively.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies
12 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

6. COMMITMENTS AND CONTINGENCIES

Operating Leases

 

Cineverse is a virtual company with one domestic operating lease, acquired through the acquisition of Digital Media Rights ("DMR") and subleased to a third party. The Company has not been relieved of the its original lease obligation and therefore recognizes both a lease liability and right-of-use asset as part of the arrangement. The end of both the original lease and sublease's term is January 2025. The Company has recognized $0.2 million of sublease income related to its subleasing arrangement for the twelve months ended March 31, 2024.

 

The Company's two operating leases for its India operations expire in July 2027.

The table below presents the lease-related assets and liabilities recorded on our Consolidated Balance Sheets (in thousands):

 

 

 

Classification on the Balance Sheet

 

March 31,
2024

 

 

March 31,
2023

 

Assets

 

 

 

 

 

 

 

 

Noncurrent

 

 Other long-term assets

 

$

834

 

 

$

1,265

 

Liabilities

 

 

 

 

 

 

 

 

Current

 

 Operating leases liabilities

 

 

401

 

 

 

418

 

Noncurrent

 

 Operating leases liabilities, net of current portion

 

 

462

 

 

 

863

 

Total operating lease liabilities

 

 

 

$

863

 

 

$

1,281

 

 

 

The table below presents the annual gross undiscounted cash flows related to the Company's operating lease commitments and subleasing arrangements (in thousands):

 

Fiscal year ending March 31,

Operating Lease Commitments

 

2025

$

423

 

2026

 

200

 

2027

 

210

 

2028

 

72

 

2029

 

 

Thereafter

 

 

Total lease payments

$

905

 

Less imputed interest

 

(42

)

Total

$

863

 

 

For leases which have a term of twelve months or less and do not contain an option to extend which the Company is

reasonably certain to extend the term, the Company has elected to not apply the recognition provisions of ASC 842

and recognizes these expenses on a straight-line basis over the term of the agreement.

 

Since our operating leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at Cineverse's lease commencement date. The average discount rate utilized was 3.34%.

The Company incurred $445 thousand and $441 thousand in rental expense associated with its operating leases during the years ended March 31, 2024 and 2023, respectively.

 

 

Commitments

 

 

In the ordinary course of business, the Company enters into contractual arrangements, from time to time, under which it agrees to commitments with content providers for certain rights which are in production or have not yet been completed, delivered to, and accepted by the Company. Based on the nature of these agreements, which may be subject to delay or project abandonment, there is uncertainty with the amounts and timing of its commitments. Certain of these advances are eligible to be recouped through future revenue sharing arrangements. Based on the stage of the Company's projects, the table presented below represents an estimate of the Company's gross project commitments over the next five fiscal years (in thousands).

 

 

 

Fiscal Year Ended March 31,

 

 

 

2025

 

 

2026

 

 

2027

 

 

2028

 

 

2029

 

Total Project Commitments

 

$

2,094

 

 

$

915

 

 

$

965

 

 

$

665

 

 

$

315

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes
12 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES

7. INCOME TAXES

 

We recorded income tax expense of $0.0 million and $0.1 million from operations for the years ended March 31, 2024 and 2023, respectively. For the year ended March 31, 2023, the income tax expense of $0.1 million was mainly related to foreign income taxes.

The following table presents the components of income tax expense (benefit) (in thousands):

 

 

 

For the Fiscal Year
Ended March 31,

 

 

 

2024

 

 

2023

 

Federal:

 

 

 

 

 

 

Current

 

$

 

 

$

 

Deferred

 

 

 

 

 

 

Total federal

 

$

 

 

$

 

State:

 

 

 

 

 

 

Current

 

$

(11

)

 

$

12

 

Deferred

 

 

 

 

 

 

Total state

 

$

(11

)

 

$

12

 

Foreign:

 

 

 

 

 

 

Current

 

$

35

 

 

$

107

 

Deferred

 

 

(14

)

 

 

 

Total foreign

 

$

21

 

 

$

107

 

Income tax expense

 

$

10

 

 

$

119

 

 

Net deferred taxes consisted of the following (in thousands):

 

 

 

As of March 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

20,945

 

 

$

18,318

 

Stock-based compensation

 

 

3,724

 

 

 

3,246

 

Intangibles

 

 

6,423

 

 

 

4,800

 

Accrued liabilities

 

 

535

 

 

 

908

 

Capital loss carryforward

 

 

3,924

 

 

 

 

Investments

 

 

1,977

 

 

 

4,344

 

Non-deductible interest expense

 

 

4,213

 

 

 

3,479

 

Other

 

 

240

 

 

 

750

 

Total deferred tax assets before valuation allowance

 

 

41,981

 

 

 

35,845

 

Less: Valuation allowance

 

 

(41,668

)

 

 

(35,755

)

Total deferred tax assets after valuation allowance

 

$

312

 

 

$

90

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use asset

 

$

(248

)

 

$

 

Depreciation and amortization

 

 

(50

)

 

 

(90

)

Total deferred tax liabilities

 

 

(298

)

 

 

(90

)

Net deferred tax

 

$

14

 

 

$

 

 

We have provided a valuation allowance to our net deferred tax assets as of March 31, 2024 and 2023. We are required to recognize all or a portion of our deferred tax assets if we believe that it is more likely than not that such assets will be realized, given the weight of all available evidence. We assess the realizability of the deferred tax assets at each interim and annual balance sheet date. In assessing the need for a valuation allowance, we considered both positive and negative evidence, including recent financial performance, projections of future taxable income and scheduled reversals of deferred tax liabilities. The net changes in the valuation allowance of $5.9 million and $2.5 million during the fiscal years ended March 31, 2024 and 2023, respectively, were mainly due to increases in the deferred tax asset related to the net operating loss carryforward and other temporary differences. We will

continue to assess the realizability of the deferred tax assets at each interim and annual balance sheet date based upon actual and forecasted operating results.

As of March 31, 2024, we had utilizable federal and state net operating loss carryforwards of approximately $70.3 million available in the United States of America (“U.S.”) to reduce future taxable income. U.S. federal and state net operating loss carryforwards of approximately $22.5 and $70.3 million, respectively, generally begin to expire in 2026. U.S. federal net operating loss carryforwards that were generated during the years ended March 31, 2020, 2021, 2022, 2023, and 2024 of approximately $47.9 million, do not expire.

On March 27, 2020, the CARES Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable.

The differences between the U.S. statutory federal tax rate and our effective tax rate are as follows:

 

 

 

For the Year
Ended March 31,

 

 

 

2024

 

 

2023

 

Provision at the U.S. statutory federal tax rate

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefit

 

 

14.2

%

 

 

8.0

%

Change in valuation allowance

 

 

(27.8

)%

 

 

(27.8

)%

Non-deductible expenses

 

 

(1.0

)%

 

 

(8.3

)%

Executive officer compensation limitation – Section 162(m)

 

 

%

 

 

(2.0

)%

Goodwill impairment

 

 

(6.3

)%

 

 

 

Losses from non-consolidated entities

 

 

%

 

 

7.9

%

Other

 

 

%

 

 

(0.1

)%

Income tax expense

 

 

(0.1

)%

 

 

(1.3

)%

 

We file income tax returns in the U.S. federal jurisdiction, various U.S. states, and India. For federal income tax purposes, our fiscal 2021 through 2024 tax years remain open for examination by the tax authorities under the normal three-year statute of limitations. For U.S. state tax purposes, our fiscal 2020 through 2024 tax years generally remain open for examination by most of the tax authorities under a four-year statute of limitations. For Indian income tax purposes, our fiscal 2022 through 2024 tax years remain open for examination by the tax authorities.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.2
Subsequent Events
12 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

8. SUBSEQUENT EVENTS

Terrifier 3 Financing

 

On April 5, 2024, Cineverse Terrifier LLC (“T3 Borrower”), a wholly-owned subsidiary of the Company entered into a Loan and Security Agreement with BondIt LLC (“T3 Lender”) and the Company, as guarantor (the “T3 Loan Agreement”).

 

The T3 Loan Agreement provides for a term loan with a principal amount not to exceed $3,666 thousand (the “T3 Loan”), and a maturity date of April 1, 2025, with a permitted extension of the term for 120 days under certain conditions. The T3 Loan bears no interest until the maturity date other than an interest advance equal to $576 thousand at the closing of the T3 Loan on April 5, 2024. If the T3 Loan is extended as noted above, the T3 Loan will bear interest at a rate of 1.44% per month. T3 Borrower may prepay the obligations under the T3 Loan, in full or in part, without penalty or premium. The proceeds under the T3 Loan Agreement will be used for the funding under the Company’s distribution arrangements for the film titled Terrifier 3 (the “Film”). The T3 Loan Agreement contains customary covenants, representation and warranties and events of default.

 

After the principal of the T3 Loan is paid in full, T3 Lender will be entitled to receive 15% of all royalties earned by the Company on the Film under its distribution agreements for the Film until T3 Lender has received 1.75 times the full commitment amount of $3,666 thousand, consisting of the principal amount plus interest and fees advanced to T3 Borrower, plus any extension interest. The T3 Loan is secured by a first priority interest in all of T3 Borrower’s rights and interest in the Film and the distribution agreements, including the proceeds to T3 Borrower from the distribution of the Film.

 

The Company entered into a Guaranty Agreement pursuant to which it provided a guarantee of the T3 Loan which is capped at obligations not exceeding $1,500 thousand (the “Guaranty Agreement”). The Guaranty is subordinated in payment and performance to the Line of Credit Facility pursuant to an intercreditor agreement between EWB and the T3 Lender, and acknowledged by the Company and the T3 Borrower. In connection with the T3 Loan Agreement, the Company entered into Amendment No. 3 to the Amended and Restated Loan, Guaranty and Security Agreement dated as of September 15, 2022 with East West Bank and the Guarantors named therein, as amended to date (the “EWB Amendment”) to facilitate the T3 Loan and the Guarantee.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Consolidation

Consolidation

 

The accompanying consolidated financial statements of Cineverse Corp. have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). These consolidated financial Statements have been prepared by the Company following the rules and regulations of the SEC. All intercompany transactions and balances have been eliminated in consolidation. Certain columns and rows may not add due to rounded numbers.

 

We own an 85% interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the internet and other consumer digital distribution platforms,

such as gaming consoles, set-top boxes, handsets, and tablets. We evaluated the investment under the voting interest entity model and determined that the entity should be consolidated as we have a controlling financial interest in the entity through our ownership of outstanding voting shares, and that other equity holders do not have substantive voting, participating or liquidation rights. We record net income or loss attributable to noncontrolling interest in our Consolidated Statements of Operations equal to the proportionate share of outstanding profit interest units retained by the noncontrolling interests.

 

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

 

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification ("ASC") 810, Consolidation ("ASC 810"). ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

Use of Estimates

Use of Estimates

 

The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include revenue recognition, share-based compensation expense, valuation allowance for deferred income taxes, recovery of content advances, goodwill and intangible asset impairments, estimated royalties payable to content partners, and the assessment of amortization lives to intangible assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On a regular basis, the Company evaluates the assumptions, judgments and estimates. Actual results may differ from these estimates.

Reclassifications

Reclassifications

 

Certain amounts have been reclassified to conform to the current presentation.

Cash and Cash Equivalents

Cash and Cash Equivalents

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal.

Non-monetary Transactions

Non-monetary Transactions

 

During the year ended March 31, 2023, the Company entered into a non-monetary transaction for the purchase and sale of content licenses with an unrelated third party. The fair value of the content was based on a market approach and determined to be $1.0 million which is included in Revenues in our Consolidated Statements of Operations. No gain or loss was recognized, as the fair value of the content licenses purchased was determined to be $1.0 million and recognized within Intangible Assets, Net on our Consolidated Balance Sheets, and will be amortized over its

three year estimated life. For the years ended March 31, 2024 and March 31, 2023, $341 thousand and $85 thousand of related amortization expense had been recognized, respectively.

Accounts Receivable, Net

Accounts Receivable, Net

We maintain reserves for expected credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical credit losses, customer concentrations, customer credit worthiness, current and forecasted economic trends and changes in customer payment patterns to evaluate the adequacy of this allowance.

During the year ended March 31, 2024, the Company had no write-offs of previously reserved accounts receivable and as of March 31, 2024, accrued an allowance for expected credit losses of $0.3 million. During the year ended March 31, 2023, the Company had written off $2.8 million of previously reserved accounts receivable balances and as of March 31, 2023, carried an allowance for credit losses of $0.

Employee Retention Tax Credit

Employee Retention Tax Credit

 

The Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") provided an employee retention credit which was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the "Appropriations Act") extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to 70% of qualified wages paid to employees during the 2021 fiscal year.

 

The Company qualified for the employee retention credit beginning in June 2020 for qualified wages through September 2021 and filed a cash refund claim during the fiscal year ended March 31, 2023 in the amount of $2.5 million in the Employee retention tax credit line on the Company’s Consolidated Statements of Operations.

 

As of March 31, 2024 and March 31, 2023, the tax credit receivable of $1.7 and $2.1 million, respectively, has been included in the Employee retention tax credit line ("ERTC") on the Company's Consolidated Balance Sheet. The Company received notification during the second quarter of fiscal year 2024 that its ERTC claim was under examination with the Internal Revenue Service ("IRS"). In April 2024, the Company received a letter from the IRS indicating that its claim had been accepted and $1.7 million was received in June 2024.

Content Advances

Content Advances

Content advances represents amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record a provision for amounts that we expect may not be recoverable. Amounts which are expected to be recovered within 12 months are classified as current, which were $9.3 million and $3.7 million as of March 31, 2024, and March 31, 2023, respectively. Amounts estimated to be recoverable in more than 12 months are classified as long term and presented within content advances, net of current portion, which were $2.6 million and $1.4 million as of March 31, 2024, and March 31, 2023, respectively. For the twelve months ended March 31, 2024 and March 31, 2023, the Company recorded a recovery and increase in the provision for advances of $0.5 million and $1.3 million, respectively.

Property and Equipment, Net

Property and Equipment, Net

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets, with useful life ranges by major asset class as follows:

 

Computer equipment and software

 

3 - 5 years

Internal use software

 

3 - 5 years

Machinery and equipment

 

3 - 10 years

Furniture and fixtures

 

2 - 7 years

 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software on a straight-line basis. Post-configuration training and maintenance costs are expensed as incurred.

Intangible Assets, Net

Intangible Assets, Net

Intangible assets are stated at cost less accumulated amortization. For intangible assets that have finite lives, the assets are amortized using the straight-line method over the estimated useful lives of the related assets.

During both of the years ended March 31, 2024 and 2023, we did not record any impairment.

Amortization expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Content Library

 

3 – 20 years

Trademarks and Tradenames

 

2 – 15 years

Customer Relationships

 

5 – 13 years

Advertiser Relationships and Channel

 

2 – 13 years

Software

 

10 years

Capitalized Content

 

3 years

Supplier Agreements

 

2 years

 

The Company’s intangible assets include the following (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

24,133

 

 

$

(21,492

)

 

$

2,641

 

Advertiser Relationships and Channel

 

 

12,603

 

 

 

(2,541

)

 

 

10,062

 

Customer Relationships

 

 

8,690

 

 

 

(7,872

)

 

 

818

 

Software

 

 

3,200

 

 

 

(880

)

 

 

2,320

 

Trademark and Tradenames

 

 

3,914

 

 

 

(3,059

)

 

 

855

 

Capitalized Content

 

 

1,822

 

 

 

(190

)

 

 

1,632

 

Total Intangible Assets

 

$

54,362

 

 

$

(36,034

)

 

$

18,328

 

 

 

 

 

As of March 31, 2023

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

23,970

 

 

$

(21,126

)

 

$

2,844

 

Advertiser Relationships and Channel

 

 

12,604

 

 

 

(1,062

)

 

 

11,542

 

Supplier Agreements

 

 

11,430

 

 

 

(11,430

)

 

 

 

Customer Relationships

 

 

10,658

 

 

 

(9,568

)

 

 

1,090

 

Trademark and Tradenames

 

 

4,026

 

 

 

(2,274

)

 

 

1,752

 

Software

 

 

3,200

 

 

 

(560

)

 

 

2,640

 

Total Intangible Assets

 

$

65,888

 

 

$

(46,020

)

 

$

19,868

 

 

As of March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):

 

 

Total

 

In-process intangible assets

 

 

448

 

2025

 

 

3,186

 

2026

 

 

3,006

 

2027

 

 

2,225

 

2028

 

 

1,356

 

2029

 

 

1,356

 

Thereafter

 

 

6,751

 

Total

 

$

18,328

 

Capitalized Content

Capitalized Content

 

The Company capitalizes direct costs incurred in the production of content from which it expects to generate a return over the anticipated useful life and the Company’s predominant monetization strategy informs the method of amortizing these deferred costs. The determination of the predominant monetization strategy is made at commencement of the production or license period and the classification of the monetization strategy as individual or group only changes if there is a significant change to the title’s monetization strategy relative to its initial assessment. The costs are capitalized to the Capitalized Content costs within Intangible Assets and are amortized as a group within Depreciation and Amortization within the Consolidated Statements of Operations.

Impairment of Long-lived and Finite-lived Intangible Assets

Impairment of Long-lived and Finite-lived Intangible Assets

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. There were no impairment charges recorded for long-lived and finite-lived intangible assets during the twelve months ended March 31, 2024 and 2023
Goodwill

Goodwill

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test. For the twelve months ended March 31, 2024, the Company recognized a goodwill impairment loss of $14.0 million. The Company considered the sustained decrease in its share price to be a goodwill impairment indicator and determined that it would be appropriate to proceed with a quantitative test. Primarily utilizing a market-multiple approach, which took into account the sustained decrease in share price, the Company determined that goodwill impairment of $14.0 million would be recognized.

For the twelve months ended March 31, 2023, the Company assessed goodwill impairment on its annual measurement date of March 31, 2023 by performing a qualitative analysis and determined that it was not more likely than not that the fair value of its reporting unit was greater than its carrying amount. During the year ended March 31, 2023, the Company recorded a purchase price adjustment to reduce Goodwill by $260 thousand.

No goodwill impairment charge was recorded for the twelve months ended March 31, 2023.

Fair Value Measurements

Fair Value Measurements

 

The authoritative guidance on fair value measurements establishes a framework with respect to measuring assets and liabilities at fair value on a recurring basis and non-recurring basis, within ASC 820, Fair Value Measurement. Under the framework, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as of the measurement date. The framework also establishes a three-tier hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability and are developed based on the best information available in the circumstances. The hierarchy consists of the following three levels:

Level 1 – quoted prices in active markets for identical investments
Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)
Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

 

 

 

As of March 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

Equity Investment in Metaverse

Equity Investment in Metaverse

 

On February 14, 2020, the Company acquired an approximate 11.5% interest in A Metaverse Company (“Metaverse”), a publicly traded Chinese entertainment company, formerly Starrise Media Holdings Limited, whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Metaverse that is related to our major shareholders. Our major shareholders also maintain a significant beneficial interest ownership in Metaverse.

 

On April 10, 2020, the Company purchased an additional 15% interest in Metaverse in a private transaction from shareholders of Metaverse that are affiliated with the major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which was the fair market value of the Metaverse shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.0 million, valued at the date of the issuance of the Common Stock of the Company. The difference in the value of shares received in Metaverse and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Metaverse.

 

The Company accounted for this investment under the equity method of accounting as the Company was deemed to be able to exert significant influence over Metaverse with its direct ownership and affiliation with the Company’s majority shareholders. At the time, the Company made an irrevocable election to apply the fair value option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Metaverse.

 

Following the halting of Metaverse stock trading on the Stock Exchange of Hong Kong in April 2022, the Company valued our equity investment in Metaverse using a market approach and is categorized as a Level 3 valuation based on unobservable inputs. The Company estimated the fair value of Metaverse based on the last known enterprise value at the time and then adjusting for trends in enterprise valuations for comparable companies. As of March 31, 2023, the fair value was $5.2 million, resulting in a decrease in fair value of $1.8 million for the year ended March 31, 2023.

 

On November 6, 2023, Metaverse's stock resumed trading on The Stock Exchange of Hong Kong Limited. During the year ended March 31, 2024, the Company sold 221 million of its original 362 million shares held as of March 31, 2023, which resulted in a realized loss of $0.3 thousand during the twelve months ended March 31, 2024. The resumption of active trading status represented renewed availability of quoted, unadjusted prices in active markets for identical assets, upon which the Company can execute a sale and readily access pricing information at the measurement date. Accordingly, the Company has presented the fair value of its Metaverse shares held as of March 31, 2024 within the Level 1 grouping. The fair value of the shares held as of March 31, 2024 was $0.4 million, with associated losses of $4.3 million recognized during the fiscal year ended March 31, 2024.

 

As a result of the decrease in ownership of its investment in Metaverse from its sale of shares, along with a corresponding decrease in influence, the Company no longer accounts for its investment in Metaverse under the equity method and instead will follow the guidance for equity securities for which the equity method is no longer appropriate under ASC 321, Investments - Equity Securities, and accordingly, the Company will continue to measure its investment at fair value, with changes in the value of securities held to be recognized in earnings.

Earnout Consideration on Purchase of Business

Earnout consideration on purchase of business

 

The Company estimated the fair value of its earnout liability using contractual inputs from the related business combination, which established specific fiscal year revenue growth, profitability and EBITDA targets. Prior to the completion of the earnout period at the end of fiscal year 2024, the Company utilized the most up to date forecast to estimate the outcome against these targets to determine the ultimate estimated payout. The amounts recognized are not discounted.

 

During the fiscal year ended March 31, 2024, the final year of the earnout measurement period, the Company estimated a $612 thousand decrease in its earnout liability, issued $392 thousand worth of equity to settle its liability, made cash payments of $291 thousand, and incurred interest of $29 thousand.

 

During the fiscal year ended March 31, 2023, the Company increased the estimated earnout liability by $80 thousand and made payments of $238 thousand to reduce this liability, partially offset by $83 thousand of interest accrued.

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.

Asset Acquisitions

Asset Acquisitions

An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of relative fair values.

Accounts Payable and Accrued Expenses

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

 

 

As of

 

 

 

March 31,
2024

 

 

March 31,
2023

 

Accounts payable

 

$

5,804

 

 

$

15,042

 

Amounts due to producers

 

 

9,889

 

 

 

13,114

 

Accrued compensation and benefits

 

 

1,119

 

 

 

2,532

 

Accrued other expenses

 

 

4,005

 

 

 

3,843

 

Total accounts payable and accrued expenses

 

$

20,817

 

 

$

34,531

 

Deferred Consideration

Deferred Consideration

The Company has recognized liabilities related to deferred consideration arrangements related to the acquisition of FoundationTV ("FTV") and Digital Media Rights ("DMR"). These payments are fixed in nature and are due to the sellers of the respective companies. The Company initially recognized the liability at fair value at the time of acquisition and has since recognizes interest expense related to accretion in advance of the ultimate settlement of these liabilities. Amounts due within 12 months under the terms of the agreements are classified as current within the Consolidated Balance Sheets.

The deferred consideration related to the acquisition of DMR is payable in either Class A common shares of the Company stock or cash, at the Company's discretion and subject to certain conditions. Payments of $2.4 million are due in March 2025.

The deferred consideration related to the FTV acquisition is payable in the amount of $238 thousand in each of June 2024 and December 2024, and $464 thousand in June 2025. There is $475 thousand presently due and payable. The Company has the right to pay up to 25% of post-close purchase price in equity.

Disaggregation of Revenue

Disaggregation of Revenue

The following table presents the Company’s revenue by source (in thousands):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Streaming and digital

$

37,312

 

 

$

40,423

 

Base distribution

 

5,259

 

 

 

13,341

 

Podcast and other

 

2,718

 

 

 

2,213

 

Other non-recurring

 

3,842

 

 

 

12,049

 

Total revenue

$

49,131

 

 

$

68,026

 

Streaming and digital revenue represents advertising and subscription fees earned through the operation of the Company's owned and managed channels. Certain revenue recognition estimates may be required for this source at the end of a reporting period when we are not contractually entitled to receive final performance reporting from our partners for an extended period of time.

Base distribution revenue is generated by the Company's physical revenue streams such as DVD's and related supply chain revenue, as well as theatrical revenue. Other non-recurring revenue represents remaining system sales and the release of previously constrained variable consideration, following the run-off of the Company's legacy digital cinema business at the conclusion of fiscal year 2023. The Company also has contracts for the theatrical distribution of third party feature movies and alternative content. Distribution fee revenue and participation in box office receipts are recognized at the time a feature movie and alternative content are viewed.

Podcast and other revenue represents advertising fees earned in support of the Company's podcast programming.

 

Other non-recurring revenue relates to the Company's legacy digital cinema operations, whose operations have run-off, still may generate non-recurring revenue from the sale of cinema assets or the recognition of variable consideration as the associated uncertainty associated with the revenue is resolved.

Revenue Recognition

Fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or "Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Base Distribution”). Fees earned are typically a percentage of the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”) on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the content is available for subscription on the digital platform (the Company’s digital content is considered functional IP), at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Base Distribution Revenue from the sale of physical goods is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration. Reserves for potential sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

We have the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. As the Company satisfies its performance obligations, whether relating to the delivery of digital content, physical goods, or licensing, revenue is generally measured at a point in time.

The Company follows the five-step model established by ASC 606, Revenue from Contracts with Customers when preparing its assessment of revenue recognition.

Principal Agent Considerations

Revenue earned from the delivery of digital content and physical goods may be recognized gross or net depending on the terms of the arrangement. We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

which party is primarily responsible for fulfilling the promise to provide the specified good or service; and
which party has discretion in establishing the price for the specified good or service.

Shipping and Handling

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in direct operating expenses because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

Contract Liabilities

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable. Deferred revenue includes amounts related to advances, he sale of DVDs or theatrical releases with future release dates.

The ending deferred revenue balance, all current as of March 31, 2024 and 2023 was $0.4 million and $0.2 million, respectively. There were no long term amounts at either date.

Participations and Royalties Payable

When we use third parties to distribute Company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

Concentrations

For the fiscal year ended March 31, 2024, one customer represented 26% of consolidated revenue. For the fiscal year ended March 31, 2023, one customer represented 10% of consolidated revenue.

Direct Operating Costs

Direct Operating Costs

Direct operating costs consist of operating costs such as cost of revenue, fulfillment expenses, shipping costs, property taxes and insurance on systems, royalty and participation expenses, allowance against advances, and marketing and direct personnel costs.

Stock-based Compensation

Stock-based Compensation

The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the Consolidated Statements of Operations based on their fair values. The Company measures the compensation expense of employee and non-employee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and non-employee is required

to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility, risk-free rate and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.

Income Taxes

 

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax basis.

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States and India.

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes, which provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

Earnings per Share

Earnings per Share

 

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include stock options and stock appreciation right outstanding during the period, and performance awards which are expected to be settled in shares and would be issuable at period end, using the treasury stock method. Potentially dilutive common shares are excluded from the computations of diluted income (loss) per share if their effect would be anti-dilutive. A net loss available to common stockholders causes all potentially dilutive securities to be anti-dilutive and are not included.

 

Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Basic net loss per share:

 

 

 

 

 

Net loss attributable to common stockholders

$

(21,757

)

 

$

(10,085

)

Shares used in basic computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Basic net loss per share

$

(1.78

)

 

$

(1.13

)

 

 

 

 

 

 

Shares used in diluted computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Stock options and SARs

 

 

 

 

 

Weighted-average number of shares

 

12,253

 

 

 

8,889

 

Diluted net loss per share

$

(1.78

)

 

$

(1.13

)

 

The calculation of diluted net income (loss) per share for the year ended March 31, 2024 and 2023 does not include the impact of 3,443 and 700 thousand potentially dilutive shares, respectively, relating to warrants, stock options, performance shares and stock appreciation rights, as their impact would have been anti-dilutive due to the respective period's income (loss) and an exercise price which exceeded period-end share price.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

The Company evaluates all Accounting Standard Updates ("ASUs") issued but not yet effective by FASB for consideration of their applicability. ASU's not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company's consolidated financial statements or disclosures.

 

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280)—Improvements to Reportable Segment Disclosures." The update requires disclosure of incremental segment information, including significant segment expenses, on an annual and interim basis, and would apply to single segment companies. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The Company is required to apply the updates retrospectively. The Company is assessing the impact of ASU 2023-07 on its consolidated financial statements.

 

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740)—Improvements to Income Tax Disclosures" On an annual basis, this update requires the disclosure of specific tax categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The amendments are effective for annual periods beginning after December 15, 2024. Prospective and retrospective adoption is permitted. The Company is still evaluating its method of adoption and assessing the impact of ASU 2023-09 on the disclosures within its consolidated financial statements.

 

In March 2024, the FASB issued ASU 2024-01, "Compensation—Stock Compensation (Topic 718)—Scope Application of Profits Interest and Similar Awards." This update clarifies the scope of "Profit Interest" and similar awards and adds an illustrative example to the existing ASC 718 standard that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The amendments in this Update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The amendments in this Update should be applied either (1) retrospectively to all prior periods presented in the financial statements or (2) prospectively to profits interest and similar awards granted or modified on or after the date at which the entity first applies the amendments. Based on the Company's population of awards, the Company does not anticipate a material impact on its financial results as a result of adoption.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of estimated useful lives of property and equipment, net

Computer equipment and software

 

3 - 5 years

Internal use software

 

3 - 5 years

Machinery and equipment

 

3 - 10 years

Furniture and fixtures

 

2 - 7 years

Schedule of amortization expense

Content Library

 

3 – 20 years

Trademarks and Tradenames

 

2 – 15 years

Customer Relationships

 

5 – 13 years

Advertiser Relationships and Channel

 

2 – 13 years

Software

 

10 years

Capitalized Content

 

3 years

Supplier Agreements

 

2 years

Schedule of intangible assets

 

 

As of March 31, 2024

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

24,133

 

 

$

(21,492

)

 

$

2,641

 

Advertiser Relationships and Channel

 

 

12,603

 

 

 

(2,541

)

 

 

10,062

 

Customer Relationships

 

 

8,690

 

 

 

(7,872

)

 

 

818

 

Software

 

 

3,200

 

 

 

(880

)

 

 

2,320

 

Trademark and Tradenames

 

 

3,914

 

 

 

(3,059

)

 

 

855

 

Capitalized Content

 

 

1,822

 

 

 

(190

)

 

 

1,632

 

Total Intangible Assets

 

$

54,362

 

 

$

(36,034

)

 

$

18,328

 

 

 

As of March 31, 2023

 

 

 

Cost Basis

 

 

Accumulated
Amortization

 

 

Net

 

Content Library

 

$

23,970

 

 

$

(21,126

)

 

$

2,844

 

Advertiser Relationships and Channel

 

 

12,604

 

 

 

(1,062

)

 

 

11,542

 

Supplier Agreements

 

 

11,430

 

 

 

(11,430

)

 

 

 

Customer Relationships

 

 

10,658

 

 

 

(9,568

)

 

 

1,090

 

Trademark and Tradenames

 

 

4,026

 

 

 

(2,274

)

 

 

1,752

 

Software

 

 

3,200

 

 

 

(560

)

 

 

2,640

 

Total Intangible Assets

 

$

65,888

 

 

$

(46,020

)

 

$

19,868

 

Schedule of amortization expense for intangible assets

As of March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):

 

 

Total

 

In-process intangible assets

 

 

448

 

2025

 

 

3,186

 

2026

 

 

3,006

 

2027

 

 

2,225

 

2028

 

 

1,356

 

2029

 

 

1,356

 

Thereafter

 

 

6,751

 

Total

 

$

18,328

 

Schedule of fair value measurements of our financial assets and liabilities

The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):

 

 

 

As of March 31, 2024

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

$

362

 

 

$

 

 

$

 

 

$

362

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

$

 

 

$

 

 

$

180

 

 

$

180

 

 

 

 

 

As of March 31, 2023

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Equity investment in Metaverse, at fair value

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

$

 

 

$

 

 

$

5,200

 

 

$

5,200

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Earnout consideration on purchase of a business

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

 

$

 

 

$

 

 

$

1,444

 

 

$

1,444

 

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

 

 

As of

 

 

 

March 31,
2024

 

 

March 31,
2023

 

Accounts payable

 

$

5,804

 

 

$

15,042

 

Amounts due to producers

 

 

9,889

 

 

 

13,114

 

Accrued compensation and benefits

 

 

1,119

 

 

 

2,532

 

Accrued other expenses

 

 

4,005

 

 

 

3,843

 

Total accounts payable and accrued expenses

 

$

20,817

 

 

$

34,531

 

Schedule of revenue disaggregation

The following table presents the Company’s revenue by source (in thousands):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Streaming and digital

$

37,312

 

 

$

40,423

 

Base distribution

 

5,259

 

 

 

13,341

 

Podcast and other

 

2,718

 

 

 

2,213

 

Other non-recurring

 

3,842

 

 

 

12,049

 

Total revenue

$

49,131

 

 

$

68,026

 

Schedule of basic and diluted net income (loss) per share

Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):

 

Year Ended
March 31,

 

2024

 

 

2023

 

Basic net loss per share:

 

 

 

 

 

Net loss attributable to common stockholders

$

(21,757

)

 

$

(10,085

)

Shares used in basic computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Basic net loss per share

$

(1.78

)

 

$

(1.13

)

 

 

 

 

 

 

Shares used in diluted computation:

 

 

 

 

 

Weighted-average shares of Common Stock outstanding

 

12,253

 

 

 

8,889

 

Stock options and SARs

 

 

 

 

 

Weighted-average number of shares

 

12,253

 

 

 

8,889

 

Diluted net loss per share

$

(1.78

)

 

$

(1.13

)

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of analysis of option activity

Options outstanding and exercisable under the 2000 Plan are as follows:

 

As of March 31, 2024

 

Min

 

 

Max

 

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

148.0

 

 

$

148.0

 

 

 

0.3

 

 

 

1.25

 

 

$

148

 

 

$

 

$

280.0

 

 

$

488.0

 

 

 

0.6

 

 

 

0.52

 

 

$

345

 

 

 

 

 

 

 

 

 

0.9

 

 

 

0.72

 

 

$

290

 

 

$

 

 

As of March 31, 2023

 

Min

 

 

Max

 

 

Options Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

148.0

 

 

$

148.0

 

 

 

0.3

 

 

 

2.25

 

 

$

148

 

 

$

 

$

280.0

 

 

$

488.0

 

 

 

10.0

 

 

 

0.50

 

 

$

290

 

 

 

 

 

 

 

 

 

10.2

 

 

 

0.54

 

 

$

287

 

 

$

 

Schedule of stock appreciation rights outstanding

SARs outstanding under the 2017 Plan, along with the minimum and maximum strike price of each group, are as follows:

 

As of March 31, 2024

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

5.8

 

 

$

12.8

 

 

 

632

 

 

 

7.92

 

 

$

9.45

 

 

$

 

$

23.2

 

 

$

29.4

 

 

 

98

 

 

 

5.12

 

 

$

27.77

 

 

 

 

$

39.4

 

 

$

46.4

 

 

 

46

 

 

 

6.96

 

 

$

40.15

 

 

 

 

 

 

 

 

 

 

 

776

 

 

 

7.51

 

 

$

13.58

 

 

$

 

 

As of March 31, 2023

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

7.80

 

 

$

14.80

 

 

 

430

 

 

 

8.37

 

 

$

11.15

 

 

$

3

 

$

23.20

 

 

$

29.40

 

 

 

105

 

 

 

6.25

 

 

$

27.62

 

 

 

 

$

34.20

 

 

$

42.00

 

 

 

100

 

 

 

8.78

 

 

$

40.18

 

 

 

 

$

44.60

 

 

$

51.20

 

 

 

21

 

 

 

8.57

 

 

$

45.46

 

 

 

 

 

 

 

 

 

 

 

657

 

 

 

8.10

 

 

$

19.33

 

 

$

3

 

 

Exercisable SARs under the 2017 Plan as of March 31, 2024 are as follows:

SARs Exercisable
(In thousands)

 

 

Weighted Average
Remaining Life in Years

 

 

Weighted Average
Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

 

469

 

 

 

8.5

 

 

$

17.64

 

 

$

 

Schedule of weighted average assumptions used to estimate fair value of SARs

The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:

 

 

For the Year Ended March 31,

 

 

 

2024

 

 

2023

 

Expected dividend yield

 

 

 

 

 

 

Expected equity volatility

 

 

107

%

 

 

112

%

Expected term (years)

 

 

6.50

 

 

 

6.50

 

Risk-free interest rate

 

4.51% - 3.82%

 

 

 

4.49

%

Exercise price

 

$5.80 - $10.43

 

 

$9.82

 

Market price per share

 

$5.80 - $10.43

 

 

$9.82

 

Schedule of SARs outstanding (in thousands):

 

 

 

Year Ended
March 31, 2024

 

 SARs Outstanding March 31, 2023

 

 

657

 

 Issued

 

 

207

 

 Forfeited

 

 

(88

)

 Total SARs Outstanding March 31, 2024

 

 

776

 

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies (Tables)
12 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease-related assets and liabilities

The table below presents the lease-related assets and liabilities recorded on our Consolidated Balance Sheets (in thousands):

 

 

 

Classification on the Balance Sheet

 

March 31,
2024

 

 

March 31,
2023

 

Assets

 

 

 

 

 

 

 

 

Noncurrent

 

 Other long-term assets

 

$

834

 

 

$

1,265

 

Liabilities

 

 

 

 

 

 

 

 

Current

 

 Operating leases liabilities

 

 

401

 

 

 

418

 

Noncurrent

 

 Operating leases liabilities, net of current portion

 

 

462

 

 

 

863

 

Total operating lease liabilities

 

 

 

$

863

 

 

$

1,281

 

Schedule of operating lease commitments and subleasing arrangements

The table below presents the annual gross undiscounted cash flows related to the Company's operating lease commitments and subleasing arrangements (in thousands):

 

Fiscal year ending March 31,

Operating Lease Commitments

 

2025

$

423

 

2026

 

200

 

2027

 

210

 

2028

 

72

 

2029

 

 

Thereafter

 

 

Total lease payments

$

905

 

Less imputed interest

 

(42

)

Total

$

863

 

 

For leases which have a term of twelve months or less and do not contain an option to extend which the Company is

reasonably certain to extend the term, the Company has elected to not apply the recognition provisions of ASC 842

and recognizes these expenses on a straight-line basis over the term of the agreement.

Schedule of estimate gross project commitments over the next five fiscal years Based on the stage of the Company's projects, the table presented below represents an estimate of the Company's gross project commitments over the next five fiscal years (in thousands).

 

 

Fiscal Year Ended March 31,

 

 

 

2025

 

 

2026

 

 

2027

 

 

2028

 

 

2029

 

Total Project Commitments

 

$

2,094

 

 

$

915

 

 

$

965

 

 

$

665

 

 

$

315

 

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense benefit

The following table presents the components of income tax expense (benefit) (in thousands):

 

 

 

For the Fiscal Year
Ended March 31,

 

 

 

2024

 

 

2023

 

Federal:

 

 

 

 

 

 

Current

 

$

 

 

$

 

Deferred

 

 

 

 

 

 

Total federal

 

$

 

 

$

 

State:

 

 

 

 

 

 

Current

 

$

(11

)

 

$

12

 

Deferred

 

 

 

 

 

 

Total state

 

$

(11

)

 

$

12

 

Foreign:

 

 

 

 

 

 

Current

 

$

35

 

 

$

107

 

Deferred

 

 

(14

)

 

 

 

Total foreign

 

$

21

 

 

$

107

 

Income tax expense

 

$

10

 

 

$

119

 

Schedule of net deferred tax

Net deferred taxes consisted of the following (in thousands):

 

 

 

As of March 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

20,945

 

 

$

18,318

 

Stock-based compensation

 

 

3,724

 

 

 

3,246

 

Intangibles

 

 

6,423

 

 

 

4,800

 

Accrued liabilities

 

 

535

 

 

 

908

 

Capital loss carryforward

 

 

3,924

 

 

 

 

Investments

 

 

1,977

 

 

 

4,344

 

Non-deductible interest expense

 

 

4,213

 

 

 

3,479

 

Other

 

 

240

 

 

 

750

 

Total deferred tax assets before valuation allowance

 

 

41,981

 

 

 

35,845

 

Less: Valuation allowance

 

 

(41,668

)

 

 

(35,755

)

Total deferred tax assets after valuation allowance

 

$

312

 

 

$

90

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use asset

 

$

(248

)

 

$

 

Depreciation and amortization

 

 

(50

)

 

 

(90

)

Total deferred tax liabilities

 

 

(298

)

 

 

(90

)

Net deferred tax

 

$

14

 

 

$

 

Schedule of united states statutory federal tax rate and our effective tax rate

The differences between the U.S. statutory federal tax rate and our effective tax rate are as follows:

 

 

 

For the Year
Ended March 31,

 

 

 

2024

 

 

2023

 

Provision at the U.S. statutory federal tax rate

 

 

21.0

%

 

 

21.0

%

State income taxes, net of federal benefit

 

 

14.2

%

 

 

8.0

%

Change in valuation allowance

 

 

(27.8

)%

 

 

(27.8

)%

Non-deductible expenses

 

 

(1.0

)%

 

 

(8.3

)%

Executive officer compensation limitation – Section 162(m)

 

 

%

 

 

(2.0

)%

Goodwill impairment

 

 

(6.3

)%

 

 

 

Losses from non-consolidated entities

 

 

%

 

 

7.9

%

Other

 

 

%

 

 

(0.1

)%

Income tax expense

 

 

(0.1

)%

 

 

(1.3

)%

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.2
Nature of Operations and Liquidity (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Nature of Operations and Liquidity Details [Line Items]    
Accumulated deficit   $ 504,200,000
Net loss   (21,800,000)
Working capital   1,500,000
Net cash used by operating activities   10,600,000
Revolving Credit Facility [Member] | East West Bank [Member]    
Nature of Operations and Liquidity Details [Line Items]    
Revolving line of credit   $ 7,500,000
Line of credit facility interest rate description   The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024
Credit facility covenant compliance   For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.
Revolving Credit Facility [Member] | East West Bank [Member] | Subsequent Event [Member]    
Nature of Operations and Liquidity Details [Line Items]    
Credit facility expiration date Sep. 15, 2025  
Revolving Credit Facility [Member] | Prime Rate [Member] | East West Bank [Member]    
Nature of Operations and Liquidity Details [Line Items]    
Interest rate percentage over the prime rarte   1.50%
Interest rate, stated percentage   10.00%
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details)
9 Months Ended 12 Months Ended
Apr. 10, 2020
USD ($)
Dec. 31, 2021
Mar. 31, 2024
USD ($)
Customers
shares
Mar. 31, 2023
USD ($)
Customers
shares
Jun. 30, 2024
USD ($)
Feb. 14, 2020
Summary of Significant Accounting Policies (Details) [Line Items]            
Revenues     $ 49,131,000 $ 68,026,000    
Gain loss on revenue recognized       0    
Fair value of purchased content licenses       $ 1,000,000    
Amortization estimated life       3 years    
Amortization expense (in Dollars)     341,000 $ 85,000    
Accounts receivable, allowance for credit loss, writeoff     0 2,800,000    
Allowance for credit losses     300,000 0    
Employee retention tax credit percentage   70.00%        
Employee retention credit cash refund claim       2,500,000    
Increase in provision for advances     500,000 1,300,000    
Employee retention tax credit receivable     1,700,000 2,100,000    
Impairment charges recorded for long-lived and finite-lived intangible assets     0 0    
Goodwill impairment loss     14,025,000 0    
Purchase price adjustments to goodwill       260,000    
Content advances, net of current portion     2,551,000 1,421,000    
Content advances current     $ 9,345,000 $ 3,724,000    
Initial investment $ 28,200,000          
Issuance of common stock value $ 11,000,000          
Shares sold | shares     221,000,000      
Shares held for sale | shares       362,000,000    
Shares sold resulted in a realized loss     $ 300      
Fair value of shares held     362,000 $ 5,200,000    
Decrease in accrued royalty payments     $ 2,300,000      
Anti-dilutive shares excluded from calculation of diluted net loss per share | shares | shares     3,443 700,000    
Impairment of intangible assets     $ 0 $ 0    
Deferred revenue, current     $ 436,000 $ 226,000    
Number of customers | Customers     1 1    
Concentration risk percentage     26.00% 10.00%    
Subsequent Event [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Employee retention tax credit receivable         $ 1,700,000  
Stock Exchange of Hong Kong [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Increase (decrease) in fair value of equity method investment       $ (1,800,000)    
Minimum [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Percentage of threshold tax benefit recognized upon ultimate settlement     50.00%      
Level 1 [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Fair value of shares held     $ 400,000      
Fair value of shares held resulted unrealized losses     4,300,000      
Digital Media Rights, Payment due in March 2025 [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Payments due related to the acquisition     2,400,000      
Foundation TV, Payment Due in December 2024 [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Payments due related to the acquisition     238,000      
Foundation TV, Payment Due in June 2025 [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Payments due related to the acquisition     464,000      
Foundation TV [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Payments due related to the acquisition     $ 475,000      
Right to pay post-close purchase price in equity     25.00%      
Bloody Disgusting, LLC [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Increase (decrease) in estimated earnout liability     $ 612,000 80,000    
Partially offset of accrued interest       83,000    
Incurred interest     29,000      
Issued equity to reduce liability     392,000      
Payment of earnout consideration in cash     $ 291,000 238,000    
Starrise [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Majority interest, percentage 15.00%         11.50%
Starrise [Member] | Stock Exchange of Hong Kong [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Fair value of equity method investment       5,200,000    
CON TV, LLC [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Majority interest, percentage     85.00%      
CDF2 Holdings [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Ownership percentage     100.00%      
Related Party [Member]            
Summary of Significant Accounting Policies (Details) [Line Items]            
Revenues       $ 1,000,000    
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment
Mar. 31, 2024
Computer equipment and software [Member] | Minimum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 3 years
Computer equipment and software [Member] | Maximum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 5 years
Internal use software [Member] | Minimum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 3 years
Internal use software [Member] | Maximum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 5 years
Machinery and equipment [Member] | Minimum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 3 years
Machinery and equipment [Member] | Maximum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 10 years
Furniture and fixtures [Member] | Minimum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 2 years
Furniture and fixtures [Member] | Maximum [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 7 years
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense
Mar. 31, 2024
Trademarks and Trade Names [Member] | Minimum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 2 years
Trademarks and Trade Names [Member] | Maximum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 15 years
Advertiser Relationships And Channel [Member] | Minimum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 2 years
Advertiser Relationships And Channel [Member] | Maximum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 13 years
Content Library [Member] | Minimum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 3 years
Content Library [Member] | Maximum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 20 years
Customer Relationships [Member] | Minimum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 5 years
Customer Relationships [Member] | Maximum [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 13 years
Supplier Agreements [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 2 years
Capitalized Content [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 3 years
Software [Member]  
Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]  
Estimated useful lives 10 years
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of intangible assets - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Content Library [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis $ 24,133 $ 23,970
Accumulated Amortization (21,492) (21,126)
Net 2,641 2,844
Advertiser relationships and Channel [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis 12,603 12,604
Accumulated Amortization (2,541) (1,062)
Net 10,062 11,542
Customer Relationships [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis 8,690 10,658
Accumulated Amortization (7,872) (9,568)
Net 818 1,090
Trademarks and Trade Names [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis 3,914 4,026
Accumulated Amortization (3,059) (2,274)
Net 855 1,752
Supplier Agreements [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis   11,430
Accumulated Amortization   (11,430)
Software [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis 3,200 3,200
Accumulated Amortization (880) (560)
Net 2,320 2,640
Capitalized Content [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis 1,822  
Accumulated Amortization (190)  
Net 1,632  
Total Intangible Assets [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]    
Cost Basis 54,362 65,888
Accumulated Amortization (36,034) (46,020)
Net $ 18,328 $ 19,868
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets - Intangible assets [Member]
$ in Thousands
Mar. 31, 2024
USD ($)
Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets [Line Items]  
In-process intangible assets $ 448
2025 3,186
2026 3,006
2027 2,225
2028 1,356
2029 1,356
Thereafter 6,751
Total $ 18,328
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Assets:    
Equity investment in Metaverse, at fair value $ 362 $ 5,200
Total Assets 362 5,200
Liabilities:    
Earnout consideration on purchase of a business 180 1,444
Total Liabilities 180 1,444
Level 1 [Member]    
Assets:    
Equity investment in Metaverse, at fair value 362
Total Assets 362
Liabilities:    
Earnout consideration on purchase of a business
Total Liabilities
Level 2 [Member]    
Assets:    
Equity investment in Metaverse, at fair value
Total Assets
Liabilities:    
Earnout consideration on purchase of a business
Total Liabilities
Level 3 [Member]    
Assets:    
Equity investment in Metaverse, at fair value 5,200
Total Assets 5,200
Liabilities:    
Earnout consideration on purchase of a business 180 1,444
Total Liabilities $ 180 $ 1,444
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of accounts payable and accrued expenses - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Schedule of accounts payable and accrued expenses [Abstract]    
Accounts payable $ 5,804 $ 15,042
Amounts due to producers 9,889 13,114
Accrued compensation and benefits 1,119 2,532
Accrued other expenses 4,005 3,843
Total accounts payable and accrued expenses $ 20,817 $ 34,531
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of revenue categories - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Total revenue $ 49,131 $ 68,026
Streaming and Digital [Member]    
Disaggregation of Revenue [Line Items]    
Total revenue 37,312 40,423
Base Distribution [Member]    
Disaggregation of Revenue [Line Items]    
Total revenue 5,259 13,341
Podcast And Other [Member]    
Disaggregation of Revenue [Line Items]    
Total revenue 2,718 2,213
Other Non-Recurring [Member]    
Disaggregation of Revenue [Line Items]    
Total revenue $ 3,842 $ 12,049
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Basic net loss per share:    
Net loss attributable to common stockholders $ (21,757) $ (10,085)
Weighted-average shares of Common Stock outstanding 12,253 8,889
Basic net loss per share $ (1.78) $ (1.13)
Shares used in diluted computation:    
Weighted-average shares of common stock outstanding 12,253 8,889
Weighted-average number of shares 12,253 8,889
Diluted net loss per share $ (1.78) $ (1.13)
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.2
Other Interests (Details)
12 Months Ended
Mar. 15, 2022
USD ($)
shares
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Other Interests Details [Line Items]      
Purchase price shares (in Shares) | shares 16,000    
Investments for purchase of roundtable securities $ 200,000    
Maximum roundtable investment percentage 20    
Intangible assets, net   $ 18,328,000 $ 19,868,000
Minority Owners [Member]      
Other Interests Details [Line Items]      
Percentage of minority interest   15.00%  
CDF2 Holdings [Member]      
Other Interests Details [Line Items]      
Ownership percentage   100.00%  
Accounts receivable   $ 0 500,000
Digital cinema servicing revenue   0 200,000
Total stockholders' deficit   59,200,000 59,200,000
Initial investment amount   $ 2,000,000 $ 0
CON TV, LLC [Member]      
Other Interests Details [Line Items]      
Majority interest, percentage   85.00%  
Series A Preferred Stock [Member]      
Other Interests Details [Line Items]      
Preferred stock shares (in Shares) | shares 500    
Warrant shares (in Shares) | shares 100    
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
May 03, 2024
Jun. 14, 2023
Jun. 09, 2023
Jul. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 08, 2023
Oct. 11, 2021
Jul. 31, 2020
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Reverse stock split description     1-for-20 reverse stock split            
Shares of common stock   2,150,000              
Dividends preferred stock (in Dollars)         $ 100,000 $ 100,000      
Net proceeds from from common stock         8,524,000        
Pre-funded warrants exercise price   $ 0.001              
Pre-funded warrants to purchase common stock   516,667              
Combined purchase price per share   $ 3              
Aggregate gross proceeds from equity financing   $ 8,000,000              
Stock issued value         $ 7,439,000        
Stock dividends         196,000 37,000      
Treasury stock shares         288,554 65,792      
Weighted average fair value of outstanding grants         $ 4.99 $ 8.52      
Share-based payment arrangement, option, exercise price range, outstanding, weighted average exercise price (in Dollars per share)         $ 290 $ 287      
Options expired         9,000        
Granted shares         207,000        
Maturity date         10 years        
Warrants to Purchase Common Stock   2,666,667              
Selling, General and Administrative Expenses [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Stock-based compensation         $ 1,400,000 $ 4,800,000      
Performance Stock Units [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Shares granted         0        
Shares issued         0        
Shares remained unvested           16,000      
Stock Appreciation Rights (SARs) [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Compensation cost not yet recognized related to nonvested awards         $ 703,000        
Weighted average remaining vesting period         9 months 18 days        
Equity Incentive Plan [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Percent voting power threshold         10.00%        
Exercise price if voting threshold is met, percent         110.00%        
Common Stock [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Common stock, shares authorized               275,000,000  
Shares of common stock         6,400,000 582,000      
ATM Sales Agreement [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Aggregate offering price                 $ 30,000,000
Net proceeds from from common stock         $ 1,100,000        
ATM Sales Agreement [Member] | Common Stock [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Shares of common stock         177,000        
Sales Agreement [Member] | Subsequent Event [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Percentage of aggregate gross proceeds from each sale of shares 3.00%                
Sales Agreement [Member] | Common Stock [Member] | Subsequent Event [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Aggregate offering price $ 15,000,000                
Exercise of Pre-Funded Warrants [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Gross proceeds from warrants exercised       $ 500          
Class A Common Stock [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Common stock, shares authorized         275,000,000 275,000,000      
Common stock, par value and per share (in Dollars per share)         $ 0.001 $ 0.001      
Number of shares award             2,055,000    
Class A Common Stock [Member] | Common Stock [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Number of stock issued         2,150,000        
Stock issued value         $ 2,000        
Common stock, acquired           391,000      
Preferred Stock Dividends, Shares           37,000      
Class A Common Stock [Member] | Sales Agreement [Member] | Subsequent Event [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Common stock, par value and per share (in Dollars per share) $ 0.001                
Board of Directors [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Shares issued         400,000 34,000      
Board of Directors [Member] | Restricted Stock Awards [Member]                  
Stockholders’ Equity (Deficit) (Details) [Line Items]                  
Stock based compensation (in Dollars)         $ 300,000 $ 400,000      
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Details) - Schedule of analysis of option activity - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices   $ 9.82
Options Outstanding (in Shares) 900 10,200
Weighted Average Remaining Life in Years 8 months 19 days 6 months 14 days
Weighted Average Exercise Price $ 290 $ 287
Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
Minimum [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices $ 5.8  
Maximum [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices $ 10.43  
$148 - $148 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Options Outstanding (in Shares) 300 300
Weighted Average Remaining Life in Years 1 year 3 months 2 years 3 months
Weighted Average Exercise Price $ 148 $ 148
Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
$148 - $148 [Member] | Minimum [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices $ 148 $ 148
$148 - $148 [Member] | Maximum [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices $ 148 $ 148
$280 - $488 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Options Outstanding (in Shares) 600 10,000
Weighted Average Remaining Life in Years 6 months 7 days 6 months
Weighted Average Exercise Price $ 345 $ 290
Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
$280 - $488 [Member] | Minimum [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices $ 280 $ 280
$280 - $488 [Member] | Maximum [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Range of Exercise Prices $ 488 $ 488
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Details) - Schedule of weighted average assumptions used to estimate fair value of SARs - $ / shares
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected dividend yield 0.00% 0.00%
Expected equity volatility 107.00% 112.00%
Expected term (years) 6 years 6 months 6 years 6 months
Risk-free interest rate   4.49%
Risk-free interest rate, minimum 4.51%  
Risk-free interest rate, maximum 3.82%  
Exercise price   $ 9.82
Market price per share   $ 9.82
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price $ 5.8  
Market price per share 5.8  
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price 10.43  
Market price per share $ 10.43  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]    
Options Outstanding (in Shares) 776 657
Weighted Average Remaining Life in Years 7 years 6 months 3 days 8 years 1 month 6 days
Weighted Average Exercise Price $ 13.58 $ 19.33
Aggregate Intrinsic Value (in Dollars) $ 0 $ 3
Exercise Price Range One [Member]    
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]    
Range of Prices, Minimum $ 5.8 $ 7.8
Range of Prices, Maximum $ 12.8 $ 14.8
Options Outstanding (in Shares) 632 430
Weighted Average Remaining Life in Years 7 years 11 months 1 day 8 years 4 months 13 days
Weighted Average Exercise Price $ 9.45 $ 11.15
Aggregate Intrinsic Value (in Dollars) $ 0 $ 3
Exercise Price Range Two [Member]    
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]    
Range of Prices, Minimum $ 23.2 $ 23.2
Range of Prices, Maximum $ 29.4 $ 29.4
Options Outstanding (in Shares) 98 105
Weighted Average Remaining Life in Years 5 years 1 month 13 days 6 years 3 months
Weighted Average Exercise Price $ 27.77 $ 27.62
Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
Exercise Price Range Three [Member]    
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]    
Range of Prices, Minimum $ 39.4 $ 34.2
Range of Prices, Maximum $ 46.4 $ 42
Options Outstanding (in Shares) 46 100
Weighted Average Remaining Life in Years 6 years 11 months 15 days 8 years 9 months 10 days
Weighted Average Exercise Price $ 40.15 $ 40.18
Aggregate Intrinsic Value (in Dollars) $ 0 $ 0
Exercise Price Range Four [Member]    
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]    
Range of Prices, Minimum   $ 44.6
Range of Prices, Maximum   $ 51.2
Options Outstanding (in Shares)   21
Weighted Average Remaining Life in Years   8 years 6 months 25 days
Weighted Average Exercise Price   $ 45.46
Aggregate Intrinsic Value (in Dollars)   $ 0
Options Exercisable [Member]    
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]    
Weighted Average Remaining Life in Years 8 years 6 months  
Weighted Average Exercise Price $ 17.64  
Aggregate Intrinsic Value (in Dollars) $ 0  
Options Exercisable (in Shares) 469  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.2
Stockholders' Equity (Details) - Schedule of SARs outstanding - Stock appreciation rights [Member]
shares in Thousands
12 Months Ended
Mar. 31, 2024
shares
Stockholders’ Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Outstanding March 31, 2023 657
Issued 207
Forfeited (88)
Outstanding March 31, 2024 776
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.2
Debt (Details) - Revolving Credit Facility [Member] - East West Bank [Member] - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Mar. 31, 2023
Line of Credit Facility [Line Items]      
Revolving line of credit   $ 7,500,000  
Outstanding amount of debt, gross   6,400,000 $ 5,000,000
Interest expense, including cash interest and amortization   $ 400,000 $ 200,000
Credit facility covenant compliance   For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.  
Subsequent Event [Member]      
Line of Credit Facility [Line Items]      
Credit facility expiration date Sep. 15, 2025    
Prime Rate [Member]      
Line of Credit Facility [Line Items]      
Interest rate percentage over the prime rarte   1.50%  
Interest rate, stated percentage   10.00%  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies (Details)
$ in Thousands
12 Months Ended
Mar. 31, 2024
USD ($)
Lease
Mar. 31, 2023
USD ($)
Commitments and Contingencies (Details) [Line Items]    
Sublease term 2025-01  
Sublease income | $ $ 200  
Average discount rate 3.34%  
Rental expense | $ $ 445 $ 441
Domestic Operating Lease    
Commitments and Contingencies (Details) [Line Items]    
Number of operating lease | Lease 1  
India Operations    
Commitments and Contingencies (Details) [Line Items]    
Number of operating lease | Lease 2  
Lease expiration 2027-07  
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Liabilities    
Total operating lease liabilities $ 863 $ 1,281
Operating lease right-of-use asset [Member]    
Assets    
Noncurrent 834 1,265
Operating leases liabilities [Member]    
Liabilities    
Current 401 418
Operating leases liabilities, net of current portion [Member]    
Liabilities    
Noncurrent $ 462 $ 863
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies (Details) - Schedule of operating lease commitments and subleasing arrangements
$ in Thousands
Mar. 31, 2024
USD ($)
Operating Lease Commitments  
2025 $ 423
2026 200
2027 210
2028 72
Total lease payments 905
Less imputed interest (42)
Total $ 863
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies (Details) - Schedule of estimate gross project commitments over the next five fiscal years
$ in Thousands
Mar. 31, 2024
USD ($)
Contractual Obligation, Fiscal Year Maturity [Abstract]  
2025 $ 2,094
2026 915
2027 965
2028 665
2029 $ 315
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Income Taxes (Details) [Line Items]          
Income tax expense from operations $ 0.0 $ 0.1      
Income tax expense related to foreign income taxes   0.1      
Net change in valuation allowance 5.9 2.5      
Net operating loss carryforwards 47.9 $ 47.9 $ 47.9 $ 47.9 $ 47.9
Domestic Tax Authority [Member]          
Income Taxes (Details) [Line Items]          
Net operating loss carryforwards 70.3        
Foreign Tax Authority [Member]          
Income Taxes (Details) [Line Items]          
Net operating loss carryforwards 22.5        
State and Local Jurisdiction [Member]          
Income Taxes (Details) [Line Items]          
Net operating loss carryforwards $ 70.3        
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details) - Schedule of components of income tax expense benefit - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
State:    
Current $ (11) $ 12
Total state (11) 12
Foreign:    
Current 35 107
Deferred (14)  
Total foreign 21 107
Income tax expense $ 10 $ 119
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details) - Schedule of net deferred tax - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Deferred tax assets:    
Net operating loss carryforwards $ 20,945 $ 18,318
Stock-based compensation 3,724 3,246
Intangibles 6,423 4,800
Accrued liabilities 535 908
Capital loss carryforward 3,924
Investments 1,977 4,344
Non-deductible interest expense 4,213 3,479
Other 240 750
Total deferred tax assets before valuation allowance 41,981 35,845
Less: Valuation allowance (41,668) (35,755)
Total deferred tax assets after valuation allowance 312 90
Deferred tax liabilities:    
Right of use asset (248)
Depreciation and amortization (50) (90)
Total deferred tax liabilities (298) (90)
Net deferred tax $ 14
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details) - Schedule of united states statutory federal tax rate and our effective tax rate
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of united states statutory federal tax rate and our effective tax rate [Abstract]    
Provision at the U.S. statutory federal tax rate 21.00% 21.00%
State income taxes, net of federal benefit 14.20% 8.00%
Change in valuation allowance (27.80%) (27.80%)
Non-deductible expenses (1.00%) (8.30%)
Executive officer compensation limitation - Section 162(m)   (2.00%)
Goodwill impairment (6.30%)  
Losses from non-consolidated entities   7.90%
Other   (0.10%)
Income tax expense (0.10%) (1.30%)
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.2
Subsequent Events (Details) - Subsequent Event [Member] - Terrifier 3 Financing [Member]
Apr. 05, 2024
USD ($)
Subsequent Event [Line Items]  
Principal amount not to exceed $ 3,666,000
Debt instrument other than interest in advance $ 576,000
Interest rate, stated percentage 1.44%
Line of credit, maturity date Apr. 01, 2025
Distribution Agreements [Member]  
Subsequent Event [Line Items]  
Percentage of royalties earned receive by entitled 15.00%
Received 1.75 times full commitment amount $ 3,666,000
Guaranty Agreement [Member]  
Subsequent Event [Line Items]  
Capped obligations amount $ 1,500,000
EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 61 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 203 420 1 false 76 0 false 6 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 100030 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 100040 - Statement - Consolidated Statements of Operations Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement Consolidated Statements of Operations Statements 4 false false R5.htm 100050 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 100060 - Statement - Consolidated Statements of Cash Flows Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100070 - Statement - Consolidated Statements of Shareholders Equity Sheet http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity Consolidated Statements of Shareholders Equity Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995455 - Disclosure - Nature of Operations and Liquidity Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidity Nature of Operations and Liquidity Notes 10 false false R11.htm 995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies1 Basis of Presentation and Summary of Significant Accounting Policies Notes 11 false false R12.htm 995475 - Disclosure - Other Interests Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterests Other Interests Notes 12 false false R13.htm 995485 - Disclosure - Stockholders' Equity Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquity2 Stockholders' Equity Notes 13 false false R14.htm 995495 - Disclosure - Debt Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureDebt1 Debt Notes 14 false false R15.htm 995505 - Disclosure - Commitments and Contingencies Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingencies Commitments and Contingencies Notes 15 false false R16.htm 995515 - Disclosure - Income Taxes Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxes Income Taxes Notes 16 false false R17.htm 995525 - Disclosure - Subsequent Events Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_SubsequentEvents Subsequent Events Notes 17 false false R18.htm 995535 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies1 18 false false R19.htm 995545 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies1 19 false false R20.htm 995565 - Disclosure - Stockholders' Equity (Tables) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquity2 20 false false R21.htm 995575 - Disclosure - Commitments and Contingencies (Tables) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingencies 21 false false R22.htm 995585 - Disclosure - Income Taxes (Tables) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables Income Taxes (Tables) Tables http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxes 22 false false R23.htm 995595 - Disclosure - Nature of Operations and Liquidity (Details) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails Nature of Operations and Liquidity (Details) Details http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidity 23 false false R24.htm 995605 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1 Basis of Presentation and Summary of Significant Accounting Policies (Details) Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 995615 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 995625 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1 Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 995635 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of intangible assets Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of intangible assets Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 27 false false R28.htm 995645 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 28 false false R29.htm 995655 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 29 false false R30.htm 995665 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of accounts payable and accrued expenses Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of accounts payable and accrued expenses Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 30 false false R31.htm 995675 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of revenue categories Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of revenue categories Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 995685 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share Details http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 32 false false R33.htm 995695 - Disclosure - Other Interests (Details) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails Other Interests (Details) Details http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterests 33 false false R34.htm 995725 - Disclosure - Stockholders' Equity (Details) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1 Stockholders' Equity (Details) Details http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables 34 false false R35.htm 995735 - Disclosure - Stockholders' Equity (Details) - Schedule of analysis of option activity Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity Stockholders' Equity (Details) - Schedule of analysis of option activity Details http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables 35 false false R36.htm 995745 - Disclosure - Stockholders' Equity (Details) - Schedule of weighted average assumptions used to estimate fair value of SARs Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars Stockholders' Equity (Details) - Schedule of weighted average assumptions used to estimate fair value of SARs Details http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables 36 false false R37.htm 995755 - Disclosure - Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding Details http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables 37 false false R38.htm 995765 - Disclosure - Stockholders' Equity (Details) - Schedule of SARs outstanding Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding Stockholders' Equity (Details) - Schedule of SARs outstanding Details http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables 38 false false R39.htm 995775 - Disclosure - Debt (Details) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails Debt (Details) Details http://cineverse.com/20240331/taxonomy/role/DisclosureDebt1 39 false false R40.htm 995785 - Disclosure - Commitments and Contingencies (Details) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables 40 false false R41.htm 995795 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities Details http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables 41 false false R42.htm 995805 - Disclosure - Commitments and Contingencies (Details) - Schedule of operating lease commitments and subleasing arrangements Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements Commitments and Contingencies (Details) - Schedule of operating lease commitments and subleasing arrangements Details http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables 42 false false R43.htm 995825 - Disclosure - Commitments and Contingencies (Details) - Schedule of estimate gross project commitments over the next five fiscal years Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears Commitments and Contingencies (Details) - Schedule of estimate gross project commitments over the next five fiscal years Details http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables 43 false false R44.htm 995835 - Disclosure - Income Taxes (Details) Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails Income Taxes (Details) Details http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables 44 false false R45.htm 995845 - Disclosure - Income Taxes (Details) - Schedule of components of income tax expense benefit Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable Income Taxes (Details) - Schedule of components of income tax expense benefit Details http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables 45 false false R46.htm 995855 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable Income Taxes (Details) - Schedule of net deferred tax Details http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables 46 false false R47.htm 995865 - Disclosure - Income Taxes (Details) - Schedule of united states statutory federal tax rate and our effective tax rate Sheet http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable Income Taxes (Details) - Schedule of united states statutory federal tax rate and our effective tax rate Details http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables 47 false false R48.htm 995875 - Disclosure - Subsequent Events (Details) Sheet http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://cineverse.com/20240331/taxonomy/role/cidm_r_SubsequentEvents 48 false false All Reports Book All Reports cnvs-20240331.htm cnvs-20240331.xsd http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 false false JSON 67 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cnvs-20240331.htm": { "nsprefix": "cnvs", "nsuri": "http://cineverse.com/20240331", "dts": { "inline": { "local": [ "cnvs-20240331.htm" ] }, "schema": { "local": [ "cnvs-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] } }, "keyStandard": 298, "keyCustom": 122, "axisStandard": 27, "axisCustom": 0, "memberStandard": 37, "memberCustom": 37, "hidden": { "total": 28, "http://fasb.org/us-gaap/2023": 20, "http://xbrl.sec.gov/dei/2023": 3, "http://cineverse.com/20240331": 1, "http://xbrl.sec.gov/ecd/2023": 4 }, "contextCount": 203, "entityCount": 1, "segmentCount": 76, "elementCount": 838, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 646, "http://xbrl.sec.gov/dei/2023": 38, "http://xbrl.sec.gov/ecd/2023": 4, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet", "longName": "100010 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R3": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals", "longName": "100030 - Statement - Consolidated Balance Sheets (Parentheticals)", "shortName": "Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R4": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement", "longName": "100040 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "cnvs:DirectOperatingExpenses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "unique": true } }, "R5": { "role": "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss", "longName": "100050 - Statement - Consolidated Statements of Comprehensive Loss", "shortName": "Consolidated Statements of Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "cnvs:OtherComprehensiveLossForeignExchangeTranslation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "unique": true } }, "R6": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow", "longName": "100060 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "unique": true } }, "R7": { "role": "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "longName": "100070 - Statement - Consolidated Statements of Shareholders Equity", "shortName": "Consolidated Statements of Shareholders Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_a533205e-a228-4cee-9739-03c54caf81b4", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_a533205e-a228-4cee-9739-03c54caf81b4", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": null, "uniqueAnchor": null }, "R10": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidity", "longName": "995455 - Disclosure - Nature of Operations and Liquidity", "shortName": "Nature of Operations and Liquidity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies1", "longName": "995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterests", "longName": "995475 - Disclosure - Other Interests", "shortName": "Other Interests", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquity2", "longName": "995485 - Disclosure - Stockholders' Equity", "shortName": "Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureDebt1", "longName": "995495 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingencies", "longName": "995505 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxes", "longName": "995515 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_SubsequentEvents", "longName": "995525 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995535 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "18", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "longName": "995545 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables", "longName": "995565 - Disclosure - Stockholders' Equity (Tables)", "shortName": "Stockholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables", "longName": "995575 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "cnvs:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "cnvs:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables", "longName": "995585 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails", "longName": "995595 - Disclosure - Nature of Operations and Liquidity (Details)", "shortName": "Nature of Operations and Liquidity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "cnvs:AccumulatedDeficit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "cnvs:AccumulatedDeficit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "longName": "995605 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_b254517f-47b0-4b1a-b941-1c81a821c151", "name": "cnvs:GainLossOnRevenueRecognized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "cnvs:NonMonetaryTransactionsPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "unique": true } }, "R25": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment", "longName": "995615 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "C_72ed3eb9-51e3-4f3a-9496-fb51e6e85901", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_72ed3eb9-51e3-4f3a-9496-fb51e6e85901", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "longName": "995625 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "C_1c7f0246-5a32-4584-a125-b7610b962a00", "name": "us-gaap:IntermediateLifePlantsUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "cnvs:ScheduleOfAmortizationExpenseIsRecordedUsingStraightLineMethodOverTheEstimatedUsefulLivesOfAssetsTableTextBlock", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_1c7f0246-5a32-4584-a125-b7610b962a00", "name": "us-gaap:IntermediateLifePlantsUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "cnvs:ScheduleOfAmortizationExpenseIsRecordedUsingStraightLineMethodOverTheEstimatedUsefulLivesOfAssetsTableTextBlock", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets", "longName": "995635 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of intangible assets", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of intangible assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "C_132be85e-5e81-4683-a015-5092f29599b6", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_132be85e-5e81-4683-a015-5092f29599b6", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets", "longName": "995645 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "C_ce86f9f3-f667-4390-ac0e-50e3eb5867e6", "name": "cnvs:FiniteLivedIntangibleAssetExpectedAmortizationInProcessIntangibleAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ce86f9f3-f667-4390-ac0e-50e3eb5867e6", "name": "cnvs:FiniteLivedIntangibleAssetExpectedAmortizationInProcessIntangibleAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil", "longName": "995655 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "div", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses", "longName": "995665 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of accounts payable and accrued expenses", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of accounts payable and accrued expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "div", "cnvs:AccountsPayableAndAccruedExpensesPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "div", "cnvs:AccountsPayableAndAccruedExpensesPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories", "longName": "995675 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of revenue categories", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of revenue categories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "us-gaap:RevenueRecognitionPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "us-gaap:RevenueRecognitionPolicyTextBlock", "div", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare", "longName": "995685 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Income (Loss) Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": null }, "R33": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails", "longName": "995695 - Disclosure - Other Interests (Details)", "shortName": "Other Interests (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "C_d81fbff7-2d62-4f09-91c3-d5e5979bdfe7", "name": "cnvs:PurchasePriceShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d81fbff7-2d62-4f09-91c3-d5e5979bdfe7", "name": "cnvs:PurchasePriceShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "longName": "995725 - Disclosure - Stockholders' Equity (Details)", "shortName": "Stockholders' Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "C_fd1ab61c-e28e-4ec0-9ee5-6a95cd86cba4", "name": "us-gaap:StockholdersEquityReverseStockSplit", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_fd1ab61c-e28e-4ec0-9ee5-6a95cd86cba4", "name": "us-gaap:StockholdersEquityReverseStockSplit", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R35": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "longName": "995735 - Disclosure - Stockholders' Equity (Details) - Schedule of analysis of option activity", "shortName": "Stockholders' Equity (Details) - Schedule of analysis of option activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "C_5d290fe6-b863-47b9-93a6-a3fe107dcb62", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "unique": true } }, "R36": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars", "longName": "995745 - Disclosure - Stockholders' Equity (Details) - Schedule of weighted average assumptions used to estimate fair value of SARs", "shortName": "Stockholders' Equity (Details) - Schedule of weighted average assumptions used to estimate fair value of SARs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding", "longName": "995755 - Disclosure - Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding", "shortName": "Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "cnvs:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "cnvs:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R38": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding", "longName": "995765 - Disclosure - Stockholders' Equity (Details) - Schedule of SARs outstanding", "shortName": "Stockholders' Equity (Details) - Schedule of SARs outstanding", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "C_9ab25448-fea6-4b50-a543-cb4d9103097f", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_9ab25448-fea6-4b50-a543-cb4d9103097f", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "longName": "995775 - Disclosure - Debt (Details)", "shortName": "Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "C_fbbd4ddb-6db2-4eb5-82f1-964475428cff", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_fbbd4ddb-6db2-4eb5-82f1-964475428cff", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "unique": true } }, "R40": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails", "longName": "995785 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "cnvs:LesseeOperatingSubleaseTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "cnvs:LesseeOperatingSubleaseTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities", "longName": "995795 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities", "shortName": "Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "cnvs:OperatingLeaseLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "cnvs:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "cnvs:OperatingLeaseLiabilities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "cnvs:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R42": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements", "longName": "995805 - Disclosure - Commitments and Contingencies (Details) - Schedule of operating lease commitments and subleasing arrangements", "shortName": "Commitments and Contingencies (Details) - Schedule of operating lease commitments and subleasing arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "cnvs:ScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangementTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "cnvs:ScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangementTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R43": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears", "longName": "995825 - Disclosure - Commitments and Contingencies (Details) - Schedule of estimate gross project commitments over the next five fiscal years", "shortName": "Commitments and Contingencies (Details) - Schedule of estimate gross project commitments over the next five fiscal years", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:ContractualObligationDueInNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:ContractualObligationDueInNextTwelveMonths", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R44": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails", "longName": "995835 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable", "longName": "995845 - Disclosure - Income Taxes (Details) - Schedule of components of income tax expense benefit", "shortName": "Income Taxes (Details) - Schedule of components of income tax expense benefit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R46": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable", "longName": "995855 - Disclosure - Income Taxes (Details) - Schedule of net deferred tax", "shortName": "Income Taxes (Details) - Schedule of net deferred tax", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2b7e03c6-b3aa-47ef-8b05-0a19aef6af44", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R47": { "role": "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable", "longName": "995865 - Disclosure - Income Taxes (Details) - Schedule of united states statutory federal tax rate and our effective tax rate", "shortName": "Income Taxes (Details) - Schedule of united states statutory federal tax rate and our effective tax rate", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ca06e317-c8c4-41d6-bb97-bf32d4dc3e33", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } }, "R48": { "role": "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "longName": "995875 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "C_6abce725-58c1-41a3-9e92-2593f88f6aca", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_6abce725-58c1-41a3-9e92-2593f88f6aca", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "cnvs-20240331.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "cnvs_AccountsPayableAndAccruedExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AccountsPayableAndAccruedExpensesPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "AccountsPayableAndAccruedExpensesPolicyTextBlock", "documentation": "Accounts payable and accrued expenses [Policy Text Block]", "terseLabel": "Accounts Payable and Accrued Expenses" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Current, Total", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r27" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Total accounts payable and accrued expenses", "totalLabel": "Total accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r104" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "totalLabel": "Accounts Payable, Current, Total", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r24", "r762" ] }, "us-gaap_AccountsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Accounts Payable [Member]", "terseLabel": "Accounts Payable [Member]", "documentation": "Obligations incurred and payable to vendors for goods and services received." } } }, "auth_ref": [ "r20" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses of $269 and $0, respectively", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r296", "r297" ] }, "cnvs_AccountsReceivableServiceEquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AccountsReceivableServiceEquityInvestment", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "AccountsReceivableServiceEquityInvestment", "documentation": "Accounts receivable by the company for services provided to CDF2.", "terseLabel": "Accounts receivable" } } }, "auth_ref": [] }, "cnvs_AccretionExpenseAddedToDeferredConsiderationAndEarnoutConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AccretionExpenseAddedToDeferredConsiderationAndEarnoutConsideration", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense for deferred consideration and earnouts", "label": "Accretion Expense Added To Deferred Consideration And Earnout Consideration", "documentation": "Accretion expense added to deferred consideration and earnout consideration" } } }, "auth_ref": [] }, "cnvs_AccruedDividendsOnPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AccruedDividendsOnPreferredStock", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "documentation": "Accrued dividends on preferred stock.", "label": "Accrued Dividends on Preferred Stock", "terseLabel": "Accrued dividends on preferred stock" } } }, "auth_ref": [] }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedEmployeeBenefitsCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses" ], "lang": { "en-us": { "role": { "label": "Accrued Employee Benefits, Current", "terseLabel": "Accrued compensation and benefits", "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r29" ] }, "cnvs_AccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AccumulatedDeficit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit", "documentation": "Accumulated deficit.", "terseLabel": "Accumulated deficit" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r120", "r207", "r554", "r592", "r593" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive (Loss) Income", "verboseLabel": "Accumulated Other Comprehensive Loss", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r7", "r17", "r39", "r485", "r488", "r511", "r588", "r589", "r868", "r869", "r870", "r879", "r880", "r881" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r816" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "totalLabel": "Additional Paid in Capital, Total", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r115", "r762", "r961" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r443", "r444", "r445", "r604", "r879", "r880", "r881", "r939", "r963" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r822" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r822" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r822" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r822" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in estimated equity issuance fee, net", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration." } } }, "auth_ref": [ "r18", "r144" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "cnvs_AdvertiserRelationshipsAndChannelMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AdvertiserRelationshipsAndChannelMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Advertiser Relationships And Channel Member", "label": "Advertiser Relationships And Channel [Member]", "terseLabel": "Advertiser relationships and Channel [Member]" } } }, "auth_ref": [] }, "cnvs_AggregateGrossProceedsFromEquityFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AggregateGrossProceedsFromEquityFinancing", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate gross proceeds from equity financing", "label": "Aggregate Gross Proceeds from Equity Financing", "documentation": "Aggregate gross proceeds from equity financing." } } }, "auth_ref": [] }, "cnvs_AggregateOfferingPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AggregateOfferingPrice", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Aggregate offering price.", "label": "Aggregate Offering Price", "terseLabel": "Aggregate offering price" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r786", "r798", "r808", "r834" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r789", "r801", "r811", "r837" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r822" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r829" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r793", "r802", "r812", "r829", "r838", "r842", "r850" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r848" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock-based compensation", "verboseLabel": "Stock based compensation cost", "label": "Stock-based compensation", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r441", "r450" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses (in Dollars)", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r208", "r300", "r311" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Accounts receivable, allowance for credit loss, writeoff", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r313" ] }, "cnvs_AmendedTwoThousandSeventeenPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AmendedTwoThousandSeventeenPlanMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Amended 2017 Plan [Member]", "label": "Amended Two Thousand Seventeen Plan [Member]", "documentation": "Amended two thousand seventeen plan" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cnvs_AmortizationEstimatedLife": { "xbrltype": "durationItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AmortizationEstimatedLife", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Amortization estimated life.", "label": "Amortization Estimated Life", "terseLabel": "Amortization estimated life" } } }, "auth_ref": [] }, "cnvs_AmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AmortizationExpense", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "AmortizationExpense", "documentation": "Amortization expense.", "terseLabel": "Amortization expense (in Dollars)" } } }, "auth_ref": [] }, "us-gaap_AmortizationExpensePerEquivalentUnitOfProductionOrPerDollarOfGrossRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationExpensePerEquivalentUnitOfProductionOrPerDollarOfGrossRevenueLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Amortization Expense Per Equivalent Unit of Production or Per Dollar of Gross Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AmortizationExpensePerUnitOfProductionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationExpensePerUnitOfProductionTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Amortization Expense Per Unit of Production [Table]", "documentation": "A table which provides detailed information for each cost center disclosing the amount of amortization expense (per equivalent physical unit of production if amortization is computed on the basis of physical units or per dollar of gross revenue from production if amortization is computed on the basis of gross revenue)." } } }, "auth_ref": [ "r103" ] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs", "label": "Amortization of Debt Issuance Costs", "negatedLabel": "Amortization of debt issuance costs included in interest expense", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r124", "r374", "r504", "r873" ] }, "cnvs_AmountsDueToProducers": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AmountsDueToProducers", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses" ], "lang": { "en-us": { "role": { "documentation": "Amounts due to producers.", "label": "Amounts Due To Producers", "terseLabel": "Amounts due to producers" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive shares excluded from calculation of diluted net loss per share | shares", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r264" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r476" ] }, "us-gaap_AssetAcquisitionConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionConsiderationTransferred", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Asset Acquisition, Consideration Transferred, Total", "label": "Asset Acquisition, Consideration Transferred", "terseLabel": "Asset consideration", "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer." } } }, "auth_ref": [ "r758", "r936", "r937", "r938" ] }, "cnvs_AssetAcquisitionsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AssetAcquisitionsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "AssetAcquisitionsPolicyTextBlock", "documentation": "Disclosure of asset acquisitions policy.", "terseLabel": "Asset Acquisitions" } } }, "auth_ref": [] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment charges recorded for long-lived and finite-lived intangible assets", "label": "Asset Impairment Charges", "terseLabel": "Impairment of intangibles", "totalLabel": "Asset Impairment Charges, Total", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r13", "r60" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "terseLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r157", "r202", "r235", "r270", "r284", "r290", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r478", "r482", "r495", "r549", "r649", "r762", "r775", "r896", "r897", "r948" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil", "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "netLabel": "Assets", "verboseLabel": "Assets:", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r196", "r210", "r235", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r478", "r482", "r495", "r762", "r896", "r897", "r948" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current Assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "terseLabel": "Total fair value", "totalLabel": "Total Assets", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r96" ] }, "cnvs_AtmSalesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "AtmSalesAgreementMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "ATM sales agreement.", "label": "ATM Sales Agreement [Member]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r780", "r781", "r794" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "auth_ref": [ "r780", "r781", "r794" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "auth_ref": [ "r780", "r781", "r794" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r845" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r846" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r841" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r841" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r841" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r841" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r841" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r841" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r412", "r413", "r414", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r436", "r437", "r438", "r439", "r440" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r844" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r843" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r842" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r842" ] }, "cnvs_BarterRelatedNonCashExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "BarterRelatedNonCashExpenses", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Barter-related non-cash expenses", "label": "Barter Related Non Cash Expenses", "documentation": "Barter related non cash expenses" } } }, "auth_ref": [] }, "cnvs_BaseDistributionMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "BaseDistributionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "documentation": "Base distribution.", "label": "Base Distribution [Member]", "terseLabel": "Base Distribution [Member]" } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies1" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r132" ] }, "cnvs_BloodyDisgustingLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "BloodyDisgustingLLCMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Bloody Disgusting, LLC [Member]", "label": "Bloody Disgusting, L L C. [Member]", "documentation": "Bloody Disgusting, LLC." } } }, "auth_ref": [] }, "srt_BoardOfDirectorsChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "BoardOfDirectorsChairmanMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]", "terseLabel": "Board of Directors [Member]", "documentation": "Leader of board of directors." } } }, "auth_ref": [ "r884" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r472", "r752", "r753" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r80", "r81", "r472", "r752", "r753" ] }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Issued equity to reduce liability", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity." } } }, "auth_ref": [ "r153" ] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Payments due related to the acquisition", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r3", "r4", "r84", "r473" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Increase (decrease) in estimated earnout liability", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Increase in estimated earnout liability", "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement." } } }, "auth_ref": [ "r475", "r872" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "terseLabel": "Earnout consideration on purchase of a business", "label": "Business Combination, Contingent Consideration, Liability", "totalLabel": "Business Combination, Contingent Consideration, Liability, Total", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r5", "r85", "r474" ] }, "cnvs_CONtvMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CONtvMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "C O Ntv Member", "label": "CONtvMember", "terseLabel": "CON TV, LLC [Member]" } } }, "auth_ref": [] }, "cnvs_CapitalizedContentExpenditures": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CapitalizedContentExpenditures", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalized content expenditures", "label": "Capitalized Content Expenditures", "documentation": "Capitalized content expenditures." } } }, "auth_ref": [] }, "cnvs_CapitalizedContentMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CapitalizedContentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Capitalized Content [Member]", "documentation": "Capitalized content member" } } }, "auth_ref": [] }, "cnvs_CapitalizedContentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CapitalizedContentPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Content", "label": "Capitalized Content Policy Text Block", "documentation": "Capitalized Content." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "totalLabel": "Total", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r170", "r551", "r615", "r644", "r762", "r775", "r862" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r45", "r198", "r727" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "CASH, CASH EQUIVALENTS, AND RESTRICTED CASH", "verboseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r46" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total", "periodStartLabel": "Cash and cash equivalents at beginning of year", "periodEndLabel": "Cash and cash equivalents at end of year", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r45", "r129", "r231" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r6", "r129" ] }, "cnvs_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaseCostsAndSupplementalCashFlowInformationRelatedToLeases" ], "lang": { "en-us": { "role": { "label": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities", "documentation": "Cash paid for amounts included in the measurement of lease liabilities.", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "auth_ref": [] }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Net cash used by operating activities", "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r110", "r129" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r820" ] }, "cnvs_ChristianCinemaLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ChristianCinemaLlcMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Christian cinema LLC.", "label": "Christian Cinema LLC [Member]", "terseLabel": "Christian Cinema LLC [Member]" } } }, "auth_ref": [] }, "cnvs_CinedigmEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CinedigmEquityIncentivePlanMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Cinedigm Equity Incentive Plan Member", "label": "CinedigmEquityIncentivePlanMember", "terseLabel": "Cinedigm Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "cnvs_CinemaEquipmentBusinessOneMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CinemaEquipmentBusinessOneMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Cinema Equipment Business One Member", "label": "CinemaEquipmentBusinessOneMember", "terseLabel": "Cinema Equipment [Member]", "verboseLabel": "Cinema Equipment Segment [Member]" } } }, "auth_ref": [] }, "cnvs_CinemaEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CinemaEquipmentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Cinema Equipment Member", "label": "Cinema Equipment [Member]", "terseLabel": "Cinema Equipment [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r181", "r204", "r205", "r206", "r235", "r257", "r258", "r261", "r263", "r267", "r268", "r307", "r343", "r345", "r346", "r347", "r350", "r351", "r383", "r384", "r386", "r389", "r395", "r495", "r596", "r597", "r598", "r599", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r616", "r636", "r658", "r677", "r703", "r704", "r705", "r706", "r707", "r857", "r874", "r882" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants exercise price", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price per share", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r396" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to purchase common stock, shares", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r396" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r821" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r821" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (see Note 6)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r34", "r106", "r550", "r635" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r139", "r337", "r338", "r711", "r893" ] }, "cnvs_CommitmentsandContingenciesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CommitmentsandContingenciesDetailsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Commitmentsand Contingencies Details Line Items", "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "auth_ref": [] }, "cnvs_CommitmentsandContingenciesDetailsScheduleofleaserelatedassetsandliabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CommitmentsandContingenciesDetailsScheduleofleaserelatedassetsandliabilitiesLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "documentation": "Commitmentsand Contingencies Details Scheduleofleaserelatedassetsandliabilities Line Items", "label": "Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities [Line Items]" } } }, "auth_ref": [] }, "cnvs_CommitmentsandContingenciesDetailsScheduleofleaserelatedassetsandliabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CommitmentsandContingenciesDetailsScheduleofleaserelatedassetsandliabilitiesTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "documentation": "Commitmentsand Contingencies Details Scheduleofleaserelatedassetsandliabilities Table", "label": "Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities [Table]" } } }, "auth_ref": [] }, "cnvs_CommitmentsandContingenciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CommitmentsandContingenciesDetailsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Commitmentsand Contingencies Details Table", "label": "Commitments and Contingencies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Class A Common Stock [Member]", "netLabel": "Common Class A [Member]", "verboseLabel": "Class A", "terseLabel": "Class A Common Stock", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r963" ] }, "cnvs_CommonStockAvailableForFutureIssuanceUnderPurchaseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CommonStockAvailableForFutureIssuanceUnderPurchaseAgreement", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Common Stock Available for Future Issuance under Purchase Agreement", "label": "Common Stock Available for Future Issuance under Purchase Agreement", "terseLabel": "Common stock available for future issuance under purchase agreement" } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Common Stock Dividends, Shares", "terseLabel": "Common stock shares", "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r18" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "verboseLabel": "Common Stock [Member]", "terseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r765", "r766", "r767", "r769", "r770", "r771", "r772", "r879", "r880", "r939", "r959", "r963" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, par value and per share (in Dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r114" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r114", "r636" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock shares, issued (in Shares)", "terseLabel": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r114" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r18", "r114", "r636", "r655", "r963", "r964" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, $0.001 par value; Class A Stock: 275,000,000 shares authorized as of March 31, 2024, and March 31, 2023; 15,985,620 and 9,413,597 shares issued, with 15,699,135 and 9,347,805 shares outstanding as of March 31, 2024, and March 31, 2023, respectively.", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r114", "r553", "r762" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r826" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r825" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r827" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r824" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r212", "r214", "r222", "r545", "r565" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Net income attributable to noncontrolling interest", "totalLabel": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive loss attributable to noncontrolling interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r10", "r88", "r93", "r212", "r214", "r221", "r544", "r564" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software\t[Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "cnvs_ConcentrationRiskPercentage": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ConcentrationRiskPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "ConcentrationRiskPercentage", "documentation": "Concentration risk percentage.", "terseLabel": "Concentration risk percentage" } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r89", "r728" ] }, "cnvs_ContentAdvancesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ContentAdvancesCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "verboseLabel": "Content advances", "terseLabel": "Content advances current", "label": "Content Advances Current", "documentation": "Content advances current." } } }, "auth_ref": [] }, "cnvs_ContentAdvancesNoncurrentNetOfCurrentPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ContentAdvancesNoncurrentNetOfCurrentPortion", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Content advances, net of current portion", "label": "Content Advances Noncurrent Net of Current Portion", "documentation": "Content advances noncurrent net of current portion." } } }, "auth_ref": [] }, "cnvs_ContentAdvancesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ContentAdvancesPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Content Advances", "label": "Content Advances [Policy Text Block]", "documentation": "Content Advances." } } }, "auth_ref": [] }, "cnvs_ContentEntertainmentBusinessOneMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ContentEntertainmentBusinessOneMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Content Entertainment Business One Member", "label": "ContentEntertainmentBusinessOneMember", "terseLabel": "Content & Entertainment [Member]", "verboseLabel": "Content & Entertainment Segment [Member]" } } }, "auth_ref": [] }, "cnvs_ContentLibraryMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ContentLibraryMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Content Library Member", "label": "ContentLibraryMember", "terseLabel": "Content Library [Member]" } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInFifthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInFifthYear", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears" ], "lang": { "en-us": { "role": { "terseLabel": "2029", "label": "Contractual Obligation, to be Paid, Year Five", "documentation": "Amount of contractual obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInFourthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInFourthYear", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Contractual Obligation, to be Paid, Year Four", "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInNextTwelveMonths", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Contractual Obligation, to be Paid, Year One", "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInSecondYear", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Contractual Obligation, to be Paid, Year Two", "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationDueInThirdYear", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfEstimateGrossProjectCommitmentsOverTheNextFiveFiscalYears" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Contractual Obligation, to be Paid, Year Three", "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationFiscalYearMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligationFiscalYearMaturityAbstract", "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Schedule of estimate gross project commitments over the next five fiscal years", "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation." } } }, "auth_ref": [ "r878" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Costs and expenses", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "cnvs_CreditFacility": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CreditFacility", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "CreditFacility", "documentation": "This value payment of credit facility.", "terseLabel": "Credit Facility" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "cnvs_CurrentEarnoutConsiderationOnPurchaseOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CurrentEarnoutConsiderationOnPurchaseOfBusiness", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Earnout consideration on purchase of business", "label": "Current Earnout Consideration On Purchase of Business", "documentation": "The amount of current earnout consideration on purchase of a business." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Current", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r860", "r877", "r934" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Income tax expense related to foreign income taxes", "verboseLabel": "Current", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r860", "r877" ] }, "cnvs_CurrentPortionMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CurrentPortionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "CurrentPortionMember", "terseLabel": "Current Portion [Member]", "documentation": "Current portion." } } }, "auth_ref": [] }, "cnvs_CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness", "documentation": "Current portion of deferred consideration on purchase of a business.", "terseLabel": "Current portion of deferred consideration on purchase of business" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "Current", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r860", "r877", "r934" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r83" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Notes Payable [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebt1" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "DEBT", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r140", "r232", "r352", "r358", "r359", "r360", "r361", "r362", "r363", "r368", "r375", "r376", "r378" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Interest rate percentage over the prime rarte", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "verboseLabel": "Outstanding amount of debt, gross", "label": "Long-Term Debt, Gross", "terseLabel": "Prospect Loan, gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r21", "r159", "r379" ] }, "us-gaap_DebtInstrumentCovenantCompliance": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCovenantCompliance", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility covenant compliance", "label": "Debt Instrument, Covenant Compliance", "documentation": "States whether the entity was in compliance with the debt covenants throughout the reporting period, and describes facts and circumstances of any compliance failure." } } }, "auth_ref": [ "r21", "r108" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Prospect Loan, at issuance", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r100", "r102", "r353", "r505", "r737", "r738" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt interest rate", "verboseLabel": "Interest rate, stated percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r31", "r354" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r240", "r353", "r354", "r355", "r356", "r357", "r359", "r364", "r365", "r366", "r367", "r369", "r370", "r371", "r372", "r373", "r374", "r377", "r505", "r736", "r737", "r738", "r739", "r740", "r875" ] }, "cnvs_DebtInstrumentPaymentsToDate": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DebtInstrumentPaymentsToDate", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "DebtInstrumentPaymentsToDate", "documentation": "Debt instrument payments to date.", "terseLabel": "Payments to date" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r32", "r65", "r67", "r99", "r100", "r102", "r107", "r142", "r143", "r240", "r353", "r354", "r355", "r356", "r357", "r359", "r364", "r365", "r366", "r367", "r369", "r370", "r371", "r372", "r373", "r374", "r377", "r505", "r736", "r737", "r738", "r739", "r740", "r875" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "totalLabel": "Debt Instrument, Unamortized Discount, Total", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized debt discount (in Dollars)", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r99", "r102", "r899" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount, Current", "terseLabel": "Less: Unamortized debt issuance costs and debt discounts", "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer." } } }, "auth_ref": [ "r99", "r102" ] }, "cnvs_DeferredConsiderationOnPurchaseOfBusinessNetOfCurrentPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredConsiderationOnPurchaseOfBusinessNetOfCurrentPortion", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred consideration on purchase of business, net of current portion", "documentation": "Deferred consideration on purchase of business, net of current portion.", "label": "Deferred Consideration on Purchase of Business net of Current Portion" } } }, "auth_ref": [] }, "cnvs_DeferredConsiderationSettledInStock": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredConsiderationSettledInStock", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred consideration settled in stock", "label": "Deferred Consideration Settled in Stock", "documentation": "Deferred consideration settled in stock." } } }, "auth_ref": [] }, "cnvs_DeferredConsiderationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredConsiderationsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Consideration", "label": "Deferred Considerations [Policy Text Block]", "documentation": "Deferred Considerations [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Deferred", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r877", "r932", "r934" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Tax benefit release of valuation allowances", "verboseLabel": "Deferred", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r151", "r877", "r932" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross", "negatedLabel": "Total deferred tax liabilities", "totalLabel": "Deferred Tax Liabilities, Gross, Total", "negatedTotalLabel": "Total deferred tax liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r111", "r112", "r158", "r460" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Revenue, Current", "totalLabel": "Deferred Revenue, Current, Total", "verboseLabel": "Deferred revenue, current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r865" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r877", "r932", "r934" ] }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetInterestCarryforward", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Non-deductible interest expense", "label": "Deferred Tax Asset, Interest Carryforward", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward." } } }, "auth_ref": [ "r931" ] }, "cnvs_DeferredTaxAssetValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredTaxAssetValuationAllowance", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "DeferredTaxAssetValuationAllowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "negatedLabel": "Less: Valuation allowance" } } }, "auth_ref": [] }, "cnvs_DeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredTaxAssetsAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Abstract", "label": "DeferredTaxAssetsAbstract", "terseLabel": "Deferred tax assets:" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Capital loss carryforward", "label": "Deferred Tax Assets, Capital Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards." } } }, "auth_ref": [ "r79", "r931" ] }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "terseLabel": "Intangibles", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInvestments", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Investments", "terseLabel": "Investments", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments)." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "terseLabel": "Net deferred tax", "totalLabel": "Net deferred tax", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r930" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Total deferred tax assets before valuation allowance", "totalLabel": "Total deferred tax assets before valuation allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r930" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards", "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r79", "r931" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Other", "terseLabel": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r79", "r931" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "terseLabel": "Stock-based compensation", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r79", "r931" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued liabilities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities." } } }, "auth_ref": [ "r79", "r931" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Liabilities, Net, Total", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax liabilities", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r77", "r930" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "auth_ref": [] }, "cnvs_DeferredTaxLiabilitiesDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "DeferredTaxLiabilitiesDepreciationAndAmortization", "documentation": "Depreciation and amortization.", "terseLabel": "Depreciation and amortization", "negatedLabel": "Depreciation and amortization" } } }, "auth_ref": [] }, "cnvs_DeferredTaxLiabilitiesRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DeferredTaxLiabilitiesRightOfUseAsset", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Right of use asset", "terseLabel": "Right of use asset", "label": "Deferred Tax Liabilities Right Of Use Asset", "documentation": "Deferred tax liabilities right of use asset." } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r13", "r61" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "totalLabel": "Depreciation, Depletion and Amortization, Total", "terseLabel": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r13", "r275" ] }, "cnvs_DigitalCinemaProjectionSystemsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DigitalCinemaProjectionSystemsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "documentation": "Digital Cinema Projection Systems Member", "label": "DigitalCinemaProjectionSystemsMember", "terseLabel": "Digital cinema projection systems [Member]" } } }, "auth_ref": [] }, "cnvs_DigitalCinemaSystemSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DigitalCinemaSystemSalesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Digital cinema system sales.", "label": "Digital Cinema System Sales [Member]" } } }, "auth_ref": [] }, "cnvs_DigitalMediaRightsPaymentDueInMarchTwoThousandAndTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DigitalMediaRightsPaymentDueInMarchTwoThousandAndTwentyFiveMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Digital Media Rights, Payment due in March 2025 [Member]", "label": "Digital Media Rights Payment Due in March Two Thousand and Twenty Five Member", "documentation": "Digital Media Rights, payment due in march two thousand and twenty five." } } }, "auth_ref": [] }, "cnvs_DigitalMediaRightsPaymentDueInMarchTwoThousandAndTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DigitalMediaRightsPaymentDueInMarchTwoThousandAndTwentyFourMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Digital Media Rights, Payment due in March 2024 [Member]", "label": "Digital Media Rights Payment Due in March Two Thousand and Twenty Four Member", "documentation": "Digital Media Rights Payment Due in March Two Thousand and Twenty Four Member" } } }, "auth_ref": [] }, "cnvs_DirectOperatingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DirectOperatingCostsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "DirectOperatingCostsPolicyTextBlock", "documentation": "Direct Operating Costs Policy Text block.", "terseLabel": "Direct Operating Costs" } } }, "auth_ref": [] }, "cnvs_DirectOperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DirectOperatingExpenses", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "documentation": "Direct operating expenses.", "label": "Direct Operating Expenses", "terseLabel": "Direct operating" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r399", "r742", "r743", "r744", "r745", "r746", "r747", "r748" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r399", "r742", "r743", "r744", "r745", "r746", "r747", "r748" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of revenue disaggregation", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r901" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "cnvs_DiscountedPrecentageOfFixedVolumeWeightedAveragePriceOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DiscountedPrecentageOfFixedVolumeWeightedAveragePriceOfCommonStock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Discoounted precentage of fixed volume weighted average price of common stock.", "label": "Discounted Precentage of Fixed Volume Weighted Average Price of Common Stock", "terseLabel": "Discounted precentage of fixed volume weighted average price of common stock" } } }, "auth_ref": [] }, "cnvs_DistributionAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "DistributionAgreementsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Distribution Agreements [Member]", "documentation": "Distribution agreements." } } }, "auth_ref": [] }, "us-gaap_DividendsPreferredStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStockCash", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Preferred stock dividends", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r9", "r144" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "terseLabel": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r780", "r781", "r794" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r780", "r781", "r794", "r830" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information Line Items", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r815" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r778" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income (loss) per share attributable to common stockholders" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic net loss per share", "label": "Earnings Per Share, Basic", "totalLabel": "Earnings Per Share, Basic, Total", "terseLabel": "Net (loss) income per share attributable to common stockholders - basic: (in Dollars per share)", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r223", "r246", "r247", "r248", "r249", "r250", "r254", "r257", "r261", "r262", "r263", "r265", "r492", "r493", "r546", "r566", "r731" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Basic net loss per share:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted net loss per share", "label": "Earnings Per Share, Diluted", "totalLabel": "Earnings Per Share, Diluted, Total", "terseLabel": "Net (loss) income per share attributable to common stockholders - diluted: (in Dollars per share)", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r223", "r246", "r247", "r248", "r249", "r250", "r257", "r261", "r262", "r263", "r265", "r492", "r493", "r546", "r566", "r731" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares used in diluted computation:", "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted net income (loss) per share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r49", "r50" ] }, "cnvs_EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Earnout consideration on purchase of business", "label": "EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion", "documentation": "The amount of earnout consideration on purchase of a business, net of current portion." } } }, "auth_ref": [] }, "cnvs_EarnoutConsiderationOnPurchaseOfBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EarnoutConsiderationOnPurchaseOfBusinessPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Earnout Consideration on Purchase of Business", "label": "Earnout Consideration On Purchase Of Business [Policy Text Block]", "documentation": "Earnout consideration on purchase of business." } } }, "auth_ref": [] }, "cnvs_EarnoutLiabilitySettledInStock": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EarnoutLiabilitySettledInStock", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Earnout liability settled in stock", "label": "Earnout Liability Settled In Stock", "documentation": "Earnout liability settled in stock." } } }, "auth_ref": [] }, "cnvs_EastWestBankMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EastWestBankMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "documentation": "East West Bank.", "label": "East West Bank [Member]", "terseLabel": "East West Bank [Member]" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "totalLabel": "Income tax expense", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r455" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Provision at the U.S. statutory federal tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r237", "r455", "r468" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r929", "r935" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent", "terseLabel": "Losses from non-consolidated entities", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes." } } }, "auth_ref": [ "r929", "r935" ] }, "cnvs_EffectiveIncomeTaxRateReconciliationExecutiveOfficerCompensationLimitationPercent": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EffectiveIncomeTaxRateReconciliationExecutiveOfficerCompensationLimitationPercent", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation executive officer compensation limitation percent.", "label": "Effective Income Tax Rate Reconciliation Executive Officer Compensation Limitation Percent", "terseLabel": "Executive officer compensation limitation - Section 162(m)" } } }, "auth_ref": [] }, "cnvs_EffectiveIncomeTaxRateReconciliationGoodwillImpairment": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EffectiveIncomeTaxRateReconciliationGoodwillImpairment", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment", "label": "Effective Income Tax Rate Reconciliation, Goodwill Impairment", "documentation": "Effective income tax rate reconciliation, goodwill impairment." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "terseLabel": "Non-deductible expenses", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r929", "r935" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r929", "r935" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofunitedstatesstatutoryfederaltaxrateandoureffectivetaxrateTable" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes, net of federal benefit", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r929", "r935" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Employee Benefits and Share-Based Compensation", "terseLabel": "Stock based compensation (in Dollars)", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "cnvs_EmployeeRetentionCreditCashRefundClaim": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EmployeeRetentionCreditCashRefundClaim", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Employee Retention Credit Cash Refund Claim", "label": "Employee Retention Credit Cash Refund Claim", "terseLabel": "Employee retention credit cash refund claim" } } }, "auth_ref": [] }, "cnvs_EmployeeRetentionTaxCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EmployeeRetentionTaxCredit", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "documentation": "Employee retention tax credit.", "label": "Employee Retention Tax Credit", "terseLabel": "Employee retention tax credit" } } }, "auth_ref": [] }, "cnvs_EmployeeRetentionTaxCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EmployeeRetentionTaxCreditCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "documentation": "Employee retention tax credit current.", "label": "Employee Retention Tax Credit Current", "terseLabel": "Employee retention tax credit" } } }, "auth_ref": [] }, "cnvs_EmployeeRetentionTaxCreditPercentage": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EmployeeRetentionTaxCreditPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Employee Retention Tax Credit Percentage", "label": "Employee Retention Tax Credit Percentage", "terseLabel": "Employee retention tax credit percentage" } } }, "auth_ref": [] }, "cnvs_EmployeeRetentionTaxCreditPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EmployeeRetentionTaxCreditPolicyPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Employee Retention Tax Credit, Policy [Policy Text Block]", "label": "Employee Retention Tax Credit, Policy [Policy Text Block]", "verboseLabel": "Employee Retention Tax Credit" } } }, "auth_ref": [] }, "cnvs_EmployeeRetentionTaxCreditReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EmployeeRetentionTaxCreditReceivable", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Employee retention tax credit receivable.", "label": "Employee Retention Tax Credit Receivable", "terseLabel": "Employee retention tax credit receivable" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Compensation cost not yet recognized related to nonvested awards", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r442" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average remaining vesting period", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r442" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r777" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r777" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r777" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r855" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "terseLabel": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r777" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r777" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r777" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r777" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r856" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r18", "r192", "r216", "r217", "r218", "r241", "r242", "r243", "r245", "r251", "r253", "r266", "r309", "r310", "r397", "r443", "r444", "r445", "r464", "r465", "r484", "r485", "r486", "r487", "r488", "r489", "r491", "r496", "r497", "r498", "r499", "r500", "r501", "r511", "r588", "r589", "r590", "r604", "r677" ] }, "cnvs_EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EquityIncentivePlanMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Equity Incentive Plan.", "label": "Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "cnvs_EquityInvestmentsForPurchaseOfRoundtableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EquityInvestmentsForPurchaseOfRoundtableSecurities", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "EquityInvestmentsForPurchaseOfRoundtableSecurities", "documentation": "This amount for equity investments for purchase of roundtable securities.", "terseLabel": "Investments for purchase of roundtable securities" } } }, "auth_ref": [] }, "cnvs_EquityLinePurchaseAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EquityLinePurchaseAgreementDescription", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "EquityLinePurchaseAgreementDescription", "documentation": "Equity line purchase agreement, description.", "terseLabel": "Equity line purchase agreement, description" } } }, "auth_ref": [] }, "cnvs_EquityLinePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EquityLinePurchaseAgreementMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Equity line purchase agreement.", "label": "Equity Line Purchase Agreement [Member]" } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r303", "r304", "r306" ] }, "us-gaap_EquityMethodInvestmentAggregateCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentAggregateCost", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Initial investment amount", "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting." } } }, "auth_ref": [ "r23" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "verboseLabel": "Majority interest, percentage", "terseLabel": "Ownership percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r303" ] }, "us-gaap_EquityMethodInvestmentQuotedMarketValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentQuotedMarketValue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Quoted Market Value", "terseLabel": "Initial investment", "documentation": "This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available." } } }, "auth_ref": [ "r306" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investment in Metaverse, a related party, at fair value", "verboseLabel": "Fair value of shares held", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r280", "r302", "r863", "r886" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsDisclosureTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterests" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "OTHER INTERESTS", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group." } } }, "auth_ref": [ "r180", "r305", "r308", "r858" ] }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Fair value of equity method investment", "documentation": "Fair value portion of investments accounted under the equity method." } } }, "auth_ref": [ "r864", "r940", "r941", "r942" ] }, "us-gaap_EquityMethodInvestmentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsPolicy", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Investment in Metaverse", "label": "Equity Method Investments [Policy Text Block]", "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received." } } }, "auth_ref": [ "r11", "r98", "r304" ] }, "cnvs_EquityMethodInvestmentsSummarizedFinancialInformationEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "EquityMethodInvestmentsSummarizedFinancialInformationEquity", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "EquityMethodInvestmentsSummarizedFinancialInformationEquity", "documentation": "Amount of equity, including noncontrolling interest, reported by an equity method investment of the entity.", "terseLabel": "Total stockholders' deficit" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNiGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiGainLoss", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Equity Securities, FV-NI, Gain (Loss), Total", "label": "Equity Securities, FV-NI, Gain (Loss)", "negatedLabel": "Changes in fair value of equity investment in Metaverse", "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r568", "r885" ] }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value of shares held resulted unrealized losses", "terseLabel": "Fair value of shares held resulted unrealized losses", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "totalLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total", "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r567", "r885" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r823" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r786", "r798", "r808", "r834" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r783", "r795", "r805", "r831" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r829" ] }, "cnvs_ExerciseOfPreFundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ExerciseOfPreFundedWarrantsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Exercise of Pre-Funded Warrants [Member]", "documentation": "Exercise of pref-funded warrants." } } }, "auth_ref": [] }, "cnvs_ExercisePriceRangeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ExercisePriceRangeOneMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "terseLabel": "$148 - $148 [Member]", "documentation": "Exercise Price Range One Member", "label": "ExercisePriceRangeOneMember", "verboseLabel": "Exercise Price Range One [Member]" } } }, "auth_ref": [] }, "cnvs_ExercisePriceRangeThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ExercisePriceRangeThreeMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Three Member", "label": "ExercisePriceRangeThreeMember", "terseLabel": "$1.71 - $2.10 [Member]", "verboseLabel": "Exercise Price Range Three [Member]" } } }, "auth_ref": [] }, "cnvs_ExercisePriceRangeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ExercisePriceRangeTwoMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Two Member", "label": "ExercisePriceRangeTwoMember", "verboseLabel": "Exercise Price Range Two [Member]", "terseLabel": "$280 - $488 [Member]" } } }, "auth_ref": [] }, "cnvs_ExercisesPriceRangeFourMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ExercisesPriceRangeFourMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "documentation": "Exercises Price Range Four Member", "label": "ExercisesPriceRangeFourMember", "terseLabel": "$2.23 - $2.56 [Member]", "verboseLabel": "Exercise Price Range Four [Member]" } } }, "auth_ref": [] }, "us-gaap_ExtinguishmentOfDebtAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Extinguishment of Debt [Axis]", "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument." } } }, "auth_ref": [ "r63" ] }, "us-gaap_ExtinguishmentOfDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtTypeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Extinguishment of Debt, Type [Domain]", "documentation": "Type of debt extinguished." } } }, "auth_ref": [ "r63" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of fair value measurements of our financial assets and liabilities", "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r96", "r156" ] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r19" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r96", "r97" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r366", "r401", "r402", "r403", "r404", "r405", "r406", "r494", "r519", "r520", "r521", "r737", "r738", "r749", "r750", "r751" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r366", "r401", "r406", "r494", "r519", "r749", "r750", "r751" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r366", "r401", "r406", "r494", "r520", "r737", "r738", "r749", "r750", "r751" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r366", "r401", "r402", "r403", "r404", "r405", "r406", "r494", "r521", "r737", "r738", "r749", "r750", "r751" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r366", "r401", "r402", "r403", "r404", "r405", "r406", "r519", "r520", "r521", "r737", "r738", "r749", "r750", "r751" ] }, "cnvs_FairValueOfPurchasedContentLicenses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FairValueOfPurchasedContentLicenses", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Fair value of purchased content licenses.", "label": "Fair Value of Purchased Content Licenses", "terseLabel": "Fair value of purchased content licenses" } } }, "auth_ref": [] }, "cnvs_FederalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FederalAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "documentation": "Federal Abstract", "label": "FederalAbstract", "terseLabel": "Federal:" } } }, "auth_ref": [] }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Federal Income Tax Expense (Benefit), Continuing Operations", "totalLabel": "Total federal", "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r236", "r454" ] }, "cnvs_FiniteLivedIntangibleAssetExpectedAmortizationInProcessIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationInProcessIntangibleAssets", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "In-process intangible assets", "label": "Finite-Lived Intangible Asset, Expected Amortization In-process Intangible Assets", "documentation": "Finite-lived intangible asset, expected amortization in-process intangible assets" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization", "negatedLabel": "Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r200", "r329" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "terseLabel": "Schedule of amortization expense for intangible assets", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "cnvs_FiniteLivedIntangibleAssetsAmortizationExpenseThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseThereafter", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseThereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "terseLabel": "Thereafter" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "verboseLabel": "2029", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r135" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r326", "r328", "r329", "r331", "r529", "r530" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Cost Basis", "totalLabel": "Finite-Lived Intangible Assets, Gross, Total", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r134", "r530" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r56", "r59" ] }, "us-gaap_FiniteLivedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Member]", "terseLabel": "Intangible assets [Member]", "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance", "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance", "totalLabel": "Total", "terseLabel": "Net", "verboseLabel": "Total", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r134", "r529" ] }, "cnvs_ForeignAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ForeignAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "documentation": "Foreign.", "label": "Foreign [Abstract]", "terseLabel": "Foreign:" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "Foreign Income Tax Expense (Benefit), Continuing Operations", "totalLabel": "Total foreign", "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations." } } }, "auth_ref": [ "r236" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r790", "r802", "r812", "r838" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r790", "r802", "r812", "r838" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r790", "r802", "r812", "r838" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r790", "r802", "r812", "r838" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r790", "r802", "r812", "r838" ] }, "cnvs_FoundationTVIncMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FoundationTVIncMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Foundation TV [Member]", "terseLabel": "FoundationTV, Inc. [Member]", "label": "FoundationTVIncMember", "documentation": "Foundation T V Inc Member" } } }, "auth_ref": [] }, "cnvs_FoundationTvPaymentDueInDecemberTwoThousandAndTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FoundationTvPaymentDueInDecemberTwoThousandAndTwentyFourMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Foundation TV, Payment Due in December 2024 [Member]", "label": "Foundation Tv Payment Due In December Two Thousand and Twenty Four [Member]", "documentation": "Foundation tv payment due in December 2024." } } }, "auth_ref": [] }, "cnvs_FoundationTvPaymentDueInJuneTwoThousandAndTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FoundationTvPaymentDueInJuneTwoThousandAndTwentyFiveMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Foundation TV, Payment Due in June 2025 [Member]", "label": "Foundation TV Payment Due in June Two Thousand and Twenty Five [Member]", "documentation": "Foundation TV, payment due in june two thousand and twenty five." } } }, "auth_ref": [] }, "cnvs_FoundationTvPaymentDueInJuneTwoThousandAndTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "FoundationTvPaymentDueInJuneTwoThousandAndTwentyFourMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Foundation TV, Payment Due in June 2024 [Member]", "label": "Foundation Tv Payment Due In June Two Thousand and Twenty Four [Member]", "documentation": "Foundation tv payment due in June2024." } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "cnvs_GaiamAmericasIncAndGaiamIncGVEMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "GaiamAmericasIncAndGaiamIncGVEMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Gaiam Americas Inc And Gaiam Inc G V E Member", "label": "GaiamAmericasIncAndGaiamIncGVEMember", "verboseLabel": "Gaiam Americas, Inc. and Gaiam, Inc. GVE [Member]", "terseLabel": "Gaiam Americas, Inc. and Gaiam, Inc. (GVE) [Member]" } } }, "auth_ref": [] }, "cnvs_GainLossOnRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "GainLossOnRevenueRecognized", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "gain loss on revenue recognized.", "label": "Gain Loss on Revenue Recognized", "terseLabel": "Gain loss on revenue recognized" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill", "totalLabel": "Goodwill, Total", "periodStartLabel": "Goodwill, Beginning Balance", "periodEndLabel": "Goodwill, Ending Balance", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r199", "r314", "r543", "r735", "r762", "r888", "r890" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r15", "r54" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of goodwill", "terseLabel": "Goodwill impairment", "label": "Goodwill impairment loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r13", "r315", "r321", "r325", "r735" ] }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Purchase price adjustments to goodwill", "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r2", "r889" ] }, "cnvs_GuarantyAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "GuarantyAgreementMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Guaranty Agreement [Member]", "documentation": "Guaranty agreement." } } }, "auth_ref": [] }, "cnvs_HoldingsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "HoldingsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Holdings Member", "label": "HoldingsMember", "terseLabel": "CDF2 Holdings [Member]" } } }, "auth_ref": [] }, "country_IN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IN", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "INDIA", "terseLabel": "India Operations" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r780", "r781", "r794" ] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Impairment of Intangible Assets, Finite-Lived", "negatedLabel": "Impairment", "netLabel": "Impairment of intangible assets", "terseLabel": "Impairment of intangible assets", "verboseLabel": "Intangible impairment", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r873", "r891" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Long-lived and Finite-lived Intangible Assets", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r138" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r121", "r162", "r270", "r283", "r289", "r291", "r547", "r560", "r733" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r332", "r334", "r661" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r334", "r661" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r237", "r451", "r456", "r457", "r462", "r466", "r469", "r470", "r471", "r601" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "totalLabel": "Income tax expense", "negatedLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r169", "r178", "r252", "r253", "r278", "r454", "r467", "r569" ] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations", "terseLabel": "Income tax expense from operations", "documentation": "Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations." } } }, "auth_ref": [ "r757" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r215", "r452", "r453", "r457", "r458", "r461", "r463", "r595" ] }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Income tax expense related to foreign income taxes", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)." } } }, "auth_ref": [ "r929" ] }, "cnvs_IncomeTaxesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncomeTaxesDetailsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "documentation": "Income Taxes Details Line Items", "label": "Income Taxes (Details) [Line Items]" } } }, "auth_ref": [] }, "cnvs_IncomeTaxesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncomeTaxesDetailsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "documentation": "Income Taxes Details Table", "label": "Income Taxes (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid", "terseLabel": "Income taxes paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r44", "r47" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease in accrued royalty payments", "terseLabel": "Decrease in accrued royalty payments", "label": "Increase (Decrease) in Accounts Payable", "totalLabel": "Increase (Decrease) in Accounts Payable, Total", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r12" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r12" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r12" ] }, "cnvs_IncreaseDecreaseInContentAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncreaseDecreaseInContentAdvances", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Content advances", "label": "Increase Decrease In Content Advances", "documentation": "Increase decrease in content advances." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r723" ] }, "cnvs_IncreaseDecreaseInEstimatedEarnoutConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncreaseDecreaseInEstimatedEarnoutConsideration", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Estimated Earnout Consideration", "label": "Increase Decrease In Estimated Earnout Consideration", "terseLabel": "Change in estimated earnout consideration" } } }, "auth_ref": [] }, "cnvs_IncreaseDecreaseInFairValueOfEquityMethodInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncreaseDecreaseInFairValueOfEquityMethodInvestment", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in fair value of equity method investment.", "label": "Increase Decrease In Fair Value Of Equity Method Investment", "terseLabel": "Increase (decrease) in fair value of equity method investment" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current and long-term assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r12" ] }, "cnvs_IncreaseDecreaseInProvisionForAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncreaseDecreaseInProvisionForAdvances", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in provision for advances", "label": "Increase (Decrease) in Provision for Advances", "documentation": "Increase (decrease) in provision for advances." } } }, "auth_ref": [] }, "cnvs_IncreaseDecreaseInUnbilledRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IncreaseDecreaseInUnbilledRevenue", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInUnbilledRevenue", "negatedLabel": "Unbilled revenue", "documentation": "Unbilled Revenue means amounts due to Borrower for services rendered in the ordinary course of Borrower's business, but which have not been billed to its customers, and which meet all Borrower's representations." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r327", "r330" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r57", "r136" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r793", "r802", "r812", "r829", "r838", "r842", "r850" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r848" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r782", "r854" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r782", "r854" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r782", "r854" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "INTANGIBLE ASSETS", "verboseLabel": "Intangible Assets, Net", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r59", "r525", "r526", "r527", "r529", "r729" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r55", "r58" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "negatedLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r101", "r164", "r219", "r274", "r503", "r662", "r773", "r962" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, including cash interest and amortization", "label": "Interest Expense, Debt", "totalLabel": "Interest Expense, Debt, Total", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r126", "r372", "r381", "r739", "r740" ] }, "cnvs_InterestInAdvanceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "InterestInAdvanceAmount", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument other than interest in advance", "label": "Interest in Advance Amount", "documentation": "Interest in advance amount." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r226", "r229", "r230" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Incurred interest", "label": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r105", "r956" ] }, "us-gaap_IntermediateLifePlantsUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntermediateLifePlantsUsefulLife", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Intermediate-life Plants, Useful Life", "terseLabel": "Estimated useful lives", "documentation": "Useful life of intermediate-life plants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r523" ] }, "cnvs_InternalUseSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "InternalUseSoftwareMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "documentation": "Internal Use Software Member", "label": "InternalUseSoftwareMember", "terseLabel": "Internal use software [Member]" } } }, "auth_ref": [] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Fair Value", "terseLabel": "Equity investment in Metaverse, at fair value", "periodStartLabel": "Investment Owned, at Fair Value, Beginning Balance", "periodEndLabel": "Investment Owned, at Fair Value, Ending Balance", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r594", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r627", "r628", "r639", "r640", "r683", "r685", "r686", "r687", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r700", "r701", "r702", "r767", "r775", "r960" ] }, "cnvs_IssuanceOfClassACommonStockForIntangibleAssetPurchase": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfClassACommonStockForIntangibleAssetPurchase", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "documentation": "Issuance of class A common stock for intangible asset purchase.", "label": "Issuance Of Class A Common Stock For Intangible Asset Purchase", "terseLabel": "Issuance of Class A common stock for intangible asset purchase" } } }, "auth_ref": [] }, "cnvs_IssuanceOfClassACommonStockForPaymentOfAccruedEmployeeBonuses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfClassACommonStockForPaymentOfAccruedEmployeeBonuses", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock for payment of accrued employee bonuses", "label": "Issuance of Class A common stock for payment of accrued employee bonuses", "documentation": "Issuance of Class A common stock for payment of accrued employee bonuses." } } }, "auth_ref": [] }, "cnvs_IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock for payment of accrued preferred stock dividend", "label": "IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends", "documentation": "Issuance of Class A common stock for payment of preferred stock dividends." } } }, "auth_ref": [] }, "cnvs_IssuanceOfCommonStockInConnectionWithABusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfCommonStockInConnectionWithABusinessCombination", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Issuance Of Common Stock In Connection With A Business Combination", "label": "IssuanceOfCommonStockInConnectionWithABusinessCombination", "terseLabel": "Issuance of common stock in connection with business combinations" } } }, "auth_ref": [] }, "cnvs_IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Issuance Of Common Stock In Connection With A Business Combinationin Shares", "label": "IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares", "terseLabel": "Issuance of common stock in connection with business combinations (in Shares)" } } }, "auth_ref": [] }, "cnvs_IssuanceOfCommonStockInConnectionWithATMRaisesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfCommonStockInConnectionWithATMRaisesNet", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock in connection with ATM raises, net", "label": "IssuanceOfCommonStockInConnectionWithATMRaisesNet", "documentation": "This value for issuance of common stock in connection with ATM raises, net." } } }, "auth_ref": [] }, "cnvs_IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock in connection with ATM raises, net (in Shares)", "label": "IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares", "documentation": "This share of issuance of common stock in connection with ATM raises, net." } } }, "auth_ref": [] }, "cnvs_IssuanceOfSharesForAssetAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "IssuanceOfSharesForAssetAcquisition", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Issuance Of Shares For Asset Acquisition", "documentation": "Issuance of shares for asset acquisition.", "terseLabel": "Issuance of common stock value (in Dollars)", "verboseLabel": "Issuance of common stock value" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of lease costs and supplemental cash flow information related to leases", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r945" ] }, "cnvs_LeaseLiabilityRelatedPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "LeaseLiabilityRelatedPayments", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "documentation": "Lease liability related payments.", "label": "Lease Liability Related Payments", "terseLabel": "Lease liability related payments" } } }, "auth_ref": [] }, "cnvs_LesseeOperatingLeaseExpirationYearAndMonth": { "xbrltype": "gYearMonthItemType", "nsuri": "http://cineverse.com/20240331", "localname": "LesseeOperatingLeaseExpirationYearAndMonth", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease expiration year and month.", "label": "Lessee Operating Lease Expiration Year and Month", "verboseLabel": "Lease expiration" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r510" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "negatedLabel": "Less imputed interest", "terseLabel": "Less imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r510" ] }, "cnvs_LesseeOperatingSubleaseTerm": { "xbrltype": "gYearMonthItemType", "nsuri": "http://cineverse.com/20240331", "localname": "LesseeOperatingSubleaseTerm", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Lessee operating sublease term.", "label": "Lessee Operating Sublease Term", "terseLabel": "Sublease term" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r28", "r235", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r479", "r482", "r483", "r495", "r634", "r732", "r775", "r896", "r948", "r949" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil", "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Liabilities", "terseLabel": "Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r119", "r161", "r557", "r762", "r876", "r887", "r943" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r30", "r197", "r235", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r479", "r482", "r483", "r495", "r762", "r896", "r948", "r949" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current Liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure", "terseLabel": "Total fair value", "totalLabel": "Total Liabilities", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r96" ] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r25", "r875" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCommitmentFeeAmount", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received 1.75 times full commitment amount", "label": "Line of Credit Facility, Commitment Fee Amount", "documentation": "Amount of the fee for available but unused credit capacity under the credit facility." } } }, "auth_ref": [ "r25" ] }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityExpirationDate1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Credit facility expiration date", "verboseLabel": "Line of credit, maturity date", "documentation": "Date the credit facility terminates, in YYYY-MM-DD format." } } }, "auth_ref": [ "r25" ] }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateDescription", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Interest Rate Description", "terseLabel": "Line of credit facility interest rate description", "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate." } } }, "auth_ref": [ "r25" ] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r25", "r875" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r875" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal amount not to exceed", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Revolving line of credit", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r25" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r25", "r875" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Total long term portion", "totalLabel": "Long-Term Debt, Total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r21", "r159", "r365", "r380", "r737", "r738", "r957" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Prospect Loan, net", "totalLabel": "Long-Term Debt and Lease Obligation, Including Current Maturities, Total", "documentation": "Amount of long-term debt and lease obligation, including portion classified as current." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Current Maturities", "negatedLabel": "Less current portion", "totalLabel": "Long-Term Debt, Current Maturities, Total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r203" ] }, "cnvs_LongTermPortionMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "LongTermPortionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "LongTermPortionMember", "terseLabel": "Long Term Portion [Member]", "documentation": "Long term portion." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r32" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r32", "r62" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "us-gaap_MajorPropertyClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Major Property Class [Axis]", "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class." } } }, "auth_ref": [ "r168" ] }, "cnvs_MajorPropertyClass_Domain": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "MajorPropertyClass_Domain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "documentation": "Major Property Class_ Domain", "label": "MajorPropertyClass_ [Domain]" } } }, "auth_ref": [] }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MarketableSecuritiesUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss from equity investment in Metaverse, a related party", "label": "Marketable Security, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) on investment in marketable security." } } }, "auth_ref": [ "r123" ] }, "cnvs_MaturityDate": { "xbrltype": "durationItemType", "nsuri": "http://cineverse.com/20240331", "localname": "MaturityDate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "MaturityDate", "documentation": "Maturity date.", "terseLabel": "Maturity date" } } }, "auth_ref": [] }, "cnvs_MaximumCappedObligationLoanAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "MaximumCappedObligationLoanAmount", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capped obligations amount", "label": "Maximum Capped Obligation Loan Amount", "documentation": "Maximum capped obligation loan amount." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r339", "r340", "r341", "r342", "r408", "r524", "r587", "r625", "r626", "r684", "r688", "r690", "r691", "r699", "r721", "r722", "r734", "r741", "r754", "r764", "r898", "r950", "r951", "r952", "r953", "r954", "r955" ] }, "cnvs_MaximumRoundtableInvestmentPercentage": { "xbrltype": "pureItemType", "nsuri": "http://cineverse.com/20240331", "localname": "MaximumRoundtableInvestmentPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Maximum roundtable investment percentage.", "label": "Maximum Roundtable Investment Percentage", "terseLabel": "Maximum roundtable investment percentage" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r821" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r821" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r339", "r340", "r341", "r342", "r408", "r524", "r587", "r625", "r626", "r684", "r688", "r690", "r691", "r699", "r721", "r722", "r734", "r741", "r754", "r764", "r898", "r950", "r951", "r952", "r953", "r954", "r955" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Deficit attributable to noncontrolling interest", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r37", "r160", "r235", "r307", "r343", "r345", "r346", "r347", "r350", "r351", "r495", "r556", "r638" ] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner", "terseLabel": "Percentage of minority interest", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "cnvs_MinorityOwnersMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "MinorityOwnersMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Minority Owners.", "label": "Minority Owners [Member]", "terseLabel": "Minority Owners [Member]" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r841" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r849" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r822" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidity" ], "lang": { "en-us": { "role": { "label": "Nature of Operations [Text Block]", "terseLabel": "NATURE OF OPERATIONS AND LIQUIDITY", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r171", "r179" ] }, "cnvs_NatureofOperationsandLiquidityDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NatureofOperationsandLiquidityDetailsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "documentation": "Nature of Operations and Liquidity Details [Line Items]", "label": "Nature of Operations and Liquidity Details [Line Items]" } } }, "auth_ref": [] }, "cnvs_NatureofOperationsandLiquidityDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NatureofOperationsandLiquidityDetailsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "documentation": "Natureof Operationsand Liquidity Details Table", "label": "Nature of Operations and Liquidity (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r228" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r228" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r129", "r130", "r131" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "verboseLabel": "Net loss (income)", "totalLabel": "Net Income (Loss) Attributable to Parent, Total", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r122", "r131", "r163", "r195", "r211", "r213", "r218", "r235", "r244", "r246", "r247", "r248", "r249", "r252", "r253", "r259", "r270", "r283", "r289", "r291", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r493", "r495", "r563", "r657", "r675", "r676", "r733", "r773", "r896" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Net income attributable to noncontrolling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r92", "r154", "r211", "r213", "r252", "r253", "r562", "r870" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss attributable to common stockholders", "totalLabel": "Net loss attributable to common stockholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income (loss) attributable to common shareholders", "negatedLabel": "Net loss attributable to common shareholders", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r225", "r246", "r247", "r248", "r249", "r254", "r255", "r260", "r263", "r270", "r283", "r289", "r291", "r733" ] }, "cnvs_NetIncomeLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NetIncomeLosses", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Losses" } } }, "auth_ref": [] }, "cnvs_NetIncomelossAttributableToControllingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NetIncomelossAttributableToControllingInterests", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to controlling interests", "documentation": "Amount after tax of income (loss) attributable to nonredeemable noncontrolling preferred unit holders.", "label": "Net Income Loss Attributable To Controlling Interests" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r821" ] }, "cnvs_NonMonetaryTransactionsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NonMonetaryTransactionsPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Non Monetary Transactions Policy Text Block", "label": "NonMonetaryTransactionsPolicyTextBlock", "terseLabel": "NON-MONETARY TRANSACTIONS", "verboseLabel": "Non-monetary Transactions" } } }, "auth_ref": [] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r790", "r802", "r812", "r829", "r838" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r819" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r818" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r829" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r849" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r849" ] }, "cnvs_NoncashInvestingAndFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NoncashInvestingAndFinancingActivitiesAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "documentation": "Noncash Investing And Financing Activities Abstract", "label": "Noncash Investing And Financing Activities [Abstract]", "terseLabel": "Noncash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interest", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r86", "r397", "r879", "r880", "r881", "r963" ] }, "cnvs_NonrecourseNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NonrecourseNotesPayable", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "NonrecourseNotesPayable", "documentation": "This value of total non-recourse notes payable.", "terseLabel": "Total non-recourse notes payable" } } }, "auth_ref": [] }, "cnvs_NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "documentation": "This value of total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts.", "terseLabel": "Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts" } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit, including unamortized debt issuance costs of $81 and $76, respectively", "totalLabel": "Notes Payable, Current, Total", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r27" ] }, "cnvs_NotesPayableNetOfUnamortizedDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NotesPayableNetOfUnamortizedDebtIssuanceCosts", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "NotesPayableNetOfUnamortizedDebtIssuanceCosts", "documentation": "This value of total notes payable, net of unamortized debt issuance costs.", "terseLabel": "Total notes payable, net of unamortized debt issuance costs" } } }, "auth_ref": [] }, "cnvs_NumberOfCustomers": { "xbrltype": "integerItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NumberOfCustomers", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "NumberOfCustomers", "documentation": "Number of customers.", "terseLabel": "Number of customers" } } }, "auth_ref": [] }, "cnvs_NumberOfOperatingLease": { "xbrltype": "integerItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NumberOfOperatingLease", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of operating lease.", "label": "Number of operating lease" } } }, "auth_ref": [] }, "cnvs_NumberofEmployeesJoiningCompanyFollowingAcquisition": { "xbrltype": "integerItemType", "nsuri": "http://cineverse.com/20240331", "localname": "NumberofEmployeesJoiningCompanyFollowingAcquisition", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "NumberofEmployeesJoiningCompanyFollowingAcquisition", "documentation": "Number of employees joining company following acquisition.", "terseLabel": "Number of employees joining company following acquisition" } } }, "auth_ref": [] }, "cnvs_OTTStreamingandDigitalMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OTTStreamingandDigitalMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "verboseLabel": "Streaming and Digital [Member]", "terseLabel": "OTT Streaming and Digital [Member]", "label": "OTT Streaming and Digital [Member]", "documentation": "O T T Streaming and Digital Member" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Operating Expenses", "totalLabel": "Total operating expenses", "terseLabel": "Total operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "terseLabel": "Income (loss) from operations", "totalLabel": "Operating loss", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r270", "r283", "r289", "r291", "r733" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Expense", "terseLabel": "Rental expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r944" ] }, "cnvs_OperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeaseLiabilities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "OperatingLeaseLiabilities", "terseLabel": "Total operating lease liabilities", "documentation": "Operating lease liabilities." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]", "terseLabel": "Operating Lease Commitments" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Operating Lease, Liability", "terseLabel": "Operating Lease Liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r506" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "verboseLabel": "Current portion of operating lease liabilities", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r506" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, net of current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r506" ] }, "cnvs_OperatingLeaseRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeaseRightOfUseAssets", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "OperatingLeaseRightOfUseAssets", "terseLabel": "Noncurrent", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r509", "r761" ] }, "cnvs_OperatingLeasesCurrentPortionMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeasesCurrentPortionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases liabilities [Member]", "documentation": "Operating Leases Current Portion Member", "label": "OperatingLeasesCurrentPortionMember" } } }, "auth_ref": [] }, "cnvs_OperatingLeasesLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeasesLiabilitiesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases liabilities [Member]", "label": "Operating Leases Liabilities [Member]", "documentation": "Operating leases liabilities." } } }, "auth_ref": [] }, "cnvs_OperatingLeasesLiabilitiesNetOfCurrentPortionMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeasesLiabilitiesNetOfCurrentPortionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases liabilities, net of current portion [Member]", "label": "Operating Leases Liabilities, Net of Current Portion [Member]", "documentation": "Operating leases liabilities, net of current portion." } } }, "auth_ref": [] }, "cnvs_OperatingLeasesLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeasesLiabilityCurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "OperatingLeasesLiabilityCurrent", "terseLabel": "Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [] }, "cnvs_OperatingLeasesLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeasesLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "OperatingLeasesLiabilityNoncurrent", "terseLabel": "Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [] }, "cnvs_OperatingLeasesLongtermPortionMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OperatingLeasesLongtermPortionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases liabilities, net of current portion [Member]", "documentation": "Operating Leases Longterm Portion Member", "label": "OperatingLeasesLongtermPortionMember" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r78" ] }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OptionIndexedToIssuersEquityTypeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Option Indexed to Issuer's Equity, Type [Axis]", "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock." } } }, "auth_ref": [ "r64", "r94", "r95", "r155" ] }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OptionIndexedToIssuersEquityTypeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Option Indexed to Issuer's Equity, Type [Domain]", "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding." } } }, "auth_ref": [] }, "cnvs_OptionsExercisableMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OptionsExercisableMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "documentation": "Options Exercisable Member", "label": "OptionsExercisableMember", "terseLabel": "Options Exercisable [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAccountsPayableAndAccruedExpenses" ], "lang": { "en-us": { "role": { "label": "Other Accrued Liabilities", "terseLabel": "Accrued other expenses", "documentation": "Amount of expenses incurred but not yet paid classified as other." } } }, "auth_ref": [ "r105" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r209", "r762" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r201" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss:", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "cnvs_OtherComprehensiveLossForeignExchangeTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OtherComprehensiveLossForeignExchangeTranslation", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign exchange translation", "terseLabel": "Other comprehensive (loss) income: foreign exchange translation", "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Loss Foreign Exchange Translation" } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Other Intangible Assets [Member]", "terseLabel": "Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "cnvs_OtherInterestsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OtherInterestsDetailsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Interests Details [Line Items]", "label": "Other Interests Details [Line Items]" } } }, "auth_ref": [] }, "cnvs_OtherInterestsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OtherInterestsDetailsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Other Interests Details Table", "label": "Other Interests (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r33" ] }, "cnvs_OtherNonRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "OtherNonRecurringMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "label": "Other Non-Recurring [Member]", "documentation": "Other non-recurring" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r131" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other expenses, net", "totalLabel": "Other Nonoperating Income (Expense), Total", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r127" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r821" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r788", "r800", "r810", "r836" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r791", "r803", "r813", "r839" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r791", "r803", "r813", "r839" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Parent [Member]", "terseLabel": "Total Stockholders\u2019 Deficit", "verboseLabel": "Total Stockholders' Equity (Deficit)", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "cnvs_PartiallyOffsetOfAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PartiallyOffsetOfAccruedInterest", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Partially offset of accrued interest.", "label": "Partially Offset Of Accrued Interest", "terseLabel": "Partially offset of accrued interest" } } }, "auth_ref": [] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Patents [Member]", "terseLabel": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r152" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r817" ] }, "cnvs_PaycheckProtectionProgramLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PaycheckProtectionProgramLoan", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "PaycheckProtectionProgramLoan", "documentation": "This value of Paycheck Protection Program loan.", "terseLabel": "PPP Loan" } } }, "auth_ref": [] }, "cnvs_PaymentOfBusinessAcquisitionRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PaymentOfBusinessAcquisitionRelatedLiabilities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of business acquisition related liabilities", "label": "Payment of Business Acquisition Related Liabilities", "documentation": "Payment of business acquisition related liabilities." } } }, "auth_ref": [] }, "cnvs_PaymentOfEarnoutConsiderationInCash": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PaymentOfEarnoutConsiderationInCash", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Payment of earnout consideration in cash", "label": "Payment of Earnout Consideration in Cash", "documentation": "Payment of earnout consideration in cash." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfFinancingCosts", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Financing fees for line of credit", "label": "Payments of Financing Costs", "totalLabel": "Payments of Financing Costs, Total", "documentation": "The cash outflow for loan and debt issuance costs." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "terseLabel": "Settlement of second lien loan with Class A common stock", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total", "negatedLabel": "Purchases of property and equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r128" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r820" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r820" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r819" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r829" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r822" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r818" ] }, "cnvs_PercentageOfAggregateGrossProceedsFromEachSaleOfShares": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PercentageOfAggregateGrossProceedsFromEachSaleOfShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of aggregate gross proceeds from each sale of shares", "label": "Percentage of Aggregate Gross Proceeds From Each Sale of Shares", "documentation": "Percentage of aggregate gross proceeds from each sale of shares" } } }, "auth_ref": [] }, "cnvs_PercentageOfRoyaltiesEarnedReceivedByEntitled": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PercentageOfRoyaltiesEarnedReceivedByEntitled", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of royalties earned receive by entitled", "label": "Percentage of Royalties Earned Received by Entitled", "documentation": "Percentage of royalties earned received by entitled." } } }, "auth_ref": [] }, "cnvs_PercentageOfThresholdTaxBenefitRecognizedUponUltimateSettlement": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PercentageOfThresholdTaxBenefitRecognizedUponUltimateSettlement", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of threshold tax benefit recognized upon ultimate settlement", "label": "Percentage of Threshold Tax Benefit Recognized Upon Ultimate Settlement", "documentation": "Percentage of threshold tax benefit recognized upon ultimate settlement." } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Performance Shares [Member]", "terseLabel": "Performance Stock Units [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "cnvs_PikInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PikInterestAccrued", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "PikInterestAccrued", "documentation": "Pik interest accrued.", "terseLabel": "PIK Interest" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927" ] }, "cnvs_PodcastAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PodcastAndOtherMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "label": "Podcast And Other [Member]", "documentation": "Podcast and other." } } }, "auth_ref": [] }, "cnvs_PreFundedWarrantsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreFundedWarrantsExercisePrice", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-funded warrants exercise price", "label": "Pre-Funded Warrants Exercise Price", "documentation": "Pre-Funded Warrants Exercise Price" } } }, "auth_ref": [] }, "cnvs_PreFundedWarrantsToPurchaseCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreFundedWarrantsToPurchaseCommonStock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-funded warrants to purchase common stock", "label": "Pre-Funded Warrants to Purchase Common Stock", "documentation": "Pre-Funded Warrants to Purchase Common Stock" } } }, "auth_ref": [] }, "cnvs_PrecentageOfFixedVolumeWeightedAveragePriceOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PrecentageOfFixedVolumeWeightedAveragePriceOfCommonStock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Precentage of fixed volume weighted average price of common stock.", "label": "Precentage of Fixed Volume Weighted Average Price of Common Stock", "terseLabel": "Percenatge of volume weighted average price of common stock" } } }, "auth_ref": [] }, "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockAmountOfPreferredDividendsInArrears", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Amount of Preferred Dividends in Arrears", "terseLabel": "Dividends preferred stock (in Dollars)", "documentation": "Aggregate amount of cumulative preferred dividends in arrears." } } }, "auth_ref": [ "r66" ] }, "cnvs_PreferredStockDividendRatesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreferredStockDividendRatesPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "PreferredStockDividendRatesPercentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "terseLabel": "Preferred stock, dividend rate" } } }, "auth_ref": [] }, "cnvs_PreferredStockDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreferredStockDividends", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "PreferredStockDividends", "terseLabel": "Preferred stock dividends paid in stock", "documentation": "Preferred stock dividends value." } } }, "auth_ref": [] }, "cnvs_PreferredStockDividendsAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreferredStockDividendsAccrued", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "PreferredStockDividendsAccrued", "documentation": "This value for preferred stock dividends accrued.", "terseLabel": "Preferred stock dividends accrued" } } }, "auth_ref": [] }, "cnvs_PreferredStockDividendsPaidWithCommonStocks": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreferredStockDividendsPaidWithCommonStocks", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Dividends Paid With Common Stocks", "label": "PreferredStockDividendsPaidWithCommonStocks", "terseLabel": "Preferred stock dividends paid with common stock" } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Dividends, Shares", "terseLabel": "Preferred stock dividends paid with common stock (in Shares)", "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r18" ] }, "cnvs_PreferredStockDividendsinShares": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PreferredStockDividendsinShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "PreferredStockDividendsinShares", "terseLabel": "Preferred stock dividends paid in stock (in Shares)", "documentation": "Preferred stock dividends paid with common stock in Shares." } } }, "auth_ref": [] }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreferenceValue", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Liquidation Preference, Value", "terseLabel": "Preferred stock, Liquidation preference Value (in Dollars)", "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares." } } }, "auth_ref": [ "r233", "r386" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r765", "r766", "r769", "r770", "r771", "r772", "r959", "r963" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r113", "r383" ] }, "us-gaap_PreferredStockShareSubscriptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockShareSubscriptions", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Subscribed but Unissued", "terseLabel": "Preferred stock shares (in Shares)", "documentation": "The number of nonredeemable preferred stock (shares) (or preferred stock redeemable solely at the option of the issuer) allocated to investors to buy shares of a new issue of preferred stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds." } } }, "auth_ref": [ "r113" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r113", "r636" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r113", "r383" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r113", "r636", "r655", "r963", "r964" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; 7 shares issued and 7 shares outstanding at March 31, 2024 and March 31, 2023. Liquidation preference of $3,648.", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r113", "r552", "r762" ] }, "us-gaap_PrimeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrimeRateMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Prime Rate [Member]", "terseLabel": "Prime Rate [Member]", "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers." } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassifications", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r861" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock, net of issuance costs", "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Net proceeds from from common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Proceeds from Lines of Credit, Total", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from line of credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r41", "r875" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds from warrants exercised", "label": "Proceeds from Warrant Exercises", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r871" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r292", "r528", "r581", "r582", "r583", "r584", "r585", "r586", "r725", "r742", "r763", "r859", "r894", "r895", "r901", "r958" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r292", "r528", "r581", "r582", "r583", "r584", "r585", "r586", "r725", "r742", "r763", "r859", "r894", "r895", "r901", "r958" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss", "totalLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net (loss) income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r195", "r211", "r213", "r227", "r235", "r244", "r252", "r253", "r270", "r283", "r289", "r291", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r477", "r480", "r481", "r493", "r495", "r547", "r561", "r603", "r657", "r675", "r676", "r733", "r759", "r760", "r774", "r870", "r896" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property, Plant and Equipment, Net, Total", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r14", "r548", "r559", "r762" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "PROPERTY AND EQUIPMENT", "verboseLabel": "Property and Equipment, Net", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r14", "r174", "r177", "r558" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of estimated useful lives of property and equipment, net", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r137" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property and equipment estimated useful lives", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertySubjectToOperatingLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOperatingLeaseMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfLeaserelatedAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use asset [Member]", "label": "Property Subject to Operating Lease [Member]", "documentation": "Property subject to an operating lease." } } }, "auth_ref": [] }, "cnvs_ProspectLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ProspectLoan", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "ProspectLoan", "terseLabel": "Prospect Loan", "documentation": "Prospect loan." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for (recovery of) doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r224", "r312" ] }, "us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilityPropertyPlantAndEquipmentLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Public Utility, Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PublicUtilityPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PublicUtilityPropertyPlantAndEquipmentTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Public Utility, Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r109" ] }, "cnvs_PurchasePriceShares": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "PurchasePriceShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "PurchasePriceShares", "documentation": "Amount of purchase price shares.", "terseLabel": "Purchase price shares (in Shares)" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r817" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r817" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r339", "r340", "r341", "r342", "r400", "r408", "r437", "r438", "r439", "r522", "r524", "r587", "r625", "r626", "r684", "r688", "r690", "r691", "r699", "r721", "r722", "r734", "r741", "r754", "r764", "r767", "r892", "r898", "r951", "r952", "r953", "r954", "r955" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfEstimatedUsefulLivesOfPropertyAndEquipment", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r339", "r340", "r341", "r342", "r400", "r408", "r437", "r438", "r439", "r522", "r524", "r587", "r625", "r626", "r684", "r688", "r690", "r691", "r699", "r721", "r722", "r734", "r741", "r754", "r764", "r767", "r892", "r898", "r951", "r952", "r953", "r954", "r955" ] }, "cnvs_RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "documentation": "This value of total recourse notes payable, net of unamortized debt issuance costs and debt discounts.", "terseLabel": "Total recourse notes payable, net of unamortized debt issuance costs and debt discounts" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r783", "r795", "r805", "r831" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r407", "r512", "r513", "r629", "r630", "r631", "r632", "r633", "r654", "r656", "r682" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r238", "r239", "r512", "r513", "r514", "r515", "r629", "r630", "r631", "r632", "r633", "r654", "r656", "r682" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r407", "r512", "r513", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r629", "r630", "r631", "r632", "r633", "r654", "r656", "r682", "r947" ] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments on line of credit", "label": "Repayments of Lines of Credit", "negatedLabel": "Repayments under revolving credit agreement, net", "terseLabel": "Payments of line of credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r43", "r875" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r784", "r796", "r806", "r832" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r785", "r797", "r807", "r833" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r792", "r804", "r814", "r840" ] }, "cnvs_RestrictedStockAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "RestrictedStockAwardsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Awards Member", "label": "RestrictedStockAwardsMember", "terseLabel": "Restricted Stock Awards [Member]" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r116", "r144", "r555", "r591", "r593", "r600", "r637", "r762" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r192", "r241", "r242", "r243", "r245", "r251", "r253", "r309", "r310", "r443", "r444", "r445", "r464", "r465", "r484", "r486", "r487", "r489", "r491", "r588", "r590", "r604", "r963" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenue", "verboseLabel": "Revenue recognized", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r271", "r272", "r282", "r287", "r288", "r292", "r293", "r295", "r398", "r399", "r528" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Including Assessed Tax", "verboseLabel": "Digital cinema servicing revenue", "terseLabel": "Total Cinema Equipment Business revenue", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r271", "r272", "r282", "r287", "r288", "r292", "r293", "r295", "r398", "r399", "r528" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r659", "r724", "r730" ] }, "cnvs_RevenueRecognizedUnderNonmonetaryPurchaseAndExchangeOfContent": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "RevenueRecognizedUnderNonmonetaryPurchaseAndExchangeOfContent", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "documentation": "Revenue recognized under nonmonetary purchase and exchange of content.", "label": "Revenue Recognized Under Nonmonetary Purchase And Exchange Of Content", "terseLabel": "Revenue recognized under nonmonetary purchase and exchange of content", "negatedLabel": "Revenue recognized under nonmonetary purchase and exchange of content" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Revenues", "totalLabel": "Revenues, Total", "verboseLabel": "Total revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r220", "r235", "r271", "r272", "r282", "r287", "r288", "r292", "r293", "r295", "r307", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r495", "r547", "r896" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right of use assets recognized underlying lease arrangements", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r508", "r761" ] }, "cnvs_RightToPayMaximumPercentageOfPostClosePurchasePriceInEquity": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "RightToPayMaximumPercentageOfPostClosePurchasePriceInEquity", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Right to pay post-close purchase price in equity", "label": "Right to Pay Maximum Percentage of Post Close Purchase Price in Equity", "documentation": "Right to pay maximum percentage of post close purchase price in equity" } } }, "auth_ref": [] }, "us-gaap_RightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding" ], "lang": { "en-us": { "role": { "label": "Rights [Member]", "terseLabel": "Stock appreciation rights [Member]", "documentation": "A security giving shareholders entitlement to acquire new shares issued by the entity at an established price in proportion to the number of shares already owned. Generally, rights expire within in a short time after issuance." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r849" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r849" ] }, "cnvs_SaleOfInvestmentSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SaleOfInvestmentSecurities", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Sale of investment securities", "label": "SaleOfInvestmentSecurities", "documentation": "Sale of investment securities." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Shares of common stock", "verboseLabel": "Number of shares purchased", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Price Per Share", "terseLabel": "Market price per share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "cnvs_SalesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SalesAgreementMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Sales Agreement [Member]", "documentation": "Sales agreement." } } }, "auth_ref": [] }, "cnvs_ScheduleOfAccountsPayableAndAccruedExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfAccountsPayableAndAccruedExpensesAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Accounts Payable And Accrued Expenses Abstract", "label": "Schedule of accounts payable and accrued expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of accounts payable and accrued expenses", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "cnvs_ScheduleOfAmortizationExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfAmortizationExpenseAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Amortization Expense Abstract", "label": "Schedule of amortization expense [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfAmortizationExpenseForIntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfAmortizationExpenseForIntangibleAssetsAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Amortization Expense For Intangible Assets Abstract", "label": "Schedule of amortization expense for intangible assets [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfAmortizationExpenseIsRecordedUsingStraightLineMethodOverTheEstimatedUsefulLivesOfAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfAmortizationExpenseIsRecordedUsingStraightLineMethodOverTheEstimatedUsefulLivesOfAssetsTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of amortization expense is recorded using straight-line method over the estimated useful lives of assets.", "label": "Schedule Of Amortization Expense Is Recorded Using Straight-Line Method Over The estimated Useful Lives Of Assets [Table Text Block]", "terseLabel": "Schedule of amortization expense" } } }, "auth_ref": [] }, "cnvs_ScheduleOfAnalysisOfOptionActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfAnalysisOfOptionActivityAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Analysis Of Option Activity Abstract", "label": "Schedule of analysis of option activity [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Components Of Income Tax Expense Benefit Abstract", "label": "Schedule of components of income tax expense benefit [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of components of income tax expense benefit", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r150" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of net deferred tax", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r149" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of basic and diluted net income (loss) per share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r883" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of united states statutory federal tax rate and our effective tax rate", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r148" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r303", "r304", "r306" ] }, "cnvs_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Estimated Useful Lives Of Property And Equipment Abstract", "label": "Schedule of estimated useful lives of property and equipment [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabilitiesAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Fair Value Measurements Of Our Financial Assets And Liabilities Abstract", "label": "Schedule of fair value measurements of our financial assets and liabilities [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfIntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfIntangibleAssetsAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Intangible Assets Abstract", "label": "Schedule of intangible assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Schedule of intangible assets", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r54" ] }, "cnvs_ScheduleOfLeaseCostsAndSupplementalCashFlowInformationRelatedToLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfLeaseCostsAndSupplementalCashFlowInformationRelatedToLeasesAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Lease Costs And Supplemental Cash Flow Information Related To Leases Abstract", "label": "Schedule Of Lease Costs And Supplemental Cash Flow Information Related To Leases [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfLeaseRelatedAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfLeaseRelatedAssetsAndLiabilitiesAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Lease Related Assets And Liabilities Abstract", "label": "Schedule of lease-related assets and liabilities [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "label": "ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "terseLabel": "Schedule of lease-related assets and liabilities", "documentation": "Tabular disclosure of lease-related assets and liabilities." } } }, "auth_ref": [] }, "cnvs_ScheduleOfNetDeferredTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfNetDeferredTaxAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Net Deferred Tax Abstract", "label": "Schedule of net deferred tax [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfNotesPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfNotesPayableAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Notes Payable Abstract", "label": "Schedule of notes payable [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangementTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangementTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of operating lease commitments and subleasing arrangement.", "label": "Schedule of Operating Lease Commitments and Subleasing Arrangement [Table Text Block]", "terseLabel": "Schedule of operating lease commitments and subleasing arrangements" } } }, "auth_ref": [] }, "cnvs_ScheduleOfProspectLoanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfProspectLoanAbstract", "lang": { "en-us": { "role": { "label": "Schedule of prospect loan [Abstract]", "documentation": "Schedule of prospect loan." } } }, "auth_ref": [] }, "cnvs_ScheduleOfRevenueCategoriesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfRevenueCategoriesAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Revenue Categories Abstract", "label": "Schedule of revenue categories [Abstract]" } } }, "auth_ref": [] }, "cnvs_ScheduleOfSARsOutstandingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfSARsOutstandingTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "ScheduleOfSARsOutstandingTableTextBlock", "terseLabel": "Schedule of SARs outstanding", "documentation": "Tabular disclosure of SARs outstanding." } } }, "auth_ref": [] }, "cnvs_ScheduleOfSarsOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfSarsOutstandingAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Sars Outstanding Abstract", "label": "Schedule of SARs outstanding [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r410", "r411", "r412", "r413", "r414", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r436", "r437", "r438", "r439", "r440" ] }, "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense", "documentation": "Tabular disclosure of employee stock purchase plan activity." } } }, "auth_ref": [ "r76" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of activity for performance stock unit awards", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]", "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of analysis of option activity", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]", "terseLabel": "Schedule of stock appreciation rights outstanding", "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of weighted average assumptions used to estimate fair value of SARs", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r147" ] }, "cnvs_ScheduleOfStockAppreciationRightsOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfStockAppreciationRightsOutstandingAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of Stock Appreciation Rights Outstanding Abstract", "label": "Schedule of stock appreciation rights outstanding [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrants", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r70" ] }, "cnvs_ScheduleOfUnitedStatesStatutoryFederalTaxRateAndOurEffectiveTaxRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ScheduleOfUnitedStatesStatutoryFederalTaxRateAndOurEffectiveTaxRateAbstract", "lang": { "en-us": { "role": { "documentation": "Schedule Of United States Statutory Federal Tax Rate And Our Effective Tax Rate Abstract", "label": "Schedule of united states statutory federal tax rate and our effective tax rate [Abstract]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r776" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r779" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r295", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r335", "r336", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r735", "r859", "r958" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r293", "r294", "r619", "r621", "r623", "r685", "r689", "r694", "r701", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r726", "r743", "r767", "r901", "r958" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative", "totalLabel": "Selling, General and Administrative Expense, Total", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r125" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative [Member]", "verboseLabel": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "netLabel": "Series A Preferred Stock [Member]", "verboseLabel": "Series A", "terseLabel": "Series A Preferred Stock", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r866", "r867", "r900" ] }, "cnvs_ServicesAndDeploymentMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ServicesAndDeploymentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "documentation": "Services and deployment.", "label": "Services And Deployment [Member]", "terseLabel": "Services and Deployment [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense", "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total", "terseLabel": "Stock-based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r755" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Shares granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r427" ] }, "cnvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options issued in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period", "terseLabel": "Shares issued" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding March 31, 2024", "periodStartLabel": "Outstanding March 31, 2023", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "terseLabel": "Shares remained unvested", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r424", "r425" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested, Shares", "terseLabel": "Shares vested", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r428" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "verboseLabel": "Exercise price", "terseLabel": "Range of Exercise Prices", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r438" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected equity volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r437" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected equity volatility, maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected equity volatility, minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r439" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate, maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate, minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r410", "r411", "r412", "r413", "r414", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r436", "r437", "r438", "r439", "r440" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in number of shares authorized for issuance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares award", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r71" ] }, "cnvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "terseLabel": "Aggregate Intrinsic Value (in Dollars)" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Options expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r423" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "terseLabel": "Options forfeited", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r422" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "verboseLabel": "Shares under option, granted", "terseLabel": "Granted, Shares", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r420" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value of outstanding grants", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r430" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value (in Dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "verboseLabel": "Options, outstanding shares", "terseLabel": "Options Exercisable (in Shares)", "periodStartLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance", "periodEndLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r416", "r417" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Issued", "verboseLabel": "Shares issued", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r71" ] }, "cnvs_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross", "documentation": "Gross number of share options (or share units) granted during the period.", "terseLabel": "Granted shares" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r412", "r413", "r414", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r436", "r437", "r438", "r439", "r440" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, granted (in Dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r420" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r409", "r415", "r434", "r435", "r436", "r437", "r440", "r446", "r447", "r448", "r449" ] }, "cnvs_ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "terseLabel": "Range of Prices, Maximum" } } }, "auth_ref": [] }, "cnvs_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "terseLabel": "Options Exercisable (in Shares)" } } }, "auth_ref": [] }, "cnvs_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "terseLabel": "Options Outstanding (in Shares)" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r75" ] }, "cnvs_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit", "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "terseLabel": "Range of Prices, Minimum" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Domain]", "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r76" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "verboseLabel": "Share-based payment arrangement, option, exercise price range, shares outstanding", "terseLabel": "Options Outstanding (in Shares)", "periodStartLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Beginning Balance", "periodEndLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding, Ending Balance", "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices." } } }, "auth_ref": [ "r73" ] }, "cnvs_ShareIssuanceInConnectionWithEmployeeBonusesMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "ShareIssuanceInConnectionWithEmployeeBonusesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share Issuance in Connection with Employee Bonuses [Member]", "documentation": "Share issuance in connection with employee bonuses." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Combined purchase price per share", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "cnvs_SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent", "documentation": "Share-based compensation arrange by share-based payment award, equity incentive plan, exercise price if voting threshold is met, percent.", "terseLabel": "Exercise price if voting threshold is met, percent" } } }, "auth_ref": [] }, "cnvs_SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold": { "xbrltype": "percentItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold", "documentation": "Share-based compensation arrange by share-based payment award, equity incentive plan, percent voting power threshold.", "terseLabel": "Percent voting power threshold" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Aware expiration period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r756" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfSars" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (years)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r436" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Forfeited", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Options outstanding, weighted average remaining contractual term", "terseLabel": "Weighted Average Remaining Life in Years", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r146" ] }, "cnvs_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingsContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingsContractualTerm2", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remainings Contractual Term2", "documentation": "Weighted Average Remaining Life in Years.", "terseLabel": "Weighted Average Remaining Life in Years" } } }, "auth_ref": [] }, "cnvs_SharebasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfVested": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfVested", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "terseLabel": "Vested", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plan Exercise Price Range Number of Vested", "documentation": "Sharebased compensation shares authorized under stock option plan exercise price range number of vested" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfAnalysisOfOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "verboseLabel": "Share-based payment arrangement, option, exercise price range, outstanding, weighted average exercise price (in Dollars per share)", "terseLabel": "Weighted Average Exercise Price", "periodStartLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Beginning Balance", "periodEndLabel": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price, Ending Balance", "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices." } } }, "auth_ref": [ "r73" ] }, "cnvs_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1s": { "xbrltype": "perShareItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1s", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1s", "documentation": "Weighted Average Exercise Price.", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "cnvs_SharesHeldForSale": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharesHeldForSale", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Shares held for sale", "label": "Shares Held For Sale", "documentation": "Shares held for sale" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Shares sold", "label": "Shares, Issued", "verboseLabel": "Shares issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r18" ] }, "cnvs_SharesIssuedForEarnoutRelatedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharesIssuedForEarnoutRelatedLiabilitiesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Shares Issued for Earnout-Related Liabilities [Member]", "documentation": "Shares issued for earnout-related liabilities." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "terseLabel": "Aggregate of outstanding shares (in Shares)", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "terseLabel": "Shares withheld to pay taxes", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "cnvs_SharesSoldResultedInARealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SharesSoldResultedInARealizedLoss", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "terseLabel": "Shares sold resulted in a realized loss", "label": "Shares Sold Resulted In A Realized Loss", "documentation": "shares sold resulted in a realized loss." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r24" ] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Software Development [Member]", "terseLabel": "Software [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "cnvs_SoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SoftwareMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Software Member", "label": "SoftwareMember", "terseLabel": "Software [Member]" } } }, "auth_ref": [] }, "cnvs_StarriseMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StarriseMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Starrise [Member]", "terseLabel": "Starrise Media Holdings Limited [Member]", "label": "Starrise [Member]" } } }, "auth_ref": [] }, "cnvs_StateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StateAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "documentation": "State Abstract", "label": "StateAbstract", "terseLabel": "State:" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofcomponentsofincometaxexpensebenefitTable" ], "lang": { "en-us": { "role": { "label": "State and Local Income Tax Expense (Benefit), Continuing Operations", "totalLabel": "Total state", "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r877", "r928", "r933" ] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r194", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r295", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r333", "r335", "r336", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r735", "r859", "r958" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r181", "r204", "r205", "r206", "r235", "r257", "r258", "r261", "r263", "r267", "r268", "r307", "r343", "r345", "r346", "r347", "r350", "r351", "r383", "r384", "r386", "r389", "r395", "r495", "r596", "r597", "r598", "r599", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r616", "r636", "r658", "r677", "r703", "r704", "r705", "r706", "r707", "r857", "r874", "r882" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r18", "r36", "r192", "r216", "r217", "r218", "r241", "r242", "r243", "r245", "r251", "r253", "r266", "r309", "r310", "r397", "r443", "r444", "r445", "r464", "r465", "r484", "r485", "r486", "r487", "r488", "r489", "r491", "r496", "r497", "r498", "r499", "r500", "r501", "r511", "r588", "r589", "r590", "r604", "r677" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r182", "r191", "r293", "r294", "r619", "r621", "r623", "r685", "r689", "r694", "r701", "r710", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r726", "r743", "r767", "r901", "r958" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r241", "r242", "r243", "r266", "r528", "r594", "r616", "r627", "r629", "r630", "r631", "r632", "r633", "r636", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r651", "r652", "r653", "r654", "r656", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r677", "r768" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r241", "r242", "r243", "r266", "r528", "r594", "r616", "r627", "r629", "r630", "r631", "r632", "r633", "r636", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r651", "r652", "r653", "r654", "r656", "r659", "r660", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r677", "r768" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r787", "r799", "r809", "r835" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "cnvs_StockBasedBonusToAcquiredCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockBasedBonusToAcquiredCompany", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based bonus to acquired company", "label": "Stock Based Bonus to Acquired Company", "documentation": "Stock-based bonus to acquired company." } } }, "auth_ref": [] }, "cnvs_StockCompensationAndExpenses": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockCompensationAndExpenses", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "StockCompensationAndExpenses", "documentation": "Stock compensation and expenses.", "terseLabel": "Stock compensation and expenses (in Shares)" } } }, "auth_ref": [] }, "us-gaap_StockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockDividendsShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Stock Dividends, Shares", "terseLabel": "Stock dividends", "totalLabel": "Stock Dividends, Shares, Total", "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r18" ] }, "cnvs_StockExchangeOfHongKongLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockExchangeOfHongKongLimitedMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Stock Exchange Of Hong Kong Limited Member", "label": "StockExchangeOfHongKongLimitedMember", "terseLabel": "Stock Exchange of Hong Kong [Member]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Acquisitions", "verboseLabel": "Common stock, acquired", "terseLabel": "Issuance of common stock for third party equity purchase commitment and for acquisition (in Shares)", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r113", "r114", "r144" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Issuance of common stock for with PSUs and incentives, net of payroll taxes (in Shares)", "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r18", "r65", "r113", "r114", "r144" ] }, "cnvs_StockIssuedDuringPeriodSharesForEmployeeBonuses": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodSharesForEmployeeBonuses", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock in connection employee bonuses (in Shares)", "label": "Stock Issued During Period, Shares, For Employee Bonuses", "documentation": "Stock issued during period, shares, for employee bonuses." } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodSharesIssuanceInConnectionWithTheExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodSharesIssuanceInConnectionWithTheExerciseOfWarrants", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance in connection with the exercise of warrants (in Shares)", "label": "Stock Issued During Period, Shares, Issuance in Connection with the Exercise of Warrants", "documentation": "Stock issued during period, shares, issuance in connection with the exercise of warrants." } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodSharesIssuanceOfCommonStockForDeferredAndEarnoutConsideration": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockForDeferredAndEarnoutConsideration", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for deferred and earnout consideration (in Shares)", "label": "Stock Issued During Period Shares Issuance of Common Stock for Deferred and Earnout Consideration", "documentation": "Stock issued during period shares issuance of common stock for deferred and earnout consideration." } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodSharesIssuanceOfCommonStockForEarnoutCommitment": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockForEarnoutCommitment", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for earnout commitment (in shares)", "documentation": "Stock issued during period shares issuance of common stock for earnout commitment.", "label": "Stock Issued During Period Shares Issuance of Common Stock for Earnout Commitment" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of Class A common stock in connection with direct equity offering (in Shares)", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of stock issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r18", "r113", "r114", "r144", "r596", "r677", "r704" ] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Treasury stock in connection with taxes withheld from employees (in Shares)", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Reverse Stock Splits", "terseLabel": "Stock issued during period shares, reverse stock splits", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r18" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation (in Shares)", "totalLabel": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r18", "r113", "r114", "r144" ] }, "cnvs_StockIssuedDuringPeriodSharesShareBasedCompensationForBoardOfDirector": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForBoardOfDirector", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares share based compensation for board of director.", "label": "Stock Issued During Period Shares Share Based Compensation for Board of Director", "terseLabel": "Issuance of common stock for Board of Director compensation (in shares)" } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodStockCompensationAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodStockCompensationAndExpenses", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "StockIssuedDuringPeriodStockCompensationAndExpenses", "documentation": "This value for stock compensation and expenses.", "terseLabel": "Stock compensation and expenses" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of common stock for third party equity purchase commitment and for acquisition", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r18", "r36", "r144" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Issuance of common stock for with PSUs and incentives, net of payroll taxes", "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r18", "r36", "r144" ] }, "cnvs_StockIssuedDuringPeriodValueForEmployeeBonuses": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodValueForEmployeeBonuses", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of Class A common stock in connection employee bonuses", "label": "Stock Issued During Period, Value, For Employee Bonuses", "documentation": "Stock issued during period, value, for employee bonuses." } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodValueIssuanceOfCommonStockForDeferredAndEarnoutConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockForDeferredAndEarnoutConsideration", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for deferred and earnout consideration", "label": "Stock Issued During Period Value Issuance of Common Stock for Deferred and Earnout Consideration", "documentation": "Stock issued during period value issuance of common stock for deferred and earnout consideration." } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodValueIssuanceOfCommonStockForEarnoutCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockForEarnoutCommitment", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock for earnout commitment", "documentation": "Stock issued during period value issuance of common stock for earnout commitment.", "label": "Stock Issued During Period Value Issuance of Common Stock For Earnout Commitment" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of Class A common stock in connection with direct equity offering", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Stock issued value", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r18", "r113", "r114", "r144", "r604", "r677", "r704", "r774" ] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Other", "terseLabel": "Treasury stock in connection with taxes withheld from employees", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "cnvs_StockIssuedDuringPeriodValueReverseStockSplits": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodValueReverseStockSplits", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value reverse stock splits.", "label": "Stock Issued During Period Value Reverse Stock Splits", "terseLabel": "Stock issued during period value, reverse stock splits" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation", "totalLabel": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture, Total", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r74", "r113", "r114", "r144" ] }, "cnvs_StockIssuedDuringPeriodValueShareBasedCompensationForBoardOfDirector": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForBoardOfDirector", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value share based compensation for board of director.", "label": "Stock Issued During Period Value Share Based Compensation for Board of Director", "terseLabel": "Issuance of common stock for Board of Director compensation" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "totalLabel": "Total stockholders' equity of Cineverse Corp.", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r114", "r117", "r118", "r133", "r638", "r655", "r678", "r679", "r762", "r775", "r876", "r887", "r943", "r963" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "auth_ref": [] }, "cnvs_StockholdersEquityDeficitDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockholdersEquityDeficitDetailsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Stockholders Equity Deficit Details Line Items", "label": "Stockholders\u2019 Equity (Deficit) (Details) [Line Items]" } } }, "auth_ref": [] }, "cnvs_StockholdersEquityDeficitDetailsScheduleofstockappreciationrightsoutstandingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockholdersEquityDeficitDetailsScheduleofstockappreciationrightsoutstandingLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "documentation": "Stockholders Equity Deficit Details Scheduleofstockappreciationrightsoutstanding Line Items", "label": "Stockholders\u2019 Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Line Items]" } } }, "auth_ref": [] }, "cnvs_StockholdersEquityDeficitDetailsScheduleofstockappreciationrightsoutstandingTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockholdersEquityDeficitDetailsScheduleofstockappreciationrightsoutstandingTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfSarsOutstanding", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetailsScheduleOfStockAppreciationRightsOutstanding" ], "lang": { "en-us": { "role": { "documentation": "Stockholders Equity Deficit Details Scheduleofstockappreciationrightsoutstanding Table", "label": "Stockholders\u2019 Equity (Deficit) (Details) - Schedule of stock appreciation rights outstanding [Table]" } } }, "auth_ref": [] }, "cnvs_StockholdersEquityDeficitDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "StockholdersEquityDeficitDetailsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Stockholders Equity Deficit Details Table", "label": "Stockholders\u2019 Equity (Deficit) (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r86", "r87", "r91", "r192", "r193", "r217", "r241", "r242", "r243", "r245", "r251", "r309", "r310", "r397", "r443", "r444", "r445", "r464", "r465", "r484", "r485", "r486", "r487", "r488", "r489", "r491", "r496", "r497", "r501", "r511", "r589", "r590", "r602", "r638", "r655", "r678", "r679", "r708", "r774", "r876", "r887", "r943", "r963" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquity2" ], "lang": { "en-us": { "role": { "label": "Equity [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r141", "r234", "r382", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r397", "r490", "r680", "r681", "r709" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Reverse stock split", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r22" ] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Reverse Stock Split", "terseLabel": "Reverse stock split description", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r145" ] }, "cnvs_SubleaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SubleaseAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Sublease abstract.", "label": "Sublease [Abstract]", "terseLabel": "Sublease Payments" } } }, "auth_ref": [] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Sublease Income", "terseLabel": "Sublease income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r507", "r761" ] }, "cnvs_SubleasePaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SubleasePaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Sublease payments, due next twelve months.", "label": "Sublease Payments, Due Next Twelve Months", "terseLabel": "2024" } } }, "auth_ref": [] }, "cnvs_SubleasePaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SubleasePaymentsDueYearTwo", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesDetailsScheduleOfOperatingLeaseCommitmentsAndSubleasingArrangements" ], "lang": { "en-us": { "role": { "documentation": "Sublease payments, due year two.", "label": "Sublease Payments, Due Year Two", "terseLabel": "2025" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r502", "r517" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r502", "r517" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r502", "r517" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r502", "r517" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r502", "r517" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r516", "r518" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Line Items", "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsScheduleofamortizationexpenseforintangibleassetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofamortizationexpenseforintangibleassetsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Scheduleofamortizationexpenseforintangibleassets Line Items", "label": "Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets [Line Items]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsScheduleofamortizationexpenseforintangibleassetsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofamortizationexpenseforintangibleassetsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpenseForIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Scheduleofamortizationexpenseforintangibleassets Table", "label": "Summary of Significant Accounting Policies (Details) - Schedule of amortization expense for intangible assets [Table]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsofourfinancialassetsandliabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsofourfinancialassetsandliabilitiesLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Scheduleoffairvaluemeasurementsofourfinancialassetsandliabilities Line Items", "label": "Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities [Line Items]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsofourfinancialassetsandliabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsofourfinancialassetsandliabilitiesTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfFairValueMeasurementsOfOurFinancialAssetsAndLiabil" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Scheduleoffairvaluemeasurementsofourfinancialassetsandliabilities Table", "label": "Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of our financial assets and liabilities [Table]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsScheduleofintangibleassetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofintangibleassetsLineItems", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Scheduleofintangibleassets Line Items", "label": "Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Line Items]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsScheduleofintangibleassetsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofintangibleassetsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Scheduleofintangibleassets Table", "label": "Summary of Significant Accounting Policies (Details) - Schedule of intangible assets [Table]" } } }, "auth_ref": [] }, "cnvs_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Summaryof Significant Accounting Policies Details Table", "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "auth_ref": [] }, "cnvs_SupplierAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SupplierAgreementsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Supplier Agreements Member", "label": "SupplierAgreementsMember", "terseLabel": "Supplier Agreements [Member]" } } }, "auth_ref": [] }, "cnvs_SystemSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "SystemSalesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "documentation": "System sales.", "label": "System Sales [Member]", "terseLabel": "System Sales [Member]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r828" ] }, "us-gaap_TemporaryEquityForeignCurrencyTranslationAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityForeignCurrencyTranslationAdjustments", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Foreign Currency Translation Adjustments", "terseLabel": "Foreign exchange translation", "documentation": "Adjustments to temporary equity resulting from foreign currency translation adjustments." } } }, "auth_ref": [] }, "cnvs_TerrifierThreeFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TerrifierThreeFinancingMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Terrifier 3 Financing [Member]", "label": "Terrifier Three Financing [Member]", "documentation": "Terrifier three financing." } } }, "auth_ref": [] }, "cnvs_TheatreRelationshipMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TheatreRelationshipMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "documentation": "Theatre Relationship Member", "label": "TheatreRelationshipMember", "terseLabel": "Theatre Relationship [Member]", "verboseLabel": "Theatre Relationship [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r884", "r946" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "cnvs_TotalDeferredTaxAssetsAfterValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TotalDeferredTaxAssetsAfterValuationAllowance", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnetdeferredtaxTable" ], "lang": { "en-us": { "role": { "label": "TotalDeferredTaxAssetsAfterValuationAllowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "terseLabel": "Total deferred tax assets after valuation allowance", "totalLabel": "Total deferred tax assets after valuation allowance" } } }, "auth_ref": [] }, "cnvs_TotalIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TotalIntangibleAssetsMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "documentation": "Total Intangible Assets Member", "label": "TotalIntangibleAssetsMember", "terseLabel": "Total Intangible Assets [Member]" } } }, "auth_ref": [] }, "cnvs_TotalRecourseNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TotalRecourseNotesPayable", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofnotespayableTable" ], "lang": { "en-us": { "role": { "label": "TotalRecourseNotesPayable", "documentation": "This value of recourse notes payable.", "terseLabel": "Total recourse notes payable" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r820" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r827" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "ACCOUNTS RECEIVABLE", "verboseLabel": "Accounts Receivable, Net", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r165", "r166", "r167", "r298", "r299", "r301" ] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeNamesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Trade Names [Member]", "verboseLabel": "Trade name [Member]", "terseLabel": "Tradename [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r82" ] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1", "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and Tradenames", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r82" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfAmortizationExpense1" ], "lang": { "en-us": { "role": { "label": "Trademarks [Member]", "terseLabel": "Trademark [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r82" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r848" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r850" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r851" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r852" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r850" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r850" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r853" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r851" ] }, "cnvs_TreasurySharesAcquiredForWithholdingTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TreasurySharesAcquiredForWithholdingTaxes", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "label": "TreasurySharesAcquiredForWithholdingTaxes", "documentation": "Treasury shares acquired for withholding taxes.", "terseLabel": "Treasury shares acquired for withholding taxes" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r68" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r68" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock in connection with taxes withheld from employees (in Shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r18", "r114", "r144" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost; 288,554 and 65,792 shares at March 31, 2024 and March 31, 2023, respectively.", "label": "Treasury Stock, Value", "totalLabel": "Treasury Stock, Value, Total", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r35", "r68", "r69" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/StatementConsolidatedStatementsOfShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock in connection with taxes withheld from employees", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r18", "r68", "r144" ] }, "cnvs_TwoThousandSeventeenPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "TwoThousandSeventeenPlanMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "documentation": "Two Thousand Seventeen Plan Member", "label": "TwoThousandSeventeenPlanMember", "verboseLabel": "Two Thousand seventeen Plan [Member]", "terseLabel": "2017 Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r476" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "Domestic Operating Lease" } } }, "auth_ref": [] }, "cnvs_UnamortizedDebtIssuanceCostsAndDebtDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "UnamortizedDebtIssuanceCostsAndDebtDiscounts", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ScheduleofprospectloanTable" ], "lang": { "en-us": { "role": { "label": "UnamortizedDebtIssuanceCostsAndDebtDiscounts", "documentation": "Unamortized debt issuance costs and debt discounts.", "negatedLabel": "Less unamortized debt issuance costs and debt discounts" } } }, "auth_ref": [] }, "us-gaap_UnamortizedDebtIssuanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnamortizedDebtIssuanceExpense", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Unamortized debt issuance costs (in Dollars)", "label": "Unamortized Debt Issuance Expense", "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset." } } }, "auth_ref": [] }, "cnvs_UnbilledRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "UnbilledRevenueCurrent", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "label": "UnbilledRevenueCurrent", "terseLabel": "Unbilled revenue", "documentation": "Unbilled revenue current." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r847" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "USE OF ESTIMATES", "verboseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r51", "r52", "r53", "r172", "r173", "r175", "r176" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Net change in valuation allowance", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r459" ] }, "cnvs_VariableConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "http://cineverse.com/20240331", "localname": "VariableConsiderationMember", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueCategories" ], "lang": { "en-us": { "role": { "documentation": "Variable consideration.", "label": "Variable Consideration [Member]", "terseLabel": "Variable Consideration [Member]" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityOwnershipPercentage", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Ownership percentage", "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)." } } }, "auth_ref": [ "r90" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureDebtDetails", "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "cnvs_WarrantShares": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "WarrantShares", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_OtherInterestsDetails" ], "lang": { "en-us": { "role": { "label": "WarrantShares", "documentation": "Amount of warrant shares.", "terseLabel": "Warrant shares (in Shares)" } } }, "auth_ref": [] }, "cnvs_WarrantsToPurchaseCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "WarrantsToPurchaseCommonStock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Warrants to Purchase Common Stock", "documentation": "Warrants to purchase common stock" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares of common stock outstanding: diluted (in Shares)", "verboseLabel": "Weighted-average number of shares", "totalLabel": "Weighted-average number of shares", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r256", "r263" ] }, "cnvs_WeightedAverageNumberOfSharesOnStockOptionsAndStockAppreciationRights": { "xbrltype": "sharesItemType", "nsuri": "http://cineverse.com/20240331", "localname": "WeightedAverageNumberOfSharesOnStockOptionsAndStockAppreciationRights", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare" ], "lang": { "en-us": { "role": { "documentation": "Weighted average number of shares on stock options and stock appreciation rights.", "label": "Weighted Average Number of Shares On Stock Options and Stock Appreciation Rights", "terseLabel": "Stock options and SARs" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsScheduleOfBasicAndDilutedNetIncomeLossPerShare", "http://cineverse.com/20240331/taxonomy/role/cidm_r_ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average shares of Common Stock outstanding", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "terseLabel": "Weighted average shares of common stock outstanding: basic (in Shares)", "label": "Weighted-average shares of common stock outstanding", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r254", "r263" ] }, "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesRestrictedStock", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/DisclosureStockholdersEquityDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares, Restricted Stock", "terseLabel": "Restricted shares issued", "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends." } } }, "auth_ref": [ "r48" ] }, "cnvs_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://cineverse.com/20240331", "localname": "WorkingCapital", "crdr": "debit", "presentation": [ "http://cineverse.com/20240331/taxonomy/role/cidm_r_NatureofOperationsandLiquidityDetails" ], "lang": { "en-us": { "role": { "label": "WorkingCapital", "documentation": "Working Capital", "terseLabel": "Working capital" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(19)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB TOPIC 4.C)", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.12)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-13" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481244/470-50-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "55", "Paragraph": "63", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481620/480-10-55-63" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)-(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-4" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "932", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-10.(c)(7)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481834/980-20-45-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-3" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "323", "Publisher": "FASB", "URI": "https://asc.fasb.org//323/tableOfContent" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "905", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482211/905-360-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482630/740-20-55-7" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r857": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r858": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "323", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(S-X 210.12-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2E" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 68 0000950170-24-079718-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-079718-xbrl.zip M4$L#!!0 ( .R&X5A_.W>-'A # #!**P 1 8VYV_OE/ M;)?^*0M#5_MJ>/3G/^T=O'CSYD__Y^?_]=/_)B1[^?K-^^Q]^)3MN7%U&EY6 MK1O4[:0)V0\'[W[,W@P'U3!D__W+Q[?9R]I-3L)PG)'L>#P>/7OZ]-.G3[L^ M5L.V'DS&\*YVU]4G3S-"II._:(+!S[.79ARR9YQR26A)*#NDZID0SZC8Y87F M_P^ESRA=^EH].FNJH^-Q]H/[,<-OP;N'PS 8G&6OJZ$9NLH,LH/92W=@E6XW MVQL,LH_XK3;[&-K0G :_V\UY/(;C@",9MG]^LK3R3V*W;HZ>,JWUT\\XYDDW MZ-EGVPQ\-1^+?Z:1G-+B:??PW-#QI4/S;NAX>6AU;@'+H\53.,8Q;"W,QL/! M__&5X?C8FG8^_/,7X\_M#Y_.AE:?KYJ7X3(0X@CPV?!A/7P/@&\J=_G7_+AY M.CX;A:[M@3L.)X9C@&UD@. M =.>9*[[Z\]/QN'S^&EB+4]QUJ?3:7^RM3_+VO'9(/SYR8EICJKAL\Q,QO7_ MKDY&=0.T,'X^,A[Y];-,C3X_?Y+>ZJO3V9=\U8X&Y@QI,\#3GZK/SW#NT'2_ M5MZ'8?IU0;Q9!0?]^A]<>:^YHX1;EQ,9E"(FSP51KLBCTR%GGC[)AN8$WQ*J M9S.N_QHD@QE\@)EJ_QH^:Z?;_#S^&"(Q^AP\B68 S/;GU_C/M;9 J;2:%H(8R061M@S$4!L(XX8& M;629,_Z5+1PV)\/Q_>Y 2J:$PNF-@!=1X8AFLB!4FS(72EI1ZF54>34$"CE[ M /:B/CFIQKCV=F_HD>T#DP;EN@I? M,$0.) \T \L7!GA8&2)1EH)<-TR;$ L3)1S_9%AU7_CM'[\=O 0YU5;/AM4 M9$ELSPGJF! FKGVG@OMN62W6'KNN:8QP-*!K&#I M5A,M3$& #P#BE=[9@M]TZ451AL): *TU'%B[!-EC%!@&(9<*,=[EY<6EOQF> MAC8M??_3,/B]\6M3-;^;P21<7+FVTN8R "1IX8$3&" E7U+B::#<:JFX"#== M.;> S\$%4D8'D@G0AR@>@6 C"Y2ZPEMSFY67TGE36E*J .@BC2>FR -1.356 M>^>TC#==N2N!C3 -G*#P@"ZE#P!9P,<"^"./A09*LQ=7OM>V8=S.E[NP#._R MR/-V @4O??RV,K8:@+"]N"6E MA Q.1S@E05&2>)"!EA)@:Z7S@7/EV$VW!*A2>&\=R8L^I76BES362KVZU^G6^SA./L'"/!!\+A9(7%'%;Y(R43FM3&,N#^&+A*V": MZX2%9Z5B 8[+6)"=R"2)B=03[PK-%<@\D 5KV-(ZH0346S@&8-&!P98,V(\F M@N8.3$DJQ514[HLM?1\G72= Z*EV Q@70!3JJ!G6KK'?&B=,R4*@_F"SOF M^U:_5I[$; ZZ,RQ<:; U)"(66#%@[Q6\8+K41?B"0EZ&&)HF^$/SN:/R%V94 MC1=+X$AW&/OQMS:DK=WE#@*:C1205$N0;A)^PK0@DG-?6N5 SQ/6?Q,42UMY MO[;E/SWOY6QP$6#*AO;GG_"FXUF;+A9@BBS=?#S#&X _/VFKD]$ ;QG29\<- MO@$A06:^W]W/K9]-OSQG^K.M)TWZ*]WD/)ON*QT=Z'FTH'!@#&S9"'I>R4'C M4Q3()#>,O]D]M60'&6SOX#UP=^Q"DV6EATNO2QX\>:OY]UB%[\\FZX- M1ZAF=']Z>-GGT:!RU?A=.+'P"E_!TW0Q^*1MQL\^-+6?N/%^)2_R?,%C MTXSQAO!G=/<3*@EE\WGFS^9'YV=#97>;LWA%]V3V]^PE3\^!ZPKH,99[:PTI M%$<''!CUMO1@#I:.(VL&,:WZ!KV%9NGJDW PAKWC-]_6+LG1#I"S00=A #A_ M]&L8@I@=[ W]G@>P5NT8A>YI>/5Y!-.&=LW Y=<'KE@A<#D3N8V,"&^!+X,< M0XAM,P. _G^: WP]$$>#&. M$*N':G=A.[X$4+,G-P*4Y)$[!4I^C#D(4 ?BAX-B"99@KKB57 C95T"] !%8 M@5'GDNYZ'B@?PVD]. 7R.S_H&V"Y]JO?@F:]'R];0&+CKTP[_AO8GK^8X1^; M@PG6Q-P"R:++07()TM3CS07-I:)>!1-Z*4T_&C!HNK/'/]^9S]7)Y&15@#XX M-DWXQ;3!@QF%##LQ^O1INS<9']=-]3_!_S8$4^I@7+L_]D?X_,/ #-M?SEY] M#HVKVO"A 2F_M,X.1[YX>/BI7BNRR!4B2V&\IR"M@RL*--[ @$ & C:;B,!$ MG%2F;\BR?I!V(]OI&&,'X6%J;H6-5#J*FAO8U0S,=Y#G$LP+ZF(!;*0H=-^ M?QFG &5LA9SB-4PW#F]!L_-OAD!81Q7 OS//?CE[9_Y9-R\&IFW/BZD7DW8, MFF3S,71A3.UQ-5J#1K@F)E!:RF1NB-(%QQLN!TQ @AK/F4&66/WQ+"O_8$5+0U^'+3-16_-YCG]O?K7!$/20+>JARGPY1Q\]CR8 M3/!%,_A@*I"44R_RQD#(>.6YD$1H6N ])",VB$",]H4-5.?,]>@07+"@S0 HE%%.BDQ)4R"L]*8V1O?1EH M7KPW)^<,Q$1'(-QP]M. (QZF='),N^!SXD%MQ)!7210'XO(N1NHED&B4!8=4,!52\Z(UZ4,>5XZEO=6!9W=M>\Y(-JV M6JB?B9)_&=2U/WM9M4< >5!"W[Y]L3% "0)HTWHB! <;S^)%)08] <5B7+I6 M-L1U ^7[-D]7N/G(3![ MLU] (S4FH*XIZ; M.EE'P,-"$]KQ@[R3 GP-2CI#-(H865)&C'(%R7C@F4?*AJ6&_ M ,LO1'F4(HPTFJK2&$](](S \PLE,3(LC1.Z(*NWZ7S?9MG*]R\+$P1E23! M8>A(830Q!I42:J,/W@FK>W1E:7O MKXOR+KGC<1,V1][K$'T,G ";=$0:%XCVH"8*Z85G(D;G>ROR-N1F?)6\TEB> M2ZE(#*8 .P:HSV#2K<,$*T8%U>4F\,H$HTM@TY7\V1A@7">AKO_ N+'@XAO# MXZ*G#$!"(L5<;Q5!PW"\(&7NR^"H<)[W]OZFBT' A(Q.2EV,1WT)3]MQY5YT M)8XV!22&.@^F&RA]0"Q$:H-IC#HGA<^E$@ OFXN^@63]H5XS;QOJ'>.]H4>] M?X2K^^4,BQ%=(,E) ^)OT@08^+KZC+]M3(2780;E&,/,(:RY$"-0I V$%M0J MXPN&&?6/#OP/R26U0CEK."NHXU37@L MYP*0OD90Q/>_^>J@C.ZMG1ZV5F3@JT0&:_)2@_U),7XI,D.LY(P$4_+@A.;" M]%:6KQP9;GM?=C]Q&48J+4LLM& 9WL@(32SU6.^(%SO 3U_([!X M;WR"#]J]HR:D%3Y,W,D%@#0/Q' ./,"%0#0B$"CQN708S6C73O[WQ_N4C488 M3T*!OFP;%+$1*XN6RBAN.;>B=W'QJ"9A95@_0:3MJ.9= %W&+ZJH?/EI"!=B MUOY2#[""YL-,:C5:1,6!%P9E--BG)2>:>4%TKB/G15$PWEL%YT'D2E[[E;^; MIL+TJX\ ZHN!$C :/WZ8;-<&7WC%2+0&;X5!X<+02F)S'VFIHG3EXQ'9&\ID MG/ F1HYJEL.RJH$ +$'KHDKGT3E>Y+UU'?@P2*5=02W,79G /)!UP.790$R.N? _*@G- @T M.QECNG/^D'L^(Y]=0 M'S5F=%PY,[U^F38N>/;;0?]]NI8*F[.R)$(QK%#-(S$%D\0YRPTSOF2<]^WX MOY-_?3#-0S6L\5X9H!>QC!=F"*)?#4M@,:<8&)<,*^KUP+#N@2)E!7,E,'SB MO8Y8:5P3[85%10K4* >L9N-S*1^X.WJ53$^&$F!N"2\D%E,L"J(<5827JI2Y M$-B"HZ_(<(\!&7U@> 6W10E64)Z*C92N[$)$2Z=,7BA&N>N=/727"MV:Z$6! MN5F6.5&*6BRM*(C!,IO>YBJJDCHL6MRS4_]6KLRT1,]R7DR[5#ASO43$P1OL*FC5EH*]H#Z((E-26Z MIT&QCZ DEE;F-.>"1]-;Q\2WPJ<2X/:&'FN[#/YKTE2MKU(5W8VA6BU]L,H2 M8*58YM?E8'7!;]R4)<]U+FU_"Z9M2/SN"J'EA(R!Y8;P$ WPV( -VR*V0*%@ M411Y#+2WJ>B/V';H@=7I9,E $CMB14Z[PHA:**S:7HB\P,8__56"V\+6D!V!!R4)<=V)G8XZ!@J%#G@)E&J[(0P/3SWG+] MAQ3EN$J0YM(;ZBDQSF,Q_0+4;PDZN,=V*,%*JN,C!FF[>/JZGC0/D\7G(1?, M6<*POZA$W[EQ0-1>6NFY587L;W+//3O0UT22!9B\3H.E$PL' DE45$K,(L+ M6S)3 %QZ=Z.QHG@K@&<#QM!ZN2=%,F-T):!2HG0F!")RA25C2T^ F4JB3*F- M+ZPSLK?.BS[78%EA?(-3.F=YB8RU5%AYLB1&P0\12R$8E9S;_ML^?:IPF%P\ M+%\);#13C+I '"VQF2OS1%M;D, X]PRL"VK7G@7\W6R^(*Q:OU<7ZWC?? M@SL39\O2TB"PDU1*%N? 8 M.2IX73AM=&M9;3^!W.9NZB'I_"FP7A.!Y7Q/V M6SXVPV'8F H;SH4R>!6Q:4Y.I(B8; EV(WQ64F%%S'NL6#Z@LC8K!6GT 3M7 M:V\PFA-^&&T="=0ZG0M@WOT-%ORN+-=WQAU7P]"<+0_<.H!<4$7$DI&QP&!1 M@14D'0TDQWA$FROLR]Y7^%\C[N KS'IC(!0I:KP2FX1:(F-A0:%0GH@B=[I@ MA?:^MQ"Z=X?[FIAF-%[0F!/NL*]C:]].>_UI?Q_%Q:-[7 MPX_!3B:W_"$P.GU,JO [$,+ [9"@#T8Y;0H.D>6"F"*S_"FT_$@A[X,KS MN?12&D?* BLP.6H!FA08/(N%2K=;NK]U5!Y0!,$J9781@F9:8Y>;T.7Q6*<4 MB0 #H;D-RO37S=<;+7E-S%.Q:&,L"??8TC)BTA!S@O@<)&JIK8]A[8KOAI@( MRI<:LS%$3AV1%AF39B51>5"Y<*X(1?^Q^.MBYF,8FVH8_"O3#-=3U&0]@> @ M_*DT7A#X!PMPY/JM0/#7=1.JH^&&E='TEENFF"$E M]18@PBA1$9A_R20KI/?!V]Y"Y)K$LN?H='[QF-ON;]QM 6<$+7Q@00Q9[/@:N MB*:*$;!XF.5H'^O>7;#=R_'W@52BE P+A$K.-'H5(\%2:407Q@)[!-W*]S8C M^_M=2@=U''\"4V=CS)*H"B<%(U$8C/LJ/-&A8(2SX 0U(+W67SGE!GB\W'WK M&]<!L9QZ.!I@/:#ZYMBUIE".8-T954J\VN]=$./ZJR(_%J=KX"4' M0UV2@BI!)$9SI'I=15[F+/>Y=J%W3M>'51-[@^)_ M:8<]JF1[/@B]7!E0C E@KJ?M"TMPE6#Z+*ZFV-B_N)/0F2 MR1A"3KPMP;@H9([J*\P>N6*%*PV-O5/*^I>5M4(O9,@=Y<9I$BP&UCGT#:N" MDKPLG:>">=T_RWSNS +#S7\9Y-I)P-&H":Y*^DU7=^E@[^/!@_1MA<(;7Q:@ MVTI4=0,6K0@PNV=6E3QZ)4SO O&6M9?PKPD2U2G\N 28YP>L6SP61*PD@RXH MKZ/CGN2%#F!^J()8JH%NM08>1ZT)_>ON>+?)CJMBN]-W LF_^NR.TR5S_$L] M//HK_/]M=0+&KM\8,T1YZ[#DJLP9!5[LP&;E,1"6&^/SW @=>DO(OTQ:4&W: M=L\!E-K407<)/J_KR= G7GQX^L&0F7Y/_%H76@0++_<(YC)*$+E,$E9Z%THG>-[?%KV]N9/M!1Q+;[B@Z%:, M8 *%@F@5)'&@R#KNG(^NM\U>OTZNOPSJVI^]K-JC29LRH]^^>)@0-"(O*;;K MU1I=#*!8ZR#AMX)Z'K1TON@MP[V!([?K9(X>OJE/=V.<#38X*S70%V822^L, M4518$KT!D9B;*&/O,A90FSJLQJA*O1GZZK3RD]G5(3[ZI0;;93^^K,!*&==- M^^+85,V)68/_IP=T%JGRGBN\@(D>:QXJ4&S TBQ4:4QIM#)E[UQY&U;Z@R_= MFMV&U"*GPA@!L E.=W7G+0^"A,@!@#0&U=_N2=>-@?$^"3PS^& J@-N4+SY, MRN,EE]1JP@662"SP4H/"0G@ )25HPVU_FS7W&ISWXSZ-7!6NX)@Y)-&M@!4, MN<2&?<8*[4&;Z5_/NJW7_?ZY@,ACX(7!%H\%_#"@/Y54$54(05:$LO0[<],$*QW1NJ* M5*\7^^_'IQL#)VN]]-Z2PEN.28(Y43PRT)BE+'/)L6A\W^#TV#G[FC#!,V,+ MYD#&JX#7.91HO#$MC,Z=!_EOU]^3^P9BK2!47U,;6AYZ*['FRQQTGD!$R$&V MQ9@34[J'-6BU=UJ_9857&]&;O!"*$I%["8IK+(C1 M!NQ6XV(HE75*]TYQW?PDXQC@W(7TI(C!$8G-KBUSC/A2ZU+S6 K;6Z'2GVB+ M%9(!95$92[$A3(XE_ZPDIB@HP5+%DH-11U7OHBT0[_<_#4.#.?Q+_ BT\93Y MU3W;%)( "!CA05(PYQF15F 9'%\0S\!VUL*H8'O9>?0K58L^U-Z!G@,63$KI M>I 6+#HEK0^41(G%IB*UQ IG21Z4,F7!)("O;V"[EZ#KXR8\S P^6G OBE(3 MD^L"6:?&UCP>=(E@@Z&E]1M?,./^DS/OQZM)C0'(>DZ8Q5ZW(K=$,Z:($K0H M05?DHNB=>VH30+N>B%%J!2N=SHGGV-N68RHM5AA@6N9.>PO_]5:I?!">BFN_ M\G?35 9,Q8_8E>U"$7P8C1]OC-IF16 N,%(X!]R?>TN4#EAYN9!Y 2R#V5[& M4ZZW@MJC\&!3IPPKHB)1@(@ 'L- ]2MS4@*DA*0L-YL:9O6R.NIN*GUENACU MY=C(=U@*\=+ 2! 9#U/%BY2#"<8(M_!#T@(@K44@-EA7Y-BL6SM,Y<$>>M0Q*1G-=6_I8$E!W06><:[D/DC(60@JN2@$"U M!'XUQ!CAB5#4*\>,*T7O@M+GA0? .MR/>TV#YBE^]YQ5LF"-\Z(1*^D2_!6\ M.0Q-D_:4'-C ,S0?;O_PG?)\_M-,SV'L#(A;'Y-D; \]%8(6X()98TAI?(> MV0WH@5YZ$JGBRKHB9_WMH9+JB ?_ 0[J[!"PMC4NE17_Y6SYR46'WN+)P^1 MI0M2>T$^?RQ(;@2Z!94DAG$LX50P:G7! M#>U=F<+UQS1_=[^&12DBX\.):?[ +@WI#XRFW9BP#N9-KLI4#!Q5:=#- !NL M +GQI@(ZEBA^H8-:Z[6OBH&L[ALV,12\3SG7(&=18K<@=)#I28Z NBE=2RGI#X]7 MI2P\R/TB"LQQBA&+_ KBBZ(P#HQ>KWIKV'Z7K_.!*&M<%R6L.9 \@K4J"RF) M+@(8K[G(A2\TTZ:7%U(/QG]U[?=^S4_XZ\3 Q^.S-1:6[8'3C!NP);1E!$1- M)#* K6D4<_ C9Z$4S+.RMRK#QO"65:IXM@Q4N()880R198A$69H3:H"KA%B8 M*/N0/;B(%XJ;+,!^S; 4DD>N(O">A9,;Y&U-Y7%U@,:0IK5 $"!J$P9I%KN0%VHB.* 42/)HB1 GRW/>W MC.;*73ZW@PHCC!*V&J@4T5GN<^)RB;FHCA*KL 8X+XJH&=5<;>H5S'V5\U\E MS5B>ETQ:$DJ.21U@C5EEM+E?-OQ6Z>J5RZB41I0;-0$1&E"PC"39( ]93KF7O M'(/?E8LUQY]I#M9+3"2H1^OQGJW)D(TJ"!Y*HD6!!4)I(-:4B@CEG&66&3C7 M!P&C=\8= STV9\L#MY- /9>X]L9HI8O.RU,$+J_M[V7)%PY@/ MH8DU>BYYM5RXO@)N0[+L5TEF M0IFBP'((EAL0A M <]CO8L,[6/@U4I!HD _!*5!%'D V>,9,4[E)#H=K ^\B+QWSK^'U8UW?[@Y MHJ^0>6Y Z@F>8[5JY4#J*8'=(@0WWANW_I+%WRU)](H:QTE-@44Y1V(N4;T6 M M@8&%I16M"P&352]BY>]4'%QJS KY.1/&&1&)\P9,LQA M2R!3U,AC.1::^%[5ZFN5]5#[^<: M)&>:6PXF -9.)[((DF@K"K36&!.TU([WMK#0QBN)/6"RN6#P:NG@S0:#=Z0" MC1+6DC/*6VJ#Z.TM\_=7*SF8CT%R[ND)_Y!\&@UAM $1%Q"*\!A@I M\-4R%,QS[8-XE[2W]5WN M,7/T&[CS78CS76^]7Q_ >5<86@0KX;?*!Z6T(EQ0D(O"@N**9CT5>S)\US9F*THK]5W-8/_W;Q]'4]68/I MNB8ERDH;A0N$@:*++78M48%20IVE6I4TQKRW07F/N"1!'U02:V.II266&KP< ML 4HE3(GW(H8E&2Y[5\SQUL&!6P,43L3@I"8(II+(F4R7JD&;5$'9QT\[E\M MQQN%Q;V>-&#O3IH U]7G_&WE10'W.Q.:SE8OS2& DR$0A!96DVT,$">0)B, MEM[9H@^&\9IPW[L(-E&>2E\2Z0182E0$DC/I2P6LJE"]94M]2NWI@80IJ',Y M^G:4Q5KA!B\X D:A<1VM+4KG5.\\I?TJ]WP_AD+!E.:%$$13#!NPJ15J+HC) MN<):PCG(HK[!;97%^-G#I$;F6:XM):5&)V*)O3!*79 \1J6P[5F9]S>?_RZ[ MWGVJ'R95<\68 ]"7*@(/+C0'P>I*XG)&I2J\T+J_[I_>WENM4.U# !G/T(J7 M6'G*E\" +2,A-])[7VK!MP1Z)P1Z3PR:.\$*+PD/"@C4.X[P+PEGC',;L-)D M'ZK-7 Q08_=R4MK*,H!B&;$N#X/?L)6;S<$XSKT(JG]I8^MOX+;Q/O+U&)2% M**C%R^681XV-P'*B(]C5GA&F3A&$!TT)SS7(BH5L2)UW^#T MV!.XSF/"2>^NX=Y$&U4M,>#A)KVMQ.ZV) M;029@P[M20P"U+@<&(AQV,6&@^$C?*YMT;N+M^_- _,^Z=UF\,%4( A>F-%Z MFD.N)T>A"*7-74D)Y5BVDN5@!]G@"(_">:VC]^NO6O]]F[_00.TVFR]I8:*/ MF@3*0%$T*L4WE,3*TEM.C53]*]E_<^WCMCTW>L-52LX86(!*M)SH(@,@I# MM-0%B18^*(+*->U=".?Z]?7'<>M0BD*PDEN2EU@SBH*T-&C$<^:"]J#TV/[6 MC/]^_>:P!KW[XMB- 97DGHJ"$Z,MWKEK2PS5.2D"0$SZTCG96ZFXVB2&Z[]V MFY2WPJ2\4FK!"HD-)3!_ARI'=!>:I0V-.;8>[IV<>.R8<#$"9AD7OJ%>+ ^] ME7I1>"VPO &E&,SIL,8!EF.EA?2B *M,EKVKY(](*36R>,[#3 M:8R%+SD/O?3L]_K:M \6H'*T$$J0X'.P B2C1 &]@0SP!EXD ^T?7-?/2+N1 M[72, 6+>&#K5LHA4,>(#0Y&;1Z)<* FC$N <'%>RMYK:]W/1%[CWX?AM91O0 M[S9&TAE+C<.68!8+('+M@(UZ,.QDKA15N95Y;V\6KG!R=DKU:-0$5R4J[.IG M'^Q]/-@8RO%!!QW%P;U7"CA'*(P3JE8" MDA"$=QX@7% +*J&.Q,22$E[(R$34/KK>>J#O5,O'()6-X7Z1FCP:12)%%FAB M03026T&#TY*%TK/>1#OW(%.OQ"H] DR TF!A6&8EL=H[,-H**T-TP?;8 M*;GYQ'DO&# !!2V!_[=_O)BTX_HD-.TI7D"8:F:SQ[.99D]G?^-4ETP[ M@C%?S#A=&OSZG;.U":)7S-<]_,X9?T,5U2<^ ')V#W98.?.R'@Q,TR;\F;\L M!7F'Y2G>3TZPYDO=7%Q/U=:2L_+9;P6Z* MI^=7_XW3.'CYQ>%>APR9G1F>_>>_*0#0\Q;>WP2897B4C8,['L(RCLZR MT<",,6!A)_MC6'\:9J;-WIFQ.Q[5U7!\^&XGJ]K,9.W4?T4LI97:/Y M1!GLR!UGHZ9&E&HS-ZA09&:?JO%QMO?[_LN=["#]'#? 7XWK N8R'%QG]3#S M ?;ELQ^>',*H)S]F^,< Q*MI,F=&\[)).YF9P'$C869CV*Q?*H"1U3&;'L5. M^GX,)I7Q@9TTM05>E7DS-O#(#,[&E6OGB]_-X.T_/45PW0/0LMF;GX[.8Z:M M&\#LA(I\E^?1NFY\ZUF+K M@5_:M[KAOG][_^;PUW-P\&;__2,]F+_M'?SES?M?#_??[V0O7V2O_Y%S5K "K[\CQ>+(M""* M->>FQ&AHZIYD4X7Y8XAH(SE#BR!829QR$EN)%\1:71(;!??2.Q&$>)(-#5I M/E3/7M9NFSKSZN$\5>/ MY2J _^>_Z5(6S[^!]G>.AR#UWO^V]S;[^.K#_L?#[+?W+U]]S$ H'H+DRYC( M]C]F+/_!_YCMO\X.__(J6Y*79.Z CP]FJR.Q#\MZ\ZGPZY^CL M&=@W@9S 6X[Q:\2;,X);)V%X;29SW0WGL$F> N4L M\-MN>-HS]W6"X=]A']?=\Q?;O1\D?(>5_C)TPZV7W]*K>J=NK5;]H#J8TD0L M L\G3"DC@BG,"%X15]T\S__].TW7Y W^SW]C!7U^[[M;>E%Q M,_*D8(A'Q041L< XEP"6> [4*H7.2Z-I+(NX&O+\&([P6L0,QQCDNE(2_>;F MK^2$U3"P[6CX##PP6?5,*O& M;>:.30,KO7_'U#=.XYLB^WL(?(SAN!?NP?#-U? (EXI/R<"ST=-!,,K/ M=YXFE_H_GC]Y>L5#_I5G2U_\Z>FXN;B&Z04U8M.E1_P)=D-L$\P?S])/@A]< M(G0NOCS5>@"C:#H*,&)V,%.8LUV\4VSK0>6S&LK-PVT M^ -ZV[ SN@E+V; M_O!F]^/NP6[VZF0TJ,]" MT\']'+5G[^O=2X&]);@M,FVW>/^$L,E:C#6QS$$M(;D)%-M/.J)D\"3W+K>* M":7*%?DT][QOL)94]\_;:AC86C48F?UM-Q/Y^#@[&._NW.D5X3>1][O!%."D M90G:I;>V!##92 S>^@2OO1&,"\7,NL#$UPBF@PE\.\LIS?Y-R[(70+K.7>T5 M4/*%%=0;16@I.9&* 8?1I2=*.\FCYS$&NU(HO8!?]YO#^M,ZC6)D07^OFS\V M'3I%A(,V$2BG2&G"QL)O)A)M"ZYT9-&S8J7021K^/O8N/JV&;A5^XBM!]/>M MQV+KL?BFK.<8$< ="9H)(H72(.M-20H9/2"UI,"'5TH '^IV; ;_MQHEO][Z MT)_!%-\* NJ1OKAA9/+#%)IXE3)J@)-5(S/(PN?@)N/J%&]8P%(-[=8?\1"V M^ -0:X;D^E6/ _R+-T0]C*&ZYEUQR*4*1>D(+[!@#Y.@!N1:$<<%YYBCP(6^ M=70E,D)@%2MB?BNX%N6,_WBG6MRM BU6"G#I"NL"Z'W6HK=>%HS84BBBO).V M9,)R?6OE[VT-I/_AN![V*7:'8X9-07L0NG.? 0&+B(UYVNXX#,((@94-$[1V M,A!M@PGJOID!L@5D\#?)5OD^9H>C5QG>=..\0)#F3:8R$WO]/GD#0(:]P?1PVVU"#3=3H70HSWY(U8D]9W1:X; M$R$X4,D5=D:1VBMB"E"T(]ABA8ME]/'6?O.I@G/&N$W28XWNJ!=O]PX.LKU4 M4V'_?79PN/_BKSO9A[V/V>][;W][E?T[, S*L@^8\O&7O8^O5N>[O1??8R\< M*G>*KZKT!O U)]SRU#J98J2D)5H66HA@?5&*V^+K5$YU8FJ=R/K^]X,M CZ$ M/5X;Y%C$:MG)^OO>M-[\:\W>L:^'Z*_.^;J1#XNB<0^)2#^+] M>-_>[[]_M0'^$57LEE_S9K"O/>.[7*W!V=&#J[0;(O]5R/!FZ#&D,V3V+'/' M 6C]!(OB5!WF+F4II=J G\)@0+KB@6TP;3W$C*6VG:"GTK29#[$:=DE,'R> M4)+F,QI8(AT@A]WO%'$GE?>#L%DG>T,S]9(%;9)1^G=X\VU8W0ISZU<%QVOH M)26544@.'$/E*N=HTGQ_#L=(O!;B;%ZB7$?M3:V,N.<+5L:8V1>$J$*@U7V.3$%_,G ALV# M"<+K%94&^+T>3(9CTZ02'LT-RB1M9<565JQ&5GPZ#BFS\(+ ^(']F!V# 8%2 MPF=F,)B+BF498L-T ,SY%;&Q9&HL2Q!\C'6),@]/L3 Z#,6N1B%=O3&>I7)R M;?8#S!?A_^W$'6?M<8UU&+*N>0)\QXPOKOV3:;^4=.G+TSW\V!4F_X%W>[0A MP %/[#]A!S@^#84OX2JF\V!AJS8M(BW2M.-,T\R;LW8K!GLJ!J\HAI='8X2V M1!BOB2R\(2HO*"E"619ECDUQ;NV4[WC\M&QB5P0-??1C,[Y)1;ROR.A'QNM7 MM)_.C?J^[HN&LQ5AZQ%AR-J!JY]4XS'(@3 [M[40SR!P5F&59#.LC?(,+ + MQFG(7F)3BM>=471.PBWF6+:2EMUI'\/19-!E81^0P^P'Q+#R.1=\=^YOJU(% MH1%6$%JWN.O6.Y=BH?UQ*Z,V2D8YGMM@+4B9:"B1CG.B:0XRRI0\!I1@C3.]R+K]V"9KO:BJ^-D#M,OJU&;C8%2J__H#[CRK?L-NRMY?3QC(?[.-V MULGO'QR,][;0O3UT^Y"J[E4A!>B]1(L0B?0A!WU76J)U:4ME<["M;MW9X-6\ MU';S C#FJ&[.+HD]2X,2+KGIH)N$H5WMU;]$05AGP?IK&5D/EU(NOUYX<'SP MX"K][5ZA?&T07I6T;80KI6!$*VR)HPI'3.DU,2'PW&C'I%I1QWRTYK+I]RXWJ"MY=N8O[\X;$K[@=,#7^FN%(Z)I/#GE0 M9C N:5QGD[9S6< N4X>XKD-U\EW,G-_H%,=W#<[PY:FE-?I"AK#L&J48V.I) M.1J:H:O, *TX+!B.@]NQ&7K3^';6&ON*(''Q@[D\V.E6CKCU-2MZX/4&OO_" M9QJO,-5IL*4Y^J#,>!RP/CS"&,"-_1S@M>8HW>O/:SV8M@5!CA_-4"#$&))W M?#BM;(3?K)!=8]=T7&=3#[(:A. 2VBW4J0D@?;;[L'NB]VLY 464/@1-[[8Y32YP0Z RR\A=ZR:D^YF"(Y^9' 0 MT$.* O=IQ6;BJ_%T79=C\@W1] K9(XJNA/HHLOC\&!\,GZ% MI_!B?C9;VML(VOLZX:3+):21&O2Q#LT7V#^CU25Z2F)G'GV 0Q1D# HQ1#.'_[,H7^J?VBC+@=1-*!* MGB(ISU\^51B76F(!^_.^)GXX[QX64H?#7DX[;: 8KRLE".2&4,D674Q$@N M2:3.&05K5>6M*UE.G:*(K),5IG2Q(M)$Q"F7Z)[":$Y#,*-7'9QD - GG%*8243V&V>:: M=)=LG'6"'VR$F4Q<#!0''8Z77I0M_B.^:@4IWC^C? ;+KTK MMI M%SQ(2]3_?KMZI+>@@"F]OTYQ M?'!RLS:GRD0>+:&Z4&""*TJ Q O"9(Q%"(4JJ+I(\+*0>6ZX(8+G!9% ]F ] M*$$*50INO#>.Z2\)_D/R1[P>U&;\))L,JVZVW_[QV\'+)QEV@X?1] F(+%>= M .W_^0D_SQ:&DQ/BZS&9#GCR,^,[6I4[LBAV:3FCZ-GV5G._>1,([V:O01D& ME7($JO$<_6$GP(T3T9B!FT8![Z2$&5^AVEPW[IPIWF!D)M9SK^8HK==?L:^\$J]](9_]=D",I4F3B*O$X3B3NE M:2%H,%2#B<]S$.).&Z)XX0A76$Y*V^(2FG8:.W*[0!PM08A;YHG&T.+ ./?, M\TCM)33](J%98KP'"0'W)^/D0@=$/T?D'7HN4_>;]Z^_1=_Y3D&+'2%9?XA[ MB8)U0K,O6D5HZA)U9-3:PHJ8"]%, ,JD7QW*W=+*Z\D^W/[N7^R]^>_?J M_>%!]N;]B_V/'_8_[AV^>IG]\O?LXZO7KSZ^>O_BU:WA6MZV3/A#=NF\KX?A M2O2[4(5TWMA^!7L_7[^3[W(LX.EKT ?"K=M8IY7=Y# N[6/MJ].N_B^>QU$@ MP]J'V7=@7?AXAA>#\)ETDAL8$KI$)B?#YR U1P-S]@R??EG7-:^ZYS=Z1ODC"T,.9?<8-HA=G?GR?KQEBQ_BJ&<:= >&GIW#&TY\(D.-F M@9\ C\[C8R(L\9D9?#)G[=25M R:V;DG1+WLT&]SMBNE^CL^UGZ7Y+]\[$_2_$_ M Q!85X+F]?['O^U]?$G>[N__]9:=0/ 71OY#EG>>8?E'ZE7?-5L/U"WGP_N_NP M]_$P>_-X61OK 6?;4N"CV.2FDTI_A=5]:*G(LL5=**1O0/W,V.X-6/2#/I99 MEM]6=/5/=-V_(KYJ\MM;7?C>>FF/W<69?*S:/[+7)H52/%[ZDUMY> 'Y\KLC MR%\V22#>R;G\-FQ"6P\P;O]@;&),X1+H-7N\%,K$5D1>1$5S=S3Z8J-H]$X. MYL69Q9O2KGO:EC"WA#G'O^+.Z))O$EG>R;%\:.H1;C=L9>56G5W@7GEG)"DV MB23OY%C>AB,SR( P 9TPQFQ+F5MAN4!!=6>4*3>),N_D6-[!P^S Q# ^RUYB M[DK=3IJMY'SLDO.>[M8>_@X?")6LZ/9PLX78/1))/X)<]#T&N3SF*)?^WE4\ MI@B01[')3:>5K:"Z,^,JWX1;==CNR3_NY :O*ZB1BJI^G!<?9ATKAC,RV/T'UWJ?GG5B+V4"+>D_> MW4GH2*+[8H.<*G=S+/_OQ]"&YC3X_^\1DV2^E;P7<.\&.0$W),ERDTCR3H[E MW9?EJ-'=.6G;:EK#>F^IH.;K>9'9%_70=T72<0S0]6305;G='X7NY8]9[!9; ML7L!F>\NB%QM$HW?R;$LJ/9@44 7R?9@,AH-TM^F.4N-B!\OS?)R*Y=LG.]E<874/CNPO#TWB:1]IV<"ZC.V+ZE$\$I]L??,+1@2YT/4N[> M742>WJ0$D[LYE_U4#O_-L"LE"M_9TN56:G;X=W?Q>'J3DDKNYEP6:BQ>&YD& MPV6Q,C8@WS#[KTE3M;Z:-HM)%:8_-.$4O@F4W(ZF761N>J:;3LH%W8K8;>C> MPXR[ZE(/^<$V;W&[=TD<.\AD%[1WPH?CRF@[5%L*S7$#V6<_>% MI'<7B\\N*H]M4JV.NSF7:?#Z6;;_ M:0BR]+@:I19A< *F&F:_S!OW39\G6;L(Y9O&Y$U#Y[&1V/G0^4=*Y.4V]/8B M,M]A;==-JOYQ-^GJ/=P\: 7.YN+W:F@4"=RIV]@>E!:OOP M>#7JS&%B\E_F(FOQC%\I=?UJBE[8ZJ'W,,)?6BJH:M&(*D7\7K9ZQ"F M ;BA.05C^=$*Y&W,[?9B\H%>+&T]OEO\6=7%)+]!R/G*+B9_?ZS"J;^!J8_I MRNY1;'+3:64KI2YR[+O+L&#YIIA?=W8NKSX?5[::)CE>DOV8';CCX">#QVMX M]4&VN3[U97V,*N8#8OZ]PJ5S#.].@N,/WOSZ?N_PMX^O;M*^]R'@H/KJU0[\ MBYW9TZ]WS4RN-L[6T)[>5Z>9&YBV_?.3D3D*9%C[,/L.K L?SW8_")^)3Y<) MB&)P]).3X7-?M:.!.7N&3Y^/C,K;9[(&S%H!2,[WCX;#GOY$R!S/N6 "3,?%3(2U M/C.#3^:L??[DZ1R$\Y$= !).7G;ZMSGDS43RQ8'>!7O**H_S?W^C]J\BV;)3 M9@5GU+5RGYU1#Q;TU:[RH^L"[S9,X(9*W0KV_KMIJGK29@LDR?"A >'ML9;# M^+AJLR:,ZF:C$.&E9HX(G=" M3#)%S*5WI@'L>:H3D5X:LI-@ACBHCNG/&(!;@$G4SHLD9@/SJ=W%C+HK)LU, M$S)K6EAI/F+.+G[TJ1H,+G[6'M>3@?_BTQ#^N/@9B+OA MQ<\JA*:??0@KGWYNAJ V52/8V-(S/,UA.#(ID@YSAP,<,7SNZI.1:5#MR("7 M +X _AV=[> C.!2_J+$%P[$&YC@ 'M: Y2Q_::0=;1."N M8A@,'HT&@"#I;.IL FAW@#AQ-4(OX=X R#X,SA '<:??P$.$QW ,P]N)_2<, MP/IS "FBTU] M F=8MZ'+-L6W+=##)W1O:GPC_ 'P,M,9\8"G[[QJ'3O(%083E/P[<'KC;%B/ MLT%U4N%4"8S9<')B83TP5S33^.LI43V[6B'$RV\RJ-HQ"5W-I\3T -ASBVG* M49%[/I.[.5?_<5XAO,B=+U7^ &C-^'GBPP1?V3Y#N'76RP6.O6"B\#91_L=] ML7"Y6^: > O= M[+RZN\6[+=Y=P#N45P#U5%<#-9PIRHV1GR-K.TEUH;<8M<6HZV(4JE@!=&+4 MO$#:^HGK(I]'#7!@VY^)S4_$]Y%PGYI^H MY\.VZY.P%85;)+N)"H:VYE%G;Z%$-"[95 NS:5 9&%&-S[8HN47):Z+DS"<4X*/ZI'(=IG4M8!8>H2U";1'JF@B%'"S.0WK< MN38$B\]Q;U7'K+[I3\,9IXP-N5QMDW=N&%!$8UWTZ:Q@4*#[XYR;Q'3^NT_' M ;\0?/!;3-YB\G=(Z\X9?X4G>.%:;KN&66!X &:^ 6!F;&=V*_'+%!FG=Q([ MT^=[L^01H/]C+P\#B [C1UT2PJISK!VQO,#IM](4&_NX!P9@(S7;B; %[UU8L)T-W0 =)= M/)KAV(LQ&<(D6%DSW=;,EM:MR@S:.CLVIV&^ M@,SX4S"%X=VP+M<5IC]_P[2;O?KLPJB[Q,*7?:K:,+M*0GZ;[47!T=06M-%XVAB!S L7;P-D7R2I8YGNV@%EY 45I"L_-1LKNH0 M_(C%%UQ]APJ:=($3252Q,TSU+M-%,TET8:-GI (8 BTDG/R:C="LW M3L!?G&V7O@OC4S37V/R1OE3#DH\ZZP^^VNT H#B= \Z_":=X0 B^J^&V@Q(H M0>["51/ZZJM%*>/Y=5\JC9HN9>#$$L'AV/IQB)8+GJA@JVX_6U#=O\X8'R[7;X I;*S/;#F MY&XVU^CG#^8&\O3!I+WX"5A'\X^>? I/.IU]-D^R*\YF)G0*U4Q&V,4WXW

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�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


1%J+$MCDC&O0<3CRQ,7@P+5]+LF6W26!"#NWD5#Y]F1#*M#4Z!= M9L9KF'@U@D?E\Z"!5"CK^C U)\Y#252EH]>L<0-UJ(H['8AAN-JD-.E /F>> M0R!Z!NXGJ*C,F$?[9E?M+L:WQ[

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end XML 69 cnvs-20240331_htm.xml IDEA: XBRL DOCUMENT 0001173204 cnvs:OTTStreamingandDigitalMember 2023-04-01 2024-03-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2023-03-31 0001173204 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember 2023-03-31 0001173204 srt:MaximumMember cnvs:ExercisePriceRangeTwoMember 2024-03-31 0001173204 cnvs:OptionsExercisableMember 2023-04-01 2024-03-31 0001173204 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2024-03-31 0001173204 cnvs:ExerciseOfPreFundedWarrantsMember 2023-07-01 2023-07-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2024-03-31 0001173204 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001173204 cnvs:EquityIncentivePlanMember 2023-04-01 2024-03-31 0001173204 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2024-03-31 0001173204 cnvs:BloodyDisgustingLLCMember 2024-03-31 0001173204 2020-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2022-04-01 2023-03-31 0001173204 us-gaap:PropertySubjectToOperatingLeaseMember 2024-03-31 0001173204 2023-06-14 0001173204 srt:MaximumMember cnvs:ExercisePriceRangeOneMember 2024-03-31 0001173204 2021-03-31 0001173204 cnvs:ExercisePriceRangeTwoMember 2024-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001173204 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001173204 cnvs:ExercisePriceRangeThreeMember 2024-03-31 0001173204 us-gaap:CustomerRelationshipsMember 2023-03-31 0001173204 us-gaap:RightsMember 2023-03-31 0001173204 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001173204 us-gaap:DomesticCountryMember 2024-03-31 0001173204 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2024-03-31 0001173204 srt:MinimumMember cnvs:ExercisePriceRangeOneMember 2023-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001173204 us-gaap:CommonStockMember 2023-04-01 2024-03-31 0001173204 us-gaap:CommonStockMember cnvs:AtmSalesAgreementMember 2023-04-01 2024-03-31 0001173204 2022-03-31 0001173204 cnvs:HoldingsMember 2022-04-01 2023-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember us-gaap:PrimeRateMember 2023-04-01 2024-03-31 0001173204 us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2023-03-31 0001173204 us-gaap:TreasuryStockCommonMember 2022-03-31 0001173204 srt:MinimumMember 2023-04-01 2024-03-31 0001173204 country:US 2024-03-31 0001173204 us-gaap:ParentMember 2023-04-01 2024-03-31 0001173204 2022-04-01 2023-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-03-31 0001173204 us-gaap:RightsMember 2023-04-01 2024-03-31 0001173204 srt:MinimumMember 2024-03-31 0001173204 cnvs:OperatingLeasesLiabilitiesMember 2024-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001173204 us-gaap:StateAndLocalJurisdictionMember 2024-03-31 0001173204 us-gaap:CustomerRelationshipsMember 2024-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2023-03-31 0001173204 srt:MaximumMember us-gaap:TrademarksAndTradeNamesMember 2024-03-31 0001173204 cnvs:ExercisePriceRangeOneMember 2024-03-31 0001173204 cnvs:ExercisesPriceRangeFourMember 2022-04-01 2023-03-31 0001173204 us-gaap:ParentMember 2024-03-31 0001173204 cnvs:StarriseMember 2020-04-10 0001173204 us-gaap:PropertySubjectToOperatingLeaseMember 2023-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2022-03-15 0001173204 2024-06-17 0001173204 2023-04-01 2024-03-31 0001173204 cnvs:AdvertiserRelationshipsAndChannelMember 2023-03-31 0001173204 cnvs:ExercisePriceRangeTwoMember 2023-03-31 0001173204 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2024-03-31 0001173204 us-gaap:FiniteLivedIntangibleAssetsMember 2024-03-31 0001173204 us-gaap:CommonClassAMember 2023-03-31 0001173204 cnvs:OtherNonRecurringMember 2022-04-01 2023-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2022-03-01 2022-03-15 0001173204 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001173204 srt:MaximumMember cnvs:ContentLibraryMember 2024-03-31 0001173204 srt:MaximumMember cnvs:AdvertiserRelationshipsAndChannelMember 2024-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2023-04-01 2024-03-31 0001173204 cnvs:ExercisePriceRangeOneMember 2023-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001173204 2022-03-01 2022-03-15 0001173204 us-gaap:RetainedEarningsMember 2022-03-31 0001173204 us-gaap:ForeignCountryMember 2024-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2024-03-31 0001173204 country:IN 2024-03-31 0001173204 country:IN 2023-04-01 2024-03-31 0001173204 cnvs:SoftwareMember 2023-03-31 0001173204 2023-06-14 2023-06-14 0001173204 srt:MinimumMember cnvs:ContentLibraryMember 2024-03-31 0001173204 srt:MinimumMember cnvs:ExercisePriceRangeTwoMember 2023-03-31 0001173204 cnvs:AtmSalesAgreementMember 2020-07-31 0001173204 us-gaap:TreasuryStockCommonMember 2024-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember 2022-04-01 2023-03-31 0001173204 us-gaap:ParentMember 2022-03-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2023-04-01 2024-03-31 0001173204 us-gaap:SubsequentEventMember 2024-06-30 0001173204 cnvs:StarriseMember cnvs:StockExchangeOfHongKongLimitedMember 2023-03-31 0001173204 cnvs:FoundationTvPaymentDueInDecemberTwoThousandAndTwentyFourMember 2023-04-01 2024-03-31 0001173204 us-gaap:RetainedEarningsMember 2023-04-01 2024-03-31 0001173204 cnvs:BloodyDisgustingLLCMember 2023-04-01 2024-03-31 0001173204 cnvs:CapitalizedContentMember 2024-03-31 0001173204 srt:BoardOfDirectorsChairmanMember 2023-04-01 2024-03-31 0001173204 cnvs:StarriseMember 2020-02-14 0001173204 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2024-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2023-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember 2023-04-01 2024-03-31 0001173204 srt:MinimumMember cnvs:InternalUseSoftwareMember 2024-03-31 0001173204 cnvs:CONtvMember 2024-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember 2024-03-31 0001173204 2023-06-09 2023-06-09 0001173204 cnvs:TotalIntangibleAssetsMember 2023-03-31 0001173204 srt:MaximumMember 2024-03-31 0001173204 us-gaap:ParentMember 2023-03-31 0001173204 cnvs:MinorityOwnersMember 2024-03-31 0001173204 cnvs:PodcastAndOtherMember 2023-04-01 2024-03-31 0001173204 cnvs:ExercisePriceRangeThreeMember 2023-04-01 2024-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2023-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember us-gaap:PrimeRateMember 2024-03-31 0001173204 srt:MaximumMember cnvs:InternalUseSoftwareMember 2024-03-31 0001173204 cnvs:DigitalMediaRightsPaymentDueInMarchTwoThousandAndTwentyFiveMember 2023-04-01 2024-03-31 0001173204 cnvs:OperatingLeasesLiabilitiesNetOfCurrentPortionMember 2024-03-31 0001173204 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001173204 srt:BoardOfDirectorsChairmanMember cnvs:RestrictedStockAwardsMember 2022-04-01 2023-03-31 0001173204 cnvs:BaseDistributionMember 2023-04-01 2024-03-31 0001173204 cnvs:ContentLibraryMember 2024-03-31 0001173204 cnvs:OTTStreamingandDigitalMember 2022-04-01 2023-03-31 0001173204 cnvs:TerrifierThreeFinancingMember us-gaap:SubsequentEventMember cnvs:DistributionAgreementsMember 2024-04-05 2024-04-05 0001173204 us-gaap:RelatedPartyMember 2022-04-01 2023-03-31 0001173204 2020-04-01 2020-04-10 0001173204 cnvs:StockExchangeOfHongKongLimitedMember 2022-04-01 2023-03-31 0001173204 srt:MinimumMember us-gaap:TrademarksAndTradeNamesMember 2024-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001173204 cnvs:BloodyDisgustingLLCMember 2022-04-01 2023-03-31 0001173204 srt:MinimumMember cnvs:AdvertiserRelationshipsAndChannelMember 2024-03-31 0001173204 us-gaap:TrademarksAndTradeNamesMember 2024-03-31 0001173204 cnvs:TerrifierThreeFinancingMember us-gaap:SubsequentEventMember cnvs:GuarantyAgreementMember 2024-04-05 2024-04-05 0001173204 us-gaap:TrademarksAndTradeNamesMember 2023-03-31 0001173204 2024-03-31 0001173204 us-gaap:RetainedEarningsMember 2024-03-31 0001173204 srt:BoardOfDirectorsChairmanMember 2022-04-01 2023-03-31 0001173204 cnvs:HoldingsMember 2023-03-31 0001173204 us-gaap:CommonStockMember 2021-10-11 0001173204 us-gaap:TreasuryStockCommonMember 2023-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001173204 us-gaap:ParentMember 2022-04-01 2023-03-31 0001173204 us-gaap:RevolvingCreditFacilityMember cnvs:EastWestBankMember us-gaap:SubsequentEventMember 2024-06-01 2024-06-30 0001173204 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001173204 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2024-03-31 0001173204 us-gaap:PerformanceSharesMember 2023-04-01 2024-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001173204 cnvs:OperatingLeasesLiabilitiesNetOfCurrentPortionMember 2023-03-31 0001173204 us-gaap:RightsMember 2024-03-31 0001173204 us-gaap:CommonClassAMember 2024-03-31 0001173204 srt:MinimumMember cnvs:ExercisePriceRangeOneMember 2024-03-31 0001173204 2023-09-30 0001173204 cnvs:TerrifierThreeFinancingMember us-gaap:SubsequentEventMember 2024-04-05 2024-04-05 0001173204 cnvs:OtherNonRecurringMember 2023-04-01 2024-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001173204 cnvs:PodcastAndOtherMember 2022-04-01 2023-03-31 0001173204 cnvs:ExercisePriceRangeOneMember 2023-04-01 2024-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2022-03-31 0001173204 cnvs:SupplierAgreementsMember 2023-03-31 0001173204 2021-04-01 2021-12-31 0001173204 cnvs:AtmSalesAgreementMember 2023-04-01 2024-03-31 0001173204 us-gaap:CommonStockMember us-gaap:SubsequentEventMember cnvs:SalesAgreementMember 2024-05-03 0001173204 cnvs:ExercisePriceRangeOneMember 2022-04-01 2023-03-31 0001173204 cnvs:ExercisesPriceRangeFourMember 2023-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2024-03-31 0001173204 cnvs:OperatingLeasesLiabilitiesMember 2023-03-31 0001173204 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2024-03-31 0001173204 2023-03-31 0001173204 us-gaap:TreasuryStockCommonMember 2023-04-01 2024-03-31 0001173204 cnvs:BaseDistributionMember 2022-04-01 2023-03-31 0001173204 us-gaap:FairValueInputsLevel1Member 2023-04-01 2024-03-31 0001173204 cnvs:ExercisePriceRangeTwoMember 2022-04-01 2023-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2024-03-31 0001173204 cnvs:ExercisePriceRangeTwoMember 2023-04-01 2024-03-31 0001173204 2024-01-01 2024-03-31 0001173204 srt:MaximumMember cnvs:ExercisePriceRangeOneMember 2023-03-31 0001173204 srt:MaximumMember us-gaap:ComputerEquipmentMember 2024-03-31 0001173204 us-gaap:RetainedEarningsMember 2023-03-31 0001173204 cnvs:BloodyDisgustingLLCMember 2023-03-31 0001173204 srt:BoardOfDirectorsChairmanMember cnvs:RestrictedStockAwardsMember 2023-04-01 2024-03-31 0001173204 cnvs:HoldingsMember 2024-03-31 0001173204 cnvs:SupplierAgreementsMember 2024-03-31 0001173204 cnvs:TerrifierThreeFinancingMember us-gaap:SubsequentEventMember 2024-04-05 0001173204 srt:MinimumMember cnvs:ExercisePriceRangeTwoMember 2024-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001173204 2020-04-10 0001173204 cnvs:AdvertiserRelationshipsAndChannelMember 2024-03-31 0001173204 cnvs:FoundationTVIncMember 2023-04-01 2024-03-31 0001173204 us-gaap:PerformanceSharesMember 2023-03-31 0001173204 cnvs:FoundationTvPaymentDueInJuneTwoThousandAndTwentyFiveMember 2023-04-01 2024-03-31 0001173204 srt:MinimumMember us-gaap:ComputerEquipmentMember 2024-03-31 0001173204 cnvs:TotalIntangibleAssetsMember 2024-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember cnvs:SalesAgreementMember 2024-05-03 0001173204 us-gaap:SubsequentEventMember cnvs:SalesAgreementMember 2024-05-03 2024-05-03 0001173204 srt:MaximumMember cnvs:ExercisePriceRangeTwoMember 2023-03-31 0001173204 cnvs:SoftwareMember 2024-03-31 0001173204 cnvs:HoldingsMember 2023-04-01 2024-03-31 0001173204 cnvs:OptionsExercisableMember 2024-03-31 0001173204 cnvs:ContentLibraryMember 2023-03-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2024-03-31 0001173204 us-gaap:CommonClassAMember 2023-12-08 0001173204 cnvs:ExercisePriceRangeThreeMember 2023-03-31 0001173204 us-gaap:RetainedEarningsMember 2022-04-01 2023-03-31 0001173204 cnvs:ExercisePriceRangeThreeMember 2022-04-01 2023-03-31 cnvs:Customers pure shares iso4217:USD shares iso4217:USD cnvs:Lease FY false false 0001173204 false false false 10-K true 2024-03-31 --03-31 2024 false 001-31810 Cineverse Corp. DE 22-3720962 224 W. 35th St., Suite 500 #947 New York NY 10001 (212) 206-8600 CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE CNVS NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 12987466.07 15606341 274 EISNERAMPER LLP Iselin, New Jersey 5167000 7152000 269000 0 8667000 20846000 6439000 2036000 1671000 2085000 9345000 3724000 1432000 1734000 32721000 37577000 362000 5200000 2276000 1833000 18328000 19868000 6799000 20824000 2551000 1421000 1341000 1265000 64378000 87988000 20817000 34531000 81000 76000 6301000 4924000 3114000 3788000 180000 1444000 401000 418000 436000 226000 31249000 45331000 457000 2647000 462000 863000 59000 74000 32227000 48915000 15000000 15000000 0.10 0.10 0.001 0.001 20 20 7 7 7 7 3648000 3648000 3559000 3559000 0.001 0.001 275000000 275000000 15985620 9413597 15699135 9347805 194000 185000 545996000 530998000 288554 65792 11978000 11608000 -504153000 -482395000 -345000 -402000 33273000 40337000 -1122000 -1264000 32151000 39073000 64378000 87988000 49131000 68026000 19131000 36364000 27904000 36819000 3771000 3763000 14025000 64831000 76946000 -15700000 -8920000 1066000 1290000 -4299000 -1828000 2475000 -190000 -13000 -21255000 -9575000 10000 119000 -21265000 -9694000 142000 39000 -21407000 -9734000 350000 351000 -21757000 -10085000 -1.78 -1.13 -1.78 -1.13 12253000 8889000 12253000 8889000 -21265000 -9694000 57000 -239000 142000 39000 -21350000 -9973000 -21265000 -9694000 3771000 3829000 14025000 -4299000 -1828000 188000 101000 1439000 4470000 -612000 80000 503000 986000 1822000 100000 1022000 341000 16000 -130000 -11969000 -9943000 -5621000 1075000 4403000 -313000 942000 2816000 -12756000 -18049000 210000 30000 -10593000 -8796000 1069000 1271000 -538000 -531000 -1271000 43955000 31046000 42572000 26046000 576000 665000 193000 177000 8524000 9138000 4158000 -1985000 -5910000 7152000 13062000 5167000 7152000 376000 203000 446000 373000 55000 98000 1203000 89000 87000 898000 781000 370000 5000 3000000 3000000 392000 238000 350000 351000 1000 3559000 9348000 185000 66000 -11608000 530998000 -482395000 -402000 40337000 -1264000 39073000 57000 57000 57000 1271000 1271000 1271000 196000 0 350000 350000 350000 -350000 -350000 -350000 400000 168000 168000 168000 177000 3000 1080000 1084000 1084000 2150000 2000 7437000 7439000 7439000 725000 1000 1203000 1203000 1203000 517000 41000 392000 392000 392000 -223000 223000 370000 370000 370000 2369000 3000 3097000 3100000 3100000 -21407000 -21407000 142000 -21265000 1000 3559000 15699000 194000 289000 -11978000 545996000 -504153000 -345000 33273000 -1122000 32151000 1000 3559000 8766000 174000 66000 -11608000 522601000 -472310000 -163000 42253000 -1303000 40950000 -239000 -239000 -239000 3045000 3045000 3045000 37000 351000 351000 351000 -351000 -351000 -351000 103000 2000 871000 873000 873000 17000 238000 238000 238000 34000 1000 1000 1000 391000 8000 3892000 3900000 3900000 -9734000 -9734000 39000 -9694000 1000 3559000 9348000 185000 66000 -11608000 530998000 -482395000 -402000 40337000 -1264000 39073000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. NATURE OF OPERATIONS AND LIQUIDITY</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cineverse Corp. (“Cineverse”, “us”, "we", “our”, and “Company” refers to Cineverse Corp. and its subsidiaries unless the context otherwise requires) was incorporated in Delaware on March 31, 2000.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cineverse is a premier streaming technology and entertainment company with its core business operating as (i) a portfolio of owned and operated streaming channels with enthusiast fan bases; (ii) a large-scale global aggregator and full-service distributor of feature films and television programs; and (iii) a proprietary technology software-as-a-service platform for over-the-top (“OTT”) app development and content distribution through subscription video on demand ("SVOD"), dedicated ad-supported ("AVOD"), ad-supported streaming linear ("FAST") channels, social video streaming services, and audio podcasts. Our streaming channels reach audiences in several distinct ways: direct-to-consumer, through these major application platforms, and through third party distributors of content on platforms.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s streaming technology platform, known as MatchpointTM, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Condition and Liquidity</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024, the Company has an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">504.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. For the year ended March 31, 2024, the Company had a net loss attributable to common shareholders of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Though the Company had positive working capital of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, net cash used in operating activities for the year ended March 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. We may continue to generate net losses for the foreseeable future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Line of Credit Facility bears interest at a rate equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% above the prime rate, equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as of March 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 15, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, subject to definitive documentation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.</span></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. We believe our cash and cash equivalent balances as of March 31, 2024 (See Note 8 - Subsequent Events) will be sufficient to support our operations for at least twelve months from the filing of this report. The Company may also undertake equity or debt offerings, if necessary and opportunistically available, for further capital needs.</span></p> 504200000 -21800000 1500000 10600000 7500000 The Line of Credit Facility bears interest at a rate equal to 1.5% above the prime rate, equal to 10.00% as of March 31, 2024 0.015 0.10 2025-09-15 For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024. <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying consolidated financial statements of Cineverse Corp. have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). These consolidated financial Statements have been prepared by the Company following the rules and regulations of the SEC. All intercompany transactions and balances have been eliminated in consolidation. Certain columns and rows may not add due to rounded numbers.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We own an </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the internet and other consumer digital distribution platforms,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">such </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">as gaming consoles, set-top boxes, handsets, and tablets. We evaluated the investment under the voting interest entity model and determined that the entity should be consolidated as we have a controlling financial interest in the entity through our ownership of outstanding voting shares, and that other equity holders do not have substantive voting, participating or liquidation rights. We record net income or loss attributable to noncontrolling interest in our Consolidated Statements of Operations equal to the proportionate share of outstanding profit interest units retained by the noncontrolling interests.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We indirectly own </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification ("ASC") 810, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">("ASC 810")</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include revenue recognition, share-based compensation expense, valuation allowance for deferred income taxes, recovery of content advances, goodwill and intangible asset impairments, estimated royalties payable to content partners, and the assessment of amortization lives to intangible assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On a regular basis, the Company evaluates the assumptions, judgments and estimates. Actual results may differ from these estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts have been reclassified to conform to the current presentation.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Non-monetary Transactions</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended March 31, 2023, the Company entered into a non-monetary transaction for the purchase and sale of content licenses with an unrelated third party. The fair value of the content was based on a market approach and determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is included in Revenues in our Consolidated Statements of Operations. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> gain or loss was recognized, as the fair value of the content licenses purchased was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and recognized within Intangible Assets, Net on our Consolidated Balance Sheets, and will be amortized over its</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> estimated life. For the years ended March 31, 2024 and March 31, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">341</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand of related amortization expense had been recognized, respectively.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Receivable, Net</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We maintain reserves for expected credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical credit losses, customer concentrations, customer credit worthiness, current and forecasted economic trends and changes in customer payment patterns to evaluate the adequacy of this allowance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended March 31, 2024, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> write-offs of previously reserved accounts receivable and as of March 31, 2024, accrued an allowance for expected credit losses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. During the year ended March 31, 2023, the Company had written off $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of previously reserved accounts receivable balances and as of March 31, 2023, carried an allowance for credit losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Retention Tax Credit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") provided an employee retention credit which was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the "Appropriations Act") extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">70</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of qualified wages paid to employees during the 2021 fiscal year.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company qualified for the employee retention credit beginning in June 2020 for qualified wages through September 2021 and filed a cash refund claim during the fiscal year ended March 31, 2023 in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the Employee retention tax credit line on the Company’s Consolidated Statements of Operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024 and March 31, 2023, the tax credit receivable of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, has been included in the Employee retention tax credit line ("ERTC") on the Company's Consolidated Balance Sheet. The Company received notification during the second quarter of fiscal year 2024 that its ERTC claim was under examination with the Internal Revenue Service ("IRS"). In April 2024, the Company received a letter from the IRS indicating that its claim had been accepted and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million was received in June 2024.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Content Advances</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Content advances represents amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record a provision for amounts that we expect may not be recoverable. Amounts which are expected to be recovered within 12 months are classified as current, which were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of March 31, 2024, and March 31, 2023, respectively. Amounts estimated to be recoverable in more than 12 months are classified as long term and presented within content advances, net of current portion, which were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of March 31, 2024, and March 31, 2023, respectively. For the twelve months ended March 31, 2024 and March 31, 2023, the Company recorded a recovery and increase in the provision for advances of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets, with useful life ranges by major asset class as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:17.756%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Computer equipment and software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Internal use software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Machinery and equipment</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Furniture and fixtures</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software on a straight-line basis. Post-configuration training and maintenance costs are expensed as incurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Intangible Assets, Net</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Intangible assets are stated at cost less accumulated amortization. For intangible assets that have finite lives, the assets are amortized using the straight-line method over the estimated useful lives of the related assets.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During both of the years ended March 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, we did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t record any impairment.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amortization expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:17.756%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademarks and Tradenames</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized Content</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Supplier Agreements</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s intangible assets include the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost Basis</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,133</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,492</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,641</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,603</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,541</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,062</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,690</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,872</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">818</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">880</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,320</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademark and Tradenames</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,914</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,059</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized Content</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,822</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">190</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,632</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Intangible Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,034</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,328</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost Basis</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,126</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,844</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,604</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,062</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,542</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Supplier Agreements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,658</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,568</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,090</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademark and Tradenames</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,026</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,274</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">560</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,640</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Intangible Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65,888</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46,020</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,868</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:15.757%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">In-process intangible assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,006</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,225</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,356</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,356</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,751</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,328</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Capitalized Content</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company capitalizes direct costs incurred in the production of content from which it expects to generate a return over the anticipated useful life and the Company’s predominant monetization strategy informs the method of amortizing these deferred costs. The determination of the predominant monetization strategy is made at commencement of the production or license period and the classification of the monetization strategy as individual or group only changes if there is a significant change to the title’s monetization strategy relative to its initial assessment. The costs are capitalized to the Capitalized Content costs within Intangible Assets and are amortized as a group within Depreciation and Amortization within the Consolidated Statements of Operations.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-lived and Finite-lived Intangible Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> impairment charges recorded for long-lived and finite-lived intangible assets during the twelve months ende</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d March 31, 2024 and 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Goodwill</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test. For the twelve months ended March 31, 2024, the Company recognized a goodwill impairment loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company considered the sustained decrease in its share price to be a goodwill impairment indicator and determined that it would be appropriate to proceed with a quantitative test. Primarily utilizing a market-multiple approach, which took into account the sustained decrease in share price, the Company determined that goodwill impairment of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million would be recognized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the twelve months ended March 31, 2023, the Company assessed goodwill impairment on its annual measurement date of March 31, 2023 by performing a qualitative analysis and determined that it was not more likely than not that the fair value of its reporting unit was greater than </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">its carrying amount. During the year ended March 31, 2023, the Company recorded a purchase price adjustment to reduce Goodwill by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">260</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> goodwill impairment charge was recorded for the twelve months ended March 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The authoritative guidance on fair value measurements establishes a framework with respect to measuring assets and liabilities at fair value on a recurring basis and non-recurring basis, within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> ASC 820, Fair Value Measurement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Under the framework, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as of the measurement date. The framework also establishes a three-tier hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability and are developed based on the best information available in the circumstances. The hierarchy consists of the following three levels:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1 – quoted prices in active markets for identical investments</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.761%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 1</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 2</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity investment in Metaverse, at fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_667e6bb4-4ba2-4543-8a84-0e548ae9bc57;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2ba1bece-7fc1-40a3-82fe-4f1e00c6dba7;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c7b17194-26d7-47de-b8ef-628d2f698c4b;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_559b6861-6731-4833-9b59-e0c336b54865;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnout consideration on purchase of a business</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_7647702a-4731-44ce-ac16-6901c8dcb1a5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_8d26ddbc-565d-4453-90af-2c6ef3898a16;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_4abc401f-6b56-4570-8073-edeb134627b5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3c4da755-f5e2-4f55-8959-405549a81c58;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.761%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 1</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 2</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity investment in Metaverse, at fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ee5dd1a2-abc8-440a-926a-007c844db4d9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f8479db2-0b32-4487-9561-1facf701437a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b2036211-a967-443a-9cf7-cca770378646;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_8742a092-36f9-4fc7-aac1-cb3215262860;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnout consideration on purchase of a business</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f742d2b0-f687-478f-b651-7c99a6ab2e30;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_d1781ed1-ab7b-4627-af0d-dc692802a389;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_5616c151-9e1b-4a54-afc6-40a48818f8c9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ab782717-d4d8-49c8-9bdc-d37c1a785ea2;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity Investment in Metaverse</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 14, 2020, the Company acquired an approximate </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% interest in A Metaverse Company (“Metaverse”), a publicly traded Chinese entertainment company, formerly Starrise Media Holdings Limited, whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Metaverse that is related to our major shareholders. Our major shareholders also maintain a significant beneficial interest ownership in Metaverse.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 10, 2020, the Company purchased an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% interest in Metaverse in a private transaction from shareholders of Metaverse that are affiliated with the major shareholder of the Company. The Company recorded an additional equity investment of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">28.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which was the fair market value of the Metaverse shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, valued at the date of the issuance of the Common Stock of the Company. The difference in the value of shares received in Metaverse and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Metaverse.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounted for this investment under the equity method of accounting as the Company was deemed to be able to exert significant influence over Metaverse with its direct ownership and affiliation with the Company’s majority shareholders. At the time, the Company made an irrevocable election to apply the fair value option under ASC 825-10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, as it relates to its equity investment in Metaverse.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Following the halting of Metaverse stock trading on the Stock Exchange of Hong Kong in April 2022, the Company valued our equity investment in Metaverse using a market approach and is categorized as a Level 3 valuation based on unobservable inputs. The Company estimated the fair value of Metaverse based on the last known enterprise value at the time and then adjusting for trends in enterprise valuations for comparable companies. As of March 31, 2023, the fair value was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, resulting in a decrease in fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended March 31, 2023.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 6, 2023, Metaverse's stock resumed trading on The Stock Exchange of Hong Kong Limited. During the year ended March 31, 2024, the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">221</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of its original </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares held as of March 31, 2023, which resulted in a realized loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand during the twelve months ended March 31, 2024. The resumption of active trading status represented renewed availability of quoted, unadjusted prices in active markets for identical assets, upon which the Company can execute a sale and readily access pricing information at the measurement date. Accordingly, the Company has presented the fair value of its Metaverse shares held as of March 31, 2024 within the Level 1 grouping. The fair value of the shares held as of March 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, with associated losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million recognized during the fiscal year ended March 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a result of the decrease in ownership of its investment in Metaverse from its sale of shares, along with a corresponding decrease in influence, the Company no longer accounts for its investment in Metaverse under the equity method and instead will follow the guidance for equity securities for which the equity method is no longer appropriate under ASC 321, Investments - Equity Securities, and accordingly, the Company will continue to measure its investment at fair value, with changes in the value of securities held to be recognized in earnings.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnout consideration on purchase of business</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company estimated the fair value of its earnout liability using contractual inputs from the related business combination, which established specific fiscal year revenue growth, profitability and EBITDA targets. Prior to the completion of the earnout period at the end of fiscal year 2024, the Company utilized the most up to date forecast to estimate the outcome against these targets to determine the ultimate estimated payout. The amounts recognized are not discounted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the fiscal year ended March 31, 2024, the final year of the earnout measurement period, the Company estimated a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">612</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand decrease in its earnout liability, issued $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">392</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand worth of equity to settle its liability, made cash payments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">291</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand, and incurred interest of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the fiscal year ended March 31, 2023, the Company increased the estimated earnout liability by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and made payments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">238</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand to reduce this liability, partially offset by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">83</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand of interest accrued.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Asset Acquisitions</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of relative fair values.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Payable and Accrued Expenses</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts payable and accrued expenses consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,804</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,042</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amounts due to producers</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,889</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,114</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued compensation and benefits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,532</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued other expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,005</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,843</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total accounts payable and accrued expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,817</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,531</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024, the Company's accrued royalty estimate decreased by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which contributed to a decrease in Amounts due to producers relative to March 31, 2023.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Deferred Consideration</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has recognized liabilities related to deferred consideration arrangements related to the acquisition of FoundationTV ("FTV") and Digital Media Rights ("DMR"). These payments are fixed in nature and are due to the sellers of the respective companies. The Company initially recognized the liability at fair value at the time of acquisition and has since recognizes interest expense related to accretion in advance of the ultimate settlement of these liabilities. Amounts due within 12 months under the terms of the agreements are classified as current within the Consolidated Balance Sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The deferred consideration related to the acquisition of DMR is payable in either Class A common shares of the Company stock or cash, at the Company's discretion and subject to certain condit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ions. Payments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million are due in March 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The deferred consideration related to the FTV acquisition is payable in the amount of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">238</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand in each of June 2024 and December 2024, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">464</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand in June 2025. There is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">475</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand presently due and payable. The Company has the right to pay up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of post-close purchase price in equity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Disaggregation of Revenue</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the Company’s revenue by source (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:68.32%;"></td> <td style="width:1%;"></td> <td style="width:13.08%;"></td> <td style="width:1%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.08%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended<br/>March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Streaming and digital</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37,312</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40,423</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Base distribution</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,259</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,341</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Podcast and other</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,718</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,213</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other non-recurring</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,842</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,049</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total revenue</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49,131</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68,026</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Streaming and digital revenue represents advertising and subscription fees earned through the operation of the Company's owned and managed channels. Certain revenue recognition estimates may be required for this source at the end of a reporting period when we are not contractually entitled to receive final performance reporting from our partners for an extended period of time.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Base distribution revenue is generated by the Company's physical revenue streams such as DVD's and related supply chain revenue, as well as theatrical revenue. Other non-recurring revenue represents remaining system sales and the release of previously constrained variable consideration, following the run-off of the Company's legacy digital cinema business at the conclusion of fiscal year 2023. The Company also has contracts for the theatrical distribution of third party feature movies and alternative content. Distribution fee revenue and participation in box office receipts are recognized at the time a feature movie and alternative content are viewed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Podcast and other revenue represents advertising fees earned in support of the Company's podcast programming.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other non-recurring revenue relates to the Company's legacy digital cinema operations, whose operations have run-off, still may generate non-recurring revenue from the sale of cinema assets or the recognition of variable consideration as the associated uncertainty associated with the revenue is resolved.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or "Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Base Distribution”). Fees earned are typically a percentage of the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”) on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the content is available for subscription on the digital platform (the Company’s digital content is considered functional IP), at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Base Distribution Revenue from the sale of physical goods is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration. Reserves for potential sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. As the Company satisfies its performance obligations, whether relating to the delivery of digital content, physical goods, or licensing, revenue is generally measured at a point in time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company follows the five-step model established by ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">when preparing its assessment of revenue recognition.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Principal Agent Considerations</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue earned from the delivery of digital content and physical goods may be recognized gross or net depending on the terms of the arrangement. We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">which party is primarily responsible for fulfilling the promise to provide the specified good or service; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">which party has discretion in establishing the price for the specified good or service.</span></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shipping and Handling</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in direct operating expenses because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contract Liabilities</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable. Deferred revenue includes amounts related to advances, he sale of DVDs or theatrical releases with future release dates.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The ending deferred revenue balance, all current as of March 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. There were no long term amounts at either date.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Participations and Royalties Payable</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">When we use third parties to distribute Company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the fiscal year ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of consolidated revenue. For the fiscal year ended March 31, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of consolidated revenue.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Direct Operating Costs</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Direct operating costs consist of operating costs such as cost of revenue, fulfillment expenses, shipping costs, property taxes and insurance on systems, royalty and participation expenses, allowance against advances, a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">nd marketing and direct personnel costs.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-based Compensation</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the Consolidated Statements of Operations based on their fair values. The Company measures the compensation expense of employee and non-employee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and non-employee is required</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility, risk-free rate and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"> </p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax basis.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States and India.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnings per Share</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include stock options and stock appreciation right outstanding during the period, and performance awards which are expected to be settled in shares and would be issuable at period end, using the treasury stock method. Potentially dilutive common shares are excluded from the computations of diluted income (loss) per share if their effect would be anti-dilutive. A net loss available to common stockholders causes all potentially dilutive securities to be anti-dilutive and are not included.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:71.634%;"></td> <td style="width:1%;"></td> <td style="width:11.502%;"></td> <td style="width:1%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:11.502%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended<br/>March 31,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic net loss per share:</span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,757</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,085</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares used in basic computation:</span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares of Common Stock outstanding</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic net loss per share</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.78</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.13</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares used in diluted computation:</span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares of Common Stock outstanding</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options and SARs</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average number of shares</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Diluted net loss per share</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.78</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.13</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The calculation of diluted net income (loss) per share for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023 does not include the impact of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,443</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">700</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand potentially dilutive shares, respectively, relating to warrants, stock options, performance shares and stock appreciation rights, as their impact would have been anti-dilutive due to the respective period's income (loss) and an exercise price which exceeded period-end share price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company evaluates all Accounting Standard Updates ("ASUs") issued but not yet effective by FASB for consideration of their applicability. ASU's not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company's consolidated financial statements or disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280)—Improvements to Reportable Segment Disclosures." The update requires disclosure of incremental segment information, including significant segment expenses, on an annual and interim basis, and would apply to single segment companies. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The Company is required to apply the updates retrospectively. The Company is assessing the impact of ASU 2023-07 on its consolidated financial statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740)—Improvements to Income Tax Disclosures" On an annual basis, this update requires the disclosure of specific tax categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The amendments are effective for annual periods beginning after December 15, 2024. Prospective and retrospective adoption is permitted. The Company is still evaluating its method of adoption and assessing the impact of ASU 2023-09 on the disclosures within its consolidated financial statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2024, the FASB issued ASU 2024-01, "Compensation—Stock Compensation (Topic 718)—Scope Application of Profits Interest and Similar Awards." This update clarifies the scope of "Profit Interest" and similar awards and adds an illustrative example to the existing ASC 718 standard that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The amendments in this Update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The amendments in this Update should be applied either (1) retrospectively to all prior periods presented in the financial statements or (2) prospectively to profits interest and similar awards granted or modified on or after the date at which the entity first applies the amendments. Based on the Company's population of awards, the Company does not anticipate a material impact on its financial results as a result of adoption.</span></p></div> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying consolidated financial statements of Cineverse Corp. have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). These consolidated financial Statements have been prepared by the Company following the rules and regulations of the SEC. All intercompany transactions and balances have been eliminated in consolidation. Certain columns and rows may not add due to rounded numbers.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We own an </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the internet and other consumer digital distribution platforms,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">such </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">as gaming consoles, set-top boxes, handsets, and tablets. We evaluated the investment under the voting interest entity model and determined that the entity should be consolidated as we have a controlling financial interest in the entity through our ownership of outstanding voting shares, and that other equity holders do not have substantive voting, participating or liquidation rights. We record net income or loss attributable to noncontrolling interest in our Consolidated Statements of Operations equal to the proportionate share of outstanding profit interest units retained by the noncontrolling interests.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We indirectly own </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification ("ASC") 810, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">("ASC 810")</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.</span></p> 0.85 1 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include revenue recognition, share-based compensation expense, valuation allowance for deferred income taxes, recovery of content advances, goodwill and intangible asset impairments, estimated royalties payable to content partners, and the assessment of amortization lives to intangible assets. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On a regular basis, the Company evaluates the assumptions, judgments and estimates. Actual results may differ from these estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts have been reclassified to conform to the current presentation.</span></p> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Non-monetary Transactions</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended March 31, 2023, the Company entered into a non-monetary transaction for the purchase and sale of content licenses with an unrelated third party. The fair value of the content was based on a market approach and determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is included in Revenues in our Consolidated Statements of Operations. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> gain or loss was recognized, as the fair value of the content licenses purchased was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and recognized within Intangible Assets, Net on our Consolidated Balance Sheets, and will be amortized over its</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> estimated life. For the years ended March 31, 2024 and March 31, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">341</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand of related amortization expense had been recognized, respectively.</span></p> 1000000 0 1000000 P3Y 341000 85000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Receivable, Net</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We maintain reserves for expected credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical credit losses, customer concentrations, customer credit worthiness, current and forecasted economic trends and changes in customer payment patterns to evaluate the adequacy of this allowance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended March 31, 2024, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> write-offs of previously reserved accounts receivable and as of March 31, 2024, accrued an allowance for expected credit losses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. During the year ended March 31, 2023, the Company had written off $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of previously reserved accounts receivable balances and as of March 31, 2023, carried an allowance for credit losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p> 0 300000 2800000 0 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Retention Tax Credit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") provided an employee retention credit which was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the "Appropriations Act") extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">70</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of qualified wages paid to employees during the 2021 fiscal year.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company qualified for the employee retention credit beginning in June 2020 for qualified wages through September 2021 and filed a cash refund claim during the fiscal year ended March 31, 2023 in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the Employee retention tax credit line on the Company’s Consolidated Statements of Operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024 and March 31, 2023, the tax credit receivable of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, has been included in the Employee retention tax credit line ("ERTC") on the Company's Consolidated Balance Sheet. The Company received notification during the second quarter of fiscal year 2024 that its ERTC claim was under examination with the Internal Revenue Service ("IRS"). In April 2024, the Company received a letter from the IRS indicating that its claim had been accepted and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million was received in June 2024.</span></p> 0.70 2500000 1700000 2100000 1700000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Content Advances</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Content advances represents amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record a provision for amounts that we expect may not be recoverable. Amounts which are expected to be recovered within 12 months are classified as current, which were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of March 31, 2024, and March 31, 2023, respectively. Amounts estimated to be recoverable in more than 12 months are classified as long term and presented within content advances, net of current portion, which were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of March 31, 2024, and March 31, 2023, respectively. For the twelve months ended March 31, 2024 and March 31, 2023, the Company recorded a recovery and increase in the provision for advances of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p> 9300000 3700000 2600000 1400000 500000 1300000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets, with useful life ranges by major asset class as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:17.756%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Computer equipment and software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Internal use software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Machinery and equipment</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Furniture and fixtures</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software on a straight-line basis. Post-configuration training and maintenance costs are expensed as incurred.</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:17.756%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Computer equipment and software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Internal use software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Machinery and equipment</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Furniture and fixtures</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table> P3Y P5Y P3Y P5Y P3Y P10Y P2Y P7Y <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Intangible Assets, Net</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Intangible assets are stated at cost less accumulated amortization. For intangible assets that have finite lives, the assets are amortized using the straight-line method over the estimated useful lives of the related assets.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During both of the years ended March 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, we did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t record any impairment.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amortization expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:17.756%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademarks and Tradenames</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized Content</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Supplier Agreements</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s intangible assets include the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost Basis</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,133</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,492</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,641</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,603</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,541</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,062</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,690</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,872</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">818</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">880</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,320</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademark and Tradenames</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,914</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,059</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized Content</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,822</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">190</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,632</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Intangible Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,034</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,328</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost Basis</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,126</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,844</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,604</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,062</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,542</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Supplier Agreements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,658</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,568</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,090</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademark and Tradenames</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,026</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,274</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">560</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,640</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Intangible Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65,888</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46,020</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,868</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:15.757%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">In-process intangible assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,006</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,225</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,356</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,356</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,751</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,328</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> 0 0 <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:17.756%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademarks and Tradenames</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> – </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized Content</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Supplier Agreements</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table> P3Y P20Y P2Y P15Y P5Y P13Y P2Y P13Y P10Y P3Y P2Y <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost Basis</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24,133</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,492</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,641</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,603</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,541</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,062</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,690</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7,872</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">818</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">880</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,320</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademark and Tradenames</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,914</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,059</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">855</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capitalized Content</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,822</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">190</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,632</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Intangible Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">54,362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">36,034</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,328</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.863%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.764000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="10" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Cost Basis</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Content Library</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23,970</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,126</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,844</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Advertiser Relationships and Channel</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,604</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,062</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,542</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Supplier Agreements</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer Relationships</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,658</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,568</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,090</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trademark and Tradenames</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,026</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,274</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,752</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Software</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">560</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,640</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Intangible Assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">65,888</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46,020</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,868</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 24133000 21492000 2641000 12603000 2541000 10062000 8690000 7872000 818000 3200000 880000 2320000 3914000 3059000 855000 1822000 190000 1632000 54362000 36034000 18328000 23970000 21126000 2844000 12604000 1062000 11542000 11430000 11430000 10658000 9568000 1090000 4026000 2274000 1752000 3200000 560000 2640000 65888000 46020000 19868000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024, amortization expense for each of the successive five years is expected to be (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.444%;"></td> <td style="width:1.8%;"></td> <td style="width:1%;"></td> <td style="width:15.757%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">In-process intangible assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">448</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,186</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,006</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,225</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,356</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,356</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,751</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,328</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 448000 3186000 3006000 2225000 1356000 1356000 6751000 18328000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Capitalized Content</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company capitalizes direct costs incurred in the production of content from which it expects to generate a return over the anticipated useful life and the Company’s predominant monetization strategy informs the method of amortizing these deferred costs. The determination of the predominant monetization strategy is made at commencement of the production or license period and the classification of the monetization strategy as individual or group only changes if there is a significant change to the title’s monetization strategy relative to its initial assessment. The costs are capitalized to the Capitalized Content costs within Intangible Assets and are amortized as a group within Depreciation and Amortization within the Consolidated Statements of Operations.</span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-lived and Finite-lived Intangible Assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> impairment charges recorded for long-lived and finite-lived intangible assets during the twelve months ende</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d March 31, 2024 and 2023</span> 0 0 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Goodwill</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test. For the twelve months ended March 31, 2024, the Company recognized a goodwill impairment loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company considered the sustained decrease in its share price to be a goodwill impairment indicator and determined that it would be appropriate to proceed with a quantitative test. Primarily utilizing a market-multiple approach, which took into account the sustained decrease in share price, the Company determined that goodwill impairment of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million would be recognized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the twelve months ended March 31, 2023, the Company assessed goodwill impairment on its annual measurement date of March 31, 2023 by performing a qualitative analysis and determined that it was not more likely than not that the fair value of its reporting unit was greater than </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">its carrying amount. During the year ended March 31, 2023, the Company recorded a purchase price adjustment to reduce Goodwill by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">260</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> goodwill impairment charge was recorded for the twelve months ended March 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p> 14000000 14000000 260000 0 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The authoritative guidance on fair value measurements establishes a framework with respect to measuring assets and liabilities at fair value on a recurring basis and non-recurring basis, within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> ASC 820, Fair Value Measurement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Under the framework, fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as of the measurement date. The framework also establishes a three-tier hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability and are developed based on the best information available in the circumstances. The hierarchy consists of the following three levels:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1 – quoted prices in active markets for identical investments</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.761%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 1</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 2</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity investment in Metaverse, at fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_667e6bb4-4ba2-4543-8a84-0e548ae9bc57;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2ba1bece-7fc1-40a3-82fe-4f1e00c6dba7;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c7b17194-26d7-47de-b8ef-628d2f698c4b;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_559b6861-6731-4833-9b59-e0c336b54865;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnout consideration on purchase of a business</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_7647702a-4731-44ce-ac16-6901c8dcb1a5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_8d26ddbc-565d-4453-90af-2c6ef3898a16;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_4abc401f-6b56-4570-8073-edeb134627b5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3c4da755-f5e2-4f55-8959-405549a81c58;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.761%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 1</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 2</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity investment in Metaverse, at fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ee5dd1a2-abc8-440a-926a-007c844db4d9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f8479db2-0b32-4487-9561-1facf701437a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b2036211-a967-443a-9cf7-cca770378646;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_8742a092-36f9-4fc7-aac1-cb3215262860;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnout consideration on purchase of a business</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f742d2b0-f687-478f-b651-7c99a6ab2e30;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_d1781ed1-ab7b-4627-af0d-dc692802a389;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_5616c151-9e1b-4a54-afc6-40a48818f8c9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ab782717-d4d8-49c8-9bdc-d37c1a785ea2;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following tables summarize the levels of fair value measurements of our financial assets and liabilities (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.761%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 1</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 2</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity investment in Metaverse, at fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_667e6bb4-4ba2-4543-8a84-0e548ae9bc57;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_2ba1bece-7fc1-40a3-82fe-4f1e00c6dba7;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_c7b17194-26d7-47de-b8ef-628d2f698c4b;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_559b6861-6731-4833-9b59-e0c336b54865;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnout consideration on purchase of a business</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_7647702a-4731-44ce-ac16-6901c8dcb1a5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_8d26ddbc-565d-4453-90af-2c6ef3898a16;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_4abc401f-6b56-4570-8073-edeb134627b5;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_3c4da755-f5e2-4f55-8959-405549a81c58;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">180</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:50.761%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> <td style="width:1.121%;"></td> <td style="width:1%;"></td> <td style="width:9.189%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="14" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 1</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 2</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Level 3</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Total</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equity investment in Metaverse, at fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ee5dd1a2-abc8-440a-926a-007c844db4d9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f8479db2-0b32-4487-9561-1facf701437a;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b2036211-a967-443a-9cf7-cca770378646;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_8742a092-36f9-4fc7-aac1-cb3215262860;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,200</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Earnout consideration on purchase of a business</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_f742d2b0-f687-478f-b651-7c99a6ab2e30;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_d1781ed1-ab7b-4627-af0d-dc692802a389;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_5616c151-9e1b-4a54-afc6-40a48818f8c9;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ab782717-d4d8-49c8-9bdc-d37c1a785ea2;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,444</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 362000 362000 362000 362000 180000 180000 180000 180000 5200000 5200000 5200000 5200000 1444000 1444000 1444000 1444000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Equity Investment in Metaverse</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On February 14, 2020, the Company acquired an approximate </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% interest in A Metaverse Company (“Metaverse”), a publicly traded Chinese entertainment company, formerly Starrise Media Holdings Limited, whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Metaverse that is related to our major shareholders. Our major shareholders also maintain a significant beneficial interest ownership in Metaverse.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 10, 2020, the Company purchased an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% interest in Metaverse in a private transaction from shareholders of Metaverse that are affiliated with the major shareholder of the Company. The Company recorded an additional equity investment of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">28.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which was the fair market value of the Metaverse shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, valued at the date of the issuance of the Common Stock of the Company. The difference in the value of shares received in Metaverse and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Metaverse.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounted for this investment under the equity method of accounting as the Company was deemed to be able to exert significant influence over Metaverse with its direct ownership and affiliation with the Company’s majority shareholders. At the time, the Company made an irrevocable election to apply the fair value option under ASC 825-10, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, as it relates to its equity investment in Metaverse.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Following the halting of Metaverse stock trading on the Stock Exchange of Hong Kong in April 2022, the Company valued our equity investment in Metaverse using a market approach and is categorized as a Level 3 valuation based on unobservable inputs. The Company estimated the fair value of Metaverse based on the last known enterprise value at the time and then adjusting for trends in enterprise valuations for comparable companies. As of March 31, 2023, the fair value was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, resulting in a decrease in fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the year ended March 31, 2023.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 6, 2023, Metaverse's stock resumed trading on The Stock Exchange of Hong Kong Limited. During the year ended March 31, 2024, the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">221</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of its original </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">362</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares held as of March 31, 2023, which resulted in a realized loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand during the twelve months ended March 31, 2024. The resumption of active trading status represented renewed availability of quoted, unadjusted prices in active markets for identical assets, upon which the Company can execute a sale and readily access pricing information at the measurement date. Accordingly, the Company has presented the fair value of its Metaverse shares held as of March 31, 2024 within the Level 1 grouping. The fair value of the shares held as of March 31, 2024 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, with associated losses of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million recognized during the fiscal year ended March 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As a result of the decrease in ownership of its investment in Metaverse from its sale of shares, along with a corresponding decrease in influence, the Company no longer accounts for its investment in Metaverse under the equity method and instead will follow the guidance for equity securities for which the equity method is no longer appropriate under ASC 321, Investments - Equity Securities, and accordingly, the Company will continue to measure its investment at fair value, with changes in the value of securities held to be recognized in earnings.</span></p> 0.115 0.15 28200000 11000000 5200000 -1800000 221000000 362000000 300 400000 -4300000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnout consideration on purchase of business</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company estimated the fair value of its earnout liability using contractual inputs from the related business combination, which established specific fiscal year revenue growth, profitability and EBITDA targets. Prior to the completion of the earnout period at the end of fiscal year 2024, the Company utilized the most up to date forecast to estimate the outcome against these targets to determine the ultimate estimated payout. The amounts recognized are not discounted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the fiscal year ended March 31, 2024, the final year of the earnout measurement period, the Company estimated a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">612</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand decrease in its earnout liability, issued $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">392</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand worth of equity to settle its liability, made cash payments of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">291</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand, and incurred interest of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">29</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the fiscal year ended March 31, 2023, the Company increased the estimated earnout liability by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and made payments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">238</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand to reduce this liability, partially offset by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">83</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand of interest accrued.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.</span></p> 612000 392000 291000 29000 80000 238000 83000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Asset Acquisitions</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">An asset acquisition is an acquisition of an asset, or a group of assets, that does not meet the definition of a business. Asset acquisitions are accounted for by using the cost accumulation model whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of relative fair values.</span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounts Payable and Accrued Expenses</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts payable and accrued expenses consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,804</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,042</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amounts due to producers</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,889</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,114</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued compensation and benefits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,532</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued other expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,005</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,843</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total accounts payable and accrued expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,817</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,531</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts payable and accrued expenses consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accounts payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,804</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">15,042</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amounts due to producers</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9,889</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,114</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued compensation and benefits</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,532</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued other expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,005</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,843</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total accounts payable and accrued expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,817</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34,531</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 5804000 15042000 9889000 13114000 1119000 2532000 4005000 3843000 20817000 34531000 -2300000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Deferred Consideration</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has recognized liabilities related to deferred consideration arrangements related to the acquisition of FoundationTV ("FTV") and Digital Media Rights ("DMR"). These payments are fixed in nature and are due to the sellers of the respective companies. The Company initially recognized the liability at fair value at the time of acquisition and has since recognizes interest expense related to accretion in advance of the ultimate settlement of these liabilities. Amounts due within 12 months under the terms of the agreements are classified as current within the Consolidated Balance Sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The deferred consideration related to the acquisition of DMR is payable in either Class A common shares of the Company stock or cash, at the Company's discretion and subject to certain condit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ions. Payments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million are due in March 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The deferred consideration related to the FTV acquisition is payable in the amount of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">238</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand in each of June 2024 and December 2024, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">464</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand in June 2025. There is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">475</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand presently due and payable. The Company has the right to pay up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of post-close purchase price in equity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 2400000 238000 464000 475000 0.25 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Disaggregation of Revenue</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the Company’s revenue by source (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:68.32%;"></td> <td style="width:1%;"></td> <td style="width:13.08%;"></td> <td style="width:1%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.08%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended<br/>March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Streaming and digital</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37,312</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40,423</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Base distribution</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,259</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,341</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Podcast and other</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,718</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,213</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other non-recurring</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,842</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,049</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total revenue</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49,131</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68,026</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Streaming and digital revenue represents advertising and subscription fees earned through the operation of the Company's owned and managed channels. Certain revenue recognition estimates may be required for this source at the end of a reporting period when we are not contractually entitled to receive final performance reporting from our partners for an extended period of time.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Base distribution revenue is generated by the Company's physical revenue streams such as DVD's and related supply chain revenue, as well as theatrical revenue. Other non-recurring revenue represents remaining system sales and the release of previously constrained variable consideration, following the run-off of the Company's legacy digital cinema business at the conclusion of fiscal year 2023. The Company also has contracts for the theatrical distribution of third party feature movies and alternative content. Distribution fee revenue and participation in box office receipts are recognized at the time a feature movie and alternative content are viewed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Podcast and other revenue represents advertising fees earned in support of the Company's podcast programming.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other non-recurring revenue relates to the Company's legacy digital cinema operations, whose operations have run-off, still may generate non-recurring revenue from the sale of cinema assets or the recognition of variable consideration as the associated uncertainty associated with the revenue is resolved.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or "Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Base Distribution”). Fees earned are typically a percentage of the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”) on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the content is available for subscription on the digital platform (the Company’s digital content is considered functional IP), at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Base Distribution Revenue from the sale of physical goods is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration. Reserves for potential sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. As the Company satisfies its performance obligations, whether relating to the delivery of digital content, physical goods, or licensing, revenue is generally measured at a point in time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company follows the five-step model established by ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">when preparing its assessment of revenue recognition.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Principal Agent Considerations</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue earned from the delivery of digital content and physical goods may be recognized gross or net depending on the terms of the arrangement. We determine whether revenue should be reported on a gross or net basis based on each revenue stream. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">which party is primarily responsible for fulfilling the promise to provide the specified good or service; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.7521786492374725%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">which party has discretion in establishing the price for the specified good or service.</span></div></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Shipping and Handling</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in direct operating expenses because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contract Liabilities</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable. Deferred revenue includes amounts related to advances, he sale of DVDs or theatrical releases with future release dates.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The ending deferred revenue balance, all current as of March 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. There were no long term amounts at either date.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Participations and Royalties Payable</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">When we use third parties to distribute Company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the fiscal year ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of consolidated revenue. For the fiscal year ended March 31, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of consolidated revenue.</span></p> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the Company’s revenue by source (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:68.32%;"></td> <td style="width:1%;"></td> <td style="width:13.08%;"></td> <td style="width:1%;"></td> <td style="width:1.52%;"></td> <td style="width:1%;"></td> <td style="width:13.08%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended<br/>March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Streaming and digital</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">37,312</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40,423</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Base distribution</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,259</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13,341</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Podcast and other</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,718</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,213</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other non-recurring</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,842</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,049</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total revenue</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">49,131</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">68,026</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 37312000 40423000 5259000 13341000 2718000 2213000 3842000 12049000 49131000 68026000 400000 200000 1 0.26 1 0.10 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Direct Operating Costs</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Direct operating costs consist of operating costs such as cost of revenue, fulfillment expenses, shipping costs, property taxes and insurance on systems, royalty and participation expenses, allowance against advances, a</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">nd marketing and direct personnel costs.</span></p> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-based Compensation</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the Consolidated Statements of Operations based on their fair values. The Company measures the compensation expense of employee and non-employee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and non-employee is required</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility, risk-free rate and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.</span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"> </p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax basis.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States and India.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.</span></p> 0.50 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnings per Share</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include stock options and stock appreciation right outstanding during the period, and performance awards which are expected to be settled in shares and would be issuable at period end, using the treasury stock method. Potentially dilutive common shares are excluded from the computations of diluted income (loss) per share if their effect would be anti-dilutive. A net loss available to common stockholders causes all potentially dilutive securities to be anti-dilutive and are not included.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:71.634%;"></td> <td style="width:1%;"></td> <td style="width:11.502%;"></td> <td style="width:1%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:11.502%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended<br/>March 31,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic net loss per share:</span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,757</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,085</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares used in basic computation:</span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares of Common Stock outstanding</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic net loss per share</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.78</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.13</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares used in diluted computation:</span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares of Common Stock outstanding</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options and SARs</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average number of shares</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Diluted net loss per share</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.78</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.13</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The calculation of diluted net income (loss) per share for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023 does not include the impact of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,443</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">700</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand potentially dilutive shares, respectively, relating to warrants, stock options, performance shares and stock appreciation rights, as their impact would have been anti-dilutive due to the respective period's income (loss) and an exercise price which exceeded period-end share price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic and diluted net income (loss) per share are computed as follows (in thousands, except per share data):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:71.634%;"></td> <td style="width:1%;"></td> <td style="width:11.502%;"></td> <td style="width:1%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:11.502%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended<br/>March 31,</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="border-top:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="border-top:0.5pt solid #ffffff03;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic net loss per share:</span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21,757</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10,085</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares used in basic computation:</span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares of Common Stock outstanding</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Basic net loss per share</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.78</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.13</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:5pt;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Shares used in diluted computation:</span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average shares of Common Stock outstanding</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock options and SARs</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Weighted-average number of shares</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12,253</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8,889</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Diluted net loss per share</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.78</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.13</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> </table> -21757000 -10085000 12253000 8889000 -1.78 -1.13 12253000 8889000 12253000 8889000 -1.78 -1.13 3443 700000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company evaluates all Accounting Standard Updates ("ASUs") issued but not yet effective by FASB for consideration of their applicability. ASU's not included in the Company's disclosures were assessed and determined to be not applicable and material to the Company's consolidated financial statements or disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280)—Improvements to Reportable Segment Disclosures." The update requires disclosure of incremental segment information, including significant segment expenses, on an annual and interim basis, and would apply to single segment companies. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The Company is required to apply the updates retrospectively. The Company is assessing the impact of ASU 2023-07 on its consolidated financial statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740)—Improvements to Income Tax Disclosures" On an annual basis, this update requires the disclosure of specific tax categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. The amendments are effective for annual periods beginning after December 15, 2024. Prospective and retrospective adoption is permitted. The Company is still evaluating its method of adoption and assessing the impact of ASU 2023-09 on the disclosures within its consolidated financial statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2024, the FASB issued ASU 2024-01, "Compensation—Stock Compensation (Topic 718)—Scope Application of Profits Interest and Similar Awards." This update clarifies the scope of "Profit Interest" and similar awards and adds an illustrative example to the existing ASC 718 standard that includes four fact patterns to demonstrate how an entity should apply the scope guidance in paragraph 718-10-15-3 to determine whether a profits interest award should be accounted for in accordance with Topic 718. The amendments in this Update are effective for annual periods beginning after December 15, 2024, and interim periods within those annual periods.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The amendments in this Update should be applied either (1) retrospectively to all prior periods presented in the financial statements or (2) prospectively to profits interest and similar awards granted or modified on or after the date at which the entity first applies the amendments. Based on the Company's population of awards, the Company does not anticipate a material impact on its financial results as a result of adoption.</span></p> <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3. OTHER INTERESTS</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">CDF2 Holdings</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We indirectly own </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in ASC 810, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial statements. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023, respectively, which are included in accounts receivable, net on the accompanying Consolidated Balance Sheets.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying Consolidated Statements of Operation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">s include $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of digital cinema servicing revenue from CDF2 Holdings for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total stockholders’ deficit of CDF2 Holdings at March 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">59.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">59.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and, accordingly, our investment in CDF2 Holdings as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> is carried at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">CONtv</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We own an </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% interest in CON TV, LLC ("CONtv"), a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets. CONtv is consolidated in our consolidated financial statements with the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% minority interest presented as a non-controlling interest.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Roundtable</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 15, 2022, the Company entered into a stock purchase agreement with Roundtable Entertainment Holdings, Inc. (“Roundtable”) pursuant to which the Company purchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares of Roundtable Series A Preferred Stock and warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares of Roundtable Common Stock (together, the “Roundtable Securities”). The Company paid the purchase price for the Roundtable Securities by issuing </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares of Common Stock to Roundtable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, after taking into account the June 2023 reverse stock split (further described in the Stockholders' Equity footnote)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the purchase of the Roundtable Securities which is included in other long-term assets on the accompanying Consolidated Balance Sheets. The investment in the Roundtable Securities was made in connection with a proposed collaboration with Roundtable regarding production and distribution of streaming content including the launch of high profile branded enthusiast streaming channels. The Roundtable investment was accounted for using the cost method of accounting as we own less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of Roundtable and do not exert a significant influence over their operations. Our President and Chief Strategy Officer is on the Roundtable Board of Directors.</span></p> 1 0 500000 0 200000 59200000 59200000 2000000 0 0.85 0.15 500 100 16000 200000 20 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4. STOCKHOLDERS’ EQUITY</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">COMMON STOCK</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Common Stock</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 11, 2021, the Company filed an Amended and Restated Certificate of Incorporation which authorized an increase in the n</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">umber of shares of Common Stock for issuance to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">275</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares, the level at which it remains.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 9, 2023, the Company effected a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1-for-20 reverse stock split</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the Company's Class A common sto</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ck. All shares and price amounts in this report reflect the 1-for-20 reverse stock split effected on June 9, 2023.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the fiscal year ended March 31, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million shares of Common Stock, through a direct offering, ATM sales, preferred stock dividends, issuance for shares for employee bonuses net of shares withheld for taxes, exercise of pre-funded warrants, Board fees, deferred consideration and earnout commitments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the fiscal year ended March 31, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">582</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares of Common Stock in payment of preferred stock dividends, Board fees, payment of performance shares, pursuant to a business combinations, and the acqui</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">sition of intangible assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Direct Offering</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On June 14, 2023, the Company sold in a public offering an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,150,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s Class A common stock, pre-funded warrants to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">516,667</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock, and common warrants to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,666,667</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock at an effective combined purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share and related Common Warrant, for aggregate gross proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, before deducting placement agents fees and offering expenses payable by the Company. The purchase price of each Pre-Funded Warrant and related Common Warrant was equal to the Purchase Price less the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share exercise price of each Pre-Funded Warrant. All pre-funded and common warrants were issued as immediately exercisable. All pre-funded warrants were subsequently exercised in July 2023 for total proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand. All common warrants remain outstanding as of March 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">ATM Sales Agreement</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on Nasdaq at the time of the sale of such shares. The Company is not obligated to sell any shares under the ATM Sales Agreement. Any sales of shares made under the ATM Sales Agreement will be made pursuant to the 2020 Shelf Registration Statement, for an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No sales under the ATM Sales Agreement were made during the year ended March 31, 2023. For the twelve months ended March 31, 2024, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">177</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in net proceeds, respectively, after deduction of commissions and fees. The ATM Sales Agreement has expired in accordance with its terms.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 3, 2024, Cineverse Corp. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners and The Benchmark Company, LLC (collectively, the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of its Class A common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share (the “Common Stock”). Shares of Common Stock may be offered and sold for an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Sales Agents’ obligations to sell shares under the Sales Agreement are subject to satisfaction of certain conditions, including the continuing effectiveness of the Registration Statement on Form S-3 (Registration No. 333-273098) (the “Registration Statement”) filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on June 30, 2023 and declared effective by the SEC on January 25, 2024, and other customary closing conditions. The Company will pay the Sales Agents a commission of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of the aggregate gross proceeds from each sale of shares and has agreed to provide the Sales Agents with customary indemnification and contribution rights. The Company has also agreed to reimburse the Sales Agents for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">certain </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">specified expenses. The Company is not obligated to sell any shares under the Sales Agreement and has not sold any shares through the date of this report.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PREFERRED STOCK</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cumulative dividends in arrears on preferred stock were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million as of March 31, 2024 and 2023. For the years ended March 31, 2024 and 2023, we paid preferred stock dividends in the form of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">196</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares of Common Stock, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TREASURY STOCK</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have treasury stock, at cost, consisting of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">289</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">66</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand shares of Common Stock as of March 31, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EQUITY INCENTIVE PLANS</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Based Compensation Awards</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) were in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provided for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Common Stock on the date of grant. ISOs granted to shareholders having more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the total combined voting power of the Company must have exercise prices of at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">110</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the fair market value of our Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options were set at the discretion of our Compensation Committee. The Company does not estimate forfeitures, but recognizes forfeitures in the period in which they occur.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options outstanding and exercisable under the 2000 Plan are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.862%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:7.481%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.423%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.823%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.343%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.724%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Options Outstanding<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.25</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">280.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">488.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.52</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">345</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.72</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">290</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.862%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:7.481%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.423%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.823%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.343%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.724%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Options Outstanding<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.25</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">280.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">488.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.50</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">290</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.54</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">287</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand options expired during the year ended March 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2017, the Company adopted the 2017 Equity Incentive Plan (the “2017 Plan). The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provides for the issuance of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,055</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock as of December 8, 2023, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the year ended March 31, 2024, the Company granted </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">207</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">stock appreciation rights (“SARs”), which were granted under the 2017 Plan. All SARs issued have an exercise price equal to the market price of the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company’s </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Stock on the date of grant and a maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years after grant date. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has the option to settle the SARs through a cash payment, issuance of shares, or some combination of cash payment and shares. Based on past practice and intent to settle these awards with shares of Class A common stock, the Company has determined that these awards should be classified in equity.</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.711%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:18.823999999999998%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:18.464000000000002%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Year Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected equity volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">112</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term (years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.50</span></span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.50</span></span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.51</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.82</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.49</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercise price</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.80</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.43</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.82</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Market price per share</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.80</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.43</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.82</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The weighted average fair value of outstanding grants made during the year ended March 31, 2024, was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per award. The weighted average fair value of outstanding the grants made during the year ended March 31, 2023, was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">8.52</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">award.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SARs outstanding under the 2017 Plan, along with the minimum and maximum strike price of each group, are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.943%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:7.563000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.407%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.807%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.326999999999998%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.706999999999997%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">SARs Outstanding <br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.8</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">632</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.92</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.45</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.2</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29.4</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">98</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.12</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.77</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39.4</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46.4</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.96</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.15</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">776</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.51</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.58</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.862%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:7.481%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.423%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.823%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.343%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.724%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">SARs Outstanding <br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.80</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.80</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.37</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.15</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.20</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29.40</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">105</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.25</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.62</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.20</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42.00</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.78</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.18</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44.60</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51.20</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.57</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45.46</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">657</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.10</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.33</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercisable SARs under the 2017 Plan as of March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> are as follows:</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:10pt;font-family:Times New Roman;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:22.087999999999997%;"></td> <td style="width:1%;"></td> <td style="width:0.995%;"></td> <td style="width:1%;"></td> <td style="width:22.247999999999998%;"></td> <td style="width:1%;"></td> <td style="width:1.413%;"></td> <td style="width:1%;"></td> <td style="width:21.79%;"></td> <td style="width:1%;"></td> <td style="width:1.413%;"></td> <td style="width:1%;"></td> <td style="width:22.049%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">SARs Exercisable <br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average<br/>Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average<br/>Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">469</span></p></td> <td style="white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.64</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024, the compensation cost not yet recognized related nonvested SARS awards totaled </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">703</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand, to be recognized over the weighted average remaining vesting period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.8</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SARs activity for the year ended March 31, 2024 is as follows</span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (in thousands):</span></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:63.28%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:33.12%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended <br/>March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> SARs Outstanding March 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">657</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Issued</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">207</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">88</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Total SARs Outstanding March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">776</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of stock based compensation was included within Selling, General and Administrative expenses for the years ended March 31, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, the Company grants performance stock unit ("PSU") awards under the 2017 Plan to employees of the Company that vest upon certain performance goals being achieved. Upon vesting, the award may be settled in shares or cash at the Company's discretion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares granted or issued in fiscal year 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on performance for the year ended March 31, 2023, the Company accrued for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand unvested.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Of this stock based compensation expense, there was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of stock-based compensation expense for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023, respectively, related to Board of Director fees. During the years ended March 31, 2024 and 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">400</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand restricted shares to non-employee directors, respectively.</span></p> 275000000 1-for-20 reverse stock split 6400000 582000 2150000 516667 2666667 3 8000000 0.001 500 30000000 177000 1100000 0.001 15000000 0.03 100000 100000 196000 37000 289000 66000 0.10 1.10 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options outstanding and exercisable under the 2000 Plan are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.862%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:7.481%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.423%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.823%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.343%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.724%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Options Outstanding<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.25</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">280.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">488.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.6</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.52</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">345</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.72</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">290</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.862%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:7.481%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.423%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.823%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.343%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.724%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Options Outstanding<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.25</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">148</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">280.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">488.0</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.50</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">290</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.54</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">287</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 148 148 300 P1Y3M 148 0 280 488 600 P0Y6M7D 345 0 900 P0Y8M19D 290 0 148 148 300 P2Y3M 148 0 280 488 10000 P0Y6M 290 0 10200 P0Y6M14D 287 0 9000 2055000 207000 P10Y <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:56.711%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:18.823999999999998%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:18.464000000000002%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Year Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividend yield</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected equity volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">112</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term (years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.50</span></span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.50</span></span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.51</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.82</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.49</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercise price</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.80</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.43</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.82</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Market price per share</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.80</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10.43</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.82</span></p></td> <td style="vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table> 0 0 1.07 1.12 P6Y6M P6Y6M 0.0451 0.0382 0.0449 5.8 10.43 9.82 5.8 10.43 9.82 4.99 8.52 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SARs outstanding under the 2017 Plan, along with the minimum and maximum strike price of each group, are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.943%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:7.563000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.407%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.807%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.326999999999998%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.706999999999997%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">SARs Outstanding <br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12.8</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">632</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.92</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">9.45</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.2</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29.4</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">98</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.12</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.77</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">39.4</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46.4</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">46</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.96</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.15</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">776</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.51</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13.58</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:7.862%;"></td> <td style="width:1%;"></td> <td style="width:1.18%;"></td> <td style="width:1%;"></td> <td style="width:7.481%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.423%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:16.823%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:16.343%;"></td> <td style="width:1%;"></td> <td style="width:1.08%;"></td> <td style="width:1%;"></td> <td style="width:17.724%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="22" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Min</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Max</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">SARs Outstanding <br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.80</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.80</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">430</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.37</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11.15</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.20</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">29.40</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">105</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.25</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.62</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34.20</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42.00</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.78</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">40.18</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">44.60</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">51.20</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.57</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">45.46</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td colspan="2" style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">657</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.10</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19.33</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercisable SARs under the 2017 Plan as of March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> are as follows:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:1%;"></td> <td style="width:22.087999999999997%;"></td> <td style="width:1%;"></td> <td style="width:0.995%;"></td> <td style="width:1%;"></td> <td style="width:22.247999999999998%;"></td> <td style="width:1%;"></td> <td style="width:1.413%;"></td> <td style="width:1%;"></td> <td style="width:21.79%;"></td> <td style="width:1%;"></td> <td style="width:1.413%;"></td> <td style="width:1%;"></td> <td style="width:22.049%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">SARs Exercisable <br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average<br/>Remaining Life in Years</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Weighted Average<br/>Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Aggregate Intrinsic Value<br/>(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">469</span></p></td> <td style="white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.5</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17.64</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 5.8 12.8 632000 P7Y11M1D 9.45 0 23.2 29.4 98000 P5Y1M13D 27.77 0 39.4 46.4 46000 P6Y11M15D 40.15 0 776000 P7Y6M3D 13.58 0 7.8 14.8 430000 P8Y4M13D 11.15 3000 23.2 29.4 105000 P6Y3M 27.62 0 34.2 42 100000 P8Y9M10D 40.18 0 44.6 51.2 21000 P8Y6M25D 45.46 0 657000 P8Y1M6D 19.33 3000 469000 P8Y6M 17.64 0 703000 P0Y9M18D <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (in thousands):</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:63.28%;"></td> <td style="width:1.6%;"></td> <td style="width:1%;"></td> <td style="width:33.12%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Year Ended <br/>March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> SARs Outstanding March 31, 2023</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">657</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Issued</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">207</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">88</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Total SARs Outstanding March 31, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">776</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 657000 207000 88000 776000 1400000 4800000 0 0 16000 300000 400000 400000 34000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5. DEBT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Line of Credit Facility</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is party to a Loan, Guaranty, and Security Agreement, as amended to date, with East West Bank (“EWB”) providing for a revolving line of credit (the “Line of Credit Facility”) of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and such subsidiaries’ assets. The Line of Credit Facility bears interest at a rate equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% above the prime rate, equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as of March 31, 2024. In June 2024, the Company was notified in writing by EWB that it intends to extend the maturity date of the Line of Credit Facility to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 15, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, subject to definitive documentation.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024 and March 31, 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">6.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million was outstanding on the Line of Credit Facility, respectively. Under the Line of Credit Facility, the Company is subject to certain financial and nonfinancial covenants including terms which require the Company to maintain certain metrics and ratios, maintain certain minimum cash on hand, and to report financial information to our lender on a periodic basis. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024.</span></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the year ended March 31, 2024 and March 31, 2023, the Company incurred interest expense of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to EWB related to the Line of Credit Facility, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 7500000 0.015 0.10 2025-09-15 6400000 5000000 For the year ended March 31, 2024, the Company was out of compliance with its covenants, and received a waiver in June 2024. 400000 200000 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6. COMMITMENTS AND CONTINGENCIES</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating Leases</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cineverse is a virtual company with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> domestic operating lease, acquired through the acquisition of Digital Media Rights ("DMR") and subleased to a third party. The Company has not been relieved of the its original lease obligation and therefore recognizes both a lease liability and right-of-use asset as part of the arrangement. The end of both the original lease and sublease's term is </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has recognized </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;min-width:fit-content;color:#000000;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of sublease income related to its subleasing arrangement for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">twelve months ended March 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company's </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> operating leases for its India operations expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">July 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the lease-related assets and liabilities recorded on our Consolidated Balance Sheets (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:35.334%;"></td> <td style="width:1.281%;"></td> <td style="width:35.334%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.744%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.744%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification on the Balance Sheet</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Other long-term assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">834</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,265</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Operating leases liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">401</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">418</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Operating leases liabilities, net of current portion</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">462</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating lease liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,281</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the annual gross undiscounted cash flows related to the Company's operating lease commitments and subleasing arrangements (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:79.24%;"></td> <td style="width:1%;"></td> <td style="width:18.759999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fiscal year ending March 31,</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Lease Commitments</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">423</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">200</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">72</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">905</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less imputed interest</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For leases which have a term of twelve months or less and do not contain an option to extend which the Company is</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reasonably certain to extend the term, the Company has elected to not apply the recognition provisions of ASC 842</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and recognizes these expenses on a straight-line basis over the term of the agreement.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Since our operating leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at Cineverse's lease commencement date. The average discount rate utilized was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company incurred </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">445</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">441</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand in rental expense associated with its operating leases during the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commitments</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1.5pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the ordinary course of business, the Company enters into contractual arrangements, from time to time, under which it agrees to commitments with content providers for certain rights which are in production or have not yet been completed, delivered to, and accepted by the Company. Based on the nature of these agreements, which may be subject to delay or project abandonment, there is uncertainty with the amounts and timing of its commitments. Certain of these advances are eligible to be recouped through future revenue sharing arrangements. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on the stage of the Company's projects, the table presented below represents an estimate of the Company's gross project commitments over the next five fiscal years (in thousands). </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"> </p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:59.224%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.302%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.061999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.061999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.061999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.282%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="18" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fiscal Year Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2025</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2026</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2027</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2028</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2029</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Project Commitments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,094</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">915</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">965</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">665</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">315</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div> 1 2025-01 200000 2 2027-07 <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the lease-related assets and liabilities recorded on our Consolidated Balance Sheets (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:35.334%;"></td> <td style="width:1.281%;"></td> <td style="width:35.334%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.744%;"></td> <td style="width:1%;"></td> <td style="width:1.281%;"></td> <td style="width:1%;"></td> <td style="width:10.744%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Classification on the Balance Sheet</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">March 31,<br/>2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Assets</span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Other long-term assets</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">834</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,265</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Liabilities</span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Operating leases liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">401</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">418</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Noncurrent</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> Operating leases liabilities, net of current portion</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">462</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total operating lease liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,281</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 834000 1265000 401000 418000 462000 863000 863000 1281000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The table below presents the annual gross undiscounted cash flows related to the Company's operating lease commitments and subleasing arrangements (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:79.24%;"></td> <td style="width:1%;"></td> <td style="width:18.759999999999998%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Fiscal year ending March 31,</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Operating Lease Commitments</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2025</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">423</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2026</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">200</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2027</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">210</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2028</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">72</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2029</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Thereafter</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total lease payments</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">905</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less imputed interest</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">42</span></p></td> <td style="white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">863</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For leases which have a term of twelve months or less and do not contain an option to extend which the Company is</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reasonably certain to extend the term, the Company has elected to not apply the recognition provisions of ASC 842</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and recognizes these expenses on a straight-line basis over the term of the agreement.</span></p> 423000 200000 210000 72000 905000 42000 863000 0.0334 445000 441000 <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on the stage of the Company's projects, the table presented below represents an estimate of the Company's gross project commitments over the next five fiscal years (in thousands). </span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:59.224%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.302%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.061999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.061999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.061999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:5.282%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="18" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Fiscal Year Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2025</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2026</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2027</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2028</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2029</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total Project Commitments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2,094</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">915</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">965</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">665</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">315</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 2094000 915000 965000 665000 315000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INCOME TAXES</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We recorded income tax expense of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> mill</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ion from operations for the years ended March 31, 2024 and 2023, respectively. For the year ended March 31, 2023, the income tax expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million was mainly related to foreign income taxes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the components of income tax expense (benefit) (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Fiscal Year<br/>Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Federal:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total federal</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total state</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net deferred taxes consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.311%;"></td> <td style="width:2.04%;"></td> <td style="width:1%;"></td> <td style="width:18.304%;"></td> <td style="width:1%;"></td> <td style="width:2.04%;"></td> <td style="width:1%;"></td> <td style="width:18.304%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net operating loss carryforwards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,945</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,318</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,724</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,246</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangibles</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,423</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,800</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">535</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">908</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capital loss carryforward</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,924</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b1b5c6d8-4893-44d1-a59d-bf62619796e0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,977</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,344</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-deductible interest expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,213</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,479</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">240</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,981</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,845</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: Valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,668</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,755</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total deferred tax assets after valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">312</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right of use asset</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">248</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_24ef123b-6e08-4be2-a416-62a4e1cda729;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Depreciation and amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total deferred tax liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">298</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net deferred tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ed241067-94b2-494b-a36a-5d7b8c2c63bd;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have provided a valuation allowance to our net deferred tax assets as of March 31, 2024 and 2023. We are required to recognize all or a portion of our deferred tax assets if we believe that it is more likely than not that such assets will be realized, given the weight of all available evidence. We assess the realizability of the deferred tax assets at each interim and annual balance sheet date. In assessing the need for a valuation allowance, we considered both positive and negative evidence, including recent financial performance, projections of future taxable income and scheduled reversals of deferred tax liabilities. The net changes in the valuation allowance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million during the fiscal years ended March 31, 2024 and 2023, respectively, were mainly due to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">increases in the deferred tax asset related to the net operating loss carryforward and other temporary differences. We will</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">continue to assess the realizability of the deferred tax assets at each interim and annual balance sheet date based upon actual and forecasted operating results.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of March 31, 2024, we had utilizable federal and state net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">70.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million available in the United States of America (“U.S.”) to reduce future taxable income. U.S. federal and state net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">70.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, generally begin to expire in 2026. U.S. federal net operating loss carryforwards that were generated during the years ended March 31, 2020, 2021, 2022, 2023, and 2024 of approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">47.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">million, do not expire.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 27, 2020, the CARES Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The differences between the U.S. statutory federal tax rate and our effective tax rate are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.02%;"></td> <td style="width:1%;"></td> <td style="width:13.322000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.02%;"></td> <td style="width:1%;"></td> <td style="width:13.322000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Year<br/>Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision at the U.S. statutory federal tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-deductible expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Executive officer compensation limitation – Section 162(m)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Goodwill impairment</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Losses from non-consolidated entities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We file income tax returns in the U.S. federal jurisdiction, various U.S. states, and India. For federal income tax purposes, our fiscal 2021 through 2024 tax years remain open for examination by the tax authorities under the normal three-year statute of limitations. For U.S. state tax purposes, our fiscal 2020 through 2024 tax years generally remain open for examination by most of the tax authorities under a four-year statute of limitations. For Indian income tax purposes, our fiscal 2022 through 2024 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">tax years remain open for examination by the tax authorities.</span></p> 0 100000 100000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the components of income tax expense (benefit) (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> <td style="width:1.5%;"></td> <td style="width:1%;"></td> <td style="width:12.843%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Fiscal Year<br/>Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Federal:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total federal</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total state</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">12</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Foreign:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Current</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total foreign</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">107</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> -11000 12000 -11000 12000 35000 107000 -14000 21000 107000 10000 119000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net deferred taxes consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:55.311%;"></td> <td style="width:2.04%;"></td> <td style="width:1%;"></td> <td style="width:18.304%;"></td> <td style="width:1%;"></td> <td style="width:2.04%;"></td> <td style="width:1%;"></td> <td style="width:18.304%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">As of March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax assets:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:5pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net operating loss carryforwards</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20,945</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18,318</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock-based compensation</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,724</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,246</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Intangibles</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6,423</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,800</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accrued liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">535</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">908</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Capital loss carryforward</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,924</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_b1b5c6d8-4893-44d1-a59d-bf62619796e0;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Investments</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1,977</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,344</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-deductible interest expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4,213</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3,479</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">240</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">750</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total deferred tax assets before valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,981</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,845</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Less: Valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">41,668</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35,755</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total deferred tax assets after valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">312</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Deferred tax liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Right of use asset</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">248</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_24ef123b-6e08-4be2-a416-62a4e1cda729;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Depreciation and amortization</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Total deferred tax liabilities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">298</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">90</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Net deferred tax</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_ed241067-94b2-494b-a36a-5d7b8c2c63bd;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table> 20945000 18318000 3724000 3246000 6423000 4800000 535000 908000 3924000 1977000 4344000 4213000 3479000 240000 750000 41981000 35845000 41668000 35755000 312000 90000 248000 50000 90000 298000 90000 14000 5900000 2500000 70300000 22500000 70300000 47900000 47900000 47900000 47900000 47900000 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The differences between the U.S. statutory federal tax rate and our effective tax rate are as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.313%;"></td> <td style="width:1.02%;"></td> <td style="width:1%;"></td> <td style="width:13.322000000000001%;"></td> <td style="width:1%;"></td> <td style="width:1.02%;"></td> <td style="width:1%;"></td> <td style="width:13.322000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">For the Year<br/>Ended March 31,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Provision at the U.S. statutory federal tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">21.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">14.2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Change in valuation allowance</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">27.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-deductible expenses</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">8.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Executive officer compensation limitation – Section 162(m)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Goodwill impairment</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">6.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:top;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Losses from non-consolidated entities</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">7.9</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Income tax expense</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.1</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">)%</span></p></td> </tr> </table> 0.21 0.21 0.142 0.08 -0.278 -0.278 -0.01 -0.083 -0.02 -0.063 0.079 -0.001 -0.001 -0.013 <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8. SUBSEQUENT EVENTS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Terrifier 3 Financing</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 5, 2024, Cineverse Terrifier LLC (“T3 Borrower”), a wholly-owned subsidiary of the Company entered into a Loan and Security Agreement with BondIt LLC (“T3 Lender”) and the Company, as guarantor (the “T3 Loan Agreement”).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The T3 Loan Agreement provides for a term loan with a principal amount not to exceed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,666</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand (the “T3 Loan”), and a maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, with a permitted extension of the term for 120 days under certain conditions. The T3 Loan bears no interest until the maturity date other than an interest advance equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">576</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand at the closing of the T3 Loan on April 5, 2024. If the T3 Loan is extended as noted above, the T3 Loan will bear interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.44</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per month. T3 Borrower may prepay the obligations under the T3 Loan, in full or in part, without penalty or premium. The proceeds under the T3 Loan Agreement will be used for the funding under the Company’s distribution arrangements for the film titled Terrifier 3 (the “Film”). The T3 Loan Agreement contains customary covenants, representation and warranties and events of default.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After the principal of the T3 Loan is paid in full, T3 Lender will be entitled to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of all royalties earned by the Company on the Film under its distribution agreements for the Film until T3 Lender has received 1.75 times the full commitment amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,666</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand, consisting of the principal amount plus interest and fees advanced to T3 Borrower, plus any extension interest. The T3 Loan is secured by a first priority interest in all of T3 Borrower’s rights and interest in the Film and the distribution agreements, including the proceeds to T3 Borrower from the distribution of the Film.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company entered into a Guaranty Agreement pursuant to which it provided a guarantee of the T3 Loan which is capped at obligations not exceeding $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> thousand (the “Guaranty Agreement”). The Guaranty is subordinated in payment and performance to the Line of Credit Facility pursuant to an intercreditor agreement between EWB and the T3 Lender, and acknowledged by the Company and the T3 Borrower. In connection with the T3 Loan Agreement, the Company entered into Amendment No. 3 to the Amended and Restated Loan, Guaranty and Security Agreement dated as of September 15, 2022 with East West Bank and the Guarantors named therein, as amended to date (the “EWB Amendment”) to facilitate the T3 Loan and the Guarantee.</span></p> 3666000 2025-04-01 576000 0.0144 0.15 3666000 1500000